INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137997, 7516, 600.0, 600.0, 'mg', 'PO', 2, 'Adult', X'789c333330c84d5708f05770f274513036c855484a4dcb2f4a55c84d4dcc290600765f08ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137998, 1187, 10.0, 30.0, 'mg', 'PO', 2, 'Adult', X'789c3334d03536c84d5708f05770f27451d048cb2f5228ae2c2e49cdcd4c56484a2d49d44dcac94fce4e2d52484d4b4b4d2e29d60400829d1088', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137999, 9859, 500.0, 1000.0, 'mg', 'IV', NULL, 'Adult', X'789cd348cd4d2d4a4fcd2bd1b452303530d03534303050c84d57f00c53c82f4b2d5230058a28e466e69596a416eb2814a516a426962824162be4a5a6a6a4a6000044551363', X'789cb557db72db3610fd951d3f3933522ca9753a56fba2286d9399d8f5d89ebc44190e042e29c4e4420140c76ac6ffde0350b245dbad2f495f2491c0deceee9e5d7ddbc95d5366a26ade19d3ce5455da3475a617957526e79d1eed34ae8a478b10967ebcb7f7d59c73fdd2ba32fe327bf74978edd492f34c8528381a8c5ef507c3fe707036f865fcf3c1f8a7839707af5e1d0cf6d35dd6c158f1b8f96de79d0467d3afc09749f8947926da9960b4aa482bc7f4a531fa9c1c17ec58348e0beb284641b9f5ec69bea2af6cca4578399364a1996f1bb9c2aba0e615c7a78f9ff05419396f1fe2d99f2cec54d5f1e26cb5e4311d9a74d29bc94482c96d80ed37d6ab92e90feb6a3f26239f61292a276fab26dabcbe721ae06e1916b8361c0ca82ef7eaf73339b14d80cfb6a0495e1b313e3815c5c6f4eec34ca6b6aeadd0995339d31172e4c74f8be826848dcb0f67f4fae655c263923755c8108491b203cadbd5d222299a6ba366b2cb35bb9225bc18d3fe60806ca7201106d90b76b48f37840863b83d646fc92a90f224cc39e780d4b9c52a2ca0cbd3f7ea8267ec6a550afbd6b9fbd58cfafb77b49882a647a794f3d2b1f74098a0ca232d1ed9684b9df442897045f3caea73e809f6d2681356d1ceb03fa264c148d178ce5b4bc3417f943cfe756387f17a45a3eb30e8f8e4889a2574d17e5bc73379cd41f5ef1ad93de1c2291d2c14e07a59355a9556f62e94b7c96beb3c801b2637e62843bf46e45c551b38d2618cc8e5466902f8ecc3f501ed8a0df054a3fc580029c516732855740021ac997c1c7e9ac98be716e376e93c5c909ddbd0dfd1b39de847a9ea0874b43d94dfa79061d290ad3564d71a3af6eecdefc346b6c5fe45f376ba1f09cae6f62d44b6ebe331f1a7fbd9fa7e4b20c78c77c1197d1f897c17bf3fb7fcfed3de23a25c8b67513c4be2d98d781bf4e992b5c19563bb6c2a7533e1362e1c3b2e45895ed1094ea58cbd379dc97bf4f586ffa550822e34fe1c7e4aecc839936baa482a0d9af5840521b4988e69ae3c4780f040602dcf0e953c5589d0dcb4a2df46fb3daad52a9124a2cd1b8def8868bc0289b76f4013bc8475bdd633a6234b2affdcf8001a08cf45fb76a80f03fc26ae24ed659f19c9ae35acc19d5aec09ca488e2cdc85765255981e891b75a5bcdf8bb503ae6b50940014f415c7ade60235a92eadc4599dc7be6fa777e47c2380c98a0a91863f400ad58b343a2accdc99aa4d689cec74f4d719206a2737ba3896eabb43c22790fa82a97673141620d07201c3d1f98a2e586ce349690dca26bed4bc0cd1b056be5d08f4baf9d49a9cdfa2e6db72c02162750a8c9f3c21253905e37dc3f05b3b64cf3f63f399e4184a9eb31356fa2eacf72844f73a83203af73ea808e706a2b3ae57b46bb67de73c8d902da7daf4c6ada7a3f475e32456b6676943be2df6506c3fc8d3db00fc1fae3e56e713b37bbc50987cda56b65c75f7385515fdca143c9ec921660b5606e36b3cfc7ea91db76494b8a6470583f69e61fb90e34484d6cc16d924c9755c98dac2a68d263640ad64452c7fafeac4456e538d3d42a3a07940aba9cf841b67911ff1b549ab1af8adf11abbb74efc90a47aa937924a6fca48984902ec971a0774b7f8aa56cfe9164cae6c52f9eedf95ee4ebcd9a49fa8fec7ef491d471eb7fdfbc8b55757ff007130da82', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138000, 9859, 500.0, 1000.0, 'mg', 'IV', NULL, 'Adult', X'789c732c2acaa82cc9c8cd4c2c56d048cd4d2d4a4fcd2bd1b452303530d03534303050c84d57f00c53c82f4b2d5230058a28e466e69596a416eb2814a516a426962800f5e5a5a6a6a4a600008578180f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138001, 9859, 500.0, 1000.0, 'mg', 'IV', NULL, 'Adult', X'789cb352303530d03534303050c84d57f00c53c82f4b2d5230d23555c8cdcc2b2d492dd651284a2d484d2c51c84c5370f60b5648492d284a2d2ececccf5328482d2ace2c2e290600a19e15ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138002, 9859, 1.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789cb35230d435524857f00c53c8cc4b2b2d4e4d51c82f4b2d523034d0353250c8cdccb356284a2d484d2c5148050a572a40044b4b528b150282fc144a0b144af2154c1552f28b538b0173f41808', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138003, 9859, 1.0, 1.0, 'g', 'IV', NULL, 'Adult', X'789cd3084a4d2b4a4c2ec92faa5428c95748cf294d4e4ccfcfd32f4b2cce2f284a2d2ece2f2ad6b452304c57f00c5348cacf292d0600db451245', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138004, 9859, 1.0, 1.0, 'g', 'IV', NULL, 'Adult', X'789cb352304c57f00c0300063601b2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138005, 9859, 1.0, 1.0, 'g', 'IV', NULL, 'Adult', X'789cb352304c57f00c53d0c8cb2f51284a4dcecfcd4dcd4b494d5148cb2f5228ca2f2dc9cc4b55282d4e050006c30de8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138006, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f0d7f70c53087451c82f52283434ca5048492d48cd4bc9cc4b57c8cf53284e2d4b2dca2ca9040023a70e6b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138007, 509, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c333430c84d5708f0570874010010c102da', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138008, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2a51303430c84d5708f057283434ca50a85030544849ac0400725807f6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138009, 509, 200.0, 200.0, 'mg', 'PO', NULL, 'Adult', X'789c333230c84d5708f057283434ca000017950382', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138010, 509, 200.0, 200.0, 'mg', 'PO', NULL, 'Adult', X'789c333230c84dd74f49ac5408f057283434d23532c950a85030d53557000a16030087ae08a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138011, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138012, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138013, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a8503034514849ac2c06004851066f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138014, 509, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c333430c84d57f00c53283434ca50a8503034514849ac2c0600484a066f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138015, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138016, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a8503034514849ac2c06004851066f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138017, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a85030b2504849ac2c060048700674', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138018, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a8503032544849ac2c06004846066d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138019, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'789ced5d6d73dab816fe2b9a7cb9ed2c09819b6c3bb93b3b43485f72b749b9a5cd7467e9308a2db06e6cc92bd904ee4efffb7d24030163307149b62ffa9201477a747474cef31c1923fedaf3553aec0b1ab1bd13b27726c7136fe2855cb0bd1ad94b5568ae064912eb937afd96dfb0e840aaa179c5ebb9c6da5334667e9f26a64ff3b0f9f3fe6163bf71f8fef0d9c971f3a4d13c683e3f7ef6ecd8b6655ec2a5d068f9d7de2b2698a2a17d9db0b1edfe7e12b3939e78cf1245a763e89e38939a0e19792955a44f48e72da1c227e757e449f3301ad6c8b1fdfbecd8fc6d1cda378dec5a13d7eac7247af3b427da328aa420ef15f519b9c4c401d5f2e598d6486bc4f162522367524dc635722185c4851a790b2b181a7498e2522734a9912b7ead6834f1b8b0134aaf17e7f41997127a1d32f3ee8f4f788719dcd8370b735c9c5cb9bb979b7ffe64c668f96998f4e1162e864bfe2bb069e6e7feb9182c5e9e75b11e8353eb70e87fce8854e4cf4633203e8b99f0814fe034cd46f04032e9892baab89920f153450dd8def2948d755dd39af55b9e60fdab341ca24bf19018af27ba095509995fb2838f4983f87452806d57c29722e1490eb4b98850d0b3e5a509eb9f522f0104dcd1e522d5c528758c3d45da6f1e19738ef79f198374016e3b08110f3ea7c5539cce27ebde13ad504b122b190793908eb92603385cb3714a4342b5a6585732e258a6a868ac57084ca502b6dd5897322103ae74424cecec93543372cb93a0273c3648e084b1cc5238efe3f3b325fcb7691263ad99487a62659d8ea6839d8b5c1b8453be4d17a37b0149a401b80d982036944c367b328a439630bc48952eb2aacd141cb3b260c5932f8aca491cf030d7fb7c4002500e461426164688716b1e13182a0c79517877148fa89ad4bbcc93c237afded00413ffa5d19f30aa365a377545016a86d1ff3503a9a7e246c85bb111acf97c2dd8248a03395454a4a18c68ffca50004ba3cd708d75701f144b0255ddf52f62ee737f129522340ed7417494f456737e6b0be010d63fe39a51cd3621348ef6a76e80082946139b9f5347133e20068880b0a6ee28a01981ffd1f1d2202fe74948a06322215c8003d85050e11591dcb9086868d99586b5feabf35affad610c849a18b29c62e65df0f35a17b6d3840a26d31217ee4f17a1273228024379845cc5ecafb9047b2a09428f884e750c41617ed172412dfb6c1c4b9d420916f86e9d0edc596e142805bf830f335792190e5e7861ea170e78018781d1b6196a2e39fbcd6cc01892a24cdacf0632c5022c10292347e496b11b4de800139f37c81bb095eee74877b3eab7171a679afff0329e2f1c9c8e3b1d773aee74dce9b8d371a7e3bbd2f19daa6a5eb29dac3a5975b2ea64d5c9aa93d51f4b56efa17c79d174d2e7a4cf499f933e277d4efabe45e9db997ee585d10998133027604ec09c8039017b48017b509d59791cca098d131a27344e689cd0fc7042f340dcbff2299c237f47fe8efc1df93bf2ff8ac8ff2b61e5959b6c8e961d2d3b5a76b4fc6dd172b59272e51173475e8ebc1c7939f2fa1bc8ab3af7acecf71df938f271e4e3c8677bf2f9d27ccc53904b4897902e21bf2021ef9d40f90c7419e432e887cea02a09b05a49bb0c7019f0ad66c07da3371ffd2e7c5df8febd7b92870abf95af5cb9f873f1978fbf4a41918f2c1715df59543cbe75db1fea98ad17f3394d14f7aa1fc8d86f2e75faf53931b77cb19ca1df13cd836634acdf983966873b4da7794272ff9995d766ee3d7141c7d9b9116850f7a5c6dc5f2af667ca9038d347a6cd411448a8991584ebf97764f30f19141c5af1284617d52ec924e61efcd76e753659b07f3485c9bef2e4f31147fc4f079ca76a51b2cf1e47df38c307fe1ad486b1ebbf1e1d939be17a13bee0a1f5dcb05d6a941c49620e1c257e16df051e9b7f0e9cebdff225da79206ebdcedc7b7c58711ff06d3ebbd889b18bdbdefb006e711b6857ce9c5775f709e89d6d327283eeb8cccba12fb0cb3d54bd1c6441daef382a63d58790fa0d06dd53eff3f66ea7fff94021ebc87d37aa5b66e4633c1ef82da8f23627343a5976b2ec64d9c9b2936527cbdf812cffad12b772dbd2699cd338a7714ee39cc6398ddbe1014e3b9795b52739395d71bae274c5e98ad3951f40571e95f5d79eb3e468dfd1bea37d47fb8ef61feb93ac4765de82c38f1cf53aea75d4eba8f7c7a3deedc96ffd31408efd1cfb39f673ecf768ecb793eaabe0bb4c8e801c0139027204b41d01ed9830d61f90e118c33186638cef8031be34a5379de0e172dae5b4cbe9c7cfe91de4e0da33455c12ba247449b845127e61c66c3ad6c4a58c4b99ef31651e31c6d79ca5e282dc05f9030779c548bbe7112d2ed45ca87da533b8e7c9305d8489f941e68e8cd32ce0f5d2143ab32c3921b0f80df512dbe884208a34bf0e27e483d074c0fe453c74e53eaca3216c1468366208dc770c2944b2636748cb7ec26c7e75667e228d798c8750ffbfa94e22fb1b36af99f9391bafa44b427c36403efb15e66cbcaa28173ef70a66dc0a43a686f648752fa45ad77d950e7b62ee889e680d19f965bab23d7126c7136fe25972e19a6054fce1372ccc20a8792ac9c7cce0059d60544caa4698cefc8e463a908882ecc77780ddea10216f49cc1436989a64e816dc0021cfed004940c5ec5632498c281be7113f5576463df147e313c287a676b1b070699cc2d676c0439f5cc370e3da589ad3db61c59dd3791453aeb28568c3e9d8e952cded329a9a1a668646e3311033b3030170c33bdc2b92fd52aef647e614fbfe3b46bdd57528a2e52e438ee44eb87a2f6512109f6bd826b3e913cfcc5381177f594ac02776e5a51915b37e0a2f35e1a54e2013b970983e667e40cef86000506a1f52837ff207eeaba9cdc8e21b88c9dddb2baabdd43a09c830d7a3cacfdeb5d244f2284ab1948175b7bd6a3d0f03c6e6934d8c7dc9e2402dbc7fa18dee0c4de37a1a7a4c01166168963c03788fe6d1b5f426898c99e0d440a498e5f4cd6b16c97062d616aa13992b1dcd525f266904b6011ebb56bc274ed370686262000fa1217200d0ff36df64f582fdd74c8d0306a1510b137dc94c484312a32291935124977f08e035a33ef502c4f8a5c9091872364116c4dad8d432d5238509e6f2dcebefa80e6c3304a49c5e5b5dadab341cc9115c6488c65b0c5abb344b91017f866c44218ce4f4c365a5c76f16bd5ffefccd526be02fc46d6eddcab1567a2ce12dac7a39d462e3259482e0d86292779dfab34e4ba8b3252d879ab79c7db5da25fcd799f02b0f87b98c7719bf838cff76e268fb6a67076ee998bca3c69ce164d939341cec877cc04e48e339094c19896d0152f51aa59a8e4e509fdb1fe5b1257484f233c25c43d4e6aadefebd73747c88898d11b05955ff12659eb64d5394886683c13c949a664b2907a4e565ad4e41098698b5d90c78552abf79ddd8efce1784b3f202f037b63cfb6e4f60abebb1187821abcf56979127a94e4d790dce3fefa1e686bd91dd3fe05f23b36d335b97c5ae8a61e1c184097abceb89f95bf2047921b0df60037bdc15b04dad6fbe0b6dd1bb3fc18489c09601ed41bae60b08c8a33024b768b15821f7c407349d5b686ea27d787f4ea480254f04444c4f7402c6f6ee4ed602fec7464f0889423f41087f6cf604cd8c407cc2674ad6c8759a5803911afe826d68fdcf0dadef1a2eccccd8f44ac934262d6c56148bc9f49e872dfaf1cf8533bfa65b801707644019804cda7c3caa32e27424c14027532e5bcfd148266ba159fd578a4666236a1d6ababd55431bac36340ceac16c3a35725a23ed1a79b567ab8a39099896e71975cd61d720756606b2028c6e09c61557dca7709b9d6c01c0c7c67656502c86c0ee5f93612598172615a4273d0f10b3952b007a775f1c9e4615602ebadd568525b97857a95bbbb5bfa667d9fa75131a0707c47cf66b76e67e259fa1ccfc2f03cd5773d59b0382f0b3c5c090095664407e1636412ed930bb199307bc3c20c3ec7b5892150675993b01007de5961e8a3d52e6d60ba8eb18644921bf8911bc35d15886f3fac050539832f1bf4ae9091633b7362af4fc2d64d79a9b29e8a27c2c73e174e0fa1d0c79d13d7df35315a815a4df3aed22a0ed52fbda8abc8e6ba415c56d22d8705750b1ac923cd80a9a4aacd8cde5ec39ed4d22aa3cfb0171251b688814acbcd8dd800f2b77ee6093c8c0b51157f49a17a749a91b6620a3e93165157c000873a68bf0e04c1d1f54b102593fb47bceca086d535a646145068aa528dd8b92f75e38be298a21ac5f8a53714a2d240a828ba244a814e12d0f057bb2d988d2b5b5dbbacc0aca546a4b0d5a01e8345537810ca1958812d4d8d4e35560ba09b66f66db1a4c8dc2e6055b61f39ba845701f9b2578bf9b1b41a8e0089b562fe6be8d57c5b2970adb7cae6d0c27694895e95e45b94e55ea6dc884b2ee6fd890cb8da954e6930ec5ae235516224ae15e0f856a95007c4d5964d726359b036c2927452959e6d82b7e8d9da52128c107dc2b4cc7ee4fffc8a15c60abbe9293d9d122d6245a9c54a5e5c9c49331f83abadb9d54a92ede71ef862589e65f604696d7a81c091d6d573fb60435dabb5af7996dbc90d1c4dbaa865c09586b888404a0ee5774b8468acae58c8da04536ea5888cbc254b5c5c95866523b94d856a10485777c3e1898df412e5aa7721a5f007a62f6ac73b4a715cc7a99ea856513ccb344a60a17af5cb9599c48bb794c66bbaeb58cf169f58e8bbb71f263dc38b9efc7ff8cf5cd214a4bb17177774e932717948ba7556f7716236dbef1b9d0a73fedf3f9d3e7cf9fff0f12deb5b0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138020, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a8503034504849ac2c06004839066b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138021, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'789ced5d6d73dab816fe2b9a7cb9ed2c09819b6c3bb93b3b43485f72b749b9a5cd7467e9308a2db06e6cc92bd904ee4efffb7d24030163307149b62ffa9201477a747474cef31c1923fedaf3553aec0b1ab1bd13b27726c7136fe2855cb0bd1ad94b5568ae064912eb937afd96dfb0e840aaa179c5ebb9c6da5334667e9f26a64ff3b0f9f3fe6163bf71f8fef0d9c971f3a4d13c683e3f7ef6ecd8b6655ec2a5d068f9d7de2b2698a2a17d9db0b1edfe7e12b3939e78cf1245a763e89e38939a0e19792955a44f48e72da1c227e757e449f3301ad6c8b1fdfbecd8fc6d1cda378dec5a13d7eac7247af3b427da328aa420ef15f519b9c4c401d5f2e598d6486bc4f162522367524dc635722185c4851a790b2b181a7498e2522734a9912b7ead6834f1b8b0134aaf17e7f41997127a1d32f3ee8f4f788719dcd8370b735c9c5cb9bb979b7ffe64c668f96998f4e1162e864bfe2bb069e6e7feb9182c5e9e75b11e8353eb70e87fce8854e4cf4633203e8b99f0814fe034cd46f04032e9892baab89920f153450dd8def2948d755dd39af55b9e60fdab341ca24bf19018af27ba095509995fb2838f4983f87452806d57c29722e1490eb4b98850d0b3e5a509eb9f522f0104dcd1e522d5c528758c3d45da6f1e19738ef79f198374016e3b08110f3ea7c5539cce27ebde13ad504b122b190793908eb92603385cb3714a4342b5a6585732e258a6a868ac57084ca502b6dd5897322103ae74424cecec93543372cb93a0273c3648e084b1cc5238efe3f3b325fcb7691263ad99487a62659d8ea6839d8b5c1b8453be4d17a37b0149a401b80d982036944c367b328a439630bc48952eb2aacd141cb3b260c5932f8aca491cf030d7fb7c4002500e461426164688716b1e13182a0c79517877148fa89ad4bbcc93c237afded00413ffa5d19f30aa365a377545016a86d1ff3503a9a7e246c85bb111acf97c2dd8248a03395454a4a18c68ffca50004ba3cd708d75701f144b0255ddf52f62ee737f129522340ed7417494f456737e6b0be010d63fe39a51cd3621348ef6a76e80082946139b9f5347133e20068880b0a6ee28a01981ffd1f1d2202fe74948a06322215c8003d85050e11591dcb9086868d99586b5feabf35affad610c849a18b29c62e65df0f35a17b6d3840a26d31217ee4f17a1273228024379845cc5ecafb9047b2a09428f884e750c41617ed172412dfb6c1c4b9d420916f86e9d0edc596e142805bf830f335792190e5e7861ea170e78018781d1b6196a2e39fbcd6cc01892a24cdacf0632c5022c10292347e496b11b4de800139f37c81bb095eee74877b3eab7171a679afff0329e2f1c9c8e3b1d773aee74dce9b8d371a7e3bbd2f19daa6a5eb29dac3a5975b2ea64d5c9aa93d51f4b56efa17c79d174d2e7a4cf499f933e277d4efabe45e9db997ee585d10998133027604ec09c8039017b48017b509d59791cca098d131a27344e689cd0fc7042f340dcbff2299c237f47fe8efc1df93bf2ff8ac8ff2b61e5959b6c8e961d2d3b5a76b4fc6dd172b59272e51173475e8ebc1c7939f2fa1bc8ab3af7acecf71df938f271e4e3c8677bf2f9d27ccc53904b4897902e21bf2021ef9d40f90c7419e432e887cea02a09b05a49bb0c7019f0ad66c07da3371ffd2e7c5df8febd7b92870abf95af5cb9f873f1978fbf4a41918f2c1715df59543cbe75db1fea98ad17f3394d14f7aa1fc8d86f2e75faf53931b77cb19ca1df13cd836634acdf983966873b4da7794272ff9995d766ee3d7141c7d9b9116850f7a5c6dc5f2af667ca9038d347a6cd411448a8991584ebf97764f30f19141c5af1284617d52ec924e61efcd76e753659b07f3485c9bef2e4f31147fc4f079ca76a51b2cf1e47df38c307fe1ad486b1ebbf1e1d939be17a13bee0a1f5dcb05d6a941c49620e1c257e16df051e9b7f0e9cebdff225da79206ebdcedc7b7c58711ff06d3ebbd889b18bdbdefb006e711b6857ce9c5775f709e89d6d327283eeb8cccba12fb0cb3d54bd1c6441daef382a63d58790fa0d06dd53eff3f66ea7fff94021ebc87d37aa5b66e4633c1ef82da8f23627343a5976b2ec64d9c9b2936527cbdf812cffad12b772dbd2699cd338a7714ee39cc6398ddbe1014e3b9795b52739395d71bae274c5e98ad3951f40571e95f5d79eb3e468dfd1bea37d47fb8ef61feb93ac4765de82c38f1cf53aea75d4eba8f7c7a3deedc96ffd31408efd1cfb39f673ecf768ecb793eaabe0bb4c8e801c0139027204b41d01ed9830d61f90e118c33186638cef8031be34a5379de0e172dae5b4cbe9c7cfe91de4e0da33455c12ba247449b845127e61c66c3ad6c4a58c4b99ef31651e31c6d79ca5e282dc05f9030779c548bbe7112d2ed45ca87da533b8e7c9305d8489f941e68e8cd32ce0f5d2143ab32c3921b0f80df512dbe884208a34bf0e27e483d074c0fe453c74e53eaca3216c1468366208dc770c2944b2636748cb7ec26c7e75667e228d798c8750ffbfa94e22fb1b36af99f9391bafa44b427c36403efb15e66cbcaa28173ef70a66dc0a43a686f648752fa45ad77d950e7b62ee889e680d19f965bab23d7126c7136fe25972e19a6054fce1372ccc20a8792ac9c7cce0059d60544caa4698cefc8e463a908882ecc77780ddea10216f49cc1436989a64e816dc0021cfed004940c5ec5632498c281be7113f5576463df147e313c287a676b1b070699cc2d676c0439f5cc370e3da589ad3db61c59dd3791453aeb28568c3e9d8e952cded329a9a1a668646e3311033b3030170c33bdc2b92fd52aef647e614fbfe3b46bdd57528a2e52e438ee44eb87a2f6512109f6bd826b3e913cfcc5381177f594ac02776e5a51915b37e0a2f35e1a54e2013b970983e667e40cef86000506a1f52837ff207eeaba9cdc8e21b88c9dddb2baabdd43a09c830d7a3cacfdeb5d244f2284ab1948175b7bd6a3d0f03c6e6934d8c7dc9e2402dbc7fa18dee0c4de37a1a7a4c01166168963c03788fe6d1b5f426898c99e0d440a498e5f4cd6b16c97062d616aa13992b1dcd525f266904b6011ebb56bc274ed370686262000fa1217200d0ff36df64f582fdd74c8d0306a1510b137dc94c484312a32291935124977f08e035a33ef502c4f8a5c9091872364116c4dad8d432d5238509e6f2dcebefa80e6c3304a49c5e5b5dadab341cc9115c6488c65b0c5abb344b91017f866c44218ce4f4c365a5c76f16bd5ffefccd526be02fc46d6eddcab1567a2ce12dac7a39d462e3259482e0d86292779dfab34e4ba8b3252d879ab79c7db5da25fcd799f02b0f87b98c7719bf838cff76e268fb6a67076ee998bca3c69ce164d939341cec877cc04e48e339094c19896d0152f51aa59a8e4e509fdb1fe5b1257484f233c25c43d4e6aadefebd73747c88898d11b05955ff12659eb64d5394886683c13c949a664b2907a4e565ad4e41098698b5d90c78552abf79ddd8efce1784b3f202f037b63cfb6e4f60abebb1187821abcf56979127a94e4d790dce3fefa1e686bd91dd3fe05f23b36d335b97c5ae8a61e1c184097abceb89f95bf2047921b0df60037bdc15b04dad6fbe0b6dd1bb3fc18489c09601ed41bae60b08c8a33024b768b15821f7c407349d5b686ea27d787f4ea480254f04444c4f7402c6f6ee4ed602fec7464f0889423f41087f6cf604cd8c407cc2674ad6c8759a5803911afe826d68fdcf0dadef1a2eccccd8f44ac934262d6c56148bc9f49e872dfaf1cf8533bfa65b801707644019804cda7c3caa32e27424c14027532e5bcfd148266ba159fd578a4666236a1d6ababd55431bac36340ceac16c3a35725a23ed1a79b567ab8a39099896e71975cd61d720756606b2028c6e09c61557dca7709b9d6c01c0c7c67656502c86c0ee5f93612598172615a4273d0f10b3952b007a775f1c9e4615602ebadd568525b97857a95bbbb5bfa667d9fa75131a0707c47cf66b76e67e259fa1ccfc2f03cd5773d59b0382f0b3c5c090095664407e1636412ed930bb199307bc3c20c3ec7b5892150675993b01007de5961e8a3d52e6d60ba8eb18644921bf8911bc35d15886f3fac050539832f1bf4ae9091633b7362af4fc2d64d79a9b29e8a27c2c73e174e0fa1d0c79d13d7df35315a815a4df3aed22a0ed52fbda8abc8e6ba415c56d22d8705750b1ac923cd80a9a4aacd8cde5ec39ed4d22aa3cfb0171251b688814acbcd8dd800f2b77ee6093c8c0b51157f49a17a749a91b6620a3e93165157c000873a68bf0e04c1d1f54b102593fb47bceca086d535a646145068aa528dd8b92f75e38be298a21ac5f8a53714a2d240a828ba244a814e12d0f057bb2d988d2b5b5dbbacc0aca546a4b0d5a01e8345537810ca1958812d4d8d4e35560ba09b66f66db1a4c8dc2e6055b61f39ba845701f9b2578bf9b1b41a8e0089b562fe6be8d57c5b2970adb7cae6d0c27694895e95e45b94e55ea6dc884b2ee6fd890cb8da954e6930ec5ae235516224ae15e0f856a95007c4d5964d726359b036c2927452959e6d82b7e8d9da52128c107dc2b4cc7ee4fffc8a15c60abbe9293d9d122d6245a9c54a5e5c9c49331f83abadb9d54a92ede71ef862589e65f604696d7a81c091d6d573fb60435dabb5af7996dbc90d1c4dbaa865c09586b888404a0ee5774b8468acae58c8da04536ea5888cbc254b5c5c95866523b94d856a10485777c3e1898df412e5aa7721a5f007a62f6ac73b4a715cc7a99ea856513ccb344a60a17af5cb9599c48bb794c66bbaeb58cf169f58e8bbb71f263dc38b9efc7ff8cf5cd214a4bb17177774e932717948ba7556f7716236dbef1b9d0a73fedf3f9d3e7cf9fff0f12deb5b0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138022, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a83034d13532544849ac2c0600549e06df', X'789ced5d6d73dab816fe2b9a7cb9ed2c09819b6c3bb93b3b43485f72b749b9a5cd7467e9308a2db06e6cc92bd904ee4efffb7d24030163307149b62ffa9201477a747474cef31c1923fedaf3553aec0b1ab1bd13b27726c7136fe2855cb0bd1ad94b5568ae064912eb937afd96dfb0e840aaa179c5ebb9c6da5334667e9f26a64ff3b0f9f3fe6163bf71f8fef0d9c971f3a4d13c683e3f7ef6ecd8b6655ec2a5d068f9d7de2b2698a2a17d9db0b1edfe7e12b3939e78cf1245a763e89e38939a0e19792955a44f48e72da1c227e757e449f3301ad6c8b1fdfbecd8fc6d1cda378dec5a13d7eac7247af3b427da328aa420ef15f519b9c4c401d5f2e598d6486bc4f162522367524dc635722185c4851a790b2b181a7498e2522734a9912b7ead6834f1b8b0134aaf17e7f41997127a1d32f3ee8f4f788719dcd8370b735c9c5cb9bb979b7ffe64c668f96998f4e1162e864bfe2bb069e6e7feb9182c5e9e75b11e8353eb70e87fce8854e4cf4633203e8b99f0814fe034cd46f04032e9892baab89920f153450dd8def2948d755dd39af55b9e60fdab341ca24bf19018af27ba095509995fb2838f4983f87452806d57c29722e1490eb4b98850d0b3e5a509eb9f522f0104dcd1e522d5c528758c3d45da6f1e19738ef79f198374016e3b08110f3ea7c5539cce27ebde13ad504b122b190793908eb92603385cb3714a4342b5a6585732e258a6a868ac57084ca502b6dd5897322103ae74424cecec93543372cb93a0273c3648e084b1cc5238efe3f3b325fcb7691263ad99487a62659d8ea6839d8b5c1b8453be4d17a37b0149a401b80d982036944c367b328a439630bc48952eb2aacd141cb3b260c5932f8aca491cf030d7fb7c4002500e461426164688716b1e13182a0c79517877148fa89ad4bbcc93c237afded00413ffa5d19f30aa365a377545016a86d1ff3503a9a7e246c85bb111acf97c2dd8248a03395454a4a18c68ffca50004ba3cd708d75701f144b0255ddf52f62ee737f129522340ed7417494f456737e6b0be010d63fe39a51cd3621348ef6a76e80082946139b9f5347133e20068880b0a6ee28a01981ffd1f1d2202fe74948a06322215c8003d85050e11591dcb9086868d99586b5feabf35affad610c849a18b29c62e65df0f35a17b6d3840a26d31217ee4f17a1273228024379845cc5ecafb9047b2a09428f884e750c41617ed172412dfb6c1c4b9d420916f86e9d0edc596e142805bf830f335792190e5e7861ea170e78018781d1b6196a2e39fbcd6cc01892a24cdacf0632c5022c10292347e496b11b4de800139f37c81bb095eee74877b3eab7171a679afff0329e2f1c9c8e3b1d773aee74dce9b8d371a7e3bbd2f19daa6a5eb29dac3a5975b2ea64d5c9aa93d51f4b56efa17c79d174d2e7a4cf499f933e277d4efabe45e9db997ee585d10998133027604ec09c8039017b48017b509d59791cca098d131a27344e689cd0fc7042f340dcbff2299c237f47fe8efc1df93bf2ff8ac8ff2b61e5959b6c8e961d2d3b5a76b4fc6dd172b59272e51173475e8ebc1c7939f2fa1bc8ab3af7acecf71df938f271e4e3c8677bf2f9d27ccc53904b4897902e21bf2021ef9d40f90c7419e432e887cea02a09b05a49bb0c7019f0ad66c07da3371ffd2e7c5df8febd7b92870abf95af5cb9f873f1978fbf4a41918f2c1715df59543cbe75db1fea98ad17f3394d14f7aa1fc8d86f2e75faf53931b77cb19ca1df13cd836634acdf983966873b4da7794272ff9995d766ee3d7141c7d9b9116850f7a5c6dc5f2af667ca9038d347a6cd411448a8991584ebf97764f30f19141c5af1284617d52ec924e61efcd76e753659b07f3485c9bef2e4f31147fc4f079ca76a51b2cf1e47df38c307fe1ad486b1ebbf1e1d939be17a13bee0a1f5dcb05d6a941c49620e1c257e16df051e9b7f0e9cebdff225da79206ebdcedc7b7c58711ff06d3ebbd889b18bdbdefb006e711b6857ce9c5775f709e89d6d327283eeb8cccba12fb0cb3d54bd1c6441daef382a63d58790fa0d06dd53eff3f66ea7fff94021ebc87d37aa5b66e4633c1ef82da8f23627343a5976b2ec64d9c9b2936527cbdf812cffad12b772dbd2699cd338a7714ee39cc6398ddbe1014e3b9795b52739395d71bae274c5e98ad3951f40571e95f5d79eb3e468dfd1bea37d47fb8ef61feb93ac4765de82c38f1cf53aea75d4eba8f7c7a3deedc96ffd31408efd1cfb39f673ecf768ecb793eaabe0bb4c8e801c0139027204b41d01ed9830d61f90e118c33186638cef8031be34a5379de0e172dae5b4cbe9c7cfe91de4e0da33455c12ba247449b845127e61c66c3ad6c4a58c4b99ef31651e31c6d79ca5e282dc05f9030779c548bbe7112d2ed45ca87da533b8e7c9305d8489f941e68e8cd32ce0f5d2143ab32c3921b0f80df512dbe884208a34bf0e27e483d074c0fe453c74e53eaca3216c1468366208dc770c2944b2636748cb7ec26c7e75667e228d798c8750ffbfa94e22fb1b36af99f9391bafa44b427c36403efb15e66cbcaa28173ef70a66dc0a43a686f648752fa45ad77d950e7b62ee889e680d19f965bab23d7126c7136fe25972e19a6054fce1372ccc20a8792ac9c7cce0059d60544caa4698cefc8e463a908882ecc77780ddea10216f49cc1436989a64e816dc0021cfed004940c5ec5632498c281be7113f5576463df147e313c287a676b1b070699cc2d676c0439f5cc370e3da589ad3db61c59dd3791453aeb28568c3e9d8e952cded329a9a1a668646e3311033b3030170c33bdc2b92fd52aef647e614fbfe3b46bdd57528a2e52e438ee44eb87a2f6512109f6bd826b3e913cfcc5381177f594ac02776e5a51915b37e0a2f35e1a54e2013b970983e667e40cef86000506a1f52837ff207eeaba9cdc8e21b88c9dddb2baabdd43a09c830d7a3cacfdeb5d244f2284ab1948175b7bd6a3d0f03c6e6934d8c7dc9e2402dbc7fa18dee0c4de37a1a7a4c01166168963c03788fe6d1b5f426898c99e0d440a498e5f4cd6b16c97062d616aa13992b1dcd525f266904b6011ebb56bc274ed370686262000fa1217200d0ff36df64f582fdd74c8d0306a1510b137dc94c484312a32291935124977f08e035a33ef502c4f8a5c9091872364116c4dad8d432d5238509e6f2dcebefa80e6c3304a49c5e5b5dadab341cc9115c6488c65b0c5abb344b91017f866c44218ce4f4c365a5c76f16bd5ffefccd526be02fc46d6eddcab1567a2ce12dac7a39d462e3259482e0d86292779dfab34e4ba8b3252d879ab79c7db5da25fcd799f02b0f87b98c7719bf838cff76e268fb6a67076ee998bca3c69ce164d939341cec877cc04e48e339094c19896d0152f51aa59a8e4e509fdb1fe5b1257484f233c25c43d4e6aadefebd73747c88898d11b05955ff12659eb64d5394886683c13c949a664b2907a4e565ad4e41098698b5d90c78552abf79ddd8efce1784b3f202f037b63cfb6e4f60abebb1187821abcf56979127a94e4d790dce3fefa1e686bd91dd3fe05f23b36d335b97c5ae8a61e1c184097abceb89f95bf2047921b0df60037bdc15b04dad6fbe0b6dd1bb3fc18489c09601ed41bae60b08c8a33024b768b15821f7c407349d5b686ea27d787f4ea480254f04444c4f7402c6f6ee4ed602fec7464f0889423f41087f6cf604cd8c407cc2674ad6c8759a5803911afe826d68fdcf0dadef1a2eccccd8f44ac934262d6c56148bc9f49e872dfaf1cf8533bfa65b801707644019804cda7c3caa32e27424c14027532e5bcfd148266ba159fd578a4666236a1d6ababd55431bac36340ceac16c3a35725a23ed1a79b567ab8a39099896e71975cd61d720756606b2028c6e09c61557dca7709b9d6c01c0c7c67656502c86c0ee5f93612598172615a4273d0f10b3952b007a775f1c9e4615602ebadd568525b97857a95bbbb5bfa667d9fa75131a0707c47cf66b76e67e259fa1ccfc2f03cd5773d59b0382f0b3c5c090095664407e1636412ed930bb199307bc3c20c3ec7b5892150675993b01007de5961e8a3d52e6d60ba8eb18644921bf8911bc35d15886f3fac050539832f1bf4ae9091633b7362af4fc2d64d79a9b29e8a27c2c73e174e0fa1d0c79d13d7df35315a815a4df3aed22a0ed52fbda8abc8e6ba415c56d22d8705750b1ac923cd80a9a4aacd8cde5ec39ed4d22aa3cfb0171251b688814acbcd8dd800f2b77ee6093c8c0b51157f49a17a749a91b6620a3e93165157c000873a68bf0e04c1d1f54b102593fb47bceca086d535a646145068aa528dd8b92f75e38be298a21ac5f8a53714a2d240a828ba244a814e12d0f057bb2d988d2b5b5dbbacc0aca546a4b0d5a01e8345537810ca1958812d4d8d4e35560ba09b66f66db1a4c8dc2e6055b61f39ba845701f9b2578bf9b1b41a8e0089b562fe6be8d57c5b2970adb7cae6d0c27694895e95e45b94e55ea6dc884b2ee6fd890cb8da954e6930ec5ae235516224ae15e0f856a95007c4d5964d726359b036c2927452959e6d82b7e8d9da52128c107dc2b4cc7ee4fffc8a15c60abbe9293d9d122d6245a9c54a5e5c9c49331f83abadb9d54a92ede71ef862589e65f604696d7a81c091d6d573fb60435dabb5af7996dbc90d1c4dbaa865c09586b888404a0ee5774b8468acae58c8da04536ea5888cbc254b5c5c95866523b94d856a10485777c3e1898df412e5aa7721a5f007a62f6ac73b4a715cc7a99ea856513ccb344a60a17af5cb9599c48bb794c66bbaeb58cf169f58e8bbb71f263dc38b9efc7ff8cf5cd214a4bb17177774e932717948ba7556f7716236dbef1b9d0a73fedf3f9d3e7cf9fff0f12deb5b0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138023, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a8503033504849ac2c0600485c0670', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138024, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057283434ca50a85030d73534504849ac2c0600540206cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138025, 509, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c333430c84d5708f057087451a8503033504849ac2c56c82f5228cd2bc9cc5148cc2bc9284aac5048ad28c82f2e2d4a053292734a53525300f0251335', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138026, 509, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c333430c84d5708f0570874010010c102da', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138027, 509, 2.2, 2.2, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d233ca4dd7cf4e5708f0d7f70c53087401002a2304aa', X'789ced5d6d73dab816fe2b9a7cb9ed2c09819b6c3bb93b3b43485f72b749b9a5cd7467e9308a2db06e6cc92bd904ee4efffb7d24030163307149b62ffa9201477a747474cef31c1923fedaf3553aec0b1ab1bd13b27726c7136fe2855cb0bd1ad94b5568ae064912eb937afd96dfb0e840aaa179c5ebb9c6da5334667e9f26a64ff3b0f9f3fe6163bf71f8fef0d9c971f3a4d13c683e3f7ef6ecd8b6655ec2a5d068f9d7de2b2698a2a17d9db0b1edfe7e12b3939e78cf1245a763e89e38939a0e19792955a44f48e72da1c227e757e449f3301ad6c8b1fdfbecd8fc6d1cda378dec5a13d7eac7247af3b427da328aa420ef15f519b9c4c401d5f2e598d6486bc4f162522367524dc635722185c4851a790b2b181a7498e2522734a9912b7ead6834f1b8b0134aaf17e7f41997127a1d32f3ee8f4f788719dcd8370b735c9c5cb9bb979b7ffe64c668f96998f4e1162e864bfe2bb069e6e7feb9182c5e9e75b11e8353eb70e87fce8854e4cf4633203e8b99f0814fe034cd46f04032e9892baab89920f153450dd8def2948d755dd39af55b9e60fdab341ca24bf19018af27ba095509995fb2838f4983f87452806d57c29722e1490eb4b98850d0b3e5a509eb9f522f0104dcd1e522d5c528758c3d45da6f1e19738ef79f198374016e3b08110f3ea7c5539cce27ebde13ad504b122b190793908eb92603385cb3714a4342b5a6585732e258a6a868ac57084ca502b6dd5897322103ae74424cecec93543372cb93a0273c3648e084b1cc5238efe3f3b325fcb7691263ad99487a62659d8ea6839d8b5c1b8453be4d17a37b0149a401b80d982036944c367b328a439630bc48952eb2aacd141cb3b260c5932f8aca491cf030d7fb7c4002500e461426164688716b1e13182a0c79517877148fa89ad4bbcc93c237afded00413ffa5d19f30aa365a377545016a86d1ff3503a9a7e246c85bb111acf97c2dd8248a03395454a4a18c68ffca50004ba3cd708d75701f144b0255ddf52f62ee737f129522340ed7417494f456737e6b0be010d63fe39a51cd3621348ef6a76e80082946139b9f5347133e20068880b0a6ee28a01981ffd1f1d2202fe74948a06322215c8003d85050e11591dcb9086868d99586b5feabf35affad610c849a18b29c62e65df0f35a17b6d3840a26d31217ee4f17a1273228024379845cc5ecafb9047b2a09428f884e750c41617ed172412dfb6c1c4b9d420916f86e9d0edc596e142805bf830f335792190e5e7861ea170e78018781d1b6196a2e39fbcd6cc01892a24cdacf0632c5022c10292347e496b11b4de800139f37c81bb095eee74877b3eab7171a679afff0329e2f1c9c8e3b1d773aee74dce9b8d371a7e3bbd2f19daa6a5eb29dac3a5975b2ea64d5c9aa93d51f4b56efa17c79d174d2e7a4cf499f933e277d4efabe45e9db997ee585d10998133027604ec09c8039017b48017b509d59791cca098d131a27344e689cd0fc7042f340dcbff2299c237f47fe8efc1df93bf2ff8ac8ff2b61e5959b6c8e961d2d3b5a76b4fc6dd172b59272e51173475e8ebc1c7939f2fa1bc8ab3af7acecf71df938f271e4e3c8677bf2f9d27ccc53904b4897902e21bf2021ef9d40f90c7419e432e887cea02a09b05a49bb0c7019f0ad66c07da3371ffd2e7c5df8febd7b92870abf95af5cb9f873f1978fbf4a41918f2c1715df59543cbe75db1fea98ad17f3394d14f7aa1fc8d86f2e75faf53931b77cb19ca1df13cd836634acdf983966873b4da7794272ff9995d766ee3d7141c7d9b9116850f7a5c6dc5f2af667ca9038d347a6cd411448a8991584ebf97764f30f19141c5af1284617d52ec924e61efcd76e753659b07f3485c9bef2e4f31147fc4f079ca76a51b2cf1e47df38c307fe1ad486b1ebbf1e1d939be17a13bee0a1f5dcb05d6a941c49620e1c257e16df051e9b7f0e9cebdff225da79206ebdcedc7b7c58711ff06d3ebbd889b18bdbdefb006e711b6857ce9c5775f709e89d6d327283eeb8cccba12fb0cb3d54bd1c6441daef382a63d58790fa0d06dd53eff3f66ea7fff94021ebc87d37aa5b66e4633c1ef82da8f23627343a5976b2ec64d9c9b2936527cbdf812cffad12b772dbd2699cd338a7714ee39cc6398ddbe1014e3b9795b52739395d71bae274c5e98ad3951f40571e95f5d79eb3e468dfd1bea37d47fb8ef61feb93ac4765de82c38f1cf53aea75d4eba8f7c7a3deedc96ffd31408efd1cfb39f673ecf768ecb793eaabe0bb4c8e801c0139027204b41d01ed9830d61f90e118c33186638cef8031be34a5379de0e172dae5b4cbe9c7cfe91de4e0da33455c12ba247449b845127e61c66c3ad6c4a58c4b99ef31651e31c6d79ca5e282dc05f9030779c548bbe7112d2ed45ca87da533b8e7c9305d8489f941e68e8cd32ce0f5d2143ab32c3921b0f80df512dbe884208a34bf0e27e483d074c0fe453c74e53eaca3216c1468366208dc770c2944b2636748cb7ec26c7e75667e228d798c8750ffbfa94e22fb1b36af99f9391bafa44b427c36403efb15e66cbcaa28173ef70a66dc0a43a686f648752fa45ad77d950e7b62ee889e680d19f965bab23d7126c7136fe25972e19a6054fce1372ccc20a8792ac9c7cce0059d60544caa4698cefc8e463a908882ecc77780ddea10216f49cc1436989a64e816dc0021cfed004940c5ec5632498c281be7113f5576463df147e313c287a676b1b070699cc2d676c0439f5cc370e3da589ad3db61c59dd3791453aeb28568c3e9d8e952cded329a9a1a668646e3311033b3030170c33bdc2b92fd52aef647e614fbfe3b46bdd57528a2e52e438ee44eb87a2f6512109f6bd826b3e913cfcc5381177f594ac02776e5a51915b37e0a2f35e1a54e2013b970983e667e40cef86000506a1f52837ff207eeaba9cdc8e21b88c9dddb2baabdd43a09c830d7a3cacfdeb5d244f2284ab1948175b7bd6a3d0f03c6e6934d8c7dc9e2402dbc7fa18dee0c4de37a1a7a4c01166168963c03788fe6d1b5f426898c99e0d440a498e5f4cd6b16c97062d616aa13992b1dcd525f266904b6011ebb56bc274ed370686262000fa1217200d0ff36df64f582fdd74c8d0306a1510b137dc94c484312a32291935124977f08e035a33ef502c4f8a5c9091872364116c4dad8d432d5238509e6f2dcebefa80e6c3304a49c5e5b5dadab341cc9115c6488c65b0c5abb344b91017f866c44218ce4f4c365a5c76f16bd5ffefccd526be02fc46d6eddcab1567a2ce12dac7a39d462e3259482e0d86292779dfab34e4ba8b3252d879ab79c7db5da25fcd799f02b0f87b98c7719bf838cff76e268fb6a67076ee998bca3c69ce164d939341cec877cc04e48e339094c19896d0152f51aa59a8e4e509fdb1fe5b1257484f233c25c43d4e6aadefebd73747c88898d11b05955ff12659eb64d5394886683c13c949a664b2907a4e565ad4e41098698b5d90c78552abf79ddd8efce1784b3f202f037b63cfb6e4f60abebb1187821abcf56979127a94e4d790dce3fefa1e686bd91dd3fe05f23b36d335b97c5ae8a61e1c184097abceb89f95bf2047921b0df60037bdc15b04dad6fbe0b6dd1bb3fc18489c09601ed41bae60b08c8a33024b768b15821f7c407349d5b686ea27d787f4ea480254f04444c4f7402c6f6ee4ed602fec7464f0889423f41087f6cf604cd8c407cc2674ad6c8759a5803911afe826d68fdcf0dadef1a2eccccd8f44ac934262d6c56148bc9f49e872dfaf1cf8533bfa65b801707644019804cda7c3caa32e27424c14027532e5bcfd148266ba159fd578a4666236a1d6ababd55431bac36340ceac16c3a35725a23ed1a79b567ab8a39099896e71975cd61d720756606b2028c6e09c61557dca7709b9d6c01c0c7c67656502c86c0ee5f93612598172615a4273d0f10b3952b007a775f1c9e4615602ebadd568525b97857a95bbbb5bfa667d9fa75131a0707c47cf66b76e67e259fa1ccfc2f03cd5773d59b0382f0b3c5c090095664407e1636412ed930bb199307bc3c20c3ec7b5892150675993b01007de5961e8a3d52e6d60ba8eb18644921bf8911bc35d15886f3fac050539832f1bf4ae9091633b7362af4fc2d64d79a9b29e8a27c2c73e174e0fa1d0c79d13d7df35315a815a4df3aed22a0ed52fbda8abc8e6ba415c56d22d8705750b1ac923cd80a9a4aacd8cde5ec39ed4d22aa3cfb0171251b688814acbcd8dd800f2b77ee6093c8c0b51157f49a17a749a91b6620a3e93165157c000873a68bf0e04c1d1f54b102593fb47bceca086d535a646145068aa528dd8b92f75e38be298a21ac5f8a53714a2d240a828ba244a814e12d0f057bb2d988d2b5b5dbbacc0aca546a4b0d5a01e8345537810ca1958812d4d8d4e35560ba09b66f66db1a4c8dc2e6055b61f39ba845701f9b2578bf9b1b41a8e0089b562fe6be8d57c5b2970adb7cae6d0c27694895e95e45b94e55ea6dc884b2ee6fd890cb8da954e6930ec5ae235516224ae15e0f856a95007c4d5964d726359b036c2927452959e6d82b7e8d9da52128c107dc2b4cc7ee4fffc8a15c60abbe9293d9d122d6245a9c54a5e5c9c49331f83abadb9d54a92ede71ef862589e65f604696d7a81c091d6d573fb60435dabb5af7996dbc90d1c4dbaa865c09586b888404a0ee5774b8468acae58c8da04536ea5888cbc254b5c5c95866523b94d856a10485777c3e1898df412e5aa7721a5f007a62f6ac73b4a715cc7a99ea856513ccb344a60a17af5cb9599c48bb794c66bbaeb58cf169f58e8bbb71f263dc38b9efc7ff8cf5cd214a4bb17177774e932717948ba7556f7716236dbef1b9d0a73fedf3f9d3e7cf9fff0f12deb5b0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138028, 509, 2.2, 2.2, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0b2e492c2ab15230d233ca4dd7cf4e5708f0d7f70c53283434ca50a85030544849ac0400b38f0a00', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138029, 509, 100.0, 100.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dac50303430c84dd7cf4ed74fc92f4e05002e960587', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138030, 509, 2.2, 2.2, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d233ca4dd7cf4e5708f0d7f70c53087401002a2304aa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138031, 509, 2.2, 2.2, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0b2e492c2ab15230d233ca4dd7cf4e5708f0d7f70c53283434ca50a85030544849ac0400b38f0a00', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138032, 509, 100.0, 100.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dac50303430c84dd7cf4ed74fc92f4e05002e960587', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138033, 509, 2.0, 4.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d235c94dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a830d735345000ca140300f07d0c18', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138034, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138035, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138036, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138037, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a8503032544849ac2c06004846066d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138038, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138039, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a8503034504849ac2c06004839066b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138040, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a85030574849ac2c060042d30641', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138041, 509, 100.0, 100.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333430c84d5708f057283434ca50a83034d13532544849ac2c0600549e06df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138042, 509, 2.2, 2.2, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d233ca4dd7cf4e5708f057283434ca50a8503033504849ac2c060060820772', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138043, 509, 2.2, 2.2, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d233ca4dd7cf4e5708f057283434ca50a85030d73534504849ac2c06006e2c07d1', X'789ced5d6d73dab816fe2b9a7cb9ed2c09819b6c3bb93b3b43485f72b749b9a5cd7467e9308a2db06e6cc92bd904ee4efffb7d24030163307149b62ffa9201477a747474cef31c1923fedaf3553aec0b1ab1bd13b27726c7136fe2855cb0bd1ad94b5568ae064912eb937afd96dfb0e840aaa179c5ebb9c6da5334667e9f26a64ff3b0f9f3fe6163bf71f8fef0d9c971f3a4d13c683e3f7ef6ecd8b6655ec2a5d068f9d7de2b2698a2a17d9db0b1edfe7e12b3939e78cf1245a763e89e38939a0e19792955a44f48e72da1c227e757e449f3301ad6c8b1fdfbecd8fc6d1cda378dec5a13d7eac7247af3b427da328aa420ef15f519b9c4c401d5f2e598d6486bc4f162522367524dc635722185c4851a790b2b181a7498e2522734a9912b7ead6834f1b8b0134aaf17e7f41997127a1d32f3ee8f4f788719dcd8370b735c9c5cb9bb979b7ffe64c668f96998f4e1162e864bfe2bb069e6e7feb9182c5e9e75b11e8353eb70e87fce8854e4cf4633203e8b99f0814fe034cd46f04032e9892baab89920f153450dd8def2948d755dd39af55b9e60fdab341ca24bf19018af27ba095509995fb2838f4983f87452806d57c29722e1490eb4b98850d0b3e5a509eb9f522f0104dcd1e522d5c528758c3d45da6f1e19738ef79f198374016e3b08110f3ea7c5539cce27ebde13ad504b122b190793908eb92603385cb3714a4342b5a6585732e258a6a868ac57084ca502b6dd5897322103ae74424cecec93543372cb93a0273c3648e084b1cc5238efe3f3b325fcb7691263ad99487a62659d8ea6839d8b5c1b8453be4d17a37b0149a401b80d982036944c367b328a439630bc48952eb2aacd141cb3b260c5932f8aca491cf030d7fb7c4002500e461426164688716b1e13182a0c79517877148fa89ad4bbcc93c237afded00413ffa5d19f30aa365a377545016a86d1ff3503a9a7e246c85bb111acf97c2dd8248a03395454a4a18c68ffca50004ba3cd708d75701f144b0255ddf52f62ee737f129522340ed7417494f456737e6b0be010d63fe39a51cd3621348ef6a76e80082946139b9f5347133e20068880b0a6ee28a01981ffd1f1d2202fe74948a06322215c8003d85050e11591dcb9086868d99586b5feabf35affad610c849a18b29c62e65df0f35a17b6d3840a26d31217ee4f17a1273228024379845cc5ecafb9047b2a09428f884e750c41617ed172412dfb6c1c4b9d420916f86e9d0edc596e142805bf830f335792190e5e7861ea170e78018781d1b6196a2e39fbcd6cc01892a24cdacf0632c5022c10292347e496b11b4de800139f37c81bb095eee74877b3eab7171a679afff0329e2f1c9c8e3b1d773aee74dce9b8d371a7e3bbd2f19daa6a5eb29dac3a5975b2ea64d5c9aa93d51f4b56efa17c79d174d2e7a4cf499f933e277d4efabe45e9db997ee585d10998133027604ec09c8039017b48017b509d59791cca098d131a27344e689cd0fc7042f340dcbff2299c237f47fe8efc1df93bf2ff8ac8ff2b61e5959b6c8e961d2d3b5a76b4fc6dd172b59272e51173475e8ebc1c7939f2fa1bc8ab3af7acecf71df938f271e4e3c8677bf2f9d27ccc53904b4897902e21bf2021ef9d40f90c7419e432e887cea02a09b05a49bb0c7019f0ad66c07da3371ffd2e7c5df8febd7b92870abf95af5cb9f873f1978fbf4a41918f2c1715df59543cbe75db1fea98ad17f3394d14f7aa1fc8d86f2e75faf53931b77cb19ca1df13cd836634acdf983966873b4da7794272ff9995d766ee3d7141c7d9b9116850f7a5c6dc5f2af667ca9038d347a6cd411448a8991584ebf97764f30f19141c5af1284617d52ec924e61efcd76e753659b07f3485c9bef2e4f31147fc4f079ca76a51b2cf1e47df38c307fe1ad486b1ebbf1e1d939be17a13bee0a1f5dcb05d6a941c49620e1c257e16df051e9b7f0e9cebdff225da79206ebdcedc7b7c58711ff06d3ebbd889b18bdbdefb006e711b6857ce9c5775f709e89d6d327283eeb8cccba12fb0cb3d54bd1c6441daef382a63d58790fa0d06dd53eff3f66ea7fff94021ebc87d37aa5b66e4633c1ef82da8f23627343a5976b2ec64d9c9b2936527cbdf812cffad12b772dbd2699cd338a7714ee39cc6398ddbe1014e3b9795b52739395d71bae274c5e98ad3951f40571e95f5d79eb3e468dfd1bea37d47fb8ef61feb93ac4765de82c38f1cf53aea75d4eba8f7c7a3deedc96ffd31408efd1cfb39f673ecf768ecb793eaabe0bb4c8e801c0139027204b41d01ed9830d61f90e118c33186638cef8031be34a5379de0e172dae5b4cbe9c7cfe91de4e0da33455c12ba247449b845127e61c66c3ad6c4a58c4b99ef31651e31c6d79ca5e282dc05f9030779c548bbe7112d2ed45ca87da533b8e7c9305d8489f941e68e8cd32ce0f5d2143ab32c3921b0f80df512dbe884208a34bf0e27e483d074c0fe453c74e53eaca3216c1468366208dc770c2944b2636748cb7ec26c7e75667e228d798c8750ffbfa94e22fb1b36af99f9391bafa44b427c36403efb15e66cbcaa28173ef70a66dc0a43a686f648752fa45ad77d950e7b62ee889e680d19f965bab23d7126c7136fe25972e19a6054fce1372ccc20a8792ac9c7cce0059d60544caa4698cefc8e463a908882ecc77780ddea10216f49cc1436989a64e816dc0021cfed004940c5ec5632498c281be7113f5576463df147e313c287a676b1b070699cc2d676c0439f5cc370e3da589ad3db61c59dd3791453aeb28568c3e9d8e952cded329a9a1a668646e3311033b3030170c33bdc2b92fd52aef647e614fbfe3b46bdd57528a2e52e438ee44eb87a2f6512109f6bd826b3e913cfcc5381177f594ac02776e5a51915b37e0a2f35e1a54e2013b970983e667e40cef86000506a1f52837ff207eeaba9cdc8e21b88c9dddb2baabdd43a09c830d7a3cacfdeb5d244f2284ab1948175b7bd6a3d0f03c6e6934d8c7dc9e2402dbc7fa18dee0c4de37a1a7a4c01166168963c03788fe6d1b5f426898c99e0d440a498e5f4cd6b16c97062d616aa13992b1dcd525f266904b6011ebb56bc274ed370686262000fa1217200d0ff36df64f582fdd74c8d0306a1510b137dc94c484312a32291935124977f08e035a33ef502c4f8a5c9091872364116c4dad8d432d5238509e6f2dcebefa80e6c3304a49c5e5b5dadab341cc9115c6488c65b0c5abb344b91017f866c44218ce4f4c365a5c76f16bd5ffefccd526be02fc46d6eddcab1567a2ce12dac7a39d462e3259482e0d86292779dfab34e4ba8b3252d879ab79c7db5da25fcd799f02b0f87b98c7719bf838cff76e268fb6a67076ee998bca3c69ce164d939341cec877cc04e48e339094c19896d0152f51aa59a8e4e509fdb1fe5b1257484f233c25c43d4e6aadefebd73747c88898d11b05955ff12659eb64d5394886683c13c949a664b2907a4e565ad4e41098698b5d90c78552abf79ddd8efce1784b3f202f037b63cfb6e4f60abebb1187821abcf56979127a94e4d790dce3fefa1e686bd91dd3fe05f23b36d335b97c5ae8a61e1c184097abceb89f95bf2047921b0df60037bdc15b04dad6fbe0b6dd1bb3fc18489c09601ed41bae60b08c8a33024b768b15821f7c407349d5b686ea27d787f4ea480254f04444c4f7402c6f6ee4ed602fec7464f0889423f41087f6cf604cd8c407cc2674ad6c8759a5803911afe826d68fdcf0dadef1a2eccccd8f44ac934262d6c56148bc9f49e872dfaf1cf8533bfa65b801707644019804cda7c3caa32e27424c14027532e5bcfd148266ba159fd578a4666236a1d6ababd55431bac36340ceac16c3a35725a23ed1a79b567ab8a39099896e71975cd61d720756606b2028c6e09c61557dca7709b9d6c01c0c7c67656502c86c0ee5f93612598172615a4273d0f10b3952b007a775f1c9e4615602ebadd568525b97857a95bbbb5bfa667d9fa75131a0707c47cf66b76e67e259fa1ccfc2f03cd5773d59b0382f0b3c5c090095664407e1636412ed930bb199307bc3c20c3ec7b5892150675993b01007de5961e8a3d52e6d60ba8eb18644921bf8911bc35d15886f3fac050539832f1bf4ae9091633b7362af4fc2d64d79a9b29e8a27c2c73e174e0fa1d0c79d13d7df35315a815a4df3aed22a0ed52fbda8abc8e6ba415c56d22d8705750b1ac923cd80a9a4aacd8cde5ec39ed4d22aa3cfb0171251b688814acbcd8dd800f2b77ee6093c8c0b51157f49a17a749a91b6620a3e93165157c000873a68bf0e04c1d1f54b102593fb47bceca086d535a646145068aa528dd8b92f75e38be298a21ac5f8a53714a2d240a828ba244a814e12d0f057bb2d988d2b5b5dbbacc0aca546a4b0d5a01e8345537810ca1958812d4d8d4e35560ba09b66f66db1a4c8dc2e6055b61f39ba845701f9b2578bf9b1b41a8e0089b562fe6be8d57c5b2970adb7cae6d0c27694895e95e45b94e55ea6dc884b2ee6fd890cb8da954e6930ec5ae235516224ae15e0f856a95007c4d5964d726359b036c2927452959e6d82b7e8d9da52128c107dc2b4cc7ee4fffc8a15c60abbe9293d9d122d6245a9c54a5e5c9c49331f83abadb9d54a92ede71ef862589e65f604696d7a81c091d6d573fb60435dabb5af7996dbc90d1c4dbaa865c09586b888404a0ee5774b8468acae58c8da04536ea5888cbc254b5c5c95866523b94d856a10485777c3e1898df412e5aa7721a5f007a62f6ac73b4a715cc7a99ea856513ccb344a60a17af5cb9599c48bb794c66bbaeb58cf169f58e8bbb71f263dc38b9efc7ff8cf5cd214a4bb17177774e932717948ba7556f7716236dbef1b9d0a73fedf3f9d3e7cf9fff0f12deb5b0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138044, 509, 100.0, 100.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac50303430c84dd74fc92f4e05001fc30486', X'789ced5d6d73dab816fe2b9a7cb9ed2c09819b6c3bb93b3b43485f72b749b9a5cd7467e9308a2db06e6cc92bd904ee4efffb7d24030163307149b62ffa9201477a747474cef31c1923fedaf3553aec0b1ab1bd13b27726c7136fe2855cb0bd1ad94b5568ae064912eb937afd96dfb0e840aaa179c5ebb9c6da5334667e9f26a64ff3b0f9f3fe6163bf71f8fef0d9c971f3a4d13c683e3f7ef6ecd8b6655ec2a5d068f9d7de2b2698a2a17d9db0b1edfe7e12b3939e78cf1245a763e89e38939a0e19792955a44f48e72da1c227e757e449f3301ad6c8b1fdfbecd8fc6d1cda378dec5a13d7eac7247af3b427da328aa420ef15f519b9c4c401d5f2e598d6486bc4f162522367524dc635722185c4851a790b2b181a7498e2522734a9912b7ead6834f1b8b0134aaf17e7f41997127a1d32f3ee8f4f788719dcd8370b735c9c5cb9bb979b7ffe64c668f96998f4e1162e864bfe2bb069e6e7feb9182c5e9e75b11e8353eb70e87fce8854e4cf4633203e8b99f0814fe034cd46f04032e9892baab89920f153450dd8def2948d755dd39af55b9e60fdab341ca24bf19018af27ba095509995fb2838f4983f87452806d57c29722e1490eb4b98850d0b3e5a509eb9f522f0104dcd1e522d5c528758c3d45da6f1e19738ef79f198374016e3b08110f3ea7c5539cce27ebde13ad504b122b190793908eb92603385cb3714a4342b5a6585732e258a6a868ac57084ca502b6dd5897322103ae74424cecec93543372cb93a0273c3648e084b1cc5238efe3f3b325fcb7691263ad99487a62659d8ea6839d8b5c1b8453be4d17a37b0149a401b80d982036944c367b328a439630bc48952eb2aacd141cb3b260c5932f8aca491cf030d7fb7c4002500e461426164688716b1e13182a0c79517877148fa89ad4bbcc93c237afded00413ffa5d19f30aa365a377545016a86d1ff3503a9a7e246c85bb111acf97c2dd8248a03395454a4a18c68ffca50004ba3cd708d75701f144b0255ddf52f62ee737f129522340ed7417494f456737e6b0be010d63fe39a51cd3621348ef6a76e80082946139b9f5347133e20068880b0a6ee28a01981ffd1f1d2202fe74948a06322215c8003d85050e11591dcb9086868d99586b5feabf35affad610c849a18b29c62e65df0f35a17b6d3840a26d31217ee4f17a1273228024379845cc5ecafb9047b2a09428f884e750c41617ed172412dfb6c1c4b9d420916f86e9d0edc596e142805bf830f335792190e5e7861ea170e78018781d1b6196a2e39fbcd6cc01892a24cdacf0632c5022c10292347e496b11b4de800139f37c81bb095eee74877b3eab7171a679afff0329e2f1c9c8e3b1d773aee74dce9b8d371a7e3bbd2f19daa6a5eb29dac3a5975b2ea64d5c9aa93d51f4b56efa17c79d174d2e7a4cf499f933e277d4efabe45e9db997ee585d10998133027604ec09c8039017b48017b509d59791cca098d131a27344e689cd0fc7042f340dcbff2299c237f47fe8efc1df93bf2ff8ac8ff2b61e5959b6c8e961d2d3b5a76b4fc6dd172b59272e51173475e8ebc1c7939f2fa1bc8ab3af7acecf71df938f271e4e3c8677bf2f9d27ccc53904b4897902e21bf2021ef9d40f90c7419e432e887cea02a09b05a49bb0c7019f0ad66c07da3371ffd2e7c5df8febd7b92870abf95af5cb9f873f1978fbf4a41918f2c1715df59543cbe75db1fea98ad17f3394d14f7aa1fc8d86f2e75faf53931b77cb19ca1df13cd836634acdf983966873b4da7794272ff9995d766ee3d7141c7d9b9116850f7a5c6dc5f2af667ca9038d347a6cd411448a8991584ebf97764f30f19141c5af1284617d52ec924e61efcd76e753659b07f3485c9bef2e4f31147fc4f079ca76a51b2cf1e47df38c307fe1ad486b1ebbf1e1d939be17a13bee0a1f5dcb05d6a941c49620e1c257e16df051e9b7f0e9cebdff225da79206ebdcedc7b7c58711ff06d3ebbd889b18bdbdefb006e711b6857ce9c5775f709e89d6d327283eeb8cccba12fb0cb3d54bd1c6441daef382a63d58790fa0d06dd53eff3f66ea7fff94021ebc87d37aa5b66e4633c1ef82da8f23627343a5976b2ec64d9c9b2936527cbdf812cffad12b772dbd2699cd338a7714ee39cc6398ddbe1014e3b9795b52739395d71bae274c5e98ad3951f40571e95f5d79eb3e468dfd1bea37d47fb8ef61feb93ac4765de82c38f1cf53aea75d4eba8f7c7a3deedc96ffd31408efd1cfb39f673ecf768ecb793eaabe0bb4c8e801c0139027204b41d01ed9830d61f90e118c33186638cef8031be34a5379de0e172dae5b4cbe9c7cfe91de4e0da33455c12ba247449b845127e61c66c3ad6c4a58c4b99ef31651e31c6d79ca5e282dc05f9030779c548bbe7112d2ed45ca87da533b8e7c9305d8489f941e68e8cd32ce0f5d2143ab32c3921b0f80df512dbe884208a34bf0e27e483d074c0fe453c74e53eaca3216c1468366208dc770c2944b2636748cb7ec26c7e75667e228d798c8750ffbfa94e22fb1b36af99f9391bafa44b427c36403efb15e66cbcaa28173ef70a66dc0a43a686f648752fa45ad77d950e7b62ee889e680d19f965bab23d7126c7136fe25972e19a6054fce1372ccc20a8792ac9c7cce0059d60544caa4698cefc8e463a908882ecc77780ddea10216f49cc1436989a64e816dc0021cfed004940c5ec5632498c281be7113f5576463df147e313c287a676b1b070699cc2d676c0439f5cc370e3da589ad3db61c59dd3791453aeb28568c3e9d8e952cded329a9a1a668646e3311033b3030170c33bdc2b92fd52aef647e614fbfe3b46bdd57528a2e52e438ee44eb87a2f6512109f6bd826b3e913cfcc5381177f594ac02776e5a51915b37e0a2f35e1a54e2013b970983e667e40cef86000506a1f52837ff207eeaba9cdc8e21b88c9dddb2baabdd43a09c830d7a3cacfdeb5d244f2284ab1948175b7bd6a3d0f03c6e6934d8c7dc9e2402dbc7fa18dee0c4de37a1a7a4c01166168963c03788fe6d1b5f426898c99e0d440a498e5f4cd6b16c97062d616aa13992b1dcd525f266904b6011ebb56bc274ed370686262000fa1217200d0ff36df64f582fdd74c8d0306a1510b137dc94c484312a32291935124977f08e035a33ef502c4f8a5c9091872364116c4dad8d432d5238509e6f2dcebefa80e6c3304a49c5e5b5dadab341cc9115c6488c65b0c5abb344b91017f866c44218ce4f4c365a5c76f16bd5ffefccd526be02fc46d6eddcab1567a2ce12dac7a39d462e3259482e0d86292779dfab34e4ba8b3252d879ab79c7db5da25fcd799f02b0f87b98c7719bf838cff76e268fb6a67076ee998bca3c69ce164d939341cec877cc04e48e339094c19896d0152f51aa59a8e4e509fdb1fe5b1257484f233c25c43d4e6aadefebd73747c88898d11b05955ff12659eb64d5394886683c13c949a664b2907a4e565ad4e41098698b5d90c78552abf79ddd8efce1784b3f202f037b63cfb6e4f60abebb1187821abcf56979127a94e4d790dce3fefa1e686bd91dd3fe05f23b36d335b97c5ae8a61e1c184097abceb89f95bf2047921b0df60037bdc15b04dad6fbe0b6dd1bb3fc18489c09601ed41bae60b08c8a33024b768b15821f7c407349d5b686ea27d787f4ea480254f04444c4f7402c6f6ee4ed602fec7464f0889423f41087f6cf604cd8c407cc2674ad6c8759a5803911afe826d68fdcf0dadef1a2eccccd8f44ac934262d6c56148bc9f49e872dfaf1cf8533bfa65b801707644019804cda7c3caa32e27424c14027532e5bcfd148266ba159fd578a4666236a1d6ababd55431bac36340ceac16c3a35725a23ed1a79b567ab8a39099896e71975cd61d720756606b2028c6e09c61557dca7709b9d6c01c0c7c67656502c86c0ee5f93612598172615a4273d0f10b3952b007a775f1c9e4615602ebadd568525b97857a95bbbb5bfa667d9fa75131a0707c47cf66b76e67e259fa1ccfc2f03cd5773d59b0382f0b3c5c090095664407e1636412ed930bb199307bc3c20c3ec7b5892150675993b01007de5961e8a3d52e6d60ba8eb18644921bf8911bc35d15886f3fac050539832f1bf4ae9091633b7362af4fc2d64d79a9b29e8a27c2c73e174e0fa1d0c79d13d7df35315a815a4df3aed22a0ed52fbda8abc8e6ba415c56d22d8705750b1ac923cd80a9a4aacd8cde5ec39ed4d22aa3cfb0171251b688814acbcd8dd800f2b77ee6093c8c0b51157f49a17a749a91b6620a3e93165157c000873a68bf0e04c1d1f54b102593fb47bceca086d535a646145068aa528dd8b92f75e38be298a21ac5f8a53714a2d240a828ba244a814e12d0f057bb2d988d2b5b5dbbacc0aca546a4b0d5a01e8345537810ca1958812d4d8d4e35560ba09b66f66db1a4c8dc2e6055b61f39ba845701f9b2578bf9b1b41a8e0089b562fe6be8d57c5b2970adb7cae6d0c27694895e95e45b94e55ea6dc884b2ee6fd890cb8da954e6930ec5ae235516224ae15e0f856a95007c4d5964d726359b036c2927452959e6d82b7e8d9da52128c107dc2b4cc7ee4fffc8a15c60abbe9293d9d122d6245a9c54a5e5c9c49331f83abadb9d54a92ede71ef862589e65f604696d7a81c091d6d573fb60435dabb5af7996dbc90d1c4dbaa865c09586b888404a0ee5774b8468acae58c8da04536ea5888cbc254b5c5c95866523b94d856a10485777c3e1898df412e5aa7721a5f007a62f6ac73b4a715cc7a99ea856513ccb344a60a17af5cb9599c48bb794c66bbaeb58cf169f58e8bbb71f263dc38b9efc7ff8cf5cd214a4bb17177774e932717948ba7556f7716236dbef1b9d0a73fedf3f9d3e7cf9fff0f12deb5b0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138045, 509, 2.2, 2.2, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d233ca4dd7cf4e5708f057087451a8503033504849ac2c56c82f5228cd2bc9cc5148cc2bc9284aac5048ad28c82f2e2d4a053292734a53525300299c1437', X'789ced5d6d73dab816fe2b9a7cb9ed2c09819b6c3bb93b3b43485f72b749b9a5cd7467e9308a2db06e6cc92bd904ee4efffb7d24030163307149b62ffa9201477a747474cef31c1923fedaf3553aec0b1ab1bd13b27726c7136fe2855cb0bd1ad94b5568ae064912eb937afd96dfb0e840aaa179c5ebb9c6da5334667e9f26a64ff3b0f9f3fe6163bf71f8fef0d9c971f3a4d13c683e3f7ef6ecd8b6655ec2a5d068f9d7de2b2698a2a17d9db0b1edfe7e12b3939e78cf1245a763e89e38939a0e19792955a44f48e72da1c227e757e449f3301ad6c8b1fdfbecd8fc6d1cda378dec5a13d7eac7247af3b427da328aa420ef15f519b9c4c401d5f2e598d6486bc4f162522367524dc635722185c4851a790b2b181a7498e2522734a9912b7ead6834f1b8b0134aaf17e7f41997127a1d32f3ee8f4f788719dcd8370b735c9c5cb9bb979b7ffe64c668f96998f4e1162e864bfe2bb069e6e7feb9182c5e9e75b11e8353eb70e87fce8854e4cf4633203e8b99f0814fe034cd46f04032e9892baab89920f153450dd8def2948d755dd39af55b9e60fdab341ca24bf19018af27ba095509995fb2838f4983f87452806d57c29722e1490eb4b98850d0b3e5a509eb9f522f0104dcd1e522d5c528758c3d45da6f1e19738ef79f198374016e3b08110f3ea7c5539cce27ebde13ad504b122b190793908eb92603385cb3714a4342b5a6585732e258a6a868ac57084ca502b6dd5897322103ae74424cecec93543372cb93a0273c3648e084b1cc5238efe3f3b325fcb7691263ad99487a62659d8ea6839d8b5c1b8453be4d17a37b0149a401b80d982036944c367b328a439630bc48952eb2aacd141cb3b260c5932f8aca491cf030d7fb7c4002500e461426164688716b1e13182a0c79517877148fa89ad4bbcc93c237afded00413ffa5d19f30aa365a377545016a86d1ff3503a9a7e246c85bb111acf97c2dd8248a03395454a4a18c68ffca50004ba3cd708d75701f144b0255ddf52f62ee737f129522340ed7417494f456737e6b0be010d63fe39a51cd3621348ef6a76e80082946139b9f5347133e20068880b0a6ee28a01981ffd1f1d2202fe74948a06322215c8003d85050e11591dcb9086868d99586b5feabf35affad610c849a18b29c62e65df0f35a17b6d3840a26d31217ee4f17a1273228024379845cc5ecafb9047b2a09428f884e750c41617ed172412dfb6c1c4b9d420916f86e9d0edc596e142805bf830f335792190e5e7861ea170e78018781d1b6196a2e39fbcd6cc01892a24cdacf0632c5022c10292347e496b11b4de800139f37c81bb095eee74877b3eab7171a679afff0329e2f1c9c8e3b1d773aee74dce9b8d371a7e3bbd2f19daa6a5eb29dac3a5975b2ea64d5c9aa93d51f4b56efa17c79d174d2e7a4cf499f933e277d4efabe45e9db997ee585d10998133027604ec09c8039017b48017b509d59791cca098d131a27344e689cd0fc7042f340dcbff2299c237f47fe8efc1df93bf2ff8ac8ff2b61e5959b6c8e961d2d3b5a76b4fc6dd172b59272e51173475e8ebc1c7939f2fa1bc8ab3af7acecf71df938f271e4e3c8677bf2f9d27ccc53904b4897902e21bf2021ef9d40f90c7419e432e887cea02a09b05a49bb0c7019f0ad66c07da3371ffd2e7c5df8febd7b92870abf95af5cb9f873f1978fbf4a41918f2c1715df59543cbe75db1fea98ad17f3394d14f7aa1fc8d86f2e75faf53931b77cb19ca1df13cd836634acdf983966873b4da7794272ff9995d766ee3d7141c7d9b9116850f7a5c6dc5f2af667ca9038d347a6cd411448a8991584ebf97764f30f19141c5af1284617d52ec924e61efcd76e753659b07f3485c9bef2e4f31147fc4f079ca76a51b2cf1e47df38c307fe1ad486b1ebbf1e1d939be17a13bee0a1f5dcb05d6a941c49620e1c257e16df051e9b7f0e9cebdff225da79206ebdcedc7b7c58711ff06d3ebbd889b18bdbdefb006e711b6857ce9c5775f709e89d6d327283eeb8cccba12fb0cb3d54bd1c6441daef382a63d58790fa0d06dd53eff3f66ea7fff94021ebc87d37aa5b66e4633c1ef82da8f23627343a5976b2ec64d9c9b2936527cbdf812cffad12b772dbd2699cd338a7714ee39cc6398ddbe1014e3b9795b52739395d71bae274c5e98ad3951f40571e95f5d79eb3e468dfd1bea37d47fb8ef61feb93ac4765de82c38f1cf53aea75d4eba8f7c7a3deedc96ffd31408efd1cfb39f673ecf768ecb793eaabe0bb4c8e801c0139027204b41d01ed9830d61f90e118c33186638cef8031be34a5379de0e172dae5b4cbe9c7cfe91de4e0da33455c12ba247449b845127e61c66c3ad6c4a58c4b99ef31651e31c6d79ca5e282dc05f9030779c548bbe7112d2ed45ca87da533b8e7c9305d8489f941e68e8cd32ce0f5d2143ab32c3921b0f80df512dbe884208a34bf0e27e483d074c0fe453c74e53eaca3216c1468366208dc770c2944b2636748cb7ec26c7e75667e228d798c8750ffbfa94e22fb1b36af99f9391bafa44b427c36403efb15e66cbcaa28173ef70a66dc0a43a686f648752fa45ad77d950e7b62ee889e680d19f965bab23d7126c7136fe25972e19a6054fce1372ccc20a8792ac9c7cce0059d60544caa4698cefc8e463a908882ecc77780ddea10216f49cc1436989a64e816dc0021cfed004940c5ec5632498c281be7113f5576463df147e313c287a676b1b070699cc2d676c0439f5cc370e3da589ad3db61c59dd3791453aeb28568c3e9d8e952cded329a9a1a668646e3311033b3030170c33bdc2b92fd52aef647e614fbfe3b46bdd57528a2e52e438ee44eb87a2f6512109f6bd826b3e913cfcc5381177f594ac02776e5a51915b37e0a2f35e1a54e2013b970983e667e40cef86000506a1f52837ff207eeaba9cdc8e21b88c9dddb2baabdd43a09c830d7a3cacfdeb5d244f2284ab1948175b7bd6a3d0f03c6e6934d8c7dc9e2402dbc7fa18dee0c4de37a1a7a4c01166168963c03788fe6d1b5f426898c99e0d440a498e5f4cd6b16c97062d616aa13992b1dcd525f266904b6011ebb56bc274ed370686262000fa1217200d0ff36df64f582fdd74c8d0306a1510b137dc94c484312a32291935124977f08e035a33ef502c4f8a5c9091872364116c4dad8d432d5238509e6f2dcebefa80e6c3304a49c5e5b5dadab341cc9115c6488c65b0c5abb344b91017f866c44218ce4f4c365a5c76f16bd5ffefccd526be02fc46d6eddcab1567a2ce12dac7a39d462e3259482e0d86292779dfab34e4ba8b3252d879ab79c7db5da25fcd799f02b0f87b98c7719bf838cff76e268fb6a67076ee998bca3c69ce164d939341cec877cc04e48e339094c19896d0152f51aa59a8e4e509fdb1fe5b1257484f233c25c43d4e6aadefebd73747c88898d11b05955ff12659eb64d5394886683c13c949a664b2907a4e565ad4e41098698b5d90c78552abf79ddd8efce1784b3f202f037b63cfb6e4f60abebb1187821abcf56979127a94e4d790dce3fefa1e686bd91dd3fe05f23b36d335b97c5ae8a61e1c184097abceb89f95bf2047921b0df60037bdc15b04dad6fbe0b6dd1bb3fc18489c09601ed41bae60b08c8a33024b768b15821f7c407349d5b686ea27d787f4ea480254f04444c4f7402c6f6ee4ed602fec7464f0889423f41087f6cf604cd8c407cc2674ad6c8759a5803911afe826d68fdcf0dadef1a2eccccd8f44ac934262d6c56148bc9f49e872dfaf1cf8533bfa65b801707644019804cda7c3caa32e27424c14027532e5bcfd148266ba159fd578a4666236a1d6ababd55431bac36340ceac16c3a35725a23ed1a79b567ab8a39099896e71975cd61d720756606b2028c6e09c61557dca7709b9d6c01c0c7c67656502c86c0ee5f93612598172615a4273d0f10b3952b007a775f1c9e4615602ebadd568525b97857a95bbbb5bfa667d9fa75131a0707c47cf66b76e67e259fa1ccfc2f03cd5773d59b0382f0b3c5c090095664407e1636412ed930bb199307bc3c20c3ec7b5892150675993b01007de5961e8a3d52e6d60ba8eb18644921bf8911bc35d15886f3fac050539832f1bf4ae9091633b7362af4fc2d64d79a9b29e8a27c2c73e174e0fa1d0c79d13d7df35315a815a4df3aed22a0ed52fbda8abc8e6ba415c56d22d8705750b1ac923cd80a9a4aacd8cde5ec39ed4d22aa3cfb0171251b688814acbcd8dd800f2b77ee6093c8c0b51157f49a17a749a91b6620a3e93165157c000873a68bf0e04c1d1f54b102593fb47bceca086d535a646145068aa528dd8b92f75e38be298a21ac5f8a53714a2d240a828ba244a814e12d0f057bb2d988d2b5b5dbbacc0aca546a4b0d5a01e8345537810ca1958812d4d8d4e35560ba09b66f66db1a4c8dc2e6055b61f39ba845701f9b2578bf9b1b41a8e0089b562fe6be8d57c5b2970adb7cae6d0c27694895e95e45b94e55ea6dc884b2ee6fd890cb8da954e6930ec5ae235516224ae15e0f856a95007c4d5964d726359b036c2927452959e6d82b7e8d9da52128c107dc2b4cc7ee4fffc8a15c60abbe9293d9d122d6245a9c54a5e5c9c49331f83abadb9d54a92ede71ef862589e65f604696d7a81c091d6d573fb60435dabb5af7996dbc90d1c4dbaa865c09586b888404a0ee5774b8468acae58c8da04536ea5888cbc254b5c5c95866523b94d856a10485777c3e1898df412e5aa7721a5f007a62f6ac73b4a715cc7a99ea856513ccb344a60a17af5cb9599c48bb794c66bbaeb58cf169f58e8bbb71f263dc38b9efc7ff8cf5cd214a4bb17177774e932717948ba7556f7716236dbef1b9d0a73fedf3f9d3e7cf9fff0f12deb5b0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138046, 509, 100.0, 100.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac50303430c84dd74fc92f4e05001fc30486', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138047, 509, 2.2, 2.2, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d233ca4dd7cf4e5708f057087401001ccf03dc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138048, 509, 100.0, 100.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac50303430c84dd74fc92f4e05001fc30486', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138049, 5744, 125.0, 125.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652082e2d2e48cd2bcecccf53303432cd4dd737cdcdb15608494cca492d8188e82818991a8028530320050092381384', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138050, 5744, 250.0, 1000.0, 'mg', 'PO', 1, 'Adult', X'789c333235d035343030c84d5708f0574849cccca904002cf4054c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138051, 5744, 125.0, 250.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d633d33532d233cf4eb752303432d5353235c84d5708f0574849cccca90400714f080d', X'789ccd556d6fd3400cfe2b563ef76d856e5a90902ac6b60f30aaad202482a2dbc5494ebdf8a2bb4ba142fbeff892d12ddb44e910129f92383efbf163dfe31f51669b2225516114437466954393377aad281a40d4581dcca5f7b58bc7e36f6a85d5c8d822bca9f1436f27ada8314b850f87a693e9e17072303c982c2747f1ec653c391a1d1d1e1f1ebf687d517a65c8b1e78f689e558a94f356045b6bf2f8bd8db2dcd418273427aff2860aa1133a314e1408a7c6562e86abc6d5488ecfc1c1745615e359a55fc1525c6bf49d6500d3d9243c66137e2474691a8f0e4c0efdbc317cb021fe1b53551c6d69458670c1cc70162eb5ab133e0dc2871b2ede9eb57534d7f74bb961930fb9c3d797affca515adda8fbb9aee8ad9cdf13ddf9baf21fa3c6bb44f990345458f292e92b90e25c2e2036442e9cd7e00dbf00bcc94f056c9a7521cbc181d0ea7d3d1d1aa8803b7c396d86dba845efffa19c0ccfe16cb558d52099d2e4cdd6871372ebfe02c2c1624486ee092ff12b73686cf09bd13d2b7dec07d5a05e385f16051725f9132cca0506b24a88d47665768c88d05875699c68153dc75cc73c6e9463c2c48ec90b55cc4408630a173ac39beec599f3b0b0f6bd83d1127e1c276ce2e55946e23449cf02e709f85dd61b7fe69f04fa5f05818ab187c37776f0cf13d519429f9442be65aa32d36e00d482d9c1b0759b965ca48d49a1b6821e741682c33b830b62e3756097eddc2df7f40e6d91aadc3f412857c8ce98980d155d7e53e76694d2d2c3a5fa25322ea27ed6a0f8ad09fbdd278e382f078b5567e33002b5c3980c6f26488b6b20bd13814e3b5a95468d600f866595ba208bc884cc8121fe6da7923fe0cfec3aaff1bfcff14c8be4a570a5b0969b429363d44e742e743ad728ce198d5ae4ce83d7220a395ab6278c7da61137afb5d5aecb6c647ab0807c08a816e00354f64ad6e37d9fea8dea32c05efa42a35793a978ff6e129ef02de58417f9807ac5982bc03457cf15618b2b2aeb1d435d6b1a6858be74050c60ea5ba0e9edd2e0166924fbae78832623ad7cef46770bba55c42a75d0a45f96dd88496ccd05393b9e7ba74fbec4bd7d7c347a876c7ea8ea4f78ef4226e8bfa7d94ce8d45f4e6e627fc15305b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138052, 5744, 250.0, 500.0, 'mg', 'PO', 1, 'Pediatric', X'789cb33332d233cf4eb752303235d0353530c84d5708f0574849cccca904005bed0753', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138053, 1075, 5.0, 20.0, 'mg', 'PO', 1, 'Adult', X'789c33d5353250c84d5708f0574849cccca9040021f104ab', X'789cd5564b6f1b3710fe2b0301bd49d15aa86377d18b6ab7e8a1b605dbb72a588cb8a35dd67c810f379bc0ffbd43ca0b57568ac43aa5373e86c36fbe6f66c8cf93d6a7ae31a86952c364a9a5b25eb63499c2247995d7fa185da8e7f3bfe503e977d6777924e77ba6417874d43618f38945b5783fab4e6627d57d7556ff78562fcedf2dcecfce1755b12511a535812d3f4f96ad964686e831af95a5481f8b97fbc1510d2b1b310499f42c38f4d2746bd3cae4294ab13697366047f09bf53ad41071a328aecdad4d9102d82dec7bafe1c6a35a9b0babb53570efb125b8e6c8f9ec956c515b5ff0a5cdbf213ef152f19c677f7ee09992e6a14c5eb08e90be4edbe568f9f4217b5eb649c586e3e0c8f6a23f9d2d2ad01dac6ea045a986b7212bbe57d44a8c5e8a2ff9bfb6112453293052cb2370a33538668b4c0c475c79e7484854cdcabaa4f045e6f1d695a7cea01103dcf26e16b3865fd6e60f14b1588397e1a16609c9a082b6c0e6e9f2d14a06b9850b7fa1e0e7d38a45cca3936a765ad5e0a94d82b239c16680d3ea87b5f99d721862f401c602b67fa510358776acccafe17f83dcb9badc78acc96c775c357ccb4eff0b6b383b9f8538a06ba914f96e806841282e83792e56a6c3242f710a2838d1c17a10bdb78683f585366942da6ea56011c53005967593330e0c39b6635afa81f9e1eaf20fa8484bcc256184d532a289909845ae1d1e4ade7f4e57e03ae39498821beb1142728e8ff372413e0fa8226456a38cb900a719998d3df9974363113fbb3b22c396ed23f940cd2da13824ec0b0e2777e4a54dfb76afa247cf2471ae0cc1f743ec7526d7a17272175a60ca1df35f783054b60da5c86492c90e7e3582b94535927b8b3294aa626dade04a600a3c85c05c4ef6e3dbe540ee47fbd589ac02ce1fb3264c5711d1fb9ef8626543e96de81c0b1329df167a4618986a93a1e9148422e096ac5dc8daa6ae9fe6e09c21067b293f7d9286d1e422c116457f00eaab65fedd51fa5af4ff1fa7df07e2b73e313d7a8dc22adb0dfbd9806a3b5372cb2ff8fbd94f0cec8ad88f5532e81aae6feea1dff56716faa3c81d263fcfa5eb4f614b02d51160ae48f4c8cfbd6eecb6598a830fc5c15702c667bbe6bceae546c600c419da93e2470c826d739fcb4e0de5b6caf621f2c6aecdc6b449ea18d2ee889aa50a760fdcf82f78634ffc0f07dff607298fd0d3d33fff577ab9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138054, 3243, 4.0, 4.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230c94d5728494cd25130ca4dd737cdcd5128cecf292dc9cccf0300057d0d60', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138055, 3243, 12.0, 12.0, 'mg', NULL, NULL, 'Adult', X'789c15cc410e80200c04c0afec03bce88f14166d525a4351e3efc5f32423265d5645f620bc605eea0e093426af959699271457f58719db8bdf79b3bde88fe3f0ab052eeba2482a26695c8d71ba8d6f3c41da0719202481', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138056, 3243, 0.06, 0.06, 'mg/kg', NULL, NULL, 'Pediatric', X'789c1dcb510e83201444d1adcc679b18354dda0d742554a640541e79a0c2ee4bfa393773de3e6c5619d1e4888e8ae24d44b9048d463396be3e840b67ff9894546ad84de1d6308ff36b77d3ea90bab392099ed4861c2abc1c9a07842f226969718b525004ac4b0f1d3f9e7f3c59d3eee30ff94a2f40', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138057, 3243, 2.0, 2.0, 'mg', NULL, NULL, 'Pediatric', X'789c1d8b4b0a80201445b772870551d4165a89e92d857a829ae9eeb3a6e7b35a779a40417a3c92477405952a446825d888c3e56697eb003343fd03ebef1007b81d421a1a74e2d377b3e80630b77c32aaf6e30b561320ec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138058, 3243, 4.0, 4.0, 'mg', NULL, NULL, 'Pediatric', X'789c15cb410a80200044d1abccb2208a20ea009dc474522115d4446f9f6dffe39fc63e2ad2e3400e5837348a982085c745685b3a6d4e8385b121d90a13de9826d81b9e5454187cc8ffcc2a7bc0ba3bbd28d1c6f903a1841ee0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138059, 1004, 5.0, 10.0, 'mg', 'IN', NULL, 'Adult', X'789c0dcac10980300c05d055fe0015f4e0c5097401ef116309b4496922e8f6face6f7d9b05ab8b2944e11c219a611748a96476a105f3308d3563db7158b93da173630ab4ae09951e9ce68cf93f1f6d001b58', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138060, 5201, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353530c84d5708f05730d4355228c9cc4d2d5628482d524849ac040075f808a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138061, 5201, 125.0, 125.0, 'mg', 'PO', 1, 'Pediatric', X'789cb33132cd4eb752303432cd4d5708f0574849cccca904003dab062e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138062, 5201, 187.5, 187.5, 'mg', 'PO', 1, 'Pediatric', X'789c3332d53536cd4eb75230b430d733cd4d5708f0574849cccca90400505c06f2', X'789cd556df4fe34610fe5746794e2036170a56859472878e0ab888a40f5573b226f6d8deb23facdd35477ae27fefac5d424c5011e943db97c43b3b33fb7db3dfceeef7416e9b32d5a86890c060417625341642d3600883c6ca60adbcaf5d7278f84ddc913a30b60c5fe2f085b3cb2cd694a7e8434c3c8e8f47e368148d17e393647c9444a707c72751743a6e7d29f3c268c79edf07d35c092d9cb7186cadc9d3439b65b1ae2959eaa9f6a268748972a93f1a8725c185b1caf1d4ad693c393005f4d324f0c5a21c8237b5c842dcb951ca685858cc096e98af4be00a957042b6889ad536a84736795c490aa3dfbef2480a7dd70e9ed13dc37abb585bbe8f5f43f669de489f321ba1cb1ee778321e4dc66355c2ec0b44a318bc60b05093851cd75c8cba96eb275efcb5e3f23e3a2d9819e502bd15d96b80cea2786d36954c005b00af203bfb10fc8c0de5fe319edc950944f1a42392a390ec124f4647ddc4c90f07fda9b32e82e96f99f7e032af291328d399a91b89cf327ba233b3546ad4d91a6e7956974bd6ca4f4b7d85996fbdc10a77178c97ba40eddb2164a8b5f1b022b08da41c5875ac3dd228216f2b96803680f9ef8df38a344f7ea69ad3659be9cc6896a6d03917d17306a1a1facb45a81a850d61fb2af125a7b7f5f8311cfbced9a542a79b0c035ef03971bf2a6fa7ddf8a7c13f0d544b630583ef547fbe5d859dad994a49b60ce2864ca27387a139f1d1adacd15c276381d38b7b02c93f2c3ae1081deda19169cef18ed25bc26c17c62b090773b2c2347dbff9cff3c3c5a71b3e921937212849136b5ffcc1bb4b0f2c9d8a147a0e829a55d14816825beaf9da79521d1b0e434dc14336ecb3d437d4786b6ad20259912dc9828f416329080a2def16701e37e8f3eb2a1bfa5b0fdf0d365ca021dc1b25c2460fb962686d156c610b4a7281200b195db5d49f24ddb7d2bcba58b876bd1cb38a42eb6cca6a0805319e21fc727b096ead6a6fd40e8e37cfe67fae8a2ff7f97f51c67f0de47baf950aadc2cc4853ae7b683fa32c465214c4fd3e1ec5c78ce89a389391c2a9049e7ae7f9afb3f8fc7418fea369dcfe1f4d3f0c3bfb09a0cebbcfe894193d6496ba9bffda38cf37940ded790fd4d79455c82f09959a229d663b8f924b5d8995f00eb857f14a648d0cddbcbbdd21232941915a59d4fbb4a639513a95cef41be3e6f5c09b75d12d2474f194f61fbf5fdc7b1e30ae7f45bc0ae7ef737521e95608df0e8f8f7f02403597bb', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138063, 5201, 250.0, 250.0, 'mg', 'PO', 1, 'Pediatric', X'789cb33332cd4eb752303235c84d5708f0574849cccca904003dce062f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138064, 6527, 2.0, 2.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c3352c84d4ed7cf4ed7cfcdcc53f00c0300250c04bd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138065, 6527, 180.0, 180.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c0b2e492c2a5130b43050c84d4ed7cf4e57282d5028c9573032d23353c84d57f00c53a8300400cca00a8c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138066, 6527, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303455c84dd7cf50c8cc4b2b2dcecccf030045dd06fd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138067, 6527, 2.0, 2.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c3352c84d4ed7cf4ed7cfcdcc53f00c0300250c04bd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138068, 6527, 180.0, 180.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c0b2e492c2a5130b43050c84d4ed7cf4e57282d5028c9573032d23353c84d57f00c53a8300400cca00a8c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138069, 6527, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303455c84dd7cf50c8cc4b2b2dcecccf030045dd06fd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138070, 6527, 1.0, 1.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c732e72ce51b03135b05270494d2e4a4d2c4e55c8cc4b2b2dcecccf5328c9573054c84d4ed7cf4ed7cfcdccd351c84dac5030d73355c84dd7cf00001229121d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138071, 13086, 0.5, 1.5, 'mg', 'PO', 3, 'Adult', X'789c33d033d535d43355c84d5708f05708f174010021880409', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138072, 13086, 0.125, 0.125, 'mg', 'PO', 3, 'Adult', X'789c0b2e492c2a5130d033343255c84d5708f05708f17451a830574849ac2c5628c948cd034a42e4500433f3928b52138b5381b2e620597da09442a1394441be427a7e628e424a7e712a007e811e4f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138073, 13086, 4.5, 4.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d13355c84dd74f49ac040021f20479', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138074, 13086, 0.375, 4.5, 'mg', 'PO', 1, 'Adult', X'789c33d0333637d535d13355c84d57700d5208f0574849cccca904004469065f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138075, 13086, 0.375, 0.375, 'mg', 'PO', 1, 'Adult', X'789c0b2e492c2a5130d033363755c84d57700d5208f0574849cccca95428c948cd5328c92c294a2c49552834078a56162b240251527e592a00f41b126f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138076, 13086, 0.125, 0.5, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d03355c84d5708f05728cc280600295e04d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138077, 13086, 0.125, 1.5, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d43355c84d5708f05728cc280600296b04d7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138078, 13086, 0.125, 0.375, 'mg', 'PO', NULL, 'Pediatric', X'789c33d0333432d535d033363755c84d5708f05728cc280600318d0540', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138079, 13086, 0.125, 0.125, 'mg', NULL, 2, 'Adult', X'789c732e72ce513036d03535b052082e492c2a5130d033343255c84d5770f27451c82f02f28dcd4d15d273155c83140af353144a3252f3144a324b8a124b52010a5811f4', X'789ced596d6fdb3610fe2b0703c556cc76eca49e5b6f5fdca443032c69e064fb320f022d9e252e7c5148ca8d50e4bfef285989e578759206e85a1808108bbc3b1eef9e7bf8f6a9c56d9e449a296c8da075669912195e1b89ad36b4722b436bea7de6467b7b1fc525aaaeb149f825f6d6845d6c59863c623ee8ecf7f67feef4fa9d7eefa2f77ad4eb8df6fbdd37c3e1abfd7e298bb117463b92fcd41a7325b470deb2d0563679bc2ead5c14198ee0c86434924660890982537d641c4b107e3356b9115c8cdfb6e1dd24fc9fea89c93d3a307368da1dc107cbe4541f1aa58c860bcb38c229cd9b0c9c88e0fa75e9593e5b75ee869a3c9b490c5f7ffd4d5f52e8cbea23f48d792e7d44ee089d343cdf60ab75c6eca5d0cee81f5c74241c32870d9d63a5900be6112ccad03bd5bdeea0d3ef0e402570f6012e8e8fa6fadc33eba1d7edefaf34c3f510382b1cf8143575567d8d46a1631b8c52ef30f4ee51175c0d2b0103896112b809839eb0eb11bcead64253fdeedaa3e6c86172e7d7c170d0a96442e8c90bce842ceedc3b18aef7556e781112823472e51ba3bf995994105a897408ee049da76f17494c5ce40acdad51cd909561e8f46e237495ba4d865826788405468a4652a87de4246216cd30650b616cc4853396a3dd60bcff39e3dbf0b14bf99694afd7c87790f3a74fe15e30bede1c9e75e44792ea59591256c40f25d6d5886f0ef8e027284cc07015f72552bf3cbf4f1bed91f138cf30164c466726cb25bb9bf667d71a8b89663a2ea20969acc5f090aa3131b680435a0f591eb480f105f113079e5b1287acd6a71555b8cbb09ea29ad9c274e6e8036d20f329cc585009da5aa8d0ca3c03e6e15567002793f7471beaf27716fb720e9125bb4db7c879419002263d5a4d520be29d8b148d452fe272d48ad03828212fc949c3f372d2779edc8950afa4c18406890b941b490235c57503caca757d44d1b187120e7a9d416f046b2cfc9628d8d825ed252ad0de95e10dc65beaff7a40dae385111cf2c0a4b7f80e5b1b6267c6ffc99d0f45068a087a161683ab5c58e46d98e51e52224c6d3c756098df9cb642bcbb6136ef31a3986dac9a6a3e706a56066b38724af697a61fbdc6fd6fa0b65e043bac7d6f58fbba19bdbfeeec52fac529fdc683b88e89af14c5671cf691bb13aa3b0ab4d09c6aecfede642c25daa408c78d5832e7f6c27dc354579960339b671e3e0a9f72cb3e32f9a413f802adc368822c7ed8d6e81cad307953ee3ce79c125bee710133dadb727453fdbec80c9d831ce94e759ba0e653e30201c574ea29746c3282d251e1e88c874eb0f2d8645956849b114e8ce30a9579a3822526651e0b5d868816ba94cdb85185918513d47d7a723ed51d292ef15607c41c589cd3b9a9199fb5aaadee331a936978bdea5d1b2aff6c71cfbf5346651144a6342bedbcc8969e520301c5da74d9bb304a84557eaa8fe95cabb4a89ad3e6fc420b32cee214cb8f39b527792846a3e779f0ac4dd9d7c6964b3951ae72d4a04a3fdb101b453b5d47040ef579835cfc83760b8c7612f3509958ee174e72174b0a59c69c6a434689cd52b46412392af6881ada18bced5760abc2647d054f1538b65ba8051bda4d746c37b226dfb045c8da6e200835b49e270a15a81e307c25d7d05d45e1760b87abd20d3b3578b7db38aa251bfa35deb7ebff594b36f4eb2ad9ae7f2bd9d0afcbe80169a8251bfacbcadbaefedb52f0a63a737edb24b9cef93b96dcb1e48e25772cf9cc2cb9a395cfd2cac3b7f2bb9adad5d4b2a6ce5246c08c8d3449d1ac2c26e7b4facf7104af53f8f178f2f21778dd1dd0cf7793970447246c19299c0a275a8d619f1187ab9ff0f61be08bf0a6f7e20927cc138c53a6c96e64e6d138bef7487dee850af7f2e880d72fd51663a4e2b64fbaee478cc6d299c6202b0f89c0970f894facb0ff30b5e5b1bf567ab13f7451ad4619bbb9f91740d2f194', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138080, 2236, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138081, 1152, 1.0, 1.7, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d435d43357c84dd7cf4e57f0f4d5f70c5328b4c80000398e059f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138082, 1152, 5.0, 7.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d53557c84dd7cf4e57f00c53283432c90000285b04ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138083, 1152, 5.0, 7.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d53557c84dd7cf4e57f00c53283432c950a830574849ac2c0600580d074d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138084, 1152, 10.0, 12.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334d0353452c84dd7cf4e57f00c53283432c900002ecd0505', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138085, 1152, 2.5, 3.5, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cc29b15230d233d535d63355c84dd7cf4e57f00c5328b4c80000545406b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138086, 1152, 3.0, 3.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c05c1d10d80200c05c055de02c6045dc205f86f62a9042ada96b8be771b54d6263832deb45f28c34081cee481848fb939c8f190054681ce1e75396d0a8ca52adf3fc0ca165e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138087, 1152, 2.0, 2.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3352c84dd7cf4e57f00cd3f7f455283434ca00002fac0508', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138088, 1152, 2.0, 2.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d235d23355c84dd7cf4e57f00cd3f7f45528b4c8000039af059f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138089, 1152, 10.0, 12.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d0353452c84dd7cf4e57f00c53283432c900002ecd0505', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138090, 1152, 9.0, 9.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb354c84dd7cf4e57f00c5328543032c900002621046d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138091, 1152, 8.0, 8.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb350c84dd7cf4e57f00c53283432c900002213044c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138092, 1152, 7.0, 7.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3357c84dd7cf4e57f00c53283432c900002204044b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138093, 1152, 3.0, 6.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d63553c84dd7cf4e57f00c5348c92ccb4c494d5128b4c850482c5628482c2a51c84f53c82dcd29c9d44d292a4d57284a4dcfcc4dcd0300d8831266', X'789ced59fb6fdb3812fe57880087eba27ec44edc6683c502cea36db64dd688d3a28b7561d0d2586623912a49b95117fddfef23fd7694da51afd93d5c7e8a250d87f39e6f267fed843a8bfa9227b473c876aed440f3240f84dca9b09d4cc7eee5c8dad41cd6eb9fc5352535a523f74bd457694da0794a619f5b77a4b9db7c56dd6d541bbb57bb0787bb7b87fbad5aebd94163bfe56929b0424903cabf765e9224cd63ffdbd28d3f7e95a774d893ed444815c579a08c08a9274f94e111b1174a27e6909dbdebc96395244ab22bcd4362175002ef9d5c74e3efc906cb577dc52bcb0731b9a73f3fe02916f2da3f2cae5ebd73b315d6e8bf7e70b7b4c32cb67d882b64b4a25881543b67723879acf4073cb0a4c59a3560c6da739644f5eb889d9dd7cfdeb14f07a39e8419182848861432217170cc6316fa4b61bc56757e06079afba39d55f59d9c1d4919ec2778a5ff4a9954581e5779f029139ac215116e316337cf59c87353c0f492c04973ab74de1733dd4ca57f9c1b2b82fe500c346434fdd49a553577ab8de6ea2d0881d81eb266ad55ddabb596be1d1469732a4315701d0a2b70dd4b04673fc54d568ca96f72445994af5cb8b7a6d21006e596c5c48d654df699e8da306e58cab5656ac8123855545dbe304d914848ae0bf18d08f3123ea4abd7c3ecd1d70febebff8ebdd7bdf868f03b0dfe70a65977ca3fdf367f8f84dbf7df49c65028b8d5f0d57774ce7e73e5d82f073e95988ac39e5c78b97e76ce3e359a70f4af2b04d5e692bb3d516132dc23d4d6e4f9b5c112d59305315770cd0b1a6811531f95c46a95922f26f09bad1a4b493fa038ee5bcda549632eedaade2d96e39e9f97ee603eb05bd546c37f3a580ff946f3a9ffb019366c114d6b6aef559f2db886622c5c23836d7f7c7bfd31f1f01d65f931201e2e207e945bd6ddffe897fbf9e51f63af129dfc6f31d843ca75cfaedd4d297075b6a3d22ce60b53ce04e980b5e432c8d925becaa8270fd9714fbe4181f6d487ec9ce72c33546152b16ba93e4ba685b966036e2032a67b2f60eae2445b41a6272f4962fc9980044035376cf7e4b13e8e596bb7fa7cf790bd845da06cd5bbdf7f4022b7e61f9afbd5fd83d9975f1af3f7fb07d5e7ae07bc3a99be69edfe0b926593598b181fa2a7c0983cce51357ab233a333599ac604fb418e398a99f2df5bbeb9d1ac360e96646afe3cffb22c6da14c7577ddac18dd34981d91643cfc98019279f1e60633a4b304472885858375435d28d0d350480a57a45d7a5f7679b2eeebcdeb9313b77d9a101b94e8fe9cc3749372ac240a8190a1080a62ab1dc72ef499552c88b93175172ab021cf7c64c1043982c690f4a922aca734593c147611476749ca859e38ef844679a8fd4d6eb924834c6b7c6092d2915656dd88a08e3ffe07e3913f33390fcbf30cf98956531f13dacb00d9a0d9f0068c2e28d32ac94ce05f855f6076ad6225231c42e09748ba7638767af52f8907b7cd5254d9ba40432a5ba5fb7daa090c53994bcf00f5170a38e1e7aa7b3aafccec715db741ac826bee02ab9bc1f2f39e0b63d6d889180e517e8c42bdb08e06a1a7f588384253f27494c7fcc6a5d52da76967c4d39ba18a71d065c509e904bfaca3bef2bea014050e2f63b82a80715d82562085a53118557f5323699019dd5c861097c04ee748a0844f8a20e69b840a1ae864bfb862b4a3b7171576ac19c5349e06ca89f8f2056963200dee1cbb3215a1df5c092985cddc5b062d618d88c5ca519dc98f13bb30e8484ebf7b3484852833fb6d9166334af05d4a9f85d5b758742e11af70b9cbc69b59ae9deccf4faef09f5b771b3567a42b1ca61ed97cfedd9470e5f4cc8d5b6cc4679493daf598725ba5dc7aa57accb9c79c2b9d730f1a3c6520d2ffac653b238e640f805bd67685af783cacc6624840a700aae7041ba06c9804c85e48e10a04509754d295809b40d304f54fc0d793c6aec3d832187107877e72e7dd6f1c77134a3b98101f01011ac766bed701aeee624e1828a3dc0d704506692b4cc89118088727ddc86049c065b944dd31a268a1be1168495465a1dcb6a03b2f8f8236e3add7b46aa56e4f1a946c4ac12fa6faacd6127be2078c3887ea673de9ffb99378508e4f63c42084cbd9f251ed54b1988b71e2b227e78fec09da880488a7a16f01e01d401900e709f7ee5388e06745e1b61fecb3b023e6466df619148ccf3545bcbf05e95c42b7fc7d7b7586c902923c912e097237a783c7bcdb80fffb464f62820bb9457779dfec493e11021e80cdb4aab04166bd80999b5316b2817aef1bd40bc225cd9c4c2fb5ca52d666c66a4a598af8cc65e43a94eba78b750f0b3372a1735a63434e60e45ad8fbfd32374e6f9afd67e7db0d0449ef2574de77133beb4c277677ec771df9209f147370adcdd4a9b02394ab0a7bb9e321c4bc253bcacb492ecfd9dec169feaf272ac1e39dd022e4309b57b680c1fbc6765220a18554885c16956273ea5241052a08c062e6b90246ddfbf2115952c22ee7dd6ebbc4ede79785c736dd76dcaede71720bf30334d4d8e9049e89b0d068679beeafb18f847e50ce566f6a0cf1a782dc2accc8b48dd77c865c50e4d1a659677851631118024f292a15d56080095ff8fa506c918dfe579adfa05a7216a0c2419292e1f8aae66a539c91fc52a8c9c670ae31346151e2e4eb98064638154c51426e79717dc1869d768fde3c2dc3ea16a7d79de322469b9c32c9ed0928306985b593f418e34854ba4cacb14a55191763f0733ba462336fcedfe96996701d10fabe2c25038f9182773a7bb3142311950e958e435ea8b689d07c208af364a3043326e32c8e8083ca18012cdce25b62fa6526ad959102698f071fa325391c3b7031892b36d49461062fcade7bf10985dbff65a5ecbacca7a44a6d640aa28b0324940aae7680b9c67e5b884da9df319485532938e9cc830d5e22488e327d3d5271e8c60ae0e19407a288cd66ec45c08e5aa5a3a950184b2c9e10fe65d8fd01ff0285724653f812e3705046bf179a23018c0f61eb5646ee78996c3ad259f08d44e83efdf72658409150df954b1d8ec123d39e85db22a90058b50ca3579c12ef9ccccd07184af35239f94e0cb450ae44493114416142ae43ad7361825b39398a7992875e225e9c541bf1491ea814f53a59cc276580d2a508aec95a23be438ce9909e258c8f8b01e42dc3b62577ddf736f2731b00a9923c2844919ba439f29228f400407fcda33b7ad1c65aa3698c66e4a38e62bc960ed716a7e346641f2b4c5600a1304f2886881a119771d4329f276e6a9d33fba94c24bfc8cc92dffc4617954c9782ff1d4aadf2e3a39dcd5d77d6f80fb7772e8fab93ff8fd5c97d56715fbffe077917377c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138094, 1882, 2.5, 2.5, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b65230d233cd4dd7510012008f56094e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138095, 1882, 10.0, 10.0, 'mg', 'PO', 1, 'Adult', X'789c3334c84d5708f0572829cf4c4e554849cccca954a8503007b22a8b75144a3252f3144c812a9c3c5d001ea50d37', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138096, 1882, 5.0, 5.0, 'mg', 'PO', 2, 'Adult', X'789c3d8d4d0ac2301484af320728b1162ae24e7123088a3788cdcb0fb67992a4941cc17be8c53c89210b7703df7c33fd6470bde0703a0adc48cd03215982e25802a3133dfe0d388da74c8e7c829511d26774605d0dcde3c88bf36687bd217c5f9f6d8b4c32c4067756190b39635301ef4d8b8769c00191c23c61085456bdf3555bd7cb953a8b1f9af13531', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138097, 1882, 2.5, 2.5, 'mg', NULL, 2, 'Adult', X'789c33d233cd4d5770f27401000b5b0259', X'789ced586b6fdb3614fd2b17060a6c80133b5e1ead0b0c701b772dd0b446120c1be642a0a52b890d456a24d55828f2df7728d949e404cda32d860dfd1288f4e57d9ecb7399cfbdc45659a445c1bd31f526a55c8a85d0bd3ef52aabc256ee7de9c683c1b93ce362dbd82c7cc9c17549175b517212091f0e8c86a3fdade1ced6cef0747830de3d18ef3ddb7efa74b8bfb7dbc872eca5d10e929f7b93a4905a3a6f45d86bb63c2f1b2da775c9e3b99e682f6323b24a09ede7fad0389131bd32b67063f262a1f86af7c45bd699cff1cb687bafc8fa843f737d6c2acf8e4c4a5d73637a6f859aeb97a6288ca6532b12a6774804ce4f95fcbb92ae71b85a5cf7f9025b8dddb0faeb03564aeab36671e57cc7eb7be4b2237ef121d8982495f21122933aeb24e6169f7ab34a210461eb888b8551d215fde8f0f7d3ceb99d6191d1ec3df97319332542aa9a967480afdaf5c9e7ac43bae8c59bc35e37c4e00d526bce382a2d7f621dec46524722958b8e89bdd602546cd3312715ec402f25c6e1c384a2d0a504c9944ad401ea28178e84ae69148a144ea44629738ec8c7344161e7d568b4bff77448350b0b671726a9e99c6596fbf6b7ddfd219da1dec692635b15145b866e2df5faf04e637b90bcddbe25ba99717ecb94216508d19479adc4523a04e8d946b92c2363a333cd1c09eb730828e17cdd09bd01dc6dc9fb025e5adbdfbc749be0f851bbef55bbff59666fdc2aff665b7c63dbf7bfc55bf39c48e1ad8c6fbb814f44cabe1e709aca58c43569e3895d50275dcec923cc9d941c4ba1a29929c1015715585b9c59ceb4d0b0751c0a08521bd38bb97e2b62df489395ee2c6cbed12928a459522c74f06cc1642bc50981064186ac850ad86b60f4ce90483e56ce1701702980827c0f6653f2012961739b26c0f38a50d708bd86a35f01a1b97ecd01b4f117f4165225248b5248dbaa7d07d72cc7e05ed609bc835a8736b27c5d0ad4cec1985bb54bb06d340e491fc2acb085de78f9e7ec97c92e7a25a1d95656120aa3aa25251522953a970be98d7d34976fe6fe6e3a3f0c13552becc28d70a9a10783578abbd5bb5beda57c14e4a35878ce8c9570be9d185e1a8dc946ea04a8bc09a189526cb33adc38317ac50dc2dc87f90ad9f8c4841c00f16d700fc4ee2441d51c47c72ce29b666f2524b6d2545db923f1112859bb413ffdf6a64f45e562b483ed139732a930acf5514fc4887153cbb002183e563a841056959581485742a6e430e77de29fe7fac54a6f7f85b1305726bc149a3d09950ab4d2ab53120b8db95228e943526f524d3b2876dc9e0a57d3c262546cb4e75c086f0ad1a70cebe0d565480887a1dee62293a2890837c652deb0732f4c6ec6f3c011330a84651d2e1cb466a464ca5bb843d1d38c9ecea2c665d7056b375ff7b1b7928f1af916a1ff99c26f22f647e5bfb2f2df2d810fe5f55ca0d0b15126eb0e0bafe1ec56c8c7980eb676f629379575737dc4d0d64ce5635a911cbcc1258b09bca59db99e2e4151ed8372b4f704186cf0c80d1fa51ce3e98941ae5829c24bf439782f9030afcf9188635369ef1aa61c1d3c396d263ee321142b0c77e00e7e4e0ba92450dee84d24b8d307bc63f0905d6d71e001b9681ebdb8ed5949bc7a5ba2816f8d478fc8dc11c7399acf159149a3497ce3bd7edc004b4201a5200204f287b8625f8c9b3bcf4694acd83ca130b3150bf8e36a8dd9d63daa9a2718ff26ca992ed16d347807ffb4c67f93ea4dfcb78843d967d6c498d42d3208175703b9a373e9736a75196ce6b82d203bc5948207dba3ff55f075edd56dd58786fafdaf8ffba7f26e5fae7485b16aad2b0abaa20d5d5d1fa6f7d03ded9e5995f48e490f42b8e02e2efe01734e9468', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138098, 16585, 60.0, 60.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6523034d5513036d051303350c84d070075860790', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138099, 16585, 60.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789c333350c84d5708f05708740100106802cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138100, 16585, 30.0, 30.0, 'mg', 'PO', 1, 'Adult', X'789c333650c84d5708f05708740100104702cc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138101, 16585, 60.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789c333350c84d5708f05708740100106802cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138102, 16585, 30.0, 30.0, 'mg', 'PO', 1, 'Adult', X'789c333650c84d5708f05708740100104702cc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138103, 16585, 60.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789c333350c84d5708f05708740100106802cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138104, 16585, 30.0, 30.0, 'mg', NULL, 1, 'Adult', X'789c732e72ce513034d53535b052303650c84d5708740100345104e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138105, 16585, 30.0, 30.0, 'mg', NULL, 1, 'Adult', X'789c732e72ce513034d53536b052303650c84d5708740100343904e1', X'789ced586d6fdb3610fe2b07030312208eed24ee10a728a0c429f221693dc7ed36cc85404bb4c45a240592726314f9efbba36c3972bd2671db6d1ffa214044defb3dbc177f6ec4a64842c5246ff4a07119eb3b3661aa71008dc26474943a97db5eabf549ccb83cd426a1ff44eb21a58d0ccb791c32470c47eda317cd76a7d9698fdabff6ba47bda3eee1d169e7e4a4ed6979e4845616293f3782580a25ac338ccefc91e3775eca6891f3de5805ca8948b3a4c8987263d5d796251c5e6b236d0f3add03386e1fc08b36c864ac86ba70dc829e425d6e0fde1a968dd58596522b1819167378831ea3885b36670bcbbc65c5e4a171f778e4d824e3f4f5d707fcca849af98fb59535f31e0f5a9dfcfe03e908e22273213a2654528bc0169b1aa3d46839d11cff3261650b5dd4331e0e8cced345c6ee84ad89f08181c15bf8addfa8bb439afbef47adc16538329c39c995abb1be44de1906f5782d62ac5e2d0fbf22f72b61f34abfcd83cd78fc272e7c37a54f479cd73be0b160ce88681b5adeb4821d44dee63c122c0b073a474caee3ba923a303c514c450b18e2ad42177ad03f8360ae450c85e5b0371476464f4e32c78d6219a45c6a63527aa64cc58089360bdd9c72877731462c852207a7e1e4f4ee6678d58709b33c067c974c094934cc31cf693624b74a19e80cc641259e116264943c4a91d94aa266def93378a361a6f42755894121cce9842b1109b7d81fab6b24f52e7b12f2ecfaf80c0b02aa5940a13cf736cc0d391ab32d05fe2563cdda0e71780071ac45e622835770daed2d83f9cef2e569b7dda4637420883f16d6436c79d5e936bbed1e94d82260f9d3979d2eec29ed288857fdfdde3a3d5830df8fc60ad10a6e85d6b5a8e30d51f088ac0a7f685c89b68d8272c5730ce8567896b1818b546471735024292a63d6c23968d4fb0c354f2acb9bb07dbc32f7a90b96c436142aac243450e15a701d338f8bade843a20f238472a28d40e36b62314b4f301189ca96f113811534361fe7ff0682cf4ce98fb2fb99fde0422b1c9a848a45b4a51b0459c64db2a0ea1d91092d9a1dc7ea0a473563b9b24eccb1b4d2355db44a9a48cb5c2b9ff6000d99732ce81fd1f2551d7f8044cabb6ace5936c76664803cc1823f151323b2b23b01450965d9fd15f210466841193d103267c210c660ef1fe2b5bf435482784e0e8643cea22fa3b20d86b7dc085dd4e92e731117a6ec90d889241babf3650c0ec07254c1ab976b85854f027b656e88b8301cfaad8b2d25b79c696b7aceabc0068a4b816a86cca6f8753d3a80e076043ce3f372e0de05d85fb8f1845d61c912562cb5ea579af994e9d9d3d578c9b5c7393d55f9d07e5c663631f03335cf4ccd37076cb70dee5ff47090322359a4339d2c6a7e5eb16cdaccc494e352db6e764e2035637583f36ed9c07b7023fc747c06177f0e4e7c070e4e80fca51d17d1797917195e2ebbef8c501c7bf82f3b54ba9bd5281dea6918445f6ce5afb1006215fd838150a99808fcd8a9cb48aad17623d52c9ac1b9be83df99513487e12033e47111e17a70399d6247c2794e28a8f58800bb030cdcf24d969de4b42baf5b1229fd99501819bf63f84d608ae60b1b21dcb15f947311f6cdea2d57430ac44885dd50a8a2ec3c2b39165ccaabad622dbd128af502d9490fdd60484023874136e6fb574ae9476f1eac32481be9025b0c50b7cc7c2231a7cbb7d9bacd056d5657cb270a7ee76253dc687051e216a55bc148882d09f34245de1bc9166884c5f981029769953491491229b66cc9a82da349a86341758db6aecacdc35dd649cec320b3ba3e353cfcd103cda15e4a6d1d8d20c4375d4a31e7caef741411fb5d7e8d79b2a667fc6413ae64862833dc94192e65e25bbfbfff1be3e57555', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138106, 2707, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303550c84dd751303400d10079a407ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138107, 2707, 100.0, 100.0, 'mg', 'PO', 2, 'Adult', X'789c33343050c84d5708f05748ca4c0100164e0394', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138108, 2938, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c7349ac5430b4523035c84d572834cb000020ad0432', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138109, 2938, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c7349ac5430b2523032cd4d572834cb000020c30435', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138110, 2938, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c7349ac5430b6523032cd4d57283434ca000024f10463', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138111, 2938, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c7349ac5430b1523032cd4d57482c51c8cb4ccf2801003bb10637', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138112, 2938, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789cd308aa5048cb4c2b494dcd533032cd4d5728494c2ad6040053470742', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138113, 2938, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac50303630c84d5728482d52303251c8c82f2d2a06004b3506ec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138114, 22487, 400.0, 400.0, 'mg', 'PO', 2, 'Adult', X'789c33313050c84d5708f05748ca4c51a83034504849ac2c060042d30661', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138115, 22487, 400.0, 400.0, 'mg', 'PO', 2, 'Adult', X'789c33313050c84d5708f05748ca4c5148cb2f52482c51c8494d2c2e5130554849ac2c0600a30c0a52', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138116, 22487, 200.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789c333230c84d5708f05748ca4c51a83034504849ac2c06003fb4063f', X'789ced5a5d73db3616fd2b183f391349961db7d928fb22cb6e9226763596d3c9ce2aa3814088444c022c0828623bfeef7b004ab228d3a6c23adddda95fe290b8f7e07ee35e507fec05da86134913bed7237b033e0b84519acbbd16d9b33a762f2363d2ac7770f0555cf3a4a374e8fe270ecab419d334e5c1841ac772d43dfab1dd3d6c1f76afba2f7bc7af7a3fbcec1cbd3a7a71f4cad3726684921928ffd87bc325d734f6ff377ce1d9aff294f7c80b1d90d0af3aeab1643c8d68acb2546981c75395d190939f944eb21e31741a73b37e3b32902b3411568ebadd1639ee7693702c2f95353c236a46fa4122a4c84c01de23c35fc672a092444972a569c0c9054c02ee510a6135657ce625b7d34de16ff0ca6fec9efefd194fb190d7fee1569992d8bb987593fce6b3dba31fd8d84ca09a9061c9501532ed0d22ada4609313fc619130226b4dfa0c7a4fa69419ae058d277c018df4d4eb5e02849d4812c21a642a02b238ec9280e6d95e594f27d250720b6309da9a3098cd4a61f23665bf59a179f000e44c69420d8939cd0cf9c1a38fe539cdc9e9c180d019e4233331e77e8188195ef1a91631278be37fb45f1e9148595d294f44752e43a7eec1154c21e2b8501d2ee6a9514c31b61565472e26765075742de444c85961e46d881dccf54098f80dbe93c7b603e3c9658fe7b2ffba2def38f7ffd9988f28fbb65dbebbf08d36d8fd1c290cc403418d4689d8f10c383c7a3ec9556bf2d79c05abdd9a26c5e2f0b816fafb85f76a8bef1f2968259cc1872ab531bd75d66a97a1e6a1a492e5e412ab12ed4a8f9cbc26ae3ad80c25c1a2210849baa21acb0ff0e1b27d59117d8d5cb1986a575f661c61e3602eb9a4312942672c7d338166470f62f2a2db467306ee0529cc05fd964bff7cd1ed11b2b1f41b56ce4697a7076f4fdd02b95086047c2624c7c23a421f1bf82d4fa122bb233df40cda431b466410d32c237d82ca7ad20333a1c1179b255c56910d7af7cbfd28904dbbc46de7d7378aa7ae712f8833c4ed648db06c1a074aa271153210ac22d8fa71cc759813a308736a1cb83900e646e7ad338e0433628ef475eb8988af1176ca7021715a0da846624357af3213dcc7e2805a1f89d510c3c1c52a0c459252a10b5b9e72e622950724b11943e02690c411322c133a5db4f1ac903406244cf9946f503efbc1dc4934b9e494ddb544e5a981d2a8ec96c5244da33ca60b01114160937626d8b5e4888118ae217a098f55c3e73040fb6715c90c134596cb40ab8423ce756e229e50281c1b816ec0bdbc520b44384f45c0750213499845c579e636fac0edb54a398aea585e706bf4eae10aa53d992a969bd59bbee489fbdb22d801fcc645f5888bdfade68e390587715bc1292e8e150ce6ea07a8be50ebe20464830e09c40c7e8df9a6f191255a471ce8230bf792759dac8e07b21f2b19b671c224ae2c3dab28bbc5b055b2f0e97a930b0a2eeab29f06944590ab3f0d1426365807e1e37785c0900a466a91b98de76a4e43b78ea8cab394a799a0df50a02bdd5c9f839bc440bf45b92f02ea21b738276bce127e451cd543af98261b4c25d4fb03b11edcf34ed6bc930dded21eb7015d8fb9415bc2d848847a904de2b2b65b19b4838edb1c25bc22ff76091a4f578e97224d77088f2561897b95bef5ec3faf284bfcabc4dbe1d0595196fde1d3750757147425de558ad773af29cb562f15861dacbfa29f78fae2ac7caaf78f5fefefdc4b3d15fca782ff54f09f0afeff42c1ff8b8a519349f06fef1b77d793508c7b2acc4b1e7a4be3593b1633de23879d1fa3d7e4b8f332c2d144325450ed0ee4ed01f39cc3dc981bb3a447ce851489f3d0d9025367716df251bb732cd558d022ce1d038ba804bdff46c40aaa93e2ae8c8980c6afb15f24a6c26484f138265f29fe492c437d480d4aa12bfca8b959b341551a402b1cd193d17a8016bc7e5e7dcfcb961a8d658689da8984dd0e56d33827fb36b390387f3696efc652487762fb2b102ccd61030897934d56ed5431541a705c8ee5fa91ec2b4da43284cf7c67006c0665045ba28f9e43845c721d821e67cc5761a20d8bd1b5a6e8793e82742da1bb21ff78f58e280949f6a53f4a338302ca6e9b10e07f3a1c4ba948400d12f5d3d158d2420844036ca6558b4cadf1025a77bf702b1ba85f3c407d4bb8a19993e98d5636257de22f1c497a7b1fe96e89d6926524b0dcdd789c75c88c7200b9a6eed371931d973bad2e551f6e6e5040bc84cefb6f344dc8501506756cbfe8d00775d1a800b5b352a7454e5a64d0226ff67c17bcbeb4f194456eaf61ef415adffaf20618bf0a8dac82d9bcb2cd85a0f08554085c1256a17c3aac81397399e06f9101b1725c05d0e5b7e2089b3491e77c34ea37b0c6f965255b9dd4837ebb21e7c8a01fee90b3a20bc4915865b47775db77c8178e83a1a1ad3e7408e2cf3769eee702bbb8cd67c8050fa9cb906c1bf0a2434200e26c55bc51540300e78ff0f5a1da24f501a0345da05c52c250e220ca3d015927cadb8e2b4eb1e5f2f746aaa08eb98bd7069cef633ecd8453216b92d8cb8d0f6e61c8d9e8e4c3f326497907e9fd70d008c86777f1e92c4b5ba49fa403cc4ce16341a5aa49cd1971ed7ec5526de65d99093a20c671eecb46e13aa23172b0b1b34791081b330fdda70994db44683a15cdd26485815e3e441bd4a48a01628e2a28198c99a59d86498f071fa1d508b585dcb51645509199e66ef4ab4add6f810984fb78621b45c5264eb542757ee923491058140d42a373bdcfd0e09b8765a8051966dc064b3128d7d6b71ab4815d4facbe8e541cb80fef688653ca44154c7db6198ece51ab345a4a85b9c6e009c1df08ef5ff0309a504af8b27d715fda5823a89f344506643e868d8da976fc8d82e7445bf6402ad4b7053c14eacf24d39062eeb0da23b80b34e506c0264730e589778e75d30166cfbc2a276bf5f9554cb550ae424931136cb78c3c1719bb9395514c933cf022d18679759e63e245bd4e6ee793aaeea216e752b06b6e4c26fe8c20cbdfb2d884d0f98e3d645f5277fcdeedfddccc2f5592b3ca3eb23e68bd280ae700da7f4dc37b8ea3fa92a3f91c27920f3d1ee3b574bd6dc39c1cc40ae3153a5158a8b8ec1771236f6d02edbbd9758df6ac51adb0d986effcfd312a9a6e36050cddcf80367e0d64b3070ac7e7bb772f4f57287f8f2b946fbc921b713ee9c799da2b7f1a5c9b9eec9f5321ab3e78edf8f1a90aa9ee73c29a67b2e4b9f97c7373f31fc49ffda1', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138117, 22487, 200.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789c33323050c84d5708f05748ca4c51a83034504849ac2c060042a7065f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138118, 22487, 400.0, 400.0, 'mg', 'PO', 2, 'Pediatric', X'789c33313050c84d5708f05748ca4c51a83034504849ac2c060042d30661', X'789ced5a5d73db3616fd2b183f391349961db7d928fb22cb6e9226763596d3c9ce2aa3814088444c022c0828623bfeef7b004ab228d3a6c23adddda95fe290b8f7e07ee35e507fec05da86134913bed7237b033e0b84519acbbd16d9b33a762f2363d2ac7770f0555cf3a4a374e8fe270ecab419d334e5c1841ac772d43dfab1dd3d6c1f76afba2f7bc7af7a3fbcec1cbd3a7a71f4cad3726684921928ffd87bc325d734f6ff377ce1d9aff294f7c80b1d90d0af3aeab1643c8d68acb2546981c75395d190939f944eb21e31741a73b37e3b32902b3411568ebadd1639ee7693702c2f95353c236a46fa4122a4c84c01de23c35fc672a092444972a569c0c9054c02ee510a6135657ce625b7d34de16ff0ca6fec9efefd194fb190d7fee1569992d8bb987593fce6b3dba31fd8d84ca09a9061c9501532ed0d22ada4609313fc619130226b4dfa0c7a4fa69419ae058d277c018df4d4eb5e02849d4812c21a642a02b238ec9280e6d95e594f27d250720b6309da9a3098cd4a61f23665bf59a179f000e44c69420d8939cd0cf9c1a38fe539cdc9e9c180d019e4233331e77e8188195ef1a91631278be37fb45f1e9148595d294f44752e43a7eec1154c21e2b8501d2ee6a9514c31b61565472e26765075742de444c85961e46d881dccf54098f80dbe93c7b603e3c9658fe7b2ffba2def38f7ffd9988f28fbb65dbebbf08d36d8fd1c290cc403418d4689d8f10c383c7a3ec9556bf2d79c05abdd9a26c5e2f0b816fafb85f76a8bef1f2968259cc1872ab531bd75d66a97a1e6a1a492e5e412ab12ed4a8f9cbc26ae3ad80c25c1a2210849baa21acb0ff0e1b27d59117d8d5cb1986a575f661c61e3602eb9a4312942672c7d338166470f62f2a2db467306ee0529cc05fd964bff7cd1ed11b2b1f41b56ce4697a7076f4fdd02b95086047c2624c7c23a421f1bf82d4fa122bb233df40cda431b466410d32c237d82ca7ad20333a1c1179b255c56910d7af7cbfd28904dbbc46de7d7378aa7ae712f8833c4ed648db06c1a074aa271153210ac22d8fa71cc759813a308736a1cb83900e646e7ad338e0433628ef475eb8988af1176ca7021715a0da846624357af3213dcc7e2805a1f89d510c3c1c52a0c459252a10b5b9e72e622950724b11943e02690c411322c133a5db4f1ac903406244cf9946f503efbc1dc4934b9e494ddb544e5a981d2a8ec96c5244da33ca60b01114160937626d8b5e4888118ae217a098f55c3e73040fb6715c90c134596cb40ab8423ce756e229e50281c1b816ec0bdbc520b44384f45c0750213499845c579e636fac0edb54a398aea585e706bf4eae10aa53d992a969bd59bbee489fbdb22d801fcc645f5888bdfade68e390587715bc1292e8e150ce6ea07a8be50ebe20464830e09c40c7e8df9a6f191255a471ce8230bf792759dac8e07b21f2b19b671c224ae2c3dab28bbc5b055b2f0e97a930b0a2eeab29f06944590ab3f0d1426365807e1e37785c0900a466a91b98de76a4e43b78ea8cab394a799a0df50a02bdd5c9f839bc440bf45b92f02ea21b738276bce127e451cd543af98261b4c25d4fb03b11edcf34ed6bc930dded21eb7015d8fb9415bc2d848847a904de2b2b65b19b4838edb1c25bc22ff76091a4f578e97224d77088f2561897b95bef5ec3faf284bfcabc4dbe1d0595196fde1d3750757147425de558ad773af29cb562f15861dacbfa29f78fae2ac7caaf78f5fefefdc4b3d15fca782ff54f09f0afeff42c1ff8b8a519349f06fef1b77d793508c7b2acc4b1e7a4be3593b1633de23879d1fa3d7e4b8f332c2d144325450ed0ee4ed01f39cc3dc981bb3a447ce851489f3d0d9025367716df251bb732cd558d022ce1d038ba804bdff46c40aaa93e2ae8c8980c6afb15f24a6c26484f138265f29fe492c437d480d4aa12bfca8b959b341551a402b1cd193d17a8016bc7e5e7dcfcb961a8d658689da8984dd0e56d33827fb36b390387f3696efc652487762fb2b102ccd61030897934d56ed5431541a705c8ee5fa91ec2b4da43284cf7c67006c0665045ba28f9e43845c721d821e67cc5761a20d8bd1b5a6e8793e82742da1bb21ff78f58e280949f6a53f4a338302ca6e9b10e07f3a1c4ba948400d12f5d3d158d2420844036ca6558b4cadf1025a77bf702b1ba85f3c407d4bb8a19993e98d5636257de22f1c497a7b1fe96e89d6926524b0dcdd789c75c88c7200b9a6eed371931d973bad2e551f6e6e5040bc84cefb6f344dc8501506756cbfe8d00775d1a800b5b352a7454e5a64d0226ff67c17bcbeb4f194456eaf61ef415adffaf20618bf0a8dac82d9bcb2cd85a0f08554085c1256a17c3aac81397399e06f9101b1725c05d0e5b7e2089b3491e77c34ea37b0c6f965255b9dd4837ebb21e7c8a01fee90b3a20bc4915865b47775db77c8178e83a1a1ad3e7408e2cf3769eee702bbb8cd67c8050fa9cb906c1bf0a2434200e26c55bc51540300e78ff0f5a1da24f501a0345da05c52c250e220ca3d015927cadb8e2b4eb1e5f2f746aaa08eb98bd7069cef633ecd8453216b92d8cb8d0f6e61c8d9e8e4c3f326497907e9fd70d008c86777f1e92c4b5ba49fa403cc4ce16341a5aa49cd1971ed7ec5526de65d99093a20c671eecb46e13aa23172b0b1b34791081b330fdda70994db44683a15cdd26485815e3e441bd4a48a01628e2a28198c99a59d86498f071fa1d508b585dcb51645509199e66ef4ab4add6f810984fb78621b45c5264eb542757ee923491058140d42a373bdcfd0e09b8765a8051966dc064b3128d7d6b71ab4815d4facbe8e541cb80fef688653ca44154c7db6198ece51ab345a4a85b9c6e009c1df08ef5ff0309a504af8b27d715fda5823a89f344506643e868d8da976fc8d82e7445bf6402ad4b7053c14eacf24d39062eeb0da23b80b34e506c0264730e589778e75d30166cfbc2a276bf5f9554cb550ae424931136cb78c3c1719bb9395514c933cf022d18679759e63e245bd4e6ee793aaeea216e752b06b6e4c26fe8c20cbdfb2d884d0f98e3d645f5277fcdeedfddccc2f5592b3ca3eb23e68bd280ae700da7f4dc37b8ea3fa92a3f91c27920f3d1ee3b574bd6dc39c1cc40ae3153a5158a8b8ec1771236f6d02edbbd9758df6ac51adb0d986effcfd312a9a6e36050cddcf80367e0d64b3070ac7e7bb772f4f57287f8f2b946fbc921b713ee9c799da2b7f1a5c9b9eec9f5321ab3e78edf8f1a90aa9ee73c29a67b2e4b9f97c7373f31fc49ffda1', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138119, 22487, 400.0, 400.0, 'mg', 'PO', 2, 'Pediatric', X'789c33313050c84d5708f05748ca4c51a83034514849ac2c060042eb0665', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138120, 22487, 200.0, 200.0, 'mg', 'PO', 2, 'Pediatric', X'789c333230c84d5708f05748ca4c51a83034504849ac2c06003fb4063f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138121, 22487, 200.0, 200.0, 'mg', 'PO', 2, 'Pediatric', X'789c33323050c84d5708f05748ca4c51a83034504849ac2c060042a7065f', X'789ced5a5d73db3616fd2b183f391349961db7d928fb22cb6e9226763596d3c9ce2aa3814088444c022c0828623bfeef7b004ab228d3a6c23adddda95fe290b8f7e07ee35e507fec05da86134913bed7237b033e0b84519acbbd16d9b33a762f2363d2ac7770f0555cf3a4a374e8fe270ecab419d334e5c1841ac772d43dfab1dd3d6c1f76afba2f7bc7af7a3fbcec1cbd3a7a71f4cad3726684921928ffd87bc325d734f6ff377ce1d9aff294f7c80b1d90d0af3aeab1643c8d68acb2546981c75395d190939f944eb21e31741a73b37e3b32902b3411568ebadd1639ee7693702c2f95353c236a46fa4122a4c84c01de23c35fc672a092444972a569c0c9054c02ee510a6135657ce625b7d34de16ff0ca6fec9efefd194fb190d7fee1569992d8bb987593fce6b3dba31fd8d84ca09a9061c9501532ed0d22ada4609313fc619130226b4dfa0c7a4fa69419ae058d277c018df4d4eb5e02849d4812c21a642a02b238ec9280e6d95e594f27d250720b6309da9a3098cd4a61f23665bf59a179f000e44c69420d8939cd0cf9c1a38fe539cdc9e9c180d019e4233331e77e8188195ef1a91631278be37fb45f1e9148595d294f44752e43a7eec1154c21e2b8501d2ee6a9514c31b61565472e26765075742de444c85961e46d881dccf54098f80dbe93c7b603e3c9658fe7b2ffba2def38f7ffd9988f28fbb65dbebbf08d36d8fd1c290cc403418d4689d8f10c383c7a3ec9556bf2d79c05abdd9a26c5e2f0b816fafb85f76a8bef1f2968259cc1872ab531bd75d66a97a1e6a1a492e5e412ab12ed4a8f9cbc26ae3ad80c25c1a2210849baa21acb0ff0e1b27d59117d8d5cb1986a575f661c61e3602eb9a4312942672c7d338166470f62f2a2db467306ee0529cc05fd964bff7cd1ed11b2b1f41b56ce4697a7076f4fdd02b95086047c2624c7c23a421f1bf82d4fa122bb233df40cda431b466410d32c237d82ca7ad20333a1c1179b255c56910d7af7cbfd28904dbbc46de7d7378aa7ae712f8833c4ed648db06c1a074aa271153210ac22d8fa71cc759813a308736a1cb83900e646e7ad338e0433628ef475eb8988af1176ca7021715a0da846624357af3213dcc7e2805a1f89d510c3c1c52a0c459252a10b5b9e72e622950724b11943e02690c411322c133a5db4f1ac903406244cf9946f503efbc1dc4934b9e494ddb544e5a981d2a8ec96c5244da33ca60b01114160937626d8b5e4888118ae217a098f55c3e73040fb6715c90c134596cb40ab8423ce756e229e50281c1b816ec0bdbc520b44384f45c0750213499845c579e636fac0edb54a398aea585e706bf4eae10aa53d992a969bd59bbee489fbdb22d801fcc645f5888bdfade68e390587715bc1292e8e150ce6ea07a8be50ebe20464830e09c40c7e8df9a6f191255a471ce8230bf792759dac8e07b21f2b19b671c224ae2c3dab28bbc5b055b2f0e97a930b0a2eeab29f06944590ab3f0d1426365807e1e37785c0900a466a91b98de76a4e43b78ea8cab394a799a0df50a02bdd5c9f839bc440bf45b92f02ea21b738276bce127e451cd543af98261b4c25d4fb03b11edcf34ed6bc930dded21eb7015d8fb9415bc2d848847a904de2b2b65b19b4838edb1c25bc22ff76091a4f578e97224d77088f2561897b95bef5ec3faf284bfcabc4dbe1d0595196fde1d3750757147425de558ad773af29cb562f15861dacbfa29f78fae2ac7caaf78f5fefefdc4b3d15fca782ff54f09f0afeff42c1ff8b8a519349f06fef1b77d793508c7b2acc4b1e7a4be3593b1633de23879d1fa3d7e4b8f332c2d144325450ed0ee4ed01f39cc3dc981bb3a447ce851489f3d0d9025367716df251bb732cd558d022ce1d038ba804bdff46c40aaa93e2ae8c8980c6afb15f24a6c26484f138265f29fe492c437d480d4aa12bfca8b959b341551a402b1cd193d17a8016bc7e5e7dcfcb961a8d658689da8984dd0e56d33827fb36b390387f3696efc652487762fb2b102ccd61030897934d56ed5431541a705c8ee5fa91ec2b4da43284cf7c67006c0665045ba28f9e43845c721d821e67cc5761a20d8bd1b5a6e8793e82742da1bb21ff78f58e280949f6a53f4a338302ca6e9b10e07f3a1c4ba948400d12f5d3d158d2420844036ca6558b4cadf1025a77bf702b1ba85f3c407d4bb8a19993e98d5636257de22f1c497a7b1fe96e89d6926524b0dcdd789c75c88c7200b9a6eed371931d973bad2e551f6e6e5040bc84cefb6f344dc8501506756cbfe8d00775d1a800b5b352a7454e5a64d0226ff67c17bcbeb4f194456eaf61ef415adffaf20618bf0a8dac82d9bcb2cd85a0f08554085c1256a17c3aac81397399e06f9101b1725c05d0e5b7e2089b3491e77c34ea37b0c6f965255b9dd4837ebb21e7c8a01fee90b3a20bc4915865b47775db77c8178e83a1a1ad3e7408e2cf3769eee702bbb8cd67c8050fa9cb906c1bf0a2434200e26c55bc51540300e78ff0f5a1da24f501a0345da05c52c250e220ca3d015927cadb8e2b4eb1e5f2f746aaa08eb98bd7069cef633ecd8453216b92d8cb8d0f6e61c8d9e8e4c3f326497907e9fd70d008c86777f1e92c4b5ba49fa403cc4ce16341a5aa49cd1971ed7ec5526de65d99093a20c671eecb46e13aa23172b0b1b34791081b330fdda70994db44683a15cdd26485815e3e441bd4a48a01628e2a28198c99a59d86498f071fa1d508b585dcb51645509199e66ef4ab4add6f810984fb78621b45c5264eb542757ee923491058140d42a373bdcfd0e09b8765a8051966dc064b3128d7d6b71ab4815d4facbe8e541cb80fef688653ca44154c7db6198ece51ab345a4a85b9c6e009c1df08ef5ff0309a504af8b27d715fda5823a89f344506643e868d8da976fc8d82e7445bf6402ad4b7053c14eacf24d39062eeb0da23b80b34e506c0264730e589778e75d30166cfbc2a276bf5f9554cb550ae424931136cb78c3c1719bb9395514c933cf022d18679759e63e245bd4e6ee793aaeea216e752b06b6e4c26fe8c20cbdfb2d884d0f98e3d645f5277fcdeedfddccc2f5592b3ca3eb23e68bd280ae700da7f4dc37b8ea3fa92a3f91c27920f3d1ee3b574bd6dc39c1cc40ae3153a5158a8b8ec1771236f6d02edbbd9758df6ac51adb0d986effcfd312a9a6e36050cddcf80367e0d64b3070ac7e7bb772f4f57287f8f2b946fbc921b713ee9c799da2b7f1a5c9b9eec9f5321ab3e78edf8f1a90aa9ee73c29a67b2e4b9f97c7373f31fc49ffda1', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138122, 818, 80.0, 80.0, 'mg', 'IV', 2, 'Adult', X'789cb330c84d57f00c53a85030b45628c948cd53b0c84dd7cf2852f00f52b080ca3979ba0000dc8f0aef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138123, 818, 40.0, 40.0, 'mg', 'IV', 1, 'Adult', X'789c3331c84d57f00c53c82f5208f0574849cccca90400367e05eb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138124, 818, 20.0, 20.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333455c84e5728c957b0313100b2ac148c0c1472d31502fc150a5d122b0178d2082c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138125, 818, 40.0, 40.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333150c84e57c82f52482f4a4d2c492db252303150c84d5708f057287449ac040095eb0982', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138126, 6686, 0.2, 0.2, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d033ca4dd7cf4e5708f057a83004001cee03ee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138127, 6686, 0.15, 0.15, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d03334cd4dd7cf4e5708f057a83004001fee0422', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138128, 6686, 0.2, 0.2, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d033ca4dd7cf4e5708f057a83004001cee03ee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138129, 6686, 0.2, 0.2, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d033ca4dd7cf4e5708f057a83054c8cf534849ac2c5630d431d2b1d0b1d4313405009d8c08c6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138130, 6686, 0.2, 0.2, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d033ca4dd7cf4e5728f057283434504849ac2c56a8305248c92f4e2d06007f0e0910', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138131, 6686, 12.0, 12.0, 'mg', 'PO', NULL, 'Adult', X'789c3334ca4d5708f0572834574849ac2c56a8305648c92f4e2d060057c20799', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138132, 6686, 0.25, 0.25, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d03332cd4dd7cf4e5708f05728342acf56a8305248c92f4e2d060063bc0807', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138133, 23149, 50.0, 150.0, 'mg', 'IV', 1, 'Adult', X'789c2b294a4d2cc94dcd2bb1523035d0353435c84d57f00c534849cccca90400888c091d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138134, 23149, 1.0, 1.0, 'mg/kg', 'IV', 1, 'Adult', X'789c73cc2bc94c2bcd4b4fcc512828ca2fc8a8cc49acc82cb65230cc4dd7cf4e57f00c534849cccca9040027660e3f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138135, 23149, 2.0, 3.0, 'mg/kg', 'IV', 1, 'Pediatric', X'789cb331c9cdd751b03131c84eb75230d235ce4dd7cf4e57f00c534849cccca904007db908be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138136, 23149, 100.0, 150.0, 'mg', 'IV', 1, 'Pediatric', X'789cb331c9cdd751b03331c84eb752303430d035343550c84d57f00c534849cccca90400850108a1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138137, 18266, 4.0, 8.0, 'mg', NULL, NULL, 'Adult', X'789cf34b2c2d4e4dd40fcbcfcd2cc9cc4bb75230d1b5c84d572834c9d051c84dac50303201f2121552122b0130c10d99', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138138, 18266, 0.1, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf34b2c2d4e4dd40fcbcfcd2cc9cc4bb75230d033cc4dd7cf4e57f00c532834c950c84dac5048c92f4e55482c51c8cf4b4eb532d1b5c84dd7018b1b99e4a60300c9e41502', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138139, 18266, 2.0, 2.0, 'mg', NULL, NULL, 'Pediatric', X'789c35ca410ac0300804c0afec1bfa23838b08364294407fdff4d0eb30d76dc825110fd4cb67d396b44f43cb08f6a795b1a97f9382e04c0b42b3f80244a718d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138140, 18266, 4.0, 4.0, 'mg', NULL, NULL, 'Pediatric', X'789c35ca410ac0300804c0afec23fa21838b08364294407fdff4d0eb30d76dc825110fd4cb67d396b44f43cb08f6a795b1a97f9382e04c0b42b3f802452b18d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138141, 18266, 8.0, 8.0, 'mg', NULL, NULL, 'Pediatric', X'789c35ca410ac0300804c0afec33fa1d838b08364294407fdff4d0eb30d76dc825110fd4cb67d396b44f43cb08f6a795b1a97f9382e04c0b42b3f802463318da', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138142, 23268, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138143, 14317, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dcc492cca4c54d0484bcc49ce2c482c2acd55c82f5228cb2c4bacd05428294a4d2cc94dcd2bb15230373550c84d5708f0d75128c948cd53303580f215cc740d8d321472124b528b001af31922', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138144, 14317, 1250.0, 1250.0, 'mg', 'PO', NULL, 'Adult', X'789c2bcecc4bcf495548c92f4e55c84f5330343235c84d5708f00700699a07be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138145, 14317, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c2dcc4b0ec2301003d0ab7809120b54c1863b70082b4ccb88c9479334b4b727207696e5e73b8daec461a6052df435223bba766e4714cfe5b91b37ad374cd733e282b7c8cb76d4466f9a164cbfa68ead0ed8329ab38b7d93a487440da00b4f08390db00a2e7fc1b989c3847dfc7c004705315c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138146, 14317, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3d8c5d0a82501406b7f23d2a2876057b680f515bf8a8a31ebc3f723a89cbaf407a9c81992b234d896a647ce84a7b2714c3a61bf71a6e424f92fd8230204ddd32e17e6be0b36484d3dfe0dc867e06471783667565c4b3bc0455e20e2f7ef0f7d30fbfaefe00ae3d2765', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138147, 14317, 5.0, 5.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb33131cd4eb7523055c84dd7cf4e5708f057284f4dcdcea954d0b001c968020096f20954', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138148, 14317, 250.0, 250.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33331cd4eb75230323550c84d5708f057284f4dcdcea90400490406cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138149, 17740, 2.0, 20.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c33d23532c84d4ed7cf4ed7cfcdcc03001d81046d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138150, 17740, 10.0, 10.0, 'mcg', NULL, NULL, 'Adult', X'789c3334c84d4e5728cf2fca2e5648cb2f52c8cd2f2e010047990739', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138151, 17740, 2.0, 20.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c33d23532c84d4ed7cf4ed7cfcdcc03001d81046d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138152, 17740, 10.0, 10.0, 'mcg', NULL, NULL, 'Adult', X'789c3334c84d4e5728cf2fca2e5648cb2f52c8cd2f2e010047990739', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138153, 1257, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789c75cc3b0e83301045d1adbc052065884463da94e9b28201bd184bfea0f1c0fa83923af5d5b98fd635122f37d6e85b0f705d323d60940177297146aa6eea1b57cde82d1f9e5a0d98ae3e899435deca73c66eecb4533d9dc4dbc8bfec72a3c8f72e829fff0036d72c61', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138154, 1257, 5.0, 20.0, 'mg', 'PO', NULL, 'Adult', X'789c33d53532c84d5708f05730d6355128c9cc4d2dd64f49ac040047ae06bb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138155, 1257, 22.0, 1400.0, 'mcg', NULL, NULL, 'Adult', X'789ccb4dcccc2b49cd4bcc4b4e5500b28a124b325293137314808c5485c4b492d42285924c9070667e9e958291914249be82a1898181426e72ba7e4a6225000ca31699', X'789cdd586d6fdb3812fe2b8300b7db02962dc992dfb27b07db6992b64e6a24d93b147561d0126d7143913e524ae22efadfefa1ec38769bbea48b05eeee43535b1acecb3333cf0cfdc7416acac554b19c1ff4e860c012a9e75c1dd4e8a034d23dca8a62697b8dc6adb8e6795d9b85fb241abb9236316cc9d3292bdc81d00f5b9e1f78817fe5b77b51a717b6eb71c76f76a24a962785d0ca42f28f837e9a0b256c61987b563d2af85da5e56ab5e43d3a2b6d2239192ed91d534503ff846797cce63a15c9441d69cb169c8eb5c96d8f0a3693bca891504e63c61326c96a593ae5355a1a6eb9b981a91b4e73c3f9a3725b9d9785e16a51645bbd3d0afc1a857ebe387cf4648f62bc8f7d3f4f168d7c74f89d06dd319c0b7cbfd2eefbb43e3f5117ba2cb8253da77d9c7aa40d937b614ed450e7b956746558cae91ce984df23a1e182133d4104db6c95b3dd247cc4a32a40f7eddd7b7c93425dafbfb877fdb494c514a008b5d8cb50ec392c68fc869a5e448580c946ca5613953378c61553c97ec4f8c089cd0b6e20bd8d250ca9d014449bc0a1e1079c1cf354b0c288e4314743afbdd22e7b95a198f2ca8a735c280abd26a5e246a43ca5545b6e6b1be7b893ced91d45fee600a45da47bd213f5f736fd19edadaf6bff25082bf54fc1d4a330aa9c09badd3f81e9e5922782c9e9582f4bc91e9af61ed6b1e10be7d08a2ef0562d2648e670a2462c292a6932c25ebb872fd51c7d5b7d2557c739938fb8737081f0e463f91b9aa14493781d54c8a8010d3d10425a02090712cd5614349ae80027d6f4bdf82b62e146ec97e6178542a7ebe59c4e8f6a54da7db46f459151c2368422c18872b57bfe601f5287e2295f028d47ebf25c134b7f2f6d9173557c7af42bd9f9720abe4ddb478eedd7c2762ad474abe100061f14ef27f1db6ab7f253273f4d50950b6d049cff58a1f07f92db4f4bf62f48ee938be6895d3dd42e66a1303e1fe9e9be94dc2c568e3d12c92c081df5f24343e3861bcba7179c259f5b790cca4b6e842ef7e54e5e124cf0b49a6e6ca22eb9f8501a3e517dcb97c0878001f0118500538e152f310105e4fe8554a686ddae79e693865c0fca3d3ba7aba506b9da6afc9f3354066bdce85cb82ea95102170bb1649bed407cf82014b76072ab73a5250725d7885994118c63cdd0da50bede5b0aade0ed6f4628665650942fe516f62796c45f87cfa799f81f05e8bfc8eda72e2f1933394bb4d48bd5beff4cce3d29e6588463ca74692c3d73abdf73ac8bf518cbc2e6d90e8d3d9fa8330e635a0a9bf7684324f42c88ff86572fee12c3d76bd799b6454570ead12af896cf673cc91856d27caae7d37ef2d9fa7ed21ff4bd01b185767beb8f6c1f9c4ffbd2ea3dadf7970e24e04e24a2c0b2b97d74fbb5a2feae69fa99f6efbf054db747f6c6e8179cfb4e9d3b87eea7e89c1b57979f90f68c9919535cd2ab1a328e098cd494f4b646c7ee3356c3cb1a4dcad00f921738bccc98d4288b6c457d6b3576bc02fba6e304ba375daba453ea2b45e7bc341a5788a0db89f1b7fdacf5bcd70ada5ea74eefc6e5ec0c6723dcf8c266fc1ec493a6286314a3a6931a8df86221348de00837a6945250bf46bc2026ebf4623e7709bae1aee988a9942c9bf362e5ee3bb37bdce6aee776565fbc6332d19996c466e85ec5d70bf1fd532fe54bae528c4672858fffed7ab04b183294086332cc54dc8d0c2c820a3ef0b486f15ea234bc196a2275b450206089b86c51a6ab3a8d9ce9a2ee2e67edc366dbef05dd20f6826e183e401074fc56270e2a0c16cc206774f9ba46afb10349ba000243a95729bd1a6ee3efd352485dac8d8067b0eebb614fcb0d1b5c2338b4ee1a9a027c64d84c48b106c8b140f5a26a7d6088d1f0801af0c838932ec3ccdddee806774d6088915ca75734cc844c3779755105f161d37f163cef35db5e143cc414c67ed88982e87de0d783a0dd6ef89d4ed36f373b411437e3d88f10abb0b07786f88e042f3ed0598dce92237dcba5a463845f16059dd6e9b3ceaa52769fa27586d0b1091220aa5b8d6325c8d8723e873c928c34f44d92d1385b5972ce5df0cce151475d76a3c376ecfc0ffcae17043b1174c26ed08d0397143933629115d41fddf7c26007ae2bc359b55139708768b2990378cca45dddf7c23e6eae1fba2dfc0d9e85cf7b6db44373c76ca7836ea9cca2168dc51a3d7e53a34b56ce904545af0675f06fcaa5cbb7dbb08084ad7e74403a3565650ea15cc8eb3aca06de6d07045da19bab94b50e03bfca59147af14e1d866dbf854a8c9cedcbd3719d2e0b940933292a9d22b850b5d84b8519b8fe5d026373a94be5ae9c6f5ccc23f1ef52a4f44fb8edd6ffa0ee03cf57254605acb6eb13b565addbdb3ab3d9b2222eaf91bb1b78c39571611b9b1a5e794be3f6bf84376c845d5227d67df0dc31cf95b0976cac63ca39b3d669bcfb8764bf72f55386cfbf46c3f045748ca61bb45af110f5085c07ade0b815067eb319f78fe223ff28386a4d145ceba3c767659279a7dcedb18e78ae4acbe802bc785c6618d5a39df6fb6ad7bb3a58b019039b14ae5621b26d2f66a9d8d68b632896c0795c1548ad6cc1165812ea3bd4599568fb300a1c7376828ed709e3878475834ed78f1c6f3c3449f57313bd73bf1f2546cc5c9508054379b562bcafd31817727b2d10de798ffa37af99e1c8697248fda511d2652a021c0383a6470e478e7ed02d0a900c40c0afb1dd489498a281a323a04e275aa7aee87ea213e15efd6c5da9d1ce6652f5e580813b1d34ae0e814de9080af185e85f9ed611f02dbdd5e6ba46e76fb1622427985edea900192054a7e1d0f916d49fba0f7cfcf81f8a5de76d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138156, 1257, 10.0, 15.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d235afccb75230345028c957303455c84dd74f49ac5408f057c8cc5330d2355648c92ccb4c494d5148c92f4e2dd65128c92c294a2c4905a9ce4dac503031806a00aa36d63541550d0005fe1d1c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138157, 1257, 10.0, 15.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33357a8ccb75230345028c957303455c84dd74f49ac5408f057c8cc5330d2355648c92ccb4c494d5148c92f4e2dd65128c92c294a2c4905a9ce4dac503033806a00aa36d63541550d0006001d1d', X'789cdd586d6fdb3812fe2b8300b7db02962dc992dfb27b07db6992b64e6a24d93b147561d0126d7143913e524ae22efadfefa1ec38769bbea48b05eeee43535b1acecb3333cf0cfdc7416acac554b19c1ff4e860c012a9e75c1dd4e8a034d23dca8a62697b8dc6adb8e6795d9b85fb241abb9236316cc9d3292bdc81d00f5b9e1f78817fe5b77b51a717b6eb71c76f76a24a962785d0ca42f28f837e9a0b256c61987b563d2af85da5e56ab5e43d3a2b6d2239192ed91d534503ff846797cce63a15c9441d69cb169c8eb5c96d8f0a3693bca891504e63c61326c96a593ae5355a1a6eb9b981a91b4e73c3f9a3725b9d9785e16a51645bbd3d0afc1a857ebe387cf4648f62bc8f7d3f4f168d7c74f89d06dd319c0b7cbfd2eefbb43e3f5117ba2cb8253da77d9c7aa40d937b614ed450e7b956746558cae91ce984df23a1e182133d4104db6c95b3dd247cc4a32a40f7eddd7b7c93425dafbfb877fdb494c514a008b5d8cb50ec392c68fc869a5e448580c946ca5613953378c61553c97ec4f8c089cd0b6e20bd8d250ca9d014449bc0a1e1079c1cf354b0c288e4314743afbdd22e7b95a198f2ca8a735c280abd26a5e246a43ca5545b6e6b1be7b893ced91d45fee600a45da47bd213f5f736fd19edadaf6bff25082bf54fc1d4a330aa9c09badd3f81e9e5922782c9e9582f4bc91e9af61ed6b1e10be7d08a2ef0562d2648e670a2462c292a6932c25ebb872fd51c7d5b7d2557c739938fb8737081f0e463f91b9aa14493781d54c8a8010d3d10425a02090712cd5614349ae80027d6f4bdf82b62e146ec97e6178542a7ebe59c4e8f6a54da7db46f459151c2368422c18872b57bfe601f5287e2295f028d47ebf25c134b7f2f6d9173557c7af42bd9f9720abe4ddb478eedd7c2762ad474abe100061f14ef27f1db6ab7f253273f4d50950b6d049cff58a1f07f92db4f4bf62f48ee938be6895d3dd42e66a1303e1fe9e9be94dc2c568e3d12c92c081df5f24343e3861bcba7179c259f5b790cca4b6e842ef7e54e5e124cf0b49a6e6ca22eb9f8501a3e517dcb97c0878001f0118500538e152f310105e4fe8554a686ddae79e693865c0fca3d3ba7aba506b9da6afc9f3354066bdce85cb82ea95102170bb1649bed407cf82014b76072ab73a5250725d7885994118c63cdd0da50bede5b0aade0ed6f4628665650942fe516f62796c45f87cfa799f81f05e8bfc8eda72e2f1933394bb4d48bd5beff4cce3d29e6588463ca74692c3d73abdf73ac8bf518cbc2e6d90e8d3d9fa8330e635a0a9bf7684324f42c88ff86572fee12c3d76bd799b6454570ead12af896cf673cc91856d27caae7d37ef2d9fa7ed21ff4bd01b185767beb8f6c1f9c4ffbd2ea3dadf7970e24e04e24a2c0b2b97d74fbb5a2feae69fa99f6efbf054db747f6c6e8179cfb4e9d3b87eea7e89c1b57979f90f68c9919535cd2ab1a328e098cd494f4b646c7ee3356c3cb1a4dcad00f921738bccc98d4288b6c457d6b3576bc02fba6e304ba375daba453ea2b45e7bc341a5788a0db89f1b7fdacf5bcd70ada5ea74eefc6e5ec0c6723dcf8c266fc1ec493a6286314a3a6931a8df86221348de00837a6945250bf46bc2026ebf4623e7709bae1aee988a9942c9bf362e5ee3bb37bdce6aee776565fbc6332d19996c466e85ec5d70bf1fd532fe54bae528c4672858fffed7ab04b183294086332cc54dc8d0c2c820a3ef0b486f15ea234bc196a2275b450206089b86c51a6ab3a8d9ce9a2ee2e67edc366dbef05dd20f6826e183e401074fc56270e2a0c16cc206774f9ba46afb10349ba000243a95729bd1a6ee3efd352485dac8d8067b0eebb614fcb0d1b5c2338b4ee1a9a027c64d84c48b106c8b140f5a26a7d6088d1f0801af0c838932ec3ccdddee806774d6088915ca75734cc844c3779755105f161d37f163cef35db5e143cc414c67ed88982e87de0d783a0dd6ef89d4ed36f373b411437e3d88f10abb0b07786f88e042f3ed0598dce92237dcba5a463845f16059dd6e9b3ceaa52769fa27586d0b1091220aa5b8d6325c8d8723e873c928c34f44d92d1385b5972ce5df0cce151475d76a3c376ecfc0ffcae17043b1174c26ed08d0397143933629115d41fddf7c26007ae2bc359b55139708768b2990378cca45dddf7c23e6eae1fba2dfc0d9e85cf7b6db44373c76ca7836ea9cca2168dc51a3d7e53a34b56ce904545af0675f06fcaa5cbb7dbb08084ad7e74403a3565650ea15cc8eb3aca06de6d07045da19bab94b50e03bfca59147af14e1d866dbf854a8c9cedcbd3719d2e0b940933292a9d22b850b5d84b8519b8fe5d026373a94be5ae9c6f5ccc23f1ef52a4f44fb8edd6ffa0ee03cf57254605acb6eb13b565addbdb3ab3d9b2222eaf91bb1b78c39571611b9b1a5e794be3f6bf84376c845d5227d67df0dc31cf95b0976cac63ca39b3d669bcfb8764bf72f55386cfbf46c3f045748ca61bb45af110f5085c07ade0b815067eb319f78fe223ff28386a4d145ceba3c767659279a7dcedb18e78ae4acbe802bc785c6618d5a39df6fb6ad7bb3a58b019039b14ae5621b26d2f66a9d8d68b632896c0795c1548ad6cc1165812ea3bd4599568fb300a1c7376828ed709e3878475834ed78f1c6f3c3449f57313bd73bf1f2546cc5c9508054379b562bcafd31817727b2d10de798ffa37af99e1c8697248fda511d2652a021c0383a6470e478e7ed02d0a900c40c0afb1dd489498a281a323a04e275aa7aee87ea213e15efd6c5da9d1ce6652f5e580813b1d34ae0e814de9080af185e85f9ed611f02dbdd5e6ba46e76fb1622427985edea900192054a7e1d0f916d49fba0f7cfcf81f8a5de76d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138158, 1257, 24.0, 1199.0, 'mcg', NULL, NULL, 'Pediatric', X'789c15c8c10980300c05d055fe0222295e2a2e1362d4804da0e4d2edadb7c73ba860c48ec6e6a9ce2e8aa9cef9a8f08b09055fa91d697f5bf882b2210344b5a2c9bd9e3c3e955b189e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138159, 7483, 5.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d53534c84d5708f05730d4355628c9cc4d2d5628482d524849ac04006508080f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138160, 7483, 5.0, 10.0, 'mg', NULL, 3, 'Pediatric', X'789c33d5353450c84d5708f17401000f1002b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138161, 854, 5.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789c33d53533c84dd74f49ac5408f05748c92ccb4c494d510874d10df4740100797d0882', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138162, 854, 40.0, 80.0, 'mg', 'PO', 1, 'Adult', X'789c05c1410e40301005d0abfc8d9d6a171222b1ab358e509d62a2b4a188db7bafd3720d57e4647c8352895aed8b24f361e841fc3039c2a8c5c494c3862315b88fc41ed1990db30f2f5a542a433c1db14d8e7e2cec1a6a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138163, 854, 40.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789cf32f2d29482cc94ccd2b51482a2d2a2e5128294a4d2cc905f2ad144c0c74cd0c72d3f553122b1502fc155232cb3253525314025d74933253142a148c750d0d148092c5005a1f1717', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138164, 854, 7.5, 60.0, 'mg', 'PO', 1, 'Adult', X'789c33d733d53533c84d5708f0570874d12dcc4f010029c904e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138165, 854, 4.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c33d135cd4dd7cf0500073e0207', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138166, 854, 200.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c333230c84d5708f057087451a850305428cfd65128c948cd53b0808a17e6a7802572f30101ef0c25', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138167, 854, 40.0, 40.0, 'mg', 'PO', 1, 'Adult', X'789c3331c84d5708f057087401000ecd02ad', X'789ced5afd6fdb361afe5788000774801d3b4edce55cdc0f69b22e05d6d56bb20287d366d0122df142911a3fe26843fff73d946447b4ddc4f11adc6df30f0122f2e5fbf9bc1fa2fcdb41a25d3a91346707237230d62c91dc28a1243be89003a7855fceac2dcca8d79bf31b961f2a9dfaff786f95dac49a162c9950eb0f0dfa8397ddfe51f7a87fdd3f1df5fba3c1f1e1f1e0f49fa7c7152d8b2d57d280f2b7836f99649a8aea7fcbeeaae3d765c146913c57daf25819cbb4e249242f94a129236f94cecd888cdf9317c35764d8391a7606c3de90e4df7dd521aac86c4645ce637f3ecf9524d79a268c7c0f3371ea8d505daf7b87bce342f0a2faf77da57b878c59d2ac80c45bd6211f99ae96c8a05fa9eea66ded3f61c9d2a960fee93f3fe1497079533ddc5b139af1b86b57e83ffde4a59c254ed8093cc0651af86a83562b12bb9a99025bfc964d6225137e4fb86032ecbeece7692fa1a5776bc26f7902937fb8e8fef0f6e220b4b152c6d82ca79d098d9d6501a36f2e7a993205b7548cc849bf7bba99ed94c3c7d0c51e12272d17a460f486cc849a937f91affbff20dee53cb60c517fef6c412d67d292a9d3c612ab19b5399e2b099f511c12c81d3906020936cd03461876cb349b144c1b0e8f491b18f4f561ed1bcf1e6c7f51c926568966928a0997c6cd663c86b27119b039e90ea1661ec941242b4e1bb8bc43847921d8c4c4028183368d8727ec8ec64c4fa90f5cc076d05faa066b8fc8fca6436cc624396dd6a16fb591ab4d6a8b58654af0789231ef62bb9418eabe94b1cae301f85702be380e5781be07e21e88db00f1cf8993cfa17d0f946707ca2e2e5e0bd7dec79b7dbc9b5f56ddfbd773ccf35bb406d1678ff52e02b61fb22b197e6aa75643c6171c8f2783804dfff0e8a43b00286f769c9257f8056de7e8f39ca7febde71dbd1b9145dbf8226de86189ed3eb422fd29e3cb9a0b07c346ec7dddacd83fc87d53b158e1dc948b9f079b318ac7ef59916985a04f4c2913adf2107e957c9c5f7587ad7c71729f5527fd7b417566f9cde7188b77c1df83d3f11e807b00fed52bd3d603f31e194f9d7f77f3d85623f19fdd65bbd9b4ea9aff2fa39e5f9b270e7957058b39bc3c56851374fde668ac592a293c4f3e6057a6911c91f3487e47635b518fc858ab290494e48ace58243ff8a0917a628c6475bd3a2252119afcd799aa18e1dd633159aeed5c56d36cbc7ede9284cdb8f4652e38bd5cdff51679d5c0c7ef912ffced7e4d6c80cec9924373a57c8e6aad29c7c4116f70e899c03b485a12ab482ca8313dffb12092a64439c861f9ccc9140ee472565b1249b81a330c519a6816fbe27e4b613c13823e4895336a607a40738bb988d0a9768525736eb344d33984bdc8789a914499eabc5032ed6286ca8933ecab48c6d4f9e384cf4823a4c5f27e3392d7af23b9718ba818e0d2e4f2ea63b0ccf3dc49655c8126668c8f6d6b332b51255122cd2ab3f3cb37c133d030651696e6f009b7ce04bb86f15f9d66a0324a274c079be31f2f826727f03a482b1b63bc5de1ad6a4512aa37e0e9d6b71aa7730945800c38954a6aaccafdeb6640599832ce6a006f560a862b9b957e86e5260ffd0890a842e935a6790961280c9c9254d3db35e5bc423c2f28d73ecf3aa4ee43a1d826f51e21b3a85ff95431fc89cf59102b9a36d5641381244c600525a3195736ddca6d95bcd7af1f4f57d02c3ef5c018c3261f188dd7f37253efb8629a2b17d2d1a4f166bb2d45f2dc990c05812cca3a3221007705e2567284e8ae20bd01c7cdab4c8d993ae8dfbec508a8674a57eeed55888d640d0c1fff5e88110fa61b2aaad24205feab97178cf3522106190c802e0982e34b83f3212f0c7389b22e4745800836d53c926fcfc7303cc6586940d2a416d8a582ba58e5d407d9520dff62b1a015a5ad7325d56a6e33d2f2077911549a0eec6a0afb1217a83eec6ef1e951810b92aac84a41ef3ccb560533655e20d94c55a4eafa06e0f9b9994b5703f1a122b76118aa3f7206a1372ae12e47622718c01dbca7991fe1aa0842f32253b0ac723aa3098d33b8a8aa17a9f2a1372a4778222999be05a8249c10c95ca1799bb96f25303561de85b9f3f754648e41bf267a3d46c2b05b5a4b4a055c6d7c11b60aad044ef6d18226beaab01e8be3ac6caace8cfade4e982e511b2ad6009cd5cec357a36bf9a28ce8b00027207bfbbe1de6ba20600a992b07d3619cf0487fb1da27d653c0dc20d70b9efa625207814ea5d2391858402ee3daa024f81ae77c598532f40903d57d60dac9f47841b86c53837feb8bf2e59b2d3e23832838b596b75b8c10cd91c9f248c07191588f33ba5a5006e7db99b7c54f0edad4019f56b63dcee6ac451c705964c31691595006e79b1c7afcf8c78630947e0fecada0b1240eb804f87c98c78f4bd2baedec9bc8dfa889ac5f89efbbc8be8becbbc8be8bfcc12eb22f24ffb342b2cb8be9df1cade38cc2adb1122a0d7f817049c5ac2bf88c8dc8d169f7f86516c9770cde54027e1f11e12f583ae4fcdfe393617f448ecf4e88f7bec59c82f87d73070cd4978e4e73c9fcd938a31247899a91b3b8def31ff5fdf5576b8b222dba189c04cd736a952e497d05409cbc916a2e5f015f199f728bf2dbfc588004e4716915d0c3cc2b526895b898b528ab1488eb8f8ffe7e0da8cc79f5ebdbd62a9bf9b1ed89371de85c9f7e07f23a3bbd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138168, 854, 0.14, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d03334d135ca4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d10df4740100a1af09dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138169, 854, 1.0, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c7375d1cfc82f2ec82c49ccb15230d435ca4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d14dca4c010035610e12', X'789ced5afd6fdb361afe5788000774801d3b4edce55cdc0f69b22e05d6d56bb20287d366d0122df142911a3fe26843fff73d946447b4ddc4f11adc6df30f0122f2e5fbf9bc1fa2fcdb41a25d3a91346707237230d62c91dc28a1243be89003a7855fceac2dcca8d79bf31b961f2a9dfaff786f95dac49a162c9950eb0f0dfa8397ddfe51f7a87fdd3f1df5fba3c1f1e1f1e0f49fa7c7152d8b2d57d280f2b7836f99649a8aea7fcbeeaae3d765c146913c57daf25819cbb4e249242f94a129236f94cecd888cdf9317c35764d8391a7606c3de90e4df7dd521aac86c4645ce637f3ecf9524d79a268c7c0f3371ea8d505daf7b87bce342f0a2faf77da57b878c59d2ac80c45bd6211f99ae96c8a05fa9eea66ded3f61c9d2a960fee93f3fe1497079533ddc5b139af1b86b57e83ffde4a59c254ed8093cc0651af86a83562b12bb9a99025bfc964d6225137e4fb86032ecbeece7692fa1a5776bc26f7902937fb8e8fef0f6e220b4b152c6d82ca79d098d9d6501a36f2e7a993205b7548cc849bf7bba99ed94c3c7d0c51e12272d17a460f486cc849a937f91affbff20dee53cb60c517fef6c412d67d292a9d3c612ab19b5399e2b099f511c12c81d3906020936cd03461876cb349b144c1b0e8f491b18f4f561ed1bcf1e6c7f51c926568966928a0997c6cd663c86b27119b039e90ea1661ec941242b4e1bb8bc43847921d8c4c4028183368d8727ec8ec64c4fa90f5cc076d05faa066b8fc8fca6436cc624396dd6a16fb591ab4d6a8b58654af0789231ef62bb9418eabe94b1cae301f85702be380e5781be07e21e88db00f1cf8993cfa17d0f946707ca2e2e5e0bd7dec79b7dbc9b5f56ddfbd773ccf35bb406d1678ff52e02b61fb22b197e6aa75643c6171c8f2783804dfff0e8a43b00286f769c9257f8056de7e8f39ca7febde71dbd1b9145dbf8226de86189ed3eb422fd29e3cb9a0b07c346ec7dddacd83fc87d53b158e1dc948b9f079b318ac7ef59916985a04f4c2913adf2107e957c9c5f7587ad7c71729f5527fd7b417566f9cde7188b77c1df83d3f11e807b00fed52bd3d603f31e194f9d7f77f3d85623f19fdd65bbd9b4ea9aff2fa39e5f9b270e7957058b39bc3c56851374fde668ac592a293c4f3e6057a6911c91f3487e47635b518fc858ab290494e48ace58243ff8a0917a628c6475bd3a2252119afcd799aa18e1dd633159aeed5c56d36cbc7ede9284cdb8f4652e38bd5cdff51679d5c0c7ef912ffced7e4d6c80cec9924373a57c8e6aad29c7c4116f70e899c03b485a12ab482ca8313dffb12092a64439c861f9ccc9140ee472565b1249b81a330c519a6816fbe27e4b613c13823e4895336a607a40738bb988d0a9768525736eb344d33984bdc8789a914499eabc5032ed6286ca8933ecab48c6d4f9e384cf4823a4c5f27e3392d7af23b9718ba818e0d2e4f2ea63b0ccf3dc49655c8126668c8f6d6b332b51255122cd2ab3f3cb37c133d030651696e6f009b7ce04bb86f15f9d66a0324a274c079be31f2f826727f03a482b1b63bc5de1ad6a4512aa37e0e9d6b71aa7730945800c38954a6aaccafdeb6640599832ce6a006f560a862b9b957e86e5260ffd0890a842e935a6790961280c9c9254d3db35e5bc423c2f28d73ecf3aa4ee43a1d826f51e21b3a85ff95431fc89cf59102b9a36d5641381244c600525a3195736ddca6d95bcd7af1f4f57d02c3ef5c018c3261f188dd7f37253efb8629a2b17d2d1a4f166bb2d45f2dc990c05812cca3a3221007705e2567284e8ae20bd01c7cdab4c8d993ae8dfbec508a8674a57eeed55888d640d0c1fff5e88110fa61b2aaad24205feab97178cf3522106190c802e0982e34b83f3212f0c7389b22e4745800836d53c926fcfc7303cc6586940d2a416d8a582ba58e5d407d9520dff62b1a015a5ad7325d56a6e33d2f2077911549a0eec6a0afb1217a83eec6ef1e951810b92aac84a41ef3ccb560533655e20d94c55a4eafa06e0f9b9994b5703f1a122b76118aa3f7206a1372ae12e47622718c01dbca7991fe1aa0842f32253b0ac723aa3098d33b8a8aa17a9f2a1372a4778222999be05a8249c10c95ca1799bb96f25303561de85b9f3f754648e41bf267a3d46c2b05b5a4b4a055c6d7c11b60aad044ef6d18226beaab01e8be3ac6caace8cfade4e982e511b2ad6009cd5cec357a36bf9a28ce8b00027207bfbbe1de6ba20600a992b07d3619cf0487fb1da27d653c0dc20d70b9efa625207814ea5d2391858402ee3daa024f81ae77c598532f40903d57d60dac9f47841b86c53837feb8bf2e59b2d3e23832838b596b75b8c10cd91c9f248c07191588f33ba5a5006e7db99b7c54f0edad4019f56b63dcee6ac451c705964c31691595006e79b1c7afcf8c78630947e0fecada0b1240eb804f87c98c78f4bd2baedec9bc8dfa889ac5f89efbbc8be8becbbc8be8bfcc12eb22f24ffb342b2cb8be9df1cade38cc2adb1122a0d7f817049c5ac2bf88c8dc8d169f7f86516c9770cde54027e1f11e12f583ae4fcdfe393617f448ecf4e88f7bec59c82f87d73070cd4978e4e73c9fcd938a31247899a91b3b8def31ff5fdf5576b8b222dba189c04cd736a952e497d05409cbc916a2e5f015f199f728bf2dbfc588004e4716915d0c3cc2b526895b898b528ab1488eb8f8ffe7e0da8cc79f5ebdbd62a9bf9b1ed89371de85c9f7e07f23a3bbd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138170, 854, 60.0, 60.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523033c84dd74f49acd45148cecf2bd15328cd2bc9cc5128484dcc5648cbc92f57b0553037505528284a4dc94c2e494d0100bc901118', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138171, 854, 1.0, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789cf32f2d29482cc94ccd2b51482a2d2a2e5128294a4d2cc905f2ad140c758d72d3f5b3d3f553122b1502fc155232cb3253525314025d74933253142a148c750d0d148092c5007cbf17b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138172, 854, 60.0, 60.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523033c84dd74f49ac04001bc20428', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138173, 854, 0.25, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d03332d535ca4dd7cf4e5708f0570874d12dcc4f01003aee05df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138174, 854, 60.0, 60.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac503033c84dd74f49ac0400185703ee', X'789ced5afd6fdb361afe5788000774801d3b4edce55cdc0f69b22e05d6d56bb20287d366d0122df142911a3fe26843fff73d946447b4ddc4f11adc6df30f0122f2e5fbf9bc1fa2fcdb41a25d3a91346707237230d62c91dc28a1243be89003a7855fceac2dcca8d79bf31b961f2a9dfaff786f95dac49a162c9950eb0f0dfa8397ddfe51f7a87fdd3f1df5fba3c1f1e1f1e0f49fa7c7152d8b2d57d280f2b7836f99649a8aea7fcbeeaae3d765c146913c57daf25819cbb4e249242f94a129236f94cecd888cdf9317c35764d8391a7606c3de90e4df7dd521aac86c4645ce637f3ecf9524d79a268c7c0f3371ea8d505daf7b87bce342f0a2faf77da57b878c59d2ac80c45bd6211f99ae96c8a05fa9eea66ded3f61c9d2a960fee93f3fe1497079533ddc5b139af1b86b57e83ffde4a59c254ed8093cc0651af86a83562b12bb9a99025bfc964d6225137e4fb86032ecbeece7692fa1a5776bc26f7902937fb8e8fef0f6e220b4b152c6d82ca79d098d9d6501a36f2e7a993205b7548cc849bf7bba99ed94c3c7d0c51e12272d17a460f486cc849a937f91affbff20dee53cb60c517fef6c412d67d292a9d3c612ab19b5399e2b099f511c12c81d3906020936cd03461876cb349b144c1b0e8f491b18f4f561ed1bcf1e6c7f51c926568966928a0997c6cd663c86b27119b039e90ea1661ec941242b4e1bb8bc43847921d8c4c4028183368d8727ec8ec64c4fa90f5cc076d05faa066b8fc8fca6436cc624396dd6a16fb591ab4d6a8b58654af0789231ef62bb9418eabe94b1cae301f85702be380e5781be07e21e88db00f1cf8993cfa17d0f946707ca2e2e5e0bd7dec79b7dbc9b5f56ddfbd773ccf35bb406d1678ff52e02b61fb22b197e6aa75643c6171c8f2783804dfff0e8a43b00286f769c9257f8056de7e8f39ca7febde71dbd1b9145dbf8226de86189ed3eb422fd29e3cb9a0b07c346ec7dddacd83fc87d53b158e1dc948b9f079b318ac7ef59916985a04f4c2913adf2107e957c9c5f7587ad7c71729f5527fd7b417566f9cde7188b77c1df83d3f11e807b00fed52bd3d603f31e194f9d7f77f3d85623f19fdd65bbd9b4ea9aff2fa39e5f9b270e7957058b39bc3c56851374fde668ac592a293c4f3e6057a6911c91f3487e47635b518fc858ab290494e48ace58243ff8a0917a628c6475bd3a2252119afcd799aa18e1dd633159aeed5c56d36cbc7ede9284cdb8f4652e38bd5cdff51679d5c0c7ef912ffced7e4d6c80cec9924373a57c8e6aad29c7c4116f70e899c03b485a12ab482ca8313dffb12092a64439c861f9ccc9140ee472565b1249b81a330c519a6816fbe27e4b613c13823e4895336a607a40738bb988d0a9768525736eb344d33984bdc8789a914499eabc5032ed6286ca8933ecab48c6d4f9e384cf4823a4c5f27e3392d7af23b9718ba818e0d2e4f2ea63b0ccf3dc49655c8126668c8f6d6b332b51255122cd2ab3f3cb37c133d030651696e6f009b7ce04bb86f15f9d66a0324a274c079be31f2f826727f03a482b1b63bc5de1ad6a4512aa37e0e9d6b71aa7730945800c38954a6aaccafdeb6640599832ce6a006f560a862b9b957e86e5260ffd0890a842e935a6790961280c9c9254d3db35e5bc423c2f28d73ecf3aa4ee43a1d826f51e21b3a85ff95431fc89cf59102b9a36d5641381244c600525a3195736ddca6d95bcd7af1f4f57d02c3ef5c018c3261f188dd7f37253efb8629a2b17d2d1a4f166bb2d45f2dc990c05812cca3a3221007705e2567284e8ae20bd01c7cdab4c8d993ae8dfbec508a8674a57eeed55888d640d0c1fff5e88110fa61b2aaad24205feab97178cf3522106190c802e0982e34b83f3212f0c7389b22e4745800836d53c926fcfc7303cc6586940d2a416d8a582ba58e5d407d9520dff62b1a015a5ad7325d56a6e33d2f2077911549a0eec6a0afb1217a83eec6ef1e951810b92aac84a41ef3ccb560533655e20d94c55a4eafa06e0f9b9994b5703f1a122b76118aa3f7206a1372ae12e47622718c01dbca7991fe1aa0842f32253b0ac723aa3098d33b8a8aa17a9f2a1372a4778222999be05a8249c10c95ca1799bb96f25303561de85b9f3f754648e41bf267a3d46c2b05b5a4b4a055c6d7c11b60aad044ef6d18226beaab01e8be3ac6caace8cfade4e982e511b2ad6009cd5cec357a36bf9a28ce8b00027207bfbbe1de6ba20600a992b07d3619cf0487fb1da27d653c0dc20d70b9efa625207814ea5d2391858402ee3daa024f81ae77c598532f40903d57d60dac9f47841b86c53837feb8bf2e59b2d3e23832838b596b75b8c10cd91c9f248c07191588f33ba5a5006e7db99b7c54f0edad4019f56b63dcee6ac451c705964c31691595006e79b1c7afcf8c78630947e0fecada0b1240eb804f87c98c78f4bd2baedec9bc8dfa889ac5f89efbbc8be8becbbc8be8bfcc12eb22f24ffb342b2cb8be9df1cade38cc2adb1122a0d7f817049c5ac2bf88c8dc8d169f7f86516c9770cde54027e1f11e12f583ae4fcdfe393617f448ecf4e88f7bec59c82f87d73070cd4978e4e73c9fcd938a31247899a91b3b8def31ff5fdf5576b8b222dba189c04cd736a952e497d05409cbc916a2e5f015f199f728bf2dbfc588004e4716915d0c3cc2b526895b898b528ab1488eb8f8ffe7e0da8cc79f5ebdbd62a9bf9b1ed89371de85c9f7e07f23a3bbd', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138175, 854, 4.0, 5.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d135cd4dd7cf8d335208f057087401002096040b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138176, 854, 60.0, 60.0, 'mg', 'PO', 3, 'Pediatric', X'789c3333c84dd7cf8d33d24f49ac5408f05748c92ccb4c494d5128c94c51a850305128cfd65128c948cd5330812a04292acc87490200761a136b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138177, 1715, 5.0, 20.0, 'mg', 'PO', 3, 'Adult', X'789c0b28cdc9cdcf4b2caa54c8a82c482d2a49cd2bcecccfb35230d53532c84d5708f05708f17451c82f5230d233d5353450008a79862924e5e79416836400b12c13ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138178, 1715, 25.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c732d4a4d2ec9cc495548a92c4e2bcd03b2f3f3ac148c4c750d0d0c72d31502fc150c338a140a8a32f38b144af2158a532b4a1373141281eaca324b2a751472132b14f2f39281fa1333732a012df61b59', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138179, 148, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cccb2cc94cccb152303630c84d5708f05728b4c8280200520b06ee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138180, 148, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dac54c8cc4b2e4a4d2c4e55282d5028c957303330c84d5708f05728b4c8280200b4e40a86', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138181, 148, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c7349ac5430b452303630c84d5708f057287449ac040037ac059f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138182, 148, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c7349ac5430b252303630c84d5708f057283434ca2802003cd305bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138183, 148, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c7349ac5430b652303630c84d5708f05728b4c828020037af0595', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138184, 148, 100.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333430d0353630c84d5708f05728f408b656c84dac5428c92c294a2c495528c957004aea9a8015145a6414290404f9010075900ece', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138185, 148, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f05728f40856c8cccb2cc94cccc9a9d45108f170f55330864b5a64582be426562aa495169564a41601552617a52616a72a24162b94e4e7a4162596a4a600008f9f1938', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138186, 148, 900.0, 900.0, 'mg', 'PO', NULL, 'Adult', X'789cb33430c84dd74f49ac5408f057c8cccb2cc94cccc9a9b456c8058a64e62517a52616a72aa41725a69482c4150a8d5d122b8b154af2150c2d0c0c748dcd60da017c5d17f2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138187, 148, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c333330c84d5708f057c8c94f4c51c8cc537075010035f8058a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138188, 148, 300.0, 300.0, 'mg', 'IN', 3, 'Adult', X'789c1dc6b10980301005d0557ea9852058d9bbc8e11dc9078de11215177000477412c157bd89658ee2c170b2460c7dbf06bcf783f15f3687ca05e5413545a5a2910226e4add42e9a67ab9c916c775902056e81aba5f603a79c2036', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138189, 148, 3600.0, 3600.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4e4c4f5530363330c84d57c84c5328482cc94ccd2b5148cc294a4d4ca954c8cf53484f4c4a2c008a65e60100b08711b3', X'789ced596d4fdb3a14fe2b4795aeb449edfa0285d14d48bd940bbbda18a27c5ba6c84ddcc417c7c962a71026fefb7decb4a581960d344d9ad44f75ece3f3f29c171fbbdf1b615e44be62096f0ca871c2262ce3ca08d56852a3c8a59d8c8dc9f4a0ddbe16573c7993e6911d89769d560739be429f19bba5d7e9edb53add56b773d9d91ff47706bbfb6f7a079db7fb1d47cb032352a541f9bd71c215cf997463c36fdcf6cb32e3034f0dc13c48d5ac909a29a33df58e4e867f0f892926d3c853a354b388d33f699ee801052cd385e44d326c22b969520ab6a453595861d4eb7792a8dd4f3e7aea284d12cc5ce62ce47406d3b1fb8c17796a8d69d209f609cd9da6c56455d93b4c39eef6ebcb577c49a1aedcc7bdf20fb4fe31900f37dc7db5728661218d0f13858a6ae0acd1ab71ce722398f4c75cdc1639d7b50dc3f0bf428178c6c9c4c03a2b699ae694557b48cff7d0b530314073bf6961b000ad42969714553e12b7cc8af4d40725ecd601ed74002a9d7fa66f6fe3dc539f5849420539679a53919149696f95a251c7cf9a799e6ae343ab8c03045fc10b4c4682d50c18816d77551826e07dccf65667bb3dab839dde79a0d91ab99f0a1d48ee1fe52cc9b4ffeaf374da926cc2e5eb9ae46ea7d3bae7743a7e4709d81b617266b8350f8bad5d4760e5d0f9c5d91a59437523b829374a599500fc1cb6b26cd2e5e9f159cd904afcb4c8ad1fef91661aaa486e750ad7881f0988b4e8ba18cf4cbc5993032bac1d4208042e35a9c42ec545c89bc2ced3b71da06d8553f7ad456a6fb17d8d16957066622872ce503456e52ea344a62c84243a1ec193420731cb91e12e322b20bca2d73de891539432a060950dc54c843c8463427a0534c020435cb5167145cbb8a29c4722e1eaf523f61974229df140d8ec37481129d3eb5691d9b0bea1b0aa35958924a6a03702d58f98042a61492828d1b2227aea9239e552e07548fb564b875308a1aecc14dc535fba5f1f02f54485a9d2e5cf49f447356a9be9db4cdf66fa4f67faef4a978779bacd976dbefc81f9b24571138a3f7f89a90a0f0f053339607ce6e563d15ff8bd755dc953adc8133d88c3ba82421f52b757a6d51e9e09c9338d0c6452a7c47eb2f559e1463bad6e8f4ace72dc2cdfef54a3018dd914150977cc90f8742a021694a452435c5bd0848e79e8a9fbadf46a5e0c9c2f5e0fa8db6975fbc8f5ab65b558448fab832ba563512cd13f41ad9dd0fa0f227965468278315c311570c7da0add5dc85c5984c8ddce46799eeaafa85adfd6ebb776366beaa9c38d363eaebc4f34832f6d71b7e1b40da70de1f4cc8a36aeaaae7f9e668564f7856b1152e728dad68a922eb0aa224f0de8c8531f59601cf5808e6127149f58a50c25425ebda342cf2b7bc08aeab674012c245555d35347f9913cdceb50f2b19d08e5ac04760b4b2e3f8c2a12ccb756a840d0daafdaa6aa6d7334dd7eab77b08ec6357c96e47db7bf5cbfefcdaaf5d311e69c7bdca186932be6498a2a2f4b2d34b1298c23ce829876635a4e5bdfe63326b19fdb200f9696b9a7a901c2982c171bd40e534f2d8f8ec78b2f7d4d7be89b1f3fa78dec836645ac7da1fc2587f9c3da11cec71c911b2e55ab95178976312a6dd4059269ddb6efa32f88b9613843c470ff02b83e96b2ee181df35ca4459d6ec43394190d9ab62e4420421432038f8eff1d7bb089657129d98dd0f62312290f79c2d67498d583678df361b7f3173183cdac099fdfde0a05414da22940890ade249d260abd3392db53f625f72f906532cdec0655a27c4549810d26472ce54d62c94496d5ea840557aedf6912aab03622734043ced21c8c519b1394ea18c352a3b0c6b953a5448f94693b5c1481905866db2cd4d926495e5ca568822c4152ba9e0bea2050015d6501fa2291d9a22dc9e18119b46125f031c22e177935c8635786309a318d50957325afb988628366ab7ad87eced1f52b5df8303cb63efc3d3edce2fc729c9f7bd380ac8405a94ca3b206f82993b8848b291f50bfb5ef1e1c3918a5e89792816b9f92f9f7ad6d9f8e6f607c7550bb23d892e3eaa5404de9948641b5b6f2df91f5d9046d628ccb9c5ab449f68ae56826f670505113dd876157dc3e9586dcdeed9dd5e850c0ddf5839659c4358e46dbdfb1daff3864ebfe0ca94e85ba52e9f54b001a73ee0fd18fd6c0993ffdaef97bac3e01f7cfb8d44eb59cdb8baf3bbc97f7e4f2a547f25c811f9fc40b4270fd957f8f6de6b6d6e4e74af02b263e98f8f74c6a52eb183ecd7c8516fdc7ddddff7f4cfc2f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138190, 148, 10.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c2dcc410a83401044d1abd4325988192520c921922b3476a94d744cc65698db2b92ede7f1eb2254c894b4e062d1dc6484ce0baf0f845b11ee535f7efa5225e3fd82da664ac5af1912fe7acc4fb8791227d6ef51512b7c06bb8eaddb464c62d11925b63cd73b82b42755', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138191, 148, 40.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d63551a84c4d2c2a56d0c84dcccc2b49cd4bcc4b4ed5b4523031c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c8280200bce71128', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138192, 148, 25.0, 35.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d5353452a84c4d2c2a56d0c84dcccc2b49cd4bcc4b4ed5b4523032d53536cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c8280200f14911f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138193, 148, 300.0, 300.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb3333452a84c4d2c2a56d0c8cccb2cc94ccc5148c92f4ed5b452303630c84d5708f05728b4c8b056c84dac54c8cc4b2e4a4d2c4e55282d5028c957304352000026d2164b', X'789ced596d4fdb3a14fe2b4795aeb449edfa0285d14d48bd940bbbda18a27c5ba6c84ddcc417c7c962a71026fefb7decb4a581960d344d9ad44f75ece3f3f29c171fbbdf1b615e44be62096f0ca871c2262ce3ca08d56852a3c8a59d8c8dc9f4a0ddbe16573c7993e6911d89769d560739be429f19bba5d7e9edb53add56b773d9d91ff47706bbfb6f7a079db7fb1d47cb032352a541f9bd71c215cf997463c36fdcf6cb32e3034f0dc13c48d5ac909a29a33df58e4e867f0f892926d3c853a354b388d33f699ee801052cd385e44d326c22b969520ab6a453595861d4eb7792a8dd4f3e7aea284d12cc5ce62ce47406d3b1fb8c17796a8d69d209f609cd9da6c56455d93b4c39eef6ebcb577c49a1aedcc7bdf20fb4fe31900f37dc7db5728661218d0f13858a6ae0acd1ab71ce722398f4c75cdc1639d7b50dc3f0bf428178c6c9c4c03a2b699ae694557b48cff7d0b530314073bf6961b000ad42969714553e12b7cc8af4d40725ecd601ed74002a9d7fa66f6fe3dc539f5849420539679a53919149696f95a251c7cf9a799e6ae343ab8c03045fc10b4c4682d50c18816d77551826e07dccf65667bb3dab839dde79a0d91ab99f0a1d48ee1fe52cc9b4ffeaf374da926cc2e5eb9ae46ea7d3bae7743a7e4709d81b617266b8350f8bad5d4760e5d0f9c5d91a59437523b829374a599500fc1cb6b26cd2e5e9f159cd904afcb4c8ad1fef91661aaa486e750ad7881f0988b4e8ba18cf4cbc5993032bac1d4208042e35a9c42ec545c89bc2ced3b71da06d8553f7ad456a6fb17d8d16957066622872ce503456e52ea344a62c84243a1ec193420731cb91e12e322b20bca2d73de891539432a060950dc54c843c8463427a0534c020435cb5167145cbb8a29c4722e1eaf523f61974229df140d8ec37481129d3eb5691d9b0bea1b0aa35958924a6a03702d58f98042a61492828d1b2227aea9239e552e07548fb564b875308a1aecc14dc535fba5f1f02f54485a9d2e5cf49f447356a9be9db4cdf66fa4f67faef4a978779bacd976dbefc81f9b24571138a3f7f89a90a0f0f053339607ce6e563d15ff8bd755dc953adc8133d88c3ba82421f52b757a6d51e9e09c9338d0c6452a7c47eb2f559e1463bad6e8f4ace72dc2cdfef54a3018dd914150977cc90f8742a021694a452435c5bd0848e79e8a9fbadf46a5e0c9c2f5e0fa8db6975fbc8f5ab65b558448fab832ba563512cd13f41ad9dd0fa0f227965468278315c311570c7da0add5dc85c5984c8ddce46799eeaafa85adfd6ebb776366beaa9c38d363eaebc4f34832f6d71b7e1b40da70de1f4cc8a36aeaaae7f9e668564f7856b1152e728dad68a922eb0aa224f0de8c8531f59601cf5808e6127149f58a50c25425ebda342cf2b7bc08aeab674012c245555d35347f9913cdceb50f2b19d08e5ac04760b4b2e3f8c2a12ccb756a840d0daafdaa6aa6d7334dd7eab77b08ec6357c96e47db7bf5cbfefcdaaf5d311e69c7bdca186932be6498a2a2f4b2d34b1298c23ce829876635a4e5bdfe63326b19fdb200f9696b9a7a901c2982c171bd40e534f2d8f8ec78b2f7d4d7be89b1f3fa78dec836645ac7da1fc2587f9c3da11cec71c911b2e55ab95178976312a6dd4059269ddb6efa32f88b9613843c470ff02b83e96b2ee181df35ca4459d6ec43394190d9ab62e4420421432038f8eff1d7bb089657129d98dd0f62312290f79c2d67498d583678df361b7f3173183cdac099fdfde0a05414da22940890ade249d260abd3392db53f625f72f906532cdec0655a27c4549810d26472ce54d62c94496d5ea840557aedf6912aab03622734043ced21c8c519b1394ea18c352a3b0c6b953a5448f94693b5c1481905866db2cd4d926495e5ca568822c4152ba9e0bea2050015d6501fa2291d9a22dc9e18119b46125f031c22e177935c8635786309a318d50957325afb988628366ab7ad87eced1f52b5df8303cb63efc3d3edce2fc729c9f7bd380ac8405a94ca3b206f82993b8848b291f50bfb5ef1e1c3918a5e89792816b9f92f9f7ad6d9f8e6f607c7550bb23d892e3eaa5404de9948641b5b6f2df91f5d9046d628ccb9c5ab449f68ae56826f670505113dd876157dc3e9586dcdeed9dd5e850c0ddf5839659c4358e46dbdfb1daff3864ebfe0ca94e85ba52e9f54b001a73ee0fd18fd6c0993ffdaef97bac3e01f7cfb8d44eb59cdb8baf3bbc97f7e4f2a547f25c811f9fc40b4270fd957f8f6de6b6d6e4e74af02b263e98f8f74c6a52eb183ecd7c8516fdc7ddddff7f4cfc2f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138194, 786, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230d733d5513034cd4d07005a8506f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138195, 786, 7.5, 15.0, 'mg', 'PO', 1, 'Adult', X'789c33d733d53534cd4d5708f0570874010018a30376', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138196, 786, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac503034cd4dd74f49ac0400185203ee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138197, 786, 7.5, 15.0, 'mg', 'PO', 1, 'Adult', X'789c33d733d53534cd4d5708f0570874010018a30376', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138198, 786, 15.0, 15.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac503034cd4dd74f49ac0400185203ee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138199, 786, 7.5, 7.5, 'mg', 'PO', 1, 'Pediatric', X'789c33d733cd4d5708f05708740100111c02e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138200, 786, 7.5, 7.5, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030d733cd4dd74f49ac04001b700422', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138201, 786, 7.5, 7.5, 'mg', NULL, NULL, 'Adult', X'789cf370b152c84dac5030d733cd4dd74f49ac04002b420528', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138202, 1002, 1.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c33d435524857f00c53283434f250d0f04dacb052305348d73732c9b05648c92f4ed55148292d4a2cc9cccf53284b2cca4c2d5628cf2cc950c8cc4b4b4d068b965416001515a796a5166596546a0200d5fe1a84', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138203, 1002, 2.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c334a57f00c5328b4f000000bd2026a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138204, 1002, 0.5, 1.0, 'g', 'IV', NULL, 'Adult', X'789c33d033d5354c57f00cd3f7f455283434f250a830d73534504849ac2c56d0008ae5e7e5542aa4e517298486782aa494a62a94e42bb8ea2924e7e7646a0200fa351164', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138205, 1002, 2.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c334a57f00c53283434f250a83034504849ac2c0600318f055f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138206, 1002, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789c35cb510a83301084e1abcc0114dc28d246df94920729bd424ad7b810b4c6b4e8eddb627d9c6ff82f7c0fe219577ec5303d7914abd184c623cfd232d350709849996a57a2549dffaa8a5d3bd4445f732b2588038fa0e335ad3e4602276f86ed23073cc4fa6d91a5c2adfd95988b93f900f7a92787', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138207, 1002, 0.5, 1.0, 'g', NULL, NULL, 'Adult', X'789c7d8e4d0e82301844af3207a0e62b52a3858d81854bafd048a14d6a1b68317a7b31f89798b89d99f7327be71092d123aceff429d9e0a3443dd60e6b621b92e8ed4563c80b532e31e72cdf3de3294ecaa10d51e3ca33cc1e0f5a09c6d17f2315e77f805c101344e7177268241e82f7e053668b4575693edc5ae56ed1c612c7e6573f145b73070bec4359', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138208, 1002, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789c35cb510a83301084e1abcc0114dc28d246df94920729bd424ad7b810b4c6b4e8eddb627d9c6ff82f7c0fe219577ec5303d7914abd184c623cfd232d350709849996a57a2549dffaa8a5d3bd4445f732b2588038fa0e335ad3e4602276f86ed23073cc4fa6d91a5c2adfd95988b93f900f7a92787', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138209, 1002, 0.5, 1.0, 'g', NULL, NULL, 'Adult', X'789c7d8e4d0e82301844af3207a0e62b52a3858d81854bafd048a14d6a1b68317a7b31f89798b89d99f7327be71092d123aceff429d9e0a3443dd60e6b621b92e8ed4563c80b532e31e72cdf3de3294ecaa10d51e3ca33cc1e0f5a09c6d17f2315e77f805c101344e7177268241e82f7e053668b4575693edc5ae56ed1c612c7e6573f145b73070bec4359', X'789ced5cff6fdb3616ff57880007a498edd85ed2b5eee100c7499b6c49ce17674587f360d0122d7191489594d26843fff7fb90b26cc9512347eb76ede61f0a5822dfe3fbf2798fef514c7fdb7355e2cd040dd9de80ec8dd882451cbf5b642f518179e5c771a40707071ff82d0b3b5279e6173f28ced48ea2117367343604fd6eff79bbdb6bf7ba37ddef06872f07472f3abde7dd17dff5ed5ce6c45c0a8d99bfedbd6182291ad8df31bbb7e43769c406e430f6896747cdeca97058e4d340ea482a2ef4549c484d3d465e4b15ea01e1629168cc235a0689216891487e7099220ba930fa4bb6e88a6c122b26bcd8af221d909e7770d40d2f5aa4ef1df4baf8f5aa929b9968e64cc5b54c62a6895c90a11b72c1759c893d20e76f5be4fc722a46320cb1c68da22e2357303656bea4f77c65c1645e34cc47bc8ae93c60e6e9bf3fe329e0e2d63eac0d5536c9361e2bcdfff8b35965e826413c8359b8f04a6ea8906aef983a31539c06b373b1280ee444bd769f78509abceff5cfc83e341c90e7c43be81ffaaf882b356b1137c96c43eea8e230da070e4ff39c1d89e1fd16d1ec0eebc4e9b3bdb2218cc4afd95cf180cdae58122b1931c16949867e26c08bb30ada1f6fce5bb390076e3b94aec1162b91763b47ed9e213f38bfcc54b8ff0e30262e4d35d9c73b2982d482008ca00923b124a71de2c88057896a97b3bab02a11ed024bf615d4d74cc0d2ee43d72c2d400a161890911a05e4db6efb7977408c130cf757d9db1edcf272f9b67f98bdbd20ffecf5f0cebbefb548ec3301302f47cf4e06f9438b78fc8e11ba80db890bc7a79aeb57647c6228c9fbc3176753310c0222c141adbda8cbe2581eef2d068af2d8d7894e6860a1415692583764c2e62456d84f12f48fbaed23046a4e62350083d584f5e0231a6db2877a7e855bce5804003b55312324a1ee2f898e4326e24dd24762daf2fdff04d76688efa26b175d7fc5e87a12ae37836207ec1db0bf5460ffd1d8ac8c851d3877e0dc1a9cdb8365136b3bb4fcadd0b273f797e1eecd30fca3fcfd14bedb1f9058d66306556355cdfc12bba5d9e6f20d73edc7010c4742efe0d63bb01631992b25bd3ef165a260b590def33009adb9808856b76ba79bc7a998d83c57c7ec8559792b8edb9ec0ccfa25edfed58762037262191e75ad00ebfd1f60b18d2362c32ef28a8011a63fa9730451a170c88b8f4e4509b1ddf9cd761aa03adf94beb2c2d011872e52a5051bb5664eaa0dd6167cae80083d33d003b6f4b62b93fbfe87db6d9637392c03dd865a1559ac4532b1482e56398fe412647e2ba692d5c846c6c8df17324571a2c913c5378f2487d50a480a53e85497f32a24da90b520537b6bf97b7de4c6874a3caae7965ad5ee6c1bfebb9264f8594f77bef4c0dde26c6817b9bbc8fd8b47eee746fdc3266707fb1decbf38d8ffd9b0aceefd77b8dce1b2ea9060878baf04178f9f257c4e603c8df313cf132611734cf13e965112d087df66c78a79820a271d90e3a9b840b1bfbc003256720ebe29d174c1a6c2a29764224e85bd7cf197393a9a8ad5a9cbd78edca958a269d35557c573a992c2ab11d6106223296245b970b95301b0611030e5a5a6437302aaf581b9b645f6270cca045a4e45e9760fcc26b56e2b0620f23b347e18a7f67613e10be2a327549a09cd63630cb01c8fae4a331473a004a122e6732e6187369694888098b9b63d8cb9263ed7a63a2811be411fc9b554e6b2d46adc598f9f754c7e0b12267ea585a332b21fe59624794151f5f569ab7b518f5ba2fe9ed4e9f17f06251eb3073cf2bb5377c68eb36b3bb0e9b1aaec3741172e930dcf0a1af96940efb99e8ad3fca21bace0c374fbb935b2be5ed9f4c1854e160bee60c049516829462225057b66ce20f9af8962e0742545db91e22e09b471b246424a34611136c8080e4d30e58225b7d936391537be92e15c3a699cbf197a8a8a24b0afb4916d285868065ac467a10c5270c1cb086834814297a3671853caa79e39118dd91d60d6fe5efa429b2b76a970b10c466ee43d68200d80124225c11c256d30c2062a45dc8694840839be90ca108ce00cc0c3e5e6ac945bedb1d3175009f86059462b8a91ecf25dc9e8d75423c8cff3ab7c04a1c0885afa712a4e96cca04e1ac9c807107cac62151c5edcb4c870724358c0eeccd2b0354df4c395b7026bc1fbf5c82c4e06f73597326cb68078797e89570ea17a2eab9925fa4d24d5f3794051e297c16e1be3d879255ae3e67a4a3bab44775200d3e3b4ab9925fa4dd4d4f3794091a5985dc2f85312c6669ede658c5dc6f84a33c69f08dd26c5d9576fdfb14f918050034b2f2d59f98c068b76c017e6336ef675b7457adf768eb2df64ffece4195ebccc1f47c3f109f2ef2583c95050eb7040cc9f0e20b7b5320725e256c80f022dd04fe3c323b451cb17c877f78e62597b99a03c35c91c748aa3cbdc7f71f40f4c747c2a3ce65afee637d8dbbf4e587e979e671fa31ceed2e01576071f553e760c870501f9604e22c2c4416021edbbcce4606457cdab6ee8d4f534c35503319b2cfb0dfc63f585f20fac6cdcc9145b98768c4858ed60ddbcecdb263448a1eaf9547001bd42db4a60c87c11cb7aef02a932aac4e86c40713d15ab47b22f151132266c619b12f076a00c9ab18cfbe41b88900a3461dc6e5f767b5d5b6cdd2a6143fa11535712e677ebec67b77d617735d32582c7aaff01ff77bda91092b83446d8bdeb4f05cd84400b039b29d922f324b60222fcdc826c98fded23b3d7130b9a1999de28994464888d5eb18800e52a159e6dec64f110aaf05d70411918991df7dd619315972b09962043f19add0f39c34a68bcff46d1908c65665043f66fe559505b6818ae9d5c9d16396e91518bbcd9b3d5538eb9d4cecc52c28aed27388d730159031e6f396a0e0ab359659b0b81f8e54202b8c4abe2f2ae57c3e6d4448274a483c26de5b80a46d74fe5837aaa893c9793c9b081352eaf2bc9eaa41e0ddb0d2927310aa60e39cd0a4d948f55463baf5bbe437e61d84d1adaeaa2831a5dd8eac6fc09dc366eb31172c53c6a22446f32bcea100f0cb12d4a5689ea3a85c020449d65f343b5496a1d2915bd47b6a4c4418633f57e351eebf8940e901ad017ae373c91f28780cd35372ae82671bd5cf860cd869c4e8e2fbe6912930f38fd301e356264833bab067484422f8c46e8acbc26ea55b18a649394839ed75c696966e69c98a0207218b67d5125426d084e6880106cecec89cfbdc6c4632563866c1b7245e7bc5998e43cd0cd7ba8821ab2b84312146897898e3acd621e0f16a0cd188c4c6191618a2c144b84cb9b446e918dcbcd996dd2c4204536cdf4192244002b8aeaa00930860e8afdf87111ea32f958b3c45d0a41994a6c95411b08739ca85b5f06aeb9d4863a38a20eaf625327cf2466a81995e9b432a1d000a1a9f781fb2a7675b9e3273817d527256c59b7984f154e13fd5e2b0ae86b8bde3809a832e48d72c9b14a9c4782a0be1c601e978f85519d51c614fd46a22c077344264de3d764efa52cb4ae494c57801e34ad8ac65a7ddef2b9e2d2a426c117e660711b26975c3b0f02d20f6898ba56245a1d52f575698a4e17893a5cf7255565452d9f6beedcb238d6fcf708b2eccb9390d0bb2d6bc7a1a066df7d58f3995e5fc830752aebc77ad05a5124360094fd8a7a9fd8876aa1a7d81d76228b3c16e0b530256d7544d616f55527babf93cfbe695857cc9e35b1d4eb44171c67cfa591cc54b3d27fcca258dad631ce9bae4f6e353f3f3c6fd91d9bfc3d8e4d9e7a7b85b1d930d072affc1969657af39f0970d1f8837b35a7bab3f715cd6c49f37179bf6bc1b0d73a1b8784a79174ccdfead8af50f7dc916134154307d38c5b2780290be7a88a0e5ba4dfedbd7caa913e7efc1f60d4e394', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138210, 1002, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3cdcc495128c957c8cd4f492d4a2c4955c8cc4b4b4d2ec9cccfb352303550c84dd7cf4ed74fc92f4e55482d4b2daa54303452c8c82f2d2ab656c84dacc8cc2dcd5500495a2918e91818809583b800f5921cc1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138211, 1002, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0b4e2d4b2d4a55c8cc4b4b4d2ec9cccfb352303550c84dd7cf4ed74fc92f4e550049572a582894e42b181a2964e49716155b2be4265664e696e62a8054582918e9181880f580b8004f7c1a8c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138212, 1002, 50.0, 50.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c1d8c410ec2201405aff20ea0ad92b8a1892b5db0e84edd93f24b7f2cfc4ab1caed256e2733735608a2719195344e87e0dba78779b4a6c7eba8a60ebdfd6a28f8d655a5838963d5dd3bd9cc12b1d9c4b4e2c37902c791863fcd65a11d56da28712e35ea21712e182521f0ecf6415c83fbcdd411210bae0d0699f90772be2e51', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138213, 1002, 50.0, 50.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb33352c8cdb75270c92f4eb5523035c84dd7cf4e57f00c5328b4c8b056f04dacb052305248d74f014a030000d90c44', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138214, 1002, 50.0, 50.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb33352c8cdb75270c92f4eb5523035c84dd7cf4e57f00c5328b4c850a8302acfb656f04dacb052305248d74f01aa0100458a0df0', X'789ced5cff6fdb3616ff57880007a498edd85ed2b5eee100c7499b6c49ce17674587f360d0122d7191489594d26843fff7fb90b26cc9512347eb76ede61f0a5822dfe3fbf2798fef514c7fdb7355e2cd040dd9de80ec8dd882451cbf5b642f518179e5c771a40707071ff82d0b3b5279e6173f28ced48ea2117367343604fd6eff79bbdb6bf7ba37ddef06872f07472f3abde7dd17dff5ed5ce6c45c0a8d99bfedbd6182291ad8df31bbb7e43769c406e430f6896747cdeca97058e4d340ea482a2ef4549c484d3d465e4b15ea01e1629168cc235a0689216891487e7099220ba930fa4bb6e88a6c122b26bcd8af221d909e7770d40d2f5aa4ef1df4baf8f5aa929b9968e64cc5b54c62a6895c90a11b72c1759c893d20e76f5be4fc722a46320cb1c68da22e2357303656bea4f77c65c1645e34cc47bc8ae93c60e6e9bf3fe329e0e2d63eac0d5536c9361e2bcdfff8b35965e826413c8359b8f04a6ea8906aef983a31539c06b373b1280ee444bd769f78509abceff5cfc83e341c90e7c43be81ffaaf882b356b1137c96c43eea8e230da070e4ff39c1d89e1fd16d1ec0eebc4e9b3bdb2218cc4afd95cf180cdae58122b1931c16949867e26c08bb30ada1f6fce5bb390076e3b94aec1162b91763b47ed9e213f38bfcc54b8ff0e30262e4d35d9c73b2982d482008ca00923b124a71de2c88057896a97b3bab02a11ed024bf615d4d74cc0d2ee43d72c2d400a161890911a05e4db6efb7977408c130cf757d9db1edcf272f9b67f98bdbd20ffecf5f0cebbefb548ec3301302f47cf4e06f9438b78fc8e11ba80db890bc7a79aeb57647c6228c9fbc3176753310c0222c141adbda8cbe2581eef2d068af2d8d7894e6860a1415692583764c2e62456d84f12f48fbaed23046a4e62350083d584f5e0231a6db2877a7e855bce5804003b55312324a1ee2f898e4326e24dd24762daf2fdff04d76688efa26b175d7fc5e87a12ae37836207ec1db0bf5460ffd1d8ac8c851d3877e0dc1a9cdb8365136b3bb4fcadd0b273f797e1eecd30fca3fcfd14bedb1f9058d66306556355cdfc12bba5d9e6f20d73edc7010c4742efe0d63bb01631992b25bd3ef165a260b590def33009adb9808856b76ba79bc7a998d83c57c7ec8559792b8edb9ec0ccfa25edfed58762037262191e75ad00ebfd1f60b18d2362c32ef28a8011a63fa9730451a170c88b8f4e4509b1ddf9cd761aa03adf94beb2c2d011872e52a5051bb5664eaa0dd6167cae80083d33d003b6f4b62b93fbfe87db6d9637392c03dd865a1559ac4532b1482e56398fe412647e2ba692d5c846c6c8df17324571a2c913c5378f2487d50a480a53e85497f32a24da90b520537b6bf97b7de4c6874a3caae7965ad5ee6c1bfebb9264f8594f77bef4c0dde26c6817b9bbc8fd8b47eee746fdc3266707fb1decbf38d8ffd9b0aceefd77b8dce1b2ea9060878baf04178f9f257c4e603c8df313cf132611734cf13e965112d087df66c78a79820a271d90e3a9b840b1bfbc003256720ebe29d174c1a6c2a29764224e85bd7cf197393a9a8ad5a9cbd78edca958a269d35557c573a992c2ab11d6106223296245b970b95301b0611030e5a5a6437302aaf581b9b645f6270cca045a4e45e9760fcc26b56e2b0620f23b347e18a7f67613e10be2a327549a09cd63630cb01c8fae4a331473a004a122e6732e6187369694888098b9b63d8cb9263ed7a63a2811be411fc9b554e6b2d46adc598f9f754c7e0b12267ea585a332b21fe59624794151f5f569ab7b518f5ba2fe9ed4e9f17f06251eb3073cf2bb5377c68eb36b3bb0e9b1aaec3741172e930dcf0a1af96940efb99e8ad3fca21bace0c374fbb935b2be5ed9f4c1854e160bee60c049516829462225057b66ce20f9af8962e0742545db91e22e09b471b246424a34611136c8080e4d30e58225b7d936391537be92e15c3a699cbf197a8a8a24b0afb4916d285868065ac467a10c5270c1cb086834814297a3671853caa79e39118dd91d60d6fe5efa429b2b76a970b10c466ee43d68200d80124225c11c256d30c2062a45dc8694840839be90ca108ce00cc0c3e5e6ac945bedb1d3175009f86059462b8a91ecf25dc9e8d75423c8cff3ab7c04a1c0885afa712a4e96cca04e1ac9c807107cac62151c5edcb4c870724358c0eeccd2b0354df4c395b7026bc1fbf5c82c4e06f73597326cb68078797e89570ea17a2eab9925fa4d24d5f3794051e297c16e1be3d879255ae3e67a4a3bab44775200d3e3b4ab9925fa4dd4d4f3794091a5985dc2f85312c6669ede658c5dc6f84a33c69f08dd26c5d9576fdfb14f918050034b2f2d59f98c068b76c017e6336ef675b7457adf768eb2df64ffece4195ebccc1f47c3f109f2ef2583c95050eb7040cc9f0e20b7b5320725e256c80f022dd04fe3c323b451cb17c877f78e62597b99a03c35c91c748aa3cbdc7f71f40f4c747c2a3ce65afee637d8dbbf4e587e979e671fa31ceed2e01576071f553e760c870501f9604e22c2c4416021edbbcce4606457cdab6ee8d4f534c35503319b2cfb0dfc63f585f20fac6cdcc9145b98768c4858ed60ddbcecdb263448a1eaf9547001bd42db4a60c87c11cb7aef02a932aac4e86c40713d15ab47b22f151132266c619b12f076a00c9ab18cfbe41b88900a3461dc6e5f767b5d5b6cdd2a6143fa11535712e677ebec67b77d617735d32582c7aaff01ff77bda91092b83446d8bdeb4f05cd84400b039b29d922f324b60222fcdc826c98fded23b3d7130b9a1999de28994464888d5eb18800e52a159e6dec64f110aaf05d70411918991df7dd619315972b09962043f19add0f39c34a68bcff46d1908c65665043f66fe559505b6818ae9d5c9d16396e91518bbcd9b3d5538eb9d4cecc52c28aed27388d730159031e6f396a0e0ab359659b0b81f8e54202b8c4abe2f2ae57c3e6d4448274a483c26de5b80a46d74fe5837aaa893c9793c9b081352eaf2bc9eaa41e0ddb0d2927310aa60e39cd0a4d948f55463baf5bbe437e61d84d1adaeaa2831a5dd8eac6fc09dc366eb31172c53c6a22446f32bcea100f0cb12d4a5689ea3a85c020449d65f343b5496a1d2915bd47b6a4c4418633f57e351eebf8940e901ad017ae373c91f28780cd35372ae82671bd5cf860cd869c4e8e2fbe6912930f38fd301e356264833bab067484422f8c46e8acbc26ea55b18a649394839ed75c696966e69c98a0207218b67d5125426d084e6880106cecec89cfbdc6c4632563866c1b7245e7bc5998e43cd0cd7ba8821ab2b84312146897898e3acd621e0f16a0cd188c4c6191618a2c144b84cb9b446e918dcbcd996dd2c4204536cdf4192244002b8aeaa00930860e8afdf87111ea32f958b3c45d0a41994a6c95411b08739ca85b5f06aeb9d4863a38a20eaf625327cf2466a81995e9b432a1d000a1a9f781fb2a7675b9e3273817d527256c59b7984f154e13fd5e2b0ae86b8bde3809a832e48d72c9b14a9c4782a0be1c601e978f85519d51c614fd46a22c077344264de3d764efa52cb4ae494c57801e34ad8ac65a7ddef2b9e2d2a426c117e660711b26975c3b0f02d20f6898ba56245a1d52f575698a4e17893a5cf7255565452d9f6beedcb238d6fcf708b2eccb9390d0bb2d6bc7a1a066df7d58f3995e5fc830752aebc77ad05a5124360094fd8a7a9fd8876aa1a7d81d76228b3c16e0b530256d7544d616f55527babf93cfbe695857cc9e35b1d4eb44171c67cfa591cc54b3d27fcca258dad631ce9bae4f6e353f3f3c6fd91d9bfc3d8e4d9e7a7b85b1d930d072affc1969657af39f0970d1f8837b35a7bab3f715cd6c49f37179bf6bc1b0d73a1b8784a79174ccdfead8af50f7dc916134154307d38c5b2780290be7a88a0e5ba4dfedbd7caa913e7efc1f60d4e394', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138215, 1002, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c558e410e82301405aff20e50625bc168710731ae8c5728f8811f2b685b8ddc5e1363acdb9997ccdb51e3d9110e748f7ebad2c856a09d43e4161d377e0a1c0c2a5f392c65b6920685bcf48b738f9bd243f9314a657a93189d7fcd56a91f7f2a8138d0085da4c37d6dfe8840cf0f82ed22799cd8baf9fda1c4b14e0af97a7801ff29384f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138216, 1002, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c4bccc951c82fc9482d52c8cc4b4b4d2ec9cccf2bb652702e72ce513036d03533b0523035c84dd7cf4e57283432c9b086c8181aea1a5922642a0c75148046e4291899ea62516d63688845ada1919ea9ae9129b26a0f17ac662294e828a46796a52a24a69500dd9b92999853599c596cad1080a4afd0c4220300ca533e23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138217, 1002, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Adult', X'789c558e410e82301405aff20e50625bc168710731ae8c5728f8811f2b685b8ddc5e1363acdb9997ccdb51e3d9110e748f7ebad2c856a09d43e4161d377e0a1c0c2a5f392c65b6920685bcf48b738f9bd243f9314a657a93189d7fcd56a91f7f2a8138d0085da4c37d6dfe8840cf0f82ed22799cd8baf9fda1c4b14e0af97a7801ff29384f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138218, 1002, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Adult', X'789c4bccc951c82fc9482d52c8cc4b4b4d2ec9cccf2bb652702e72ce513036d03533b0523035c84dd7cf4e57283432c9b086c8181aea1a5922642a0c75148046e4291899ea62516d63688845ada1919ea9ae9129b26a0f17ac662294e828a46796a52a24a69500dd9b92999853599c596cad1080a4afd0c4220300ca533e23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138219, 1779, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'789ced584d6fdb3810fd2b03037bb39bc49b6e00dfbc498b06a88bc0cd5e765d08636a2413a64881a436f616f9ef1dca4d6c39aa3f64a75d04b94934f9e6cd1bfa519cafadd81669a431a3560f5a03298cc6ff8ca2561b5a85556170e27dee7a272777724ad91b63d3f0244faa739db098531ca10f4bbaa7dd3f3aa7679db3d3dbd38bdedb8b5ef7ed9b8bf3eeef67e7e55c125e1aed78e6d7563fcea496ce5b0c63e590a75989723bcfa937d27ded6552e814d5485f198729c17b6333d783ee6f706909b3911e9ac29303934015af07b72697222cbd34596634dc5a8c093e71c20c3030612aface15d9ac0d57e448d3ac0d1f8db79271dac05932103ffc4de88c1d97fc8bf16a0af73ce471ac28bcfdf385df94d4d3f26599cb3289edcaaeccbdff12d0fb71a17cc4b94b9d5614aa61d3ba441dcb58a293ae1d89c2a32653b8cab27e9eabf9a37af0e7f515780398248c4331208fc2ac0b77449c4635bb40e7566ac248189b1b2b1b209f6f43b64523dc6d8c797f1e91ee86b297319fa10eeba57e2dc42e8538a24a3f28c04b92e9f05cea45fa15c91c1e7377ab2fc3de7040e4a3431c66d651f7f9ecba09f66e3ef11caccb0a1e917233d33e30b3cdb6fd5a90ddcdfbc0c09becfb0589758c7c3698f84f4fe81851f734f2cf3909892aba3179a17029c3262fbfb1946ad4621e0dc395a16afe43e9a6e17a9290470513b419680334cb4bbe233dc039148e20e6dae914f207ac9abdf511852f29455ce66925ca03cadd442a82318be07c422c1fb3790a3424cd29d69c54e57da3079f8c879812ae01137c3cda2ae335a81f286776b5276073dcad07ef7369bf5ee457f19f8adf5c9375755f9028474a655da15f92cbd182eee9c297467b8b923fc9448d07f795229bce83ef0b85ce9d8456568328fdf85fb28ea221a1d8cde93f9395eb77f9b0d38d10856dc3b8f06c309ac0127fb5f8da3db9e8465510aead958bff5180b09aa56e836337e30716359ceabe7023fe95ecdc4f28c336642868d1e90a0d2eed3903d6db663ce4e53ec7ed92c643a0ed7daac7998cbb5c5f4f6333d2f735d1ca9a45e7ab89d24fee58af52ef22f54f93a949fbf47fa5d44df88440619449e715bd3ea04a3a4a26d483bff4549b3bd660c01f1d63a3a4cb821b6a628558bf8c3f44dcdc79caa4001c3bbedf2c247b371396169deb30bb819d0d484c5073bcc824515f3ce9aa5feb891c4befe0ecbc832a9f208b92919fccd943999da5b810e13368d18106414a4146d9d8f25d98eb9c1a666d4da0afb9e46edf9a7eff5b53d457ce54fdfcb1edcd5beafd22bad4c9036cc39db382ba4fe77d6dffd4d2d98cb55812ad2ce1dd737fff0daef66d8e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138220, 587, 140.0, 140.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c33343150c84dd7cf4e5708f057c8c94f4c0100291e050a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138221, 587, 70.0, 70.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c333750c84dd7cf4e5708f0572834c92852a830345748c92f4e2d56484c49c92cc9cccf4bccb15648c9cc292d495528c95730555528cecfc90300f8cc126d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138222, 587, 150.0, 150.0, 'mg/kg', 'IN', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4eb552303435c84dd7cf4e57c8cc5330343050c8f55170310d57c82f4b2d523033c8cdcc0300631b0e66', X'789ced5b6d6fdb3812fe2b83007b48003bb1ecd84edcc30169b32f01baa9afcd753fd441404bb4c50b456a492a89bbe87fbf194ab225c72f690e87020701456acbe4f099e1bc3ca4c8bf0e2293cdef144bf8c1080eaedb1721770b192eace342f183161c6446d24fb173a91d9d9c3c8a7b9e1c6b33a74fe264530f1b1a96f2e88e39ead8ed7407ed4ed00e3a379de1a88fff4e8fcffb9d4e70eedbf2d009ad2cb6fcebe057aeb861d27f76fcc977af8b6f813613753d516d567b0e87d717ef8e5a202c30487824424662c1c5ccd1c3ccf2089c0667383ea0be2c114aa73157a01fb889b4e5c770e520640a98b41aa63cefc448a2e2d34c8aaff8b52a5b43cc650a5263671a4a84f7906632d18a9905949a1d4fd41f344c7d50c4e4d83d7d50209999732008b6858339fd24421cc8b1a996c271b82e946da753aebeea3f3314822a8ba4507cfccfab23141f66492699e39664ba98c354478b6340c3789c96001b9e4a8e22e732730c11931cc32d370fab6e52a0415af088fac465cff231a4863f70e520620943d033a313ff6bcc53e6740edd23aa288016b859a47c04170a2df22422a65c6ba2f0af88b4e31375a92d09fb459bc48e5a70f5b905e30f2db82ead3e51ef748266851bc322b4077aab1d91626fbc0b65d3aa177dc34738b2e4f4edcb2d7e9342ddfb2f2baf2ac7deefe01765cb6fb724f922caa4bb43c042cd6b7eba01c9c1f843adc97b6e2d1970c68d21778cd1d7ae3e83d119ce4894719aa04ce104318bf8d03fd0b781a9086cc2a59ca8e0b403c9fce47e8ed641af63689761e5c99fa7b181a760987b12b028120485c93710094963a0fcfe4f60b5540775239166579feb60513eeae8858d20e877f271d047820e0efa1e2efb7ff8d08141071d71a23ef15023d6c38409e538ce6ec88f8ade95cedd7ebd336246ef888589ca913aabc6fdb59182416c362027e7409fb4f5bc8171681d89fb09f86c46d3f28031338339feafe0ef6780d64ab1491bb5e4962cf50624cd50ad753068774f9f379da8df1986b813521699629649f8c7a6a62da0888147e162c046682b9a5c1f2f182b3386536330f7fc4a0352ac66e87012deff72830199a406158743a55df1fc627c3146980f5c520ae91c4dd497e016ff74f1cf5bf496476672313ed391592041a4cceb04e39b63f0c03936f5066f473ce52aa2764285d8c772b2fcf806665a4afd482e40e2f0190126337b55d067ab312fdc02a3fc4bef767d7a7644631e4fd5ac7857ca6a22ab89ac26b2febbc81a235361ce88f0a5d56a7328de756b1db14643180b19194f7938dac4732e8a03521563a3605a311676d46fa2acce69d8b2b5d2c0258e6cb45c1471f8a0659670087592ca825fd9e30d0e39feb0866715b9c476e0918b79ec8825322917f83fc64a4ee16425eac8c796a104973e3a863be5a0f7e9cca09c99c368f174a822cfab809e83acaf6c38433b61c2c04964b2a47699f251801c0c1d88a8658d11326bd9827e7de0d805195e4ea6bc475a4c5118b168d6a0730ef7f3d144ad671198c3e1b08f418d8e4bd9a04b9fcb697933513992dcce23e8f9f8df6887632faa375c8a0a82de2e51413f1775eef19d6f8677eae17556f082ce2e99ddb3adf03cb8959e4167a79ede3d50d099077746e09e61eb91c84145e47955e40493d71ab8c1367083c276bda5acf3e14e51412f1735f4f0861be10524b2efe1015583c043a5b4b11d61771bc27e8eb07bb61477d6dd8d30c8450d3cc2c146841d8f7035b9b947ec80b7d5f97270aba918ee9e89a010d4f7e0fa9bc09d9144ef0485f5babbb1055b27d7bb7077a5e560b7a0c2834f3db4d34dd076bbf20668a7dba0f5f2590dce96b2fabb6775984bea7970bd4de0061edc4adbf33d66dbea713eba829596a7bb952cccdff5c8ba9b90bd6e1e9e03eb7a602b39bddd720ae37ba6e9f9254220701751043e3fead9b2082274ce70f11cd0f343efeef3236ad045cab4b671819c31cb79cf7acac4b03aa11136d62afa6923d55cab8f5487d292095838ecb483b3235fc04a164bb8f2fa5d7e235662b18cc9881858ce56f2a2ce1eb4889e15ef99ccf029122a849260a9eafbb9ebd40bc165c976f3329b9b1ced43257769f416c6e8cc6fbbe4acd417d325012e724455c2708f84a21c9744f8b224c21511589bf6a0189442ba810fe617685630f9d72bd6edef14f002bdfa7b202cb5fae0bf76b668d5ea78a939a8d7685515b007d316adaa1282fccb7ebdbe832eafa2053dff055b9ed8e8db8ec5eb0f66cccf97ca0d656e287343991bcadc50e686323794b9a1cc0d656e28f38fa2cc0d1b6dd868c3461b36dab0d1868d366c74c3764d43471b3adad0d1efa4a3cd42ae899c26726a91f3f253b13e783ea53c144cde8d754a878897e5a88ca5b1e173aa600bf888bf2a043482b713f556bb984eda61a4d14aab787f41e7a2caf3d374bc29efebeae79ca0f6f604aa879d4e6f270a8562fc260518284456cef8e9d5b1aa19a7424fa11bd27a5139936b8033ca42e73fe3ecfe4bdd2bfda8e8ec197fc29e2e473725190e1221ef27ea23966909f98129a20699442b5f6b07119f61b18f266a79ac6aedf96fc5b1b3efeffbda33cceb53b27f197e4967fdf3c6f64ea8bba584031cf0d54bfa779a0c2e5479307efdb4a0e466bea0f90a252e914fe8c2c12b1cf422420fb7fcee2312b3e7a36c62529fb8113a5b43a3581a2f248aa0646e0a5930cd5c7eea1f016a8c03720defa3968baf99a1b57fc80d9fa28b038f78c25af03788b951c26b4c3edb479f2da53f09743dec95622af0c7eeadc35ac14ce4dfe8b154d02152cc1274d920b319ed50d0297cc78ccb0b109b717c549e06acbfe3c3b106b7e440958388f48a9087c86ce9e201953d81acd46b81f5c9c6de21af669019f4506604c24720c8582f05c55ebc880c0522f78d989a0b5d283935184fb1b629b309eda540bc48355259eb4f5f6e9181b6d2349046826cd0cc74a901952d6461ee624ed34e8cd4986abd953df2b202537df659e463c5223ecd5103babd01968ab2018c725e24de625f87450841d822fe495a7e5f4316865f4cd4cf29824c63e3a1fa57ab0e6d1ffa83aef422964932fa3c06915f06a9e6b15afab2b45f441949cf71ee2c1d32b58b24759a68c097e1b3f39ac5715aad6a0e693339cb4cdb9f43c6f1323a5face83f56bce54d0485eb3160945911a18e897812a5e1fe9d095c53e0bc581d312a06689c304bf31f1948f4717fca190df2f8aaddbd8a47bfe4aac4aa712da1acb9c80b12d55a87ffa1b48a3fec97546d9c27bf26c93449e6072799f5bad76499ffbb2cf3c3a7f43bc9da38662661a1967a5ebfcbf31b93b3b614333ea2d08bb2b0788bb2da4fa37dbd7225e4f7efd67ff6c4dad24e78b1daa18b828f536d94f59bed45e7df8beb8736c1a17ef67cbf5806187f6d32e8411b7a673f1d51d3306618a609c5f24558b4bb2256fbc01566f7f52d3f4177253ddda5e4a7f3f749ab44499b0a1b6f98c274515ea0f4fb84fe3266914336ddc8dc749e6bef428ef3bb0bac32f58a54837388baa05ef268b9e87aed12e42572f74473ed08dd52c2ea261806c0b76fff01c9595281', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138223, 587, 50.0, 50.0, 'mg/kg', 'IN', NULL, 'Adult', X'789c0b4e4dcecf4b51d0c84dcccc2b49cd4bcc4b4ed55448c92f4eb5523035c84dd7cf4e57c8cc5330323550c8f55170310d57c82f4b2d5230c9280200281e1231', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138224, 587, 100.0, 100.0, 'mg/kg', 'IN', NULL, 'Adult', X'789c0bc9c82c4a5148c92f4eb552303430c84dd7cf4e57c8cc5330353050c8f55170310d57c82f4b2d523034cb28020031d60d39', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138225, 587, 140.0, 140.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c33343150c84dd7cf4e5748ca4fa954284fcd4ccf28d151c82f4accc9a904d279c9a90a89c50a890a39f989299979e90a29f9c5a900d4f2120f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138226, 587, 70.0, 70.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3d8b410ec2300c04bfb20fa8044848489cb9f208d3b849846b57b15bc8ef291c388e66e64e5583957464dcccf98acb11733e3c331e963a5e5c738901d648a40f38a3d8da1c34053744618851aa9a91f61ba409bc71ebff70b286d3056141f26b7cc0aac2ee68bc300527d0c84173555b0a2bc89dfad76ebc2f6a1af6ae236467f10f51303f57', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138227, 587, 15.0, 15.0, 'g', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034554857d0303755c8f5d1040071e80787', X'789ced5b6d6fdb3812fe2b83007b48003bb1ecd84edcc30169b32f01baa9afcd753fd441404bb4c50b456a492a89bbe87fbf194ab225c72f690e87020701456acbe4f099e1bc3ca4c8bf0e2293cdef144bf8c1080eaedb1721770b192eace342f183161c6446d24fb173a91d9d9c3c8a7b9e1c6b33a74fe264530f1b1a96f2e88e39ead8ed7407ed4ed00e3a379de1a88fff4e8fcffb9d4e70eedbf2d009ad2cb6fcebe057aeb861d27f76fcc977af8b6f813613753d516d567b0e87d717ef8e5a202c30487824424662c1c5ccd1c3ccf2089c0667383ea0be2c114aa73157a01fb889b4e5c770e520640a98b41aa63cefc448a2e2d34c8aaff8b52a5b43cc650a5263671a4a84f7906632d18a9905949a1d4fd41f344c7d50c4e4d83d7d50209999732008b6858339fd24421cc8b1a996c271b82e946da753aebeea3f3314822a8ba4507cfccfab23141f66492699e39664ba98c354478b6340c3789c96001b9e4a8e22e732730c11931cc32d370fab6e52a0415af088fac465cff231a4863f70e520620943d033a313ff6bcc53e6740edd23aa288016b859a47c04170a2df22422a65c6ba2f0af88b4e31375a92d09fb459bc48e5a70f5b905e30f2db82ead3e51ef748266851bc322b4077aab1d91626fbc0b65d3aa177dc34738b2e4f4edcb2d7e9342ddfb2f2baf2ac7deefe01765cb6fb724f922caa4bb43c042cd6b7eba01c9c1f843adc97b6e2d1970c68d21778cd1d7ae3e83d119ce4894719aa04ce104318bf8d03fd0b781a9086cc2a59ca8e0b403c9fce47e8ed641af63689761e5c99fa7b181a760987b12b028120485c93710094963a0fcfe4f60b5540775239166579feb60513eeae8858d20e877f271d047820e0efa1e2efb7ff8d08141071d71a23ef15023d6c38409e538ce6ec88f8ade95cedd7ebd336246ef888589ca913aabc6fdb59182416c362027e7409fb4f5bc8171681d89fb09f86c46d3f28031338339feafe0ef6780d64ab1491bb5e4962cf50624cd50ad753068774f9f379da8df1986b813521699629649f8c7a6a62da0888147e162c046682b9a5c1f2f182b3386536330f7fc4a0352ac66e87012deff72830199a406158743a55df1fc627c3146980f5c520ae91c4dd497e016ff74f1cf5bf496476672313ed391592041a4cceb04e39b63f0c03936f5066f473ce52aa2764285d8c772b2fcf806665a4afd482e40e2f0190126337b55d067ab312fdc02a3fc4bef767d7a7644631e4fd5ac7857ca6a22ab89ac26b2febbc81a235361ce88f0a5d56a7328de756b1db14643180b19194f7938dac4732e8a03521563a3605a311676d46fa2acce69d8b2b5d2c0258e6cb45c1471f8a0659670087592ca825fd9e30d0e39feb0866715b9c476e0918b79ec8825322917f83fc64a4ee16425eac8c796a104973e3a863be5a0f7e9cca09c99c368f174a822cfab809e83acaf6c38433b61c2c04964b2a47699f251801c0c1d88a8658d11326bd9827e7de0d805195e4ea6bc475a4c5118b168d6a0730ef7f3d144ad671198c3e1b08f418d8e4bd9a04b9fcb697933513992dcce23e8f9f8df6887632faa375c8a0a82de2e51413f1775eef19d6f8677eae17556f082ce2e99ddb3adf03cb8959e4167a79ede3d50d099077746e09e61eb91c84145e47955e40493d71ab8c1367083c276bda5acf3e14e51412f1735f4f0861be10524b2efe1015583c043a5b4b11d61771bc27e8eb07bb61477d6dd8d30c8450d3cc2c146841d8f7035b9b947ec80b7d5f97270aba918ee9e89a010d4f7e0fa9bc09d9144ef0485f5babbb1055b27d7bb7077a5e560b7a0c2834f3db4d34dd076bbf20668a7dba0f5f2590dce96b2fabb6775984bea7970bd4de0061edc4adbf33d66dbea713eba829596a7bb952cccdff5c8ba9b90bd6e1e9e03eb7a602b39bddd720ae37ba6e9f9254220701751043e3fead9b2082274ce70f11cd0f343efeef3236ad045cab4b671819c31cb79cf7acac4b03aa11136d62afa6923d55cab8f5487d292095838ecb483b3235fc04a164bb8f2fa5d7e235662b18cc9881858ce56f2a2ce1eb4889e15ef99ccf029122a849260a9eafbb9ebd40bc165c976f3329b9b1ced43257769f416c6e8cc6fbbe4acd417d325012e724455c2708f84a21c9744f8b224c21511589bf6a0189442ba810fe617685630f9d72bd6edef14f002bdfa7b202cb5fae0bf76b668d5ea78a939a8d7685515b007d316adaa1282fccb7ebdbe832eafa2053dff055b9ed8e8db8ec5eb0f66cccf97ca0d656e287343991bcadc50e686323794b9a1cc0d656e28f38fa2cc0d1b6dd868c3461b36dab0d1868d366c74c3764d43471b3adad0d1efa4a3cd42ae899c26726a91f3f253b13e783ea53c144cde8d754a878897e5a88ca5b1e173aa600bf888bf2a043482b713f556bb984eda61a4d14aab787f41e7a2caf3d374bc29efebeae79ca0f6f604aa879d4e6f270a8562fc260518284456cef8e9d5b1aa19a7424fa11bd27a5139936b8033ca42e73fe3ecfe4bdd2bfda8e8ec197fc29e2e473725190e1221ef27ea23966909f98129a20699442b5f6b07119f61b18f266a79ac6aedf96fc5b1b3efeffbda33cceb53b27f197e4967fdf3c6f64ea8bba584031cf0d54bfa779a0c2e5479307efdb4a0e466bea0f90a252e914fe8c2c12b1cf422420fb7fcee2312b3e7a36c62529fb8113a5b43a3581a2f248aa0646e0a5930cd5c7eea1f016a8c03720defa3968baf99a1b57fc80d9fa28b038f78c25af03788b951c26b4c3edb479f2da53f09743dec95622af0c7eeadc35ac14ce4dfe8b154d02152cc1274d920b319ed50d0297cc78ccb0b109b717c549e06acbfe3c3b106b7e440958388f48a9087c86ce9e201953d81acd46b81f5c9c6de21af669019f4506604c24720c8582f05c55ebc880c0522f78d989a0b5d283935184fb1b629b309eda540bc48355259eb4f5f6e9181b6d2349046826cd0cc74a901952d6461ee624ed34e8cd4986abd953df2b202537df659e463c5223ecd5103babd01968ab2018c725e24de625f87450841d822fe495a7e5f4316865f4cd4cf29824c63e3a1fa57ab0e6d1ffa83aef422964932fa3c06915f06a9e6b15afab2b45f441949cf71ee2c1d32b58b24759a68c097e1b3f39ac5715aad6a0e693339cb4cdb9f43c6f1323a5face83f56bce54d0485eb3160945911a18e897812a5e1fe9d095c53e0bc581d312a06689c304bf31f1948f4717fca190df2f8aaddbd8a47bfe4aac4aa712da1acb9c80b12d55a87ffa1b48a3fec97546d9c27bf26c93449e6072799f5bad76499ffbb2cf3c3a7f43bc9da38662661a1967a5ebfcbf31b93b3b614333ea2d08bb2b0788bb2da4fa37dbd7225e4f7efd67ff6c4dad24e78b1daa18b828f536d94f59bed45e7df8beb8736c1a17ef67cbf5806187f6d32e8411b7a673f1d51d3306618a609c5f24558b4bb2256fbc01566f7f52d3f4177253ddda5e4a7f3f749ab44499b0a1b6f98c274515ea0f4fb84fe3266914336ddc8dc749e6bef428ef3bb0bac32f58a54837388baa05ef268b9e87aed12e42572f74473ed08dd52c2ea261806c0b76fff01c9595281', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138228, 587, 7.5, 7.5, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230d733554857d0303657c8f5d10400a72f093e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138229, 587, 14.0, 14.0, 'g', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034514857d0303750c8f5d1040071c40781', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138230, 587, 7.0, 7.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230574857d0303655c8f5d10400957608d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138231, 587, 13.0, 13.0, 'g', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034564857d0303355c8f5d1040071cc0784', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138232, 587, 6.5, 6.5, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230d333554857d0303656c8f5d10400a70e0939', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138233, 587, 11.0, 11.0, 'g', 'IN', NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034544857d0303555c8f5d154c8cc030089d30878', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138234, 587, 5.5, 5.5, 'g', 'IN', NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230d533554857d030b250c8f5d154c8cc0300c4680a33', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138235, 587, 10.0, 10.0, 'g', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034504857d0303550c8f5d10400718c077b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138236, 587, 5.0, 5.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230554857d0303255c8f5d10400955a08d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138237, 587, 8.0, 8.0, 'g', 'IN', NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb552b0504857d0303150c8f5d154c8cc030082410848', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138238, 587, 4.0, 4.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230514857d0303250c8f5d10400953608d0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138239, 587, 7.0, 7.0, 'g', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb55230574857d0303655c8f5d104006ab60754', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138240, 587, 3.5, 3.5, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230d633554857d030b450c8f5d10400a6f40939', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138241, 587, 6.0, 6.0, 'g', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb55230534857d0303650c8f5d104006a92074e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138242, 587, 3.0, 3.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230564857d0303455c8f5d10400953e08d3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138243, 587, 4.0, 4.0, 'g', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb55230514857d0303250c8f5d104006a76074b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138244, 587, 2.0, 2.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230524857d0303450c8f5d10400951a08cd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138245, 587, 200.0, 200.0, 'mg', NULL, NULL, 'Pediatric', X'789c734c49513056c8f551c84f5348c9cc294dcd2b5128c957484d4cce503004896b18191828e4a66b82141819a82a2426a79654e624571697a466e6a52a14e7e7949664e6e7010022521754', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138246, 587, 140.0, 140.0, 'g/kg', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034315048d7cf4e0700560d0701', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138247, 587, 70.0, 70.0, 'g/kg', NULL, NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4e5570c92f4eb55230375048d7cf4e070074620858', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138248, 587, 150.0, 150.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5770c92f4eb55230343550c84dd7cf4e07005bef074f', X'789ced5b6d6fdb3812fe2b83007b48003bb1ecd84edcc30169b32f01baa9afcd753fd441404bb4c50b456a492a89bbe87fbf194ab225c72f690e87020701456acbe4f099e1bc3ca4c8bf0e2293cdef144bf8c1080eaedb1721770b192eace342f183161c6446d24fb173a91d9d9c3c8a7b9e1c6b33a74fe264530f1b1a96f2e88e39ead8ed7407ed4ed00e3a379de1a88fff4e8fcffb9d4e70eedbf2d009ad2cb6fcebe057aeb861d27f76fcc977af8b6f813613753d516d567b0e87d717ef8e5a202c30487824424662c1c5ccd1c3ccf2089c0667383ea0be2c114aa73157a01fb889b4e5c770e520640a98b41aa63cefc448a2e2d34c8aaff8b52a5b43cc650a5263671a4a84f7906632d18a9905949a1d4fd41f344c7d50c4e4d83d7d50209999732008b6858339fd24421cc8b1a996c271b82e946da753aebeea3f3314822a8ba4507cfccfab23141f66492699e39664ba98c354478b6340c3789c96001b9e4a8e22e732730c11931cc32d370fab6e52a0415af088fac465cff231a4863f70e520620943d033a313ff6bcc53e6740edd23aa288016b859a47c04170a2df22422a65c6ba2f0af88b4e31375a92d09fb459bc48e5a70f5b905e30f2db82ead3e51ef748266851bc322b4077aab1d91626fbc0b65d3aa177dc34738b2e4f4edcb2d7e9342ddfb2f2baf2ac7deefe01765cb6fb724f922caa4bb43c042cd6b7eba01c9c1f843adc97b6e2d1970c68d21778cd1d7ae3e83d119ce4894719aa04ce104318bf8d03fd0b781a9086cc2a59ca8e0b403c9fce47e8ed641af63689761e5c99fa7b181a760987b12b028120485c93710094963a0fcfe4f60b5540775239166579feb60513eeae8858d20e877f271d047820e0efa1e2efb7ff8d08141071d71a23ef15023d6c38409e538ce6ec88f8ade95cedd7ebd336246ef888589ca913aabc6fdb59182416c362027e7409fb4f5bc8171681d89fb09f86c46d3f28031338339feafe0ef6780d64ab1491bb5e4962cf50624cd50ad753068774f9f379da8df1986b813521699629649f8c7a6a62da0888147e162c046682b9a5c1f2f182b3386536330f7fc4a0352ac66e87012deff72830199a406158743a55df1fc627c3146980f5c520ae91c4dd497e016ff74f1cf5bf496476672313ed391592041a4cceb04e39b63f0c03936f5066f473ce52aa2764285d8c772b2fcf806665a4afd482e40e2f0190126337b55d067ab312fdc02a3fc4bef767d7a7644631e4fd5ac7857ca6a22ab89ac26b2febbc81a235361ce88f0a5d56a7328de756b1db14643180b19194f7938dac4732e8a03521563a3605a311676d46fa2acce69d8b2b5d2c0258e6cb45c1471f8a0659670087592ca825fd9e30d0e39feb0866715b9c476e0918b79ec8825322917f83fc64a4ee16425eac8c796a104973e3a863be5a0f7e9cca09c99c368f174a822cfab809e83acaf6c38433b61c2c04964b2a47699f251801c0c1d88a8658d11326bd9827e7de0d805195e4ea6bc475a4c5118b168d6a0730ef7f3d144ad671198c3e1b08f418d8e4bd9a04b9fcb697933513992dcce23e8f9f8df6887632faa375c8a0a82de2e51413f1775eef19d6f8677eae17556f082ce2e99ddb3adf03cb8959e4167a79ede3d50d099077746e09e61eb91c84145e47955e40493d71ab8c1367083c276bda5acf3e14e51412f1735f4f0861be10524b2efe1015583c043a5b4b11d61771bc27e8eb07bb61477d6dd8d30c8450d3cc2c146841d8f7035b9b947ec80b7d5f97270aba918ee9e89a010d4f7e0fa9bc09d9144ef0485f5babbb1055b27d7bb7077a5e560b7a0c2834f3db4d34dd076bbf20668a7dba0f5f2590dce96b2fabb6775984bea7970bd4de0061edc4adbf33d66dbea713eba829596a7bb952cccdff5c8ba9b90bd6e1e9e03eb7a602b39bddd720ae37ba6e9f9254220701751043e3fead9b2082274ce70f11cd0f343efeef3236ad045cab4b671819c31cb79cf7acac4b03aa11136d62afa6923d55cab8f5487d292095838ecb483b3235fc04a164bb8f2fa5d7e235662b18cc9881858ce56f2a2ce1eb4889e15ef99ccf029122a849260a9eafbb9ebd40bc165c976f3329b9b1ced43257769f416c6e8cc6fbbe4acd417d325012e724455c2708f84a21c9744f8b224c21511589bf6a0189442ba810fe617685630f9d72bd6edef14f002bdfa7b202cb5fae0bf76b668d5ea78a939a8d7685515b007d316adaa1282fccb7ebdbe832eafa2053dff055b9ed8e8db8ec5eb0f66cccf97ca0d656e287343991bcadc50e686323794b9a1cc0d656e28f38fa2cc0d1b6dd868c3461b36dab0d1868d366c74c3764d43471b3adad0d1efa4a3cd42ae899c26726a91f3f253b13e783ea53c144cde8d754a878897e5a88ca5b1e173aa600bf888bf2a043482b713f556bb984eda61a4d14aab787f41e7a2caf3d374bc29efebeae79ca0f6f604aa879d4e6f270a8562fc260518284456cef8e9d5b1aa19a7424fa11bd27a5139936b8033ca42e73fe3ecfe4bdd2bfda8e8ec197fc29e2e473725190e1221ef27ea23966909f98129a20699442b5f6b07119f61b18f266a79ac6aedf96fc5b1b3efeffbda33cceb53b27f197e4967fdf3c6f64ea8bba584031cf0d54bfa779a0c2e5479307efdb4a0e466bea0f90a252e914fe8c2c12b1cf422420fb7fcee2312b3e7a36c62529fb8113a5b43a3581a2f248aa0646e0a5930cd5c7eea1f016a8c03720defa3968baf99a1b57fc80d9fa28b038f78c25af03788b951c26b4c3edb479f2da53f09743dec95622af0c7eeadc35ac14ce4dfe8b154d02152cc1274d920b319ed50d0297cc78ccb0b109b717c549e06acbfe3c3b106b7e440958388f48a9087c86ce9e201953d81acd46b81f5c9c6de21af669019f4506604c24720c8582f05c55ebc880c0522f78d989a0b5d283935184fb1b629b309eda540bc48355259eb4f5f6e9181b6d2349046826cd0cc74a901952d6461ee624ed34e8cd4986abd953df2b202537df659e463c5223ecd5103babd01968ab2018c725e24de625f87450841d822fe495a7e5f4316865f4cd4cf29824c63e3a1fa57ab0e6d1ffa83aef422964932fa3c06915f06a9e6b15afab2b45f441949cf71ee2c1d32b58b24759a68c097e1b3f39ac5715aad6a0e693339cb4cdb9f43c6f1323a5face83f56bce54d0485eb3160945911a18e897812a5e1fe9d095c53e0bc581d312a06689c304bf31f1948f4717fca190df2f8aaddbd8a47bfe4aac4aa712da1acb9c80b12d55a87ffa1b48a3fec97546d9c27bf26c93449e6072799f5bad76499ffbb2cf3c3a7f43bc9da38662661a1967a5ebfcbf31b93b3b614333ea2d08bb2b0788bb2da4fa37dbd7225e4f7efd67ff6c4dad24e78b1daa18b828f536d94f59bed45e7df8beb8736c1a17ef67cbf5806187f6d32e8411b7a673f1d51d3306618a609c5f24558b4bb2256fbc01566f7f52d3f4177253ddda5e4a7f3f749ab44499b0a1b6f98c274515ea0f4fb84fe3266914336ddc8dc749e6bef428ef3bb0bac32f58a54837388baa05ef268b9e87aed12e42572f74473ed08dd52c2ea261806c0b76fff01c9595281', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138249, 587, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0b4e4dcecf4b5170c92f4eb552303550c84dd7cf4e07004d1606bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138250, 587, 100.0, 100.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0bc9c82c4a5170c92f4eb55230343050c84dd7cf4e07004abb0687', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138251, 587, 150.0, 150.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5770c92f4eb55230343550c84dd7cf4e07005bef074f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138252, 587, 50.0, 50.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0b4e4dcecf4b5170c92f4eb552303550c84dd7cf4e07004d1606bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138253, 587, 100.0, 100.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0bc9c82c4a5170c92f4eb55230343050c84dd7cf4e07004abb0687', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138254, 587, 0.0, 0.0, 'mg', NULL, NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5770c92f4eb5523034d531303050c84d070059fd06da', X'789ced5b6d6fdb3812fe2b83007b48003bb1ecd84edcc30169b32f01baa9afcd753fd441404bb4c50b456a492a89bbe87fbf194ab225c72f690e87020701456acbe4f099e1bc3ca4c8bf0e2293cdef144bf8c1080eaedb1721770b192eace342f183161c6446d24fb173a91d9d9c3c8a7b9e1c6b33a74fe264530f1b1a96f2e88e39ead8ed7407ed4ed00e3a379de1a88fff4e8fcffb9d4e70eedbf2d009ad2cb6fcebe057aeb861d27f76fcc977af8b6f813613753d516d567b0e87d717ef8e5a202c30487824424662c1c5ccd1c3ccf2089c0667383ea0be2c114aa73157a01fb889b4e5c770e520640a98b41aa63cefc448a2e2d34c8aaff8b52a5b43cc650a5263671a4a84f7906632d18a9905949a1d4fd41f344c7d50c4e4d83d7d50209999732008b6858339fd24421cc8b1a996c271b82e946da753aebeea3f3314822a8ba4507cfccfab23141f66492699e39664ba98c354478b6340c3789c96001b9e4a8e22e732730c11931cc32d370fab6e52a0415af088fac465cff231a4863f70e520620943d033a313ff6bcc53e6740edd23aa288016b859a47c04170a2df22422a65c6ba2f0af88b4e31375a92d09fb459bc48e5a70f5b905e30f2db82ead3e51ef748266851bc322b4077aab1d91626fbc0b65d3aa177dc34738b2e4f4edcb2d7e9342ddfb2f2baf2ac7deefe01765cb6fb724f922caa4bb43c042cd6b7eba01c9c1f843adc97b6e2d1970c68d21778cd1d7ae3e83d119ce4894719aa04ce104318bf8d03fd0b781a9086cc2a59ca8e0b403c9fce47e8ed641af63689761e5c99fa7b181a760987b12b028120485c93710094963a0fcfe4f60b5540775239166579feb60513eeae8858d20e877f271d047820e0efa1e2efb7ff8d08141071d71a23ef15023d6c38409e538ce6ec88f8ade95cedd7ebd336246ef888589ca913aabc6fdb59182416c362027e7409fb4f5bc8171681d89fb09f86c46d3f28031338339feafe0ef6780d64ab1491bb5e4962cf50624cd50ad753068774f9f379da8df1986b813521699629649f8c7a6a62da0888147e162c046682b9a5c1f2f182b3386536330f7fc4a0352ac66e87012deff72830199a406158743a55df1fc627c3146980f5c520ae91c4dd497e016ff74f1cf5bf496476672313ed391592041a4cceb04e39b63f0c03936f5066f473ce52aa2764285d8c772b2fcf806665a4afd482e40e2f0190126337b55d067ab312fdc02a3fc4bef767d7a7644631e4fd5ac7857ca6a22ab89ac26b2febbc81a235361ce88f0a5d56a7328de756b1db14643180b19194f7938dac4732e8a03521563a3605a311676d46fa2acce69d8b2b5d2c0258e6cb45c1471f8a0659670087592ca825fd9e30d0e39feb0866715b9c476e0918b79ec8825322917f83fc64a4ee16425eac8c796a104973e3a863be5a0f7e9cca09c99c368f174a822cfab809e83acaf6c38433b61c2c04964b2a47699f251801c0c1d88a8658d11326bd9827e7de0d805195e4ea6bc475a4c5118b168d6a0730ef7f3d144ad671198c3e1b08f418d8e4bd9a04b9fcb697933513992dcce23e8f9f8df6887632faa375c8a0a82de2e51413f1775eef19d6f8677eae17556f082ce2e99ddb3adf03cb8959e4167a79ede3d50d099077746e09e61eb91c84145e47955e40493d71ab8c1367083c276bda5acf3e14e51412f1735f4f0861be10524b2efe1015583c043a5b4b11d61771bc27e8eb07bb61477d6dd8d30c8450d3cc2c146841d8f7035b9b947ec80b7d5f97270aba918ee9e89a010d4f7e0fa9bc09d9144ef0485f5babbb1055b27d7bb7077a5e560b7a0c2834f3db4d34dd076bbf20668a7dba0f5f2590dce96b2fabb6775984bea7970bd4de0061edc4adbf33d66dbea713eba829596a7bb952cccdff5c8ba9b90bd6e1e9e03eb7a602b39bddd720ae37ba6e9f9254220701751043e3fead9b2082274ce70f11cd0f343efeef3236ad045cab4b671819c31cb79cf7acac4b03aa11136d62afa6923d55cab8f5487d292095838ecb483b3235fc04a164bb8f2fa5d7e235662b18cc9881858ce56f2a2ce1eb4889e15ef99ccf029122a849260a9eafbb9ebd40bc165c976f3329b9b1ced43257769f416c6e8cc6fbbe4acd417d325012e724455c2708f84a21c9744f8b224c21511589bf6a0189442ba810fe617685630f9d72bd6edef14f002bdfa7b202cb5fae0bf76b668d5ea78a939a8d7685515b007d316adaa1282fccb7ebdbe832eafa2053dff055b9ed8e8db8ec5eb0f66cccf97ca0d656e287343991bcadc50e686323794b9a1cc0d656e28f38fa2cc0d1b6dd868c3461b36dab0d1868d366c74c3764d43471b3adad0d1efa4a3cd42ae899c26726a91f3f253b13e783ea53c144cde8d754a878897e5a88ca5b1e173aa600bf888bf2a043482b713f556bb984eda61a4d14aab787f41e7a2caf3d374bc29efebeae79ca0f6f604aa879d4e6f270a8562fc260518284456cef8e9d5b1aa19a7424fa11bd27a5139936b8033ca42e73fe3ecfe4bdd2bfda8e8ec197fc29e2e473725190e1221ef27ea23966909f98129a20699442b5f6b07119f61b18f266a79ac6aedf96fc5b1b3efeffbda33cceb53b27f197e4967fdf3c6f64ea8bba584031cf0d54bfa779a0c2e5479307efdb4a0e466bea0f90a252e914fe8c2c12b1cf422420fb7fcee2312b3e7a36c62529fb8113a5b43a3581a2f248aa0646e0a5930cd5c7eea1f016a8c03720defa3968baf99a1b57fc80d9fa28b038f78c25af03788b951c26b4c3edb479f2da53f09743dec95622af0c7eeadc35ac14ce4dfe8b154d02152cc1274d920b319ed50d0297cc78ccb0b109b717c549e06acbfe3c3b106b7e440958388f48a9087c86ce9e201953d81acd46b81f5c9c6de21af669019f4506604c24720c8582f05c55ebc880c0522f78d989a0b5d283935184fb1b629b309eda540bc48355259eb4f5f6e9181b6d2349046826cd0cc74a901952d6461ee624ed34e8cd4986abd953df2b202537df659e463c5223ecd5103babd01968ab2018c725e24de625f87450841d822fe495a7e5f4316865f4cd4cf29824c63e3a1fa57ab0e6d1ffa83aef422964932fa3c06915f06a9e6b15afab2b45f441949cf71ee2c1d32b58b24759a68c097e1b3f39ac5715aad6a0e693339cb4cdb9f43c6f1323a5face83f56bce54d0485eb3160945911a18e897812a5e1fe9d095c53e0bc581d312a06689c304bf31f1948f4717fca190df2f8aaddbd8a47bfe4aac4aa712da1acb9c80b12d55a87ffa1b48a3fec97546d9c27bf26c93449e6072799f5bad76499ffbb2cf3c3a7f43bc9da38662661a1967a5ebfcbf31b93b3b614333ea2d08bb2b0788bb2da4fa37dbd7225e4f7efd67ff6c4dad24e78b1daa18b828f536d94f59bed45e7df8beb8736c1a17ef67cbf5806187f6d32e8411b7a673f1d51d3306618a609c5f24558b4bb2256fbc01566f7f52d3f4177253ddda5e4a7f3f749ab44499b0a1b6f98c274515ea0f4fb84fe3266914336ddc8dc749e6bef428ef3bb0bac32f58a54837388baa05ef268b9e87aed12e42572f74473ed08dd52c2ea261806c0b76fff01c9595281', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138255, 587, 0.0, 0.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b4e4dcecf4b5170c92f4eb55230d531303050c84d07004b240647', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138256, 587, 0.0, 0.0, 'mg', NULL, NULL, 'Pediatric', X'789c0bc9c82c4a5170c92f4eb5523034d031303050c84d070048c90612', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138257, 76, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353530c84d5708f0572834cb00001f9f041c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138258, 76, 3.0, 3.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33ce4dd7cf4e57f00c53c82f4b2d523032d03536c8cdccd3513036d0b504b1140a8a32f38b144af21552f352f28b93f30b2a019ed210c6', X'789ced596b6fdb3816fd2b843fa518bfe2369dadbf3999b429da74bc715a64310a0c9aba9638a1480d49b95507f9ef7b28c7761e4ad46877b103ec7e30605b9787f775eec3feb313db22996b9e5167cc3ac7b6f4a9355929a4ee7459a7b02a7c9d7a9fbbf160f0555e51d6373609efe4e0beb41396e714cfb90f8746c3d1ebde70bfb73f3c1ffe3c3e188d0ff6fbaf5efd7cf0e64d254bc24ba31d24ffecbc234d96abeabda76fd5f1f332a771a44fb9b046c99822fd8b713c21f6d6d8cc8dd9f4d72e7bffa5cbbcc9a5e02ad24726cb8c66e796c7c43ec12037ae2e2a16b7efbac6579e2f14854fbf5de29392faaafab0bb7b7b69b30f76a2d797017b1217cacfa1aad4c91d7b4607c3dec1709825d09cfdf13aadd1ad33b5d4231d1b274c5ede39fd324b0657090c666645968d86bd97c34cea2e7b39ecbd09ef586ea5b1f006db02447a2252492b72bbef98303a96d58d8cfe28b80a27145fc1b191fe6dffb273d73dd74fb8ab32f7afa1f18fc778ad34c5927b2b455d9c4ea58a7b998991909e98d4cb1be07150fc60c82ab306312f431c63b942e863c4b3f7b7d4467a06ddedad5363f67a08023c79aa8501b39c84e46a3e3579a1f82e7f3636202a89e65a94ec0c4f75124191c3487fe4c257d2cc4a7715be9c4ca64cc0cec458f91d5ee70eeece7208e172f655fa942d2c71e797049f05a033d208c1da6f63f6c9301eff5e389f91f6913ea170546c1f7f7604f8225cd9968af74d6966e42fa1a0ad85dd5ceaf916a1830b77c0779dd10cbb959f07f9f9c66b507e4dfc23a3bde512b92a6a2232518a6c5286dc158a3b37086537d27f3f070b8c323ae1cf77d24dbd41c6399a9f11170fafad2b323302ef8abb72e7c63a944dd7652b0412cc405a591697cea628f199e42ed25347456c32ca16966b002053147889272728d5d65b93a7887d5e2ab84530e749230d5c2085fc5e581870afb6544e0b35fb8e2a9a178ef8606532b94e5d70d5da9478a40b8be4e256e22d5cad1d4715596bb07da298e52e7d6e15fbafbae47e7cfe223ef90faaf1dc729d729b71b8d624775bcc0957cb9e924b1ab3114b4d6171dd29010a5170d9987d94e046a48fbf094beb6a7c28150daa12162445ca35049959b289d808e8d805961e0c67280c0be34c06cd0b18c3a262b4ff6684e29eca45e580c05d4fe864aed43e2544b60d81358aad3470d27c46da0178851735f3f803ddf5c62cd2ae7082f2aa780fdc0d18b1bdc2a16daaf245a4df475a6a4f36ab3a201ead426416aa64b78fda608ae7dae3c459a4b71fd91efab5369ed1b2ea6fc01630268c5f15faec27a85062944b208f7caffa8720a5d8574830beb51471fa0cd1ad864be07e3e7fcf8c86267bda048f822c1930b6ad14f817fb91d686c5dc23cd2e4691e66b251001f8cc9a2e5b14be5210791adfd20dd22f9f90de09deb22ce8f4ce9a22671310d752ce72e461a99390d60c0f77a3018b0b0a3973dc674b4e000a797ff1aacd8d3737692a403ec99f262dda64a56188fe3bcb3336356b878663bfdaa4caee2a35026a7f634e971d76d95197bdeb54a56f9373219b3aefd74d720bfb08d274a320b5c0f822ad8c5123d6c6d6005cecff98161cc1404145dd4d5ac11c072a18618400c42672354067cfc59145d602e674369bb470e7e959edb1a6db8e26bd474e36e700cfd33e3bce31c4da4cc6b53e6b0239eab3df0913563b577dec33a49f11a5370976c73a0566f7202a827ca23068add6076e037eeab30480e866865a2535003003cbaa3cd47be462d4144863f937544b1e46f2d0581f49c726554efaa136a982f4f756a6a08c8539a645583e285a38194c7075846ce4d1fae2c10e861dcf0e3ffed406ea01d287e9512ba08adb0b54728cd979974db2fc88694afe5d50b969537130b0623d95f56e6e2e9f37a759c6ad20f47ddd4a07aec0c1d6c19ea532697d781a062f14db4c5abe90f5346974c3066455a80463501b1f0022acf21adb387379bf8d16603d3e5429da12e128cc16ebb4624b4b05c6f23af23e0b270ea3333aebbf8ad3d2a4098882e4e298115a65f844484dfe69251a63bb5eee2a2d38615d0fb3066f017458d8abd428344b6409866c2e641b9859d81eab95f246292c263e2c98aa15dc3f105f0ca19cd1cdf4123657d106e92d163e215d95c23e6cc9e178abcc39b4857882098d530125d23c45a5fb33c18390736c1dd8cb034256c0bb02836a1b434e386555688ab01c60fd2ceb18d9a4ce17b9b0d284faa4e5528a1f63e3a974e2012353c5b332ae34e2f5946ad2e5b4142647b5ce76cb49dd6cd1047326c51579efe4236a340ebb5063cd6a0c8e8cafeac7c7074e99681e5aefc3b92fecfd3afc83f14333e4837cad3431e80098fb2d4f1ee944cd5d8456684555d691c2d73a4cb5f5646caebeca60afc20c0affc47289bc91aa2e52cf02da0b4beb16ed458bc0bd2ddcadc069125521b3ada6ff29e5de54cba3df6c5df57c8752970f7f71f9ff0f27ff1b3f9c3cf74f15a2f9443973273776bfce39b677caa57ed1f68f8c7aa4a7ff73b875667e73e6faf2fafafa9fa23ad8de', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138259, 76, 30.0, 50.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf3cdcc49d1cdcd4f492d4a2c4955c8cc4b4b4d2ec9cccf2bb6523036d0353550c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c8280200655313c6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138260, 76, 60.0, 100.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0b4e2d4b2d4a55c8cc4b4b4d2ec9cccfb3523033d035343050c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c8280200ca5910e8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138261, 4640, 1.0, 1.0, 'g', NULL, NULL, 'Adult', X'789cd3305448d737d4333756c8355228482d524849ac5448cb2f523006b18a357500914d093d', X'789ced5c6d6f1cb711fe2bac80a227e02459725cb702fac1961447a81dbb96eb06f01907de2eef8ed52eb921b9923781ff7b9f19eeab74ce5dec0449d0fd642f776648cefbcb697fdc4b5db99a1b99abbd53b1f74d953a9bac33eb743297894ef7a662af7419bd5b8750f8d3a3a35b7dadf243eb56f43f7db411c5274e162a9dcb4098270f4efe7af0e0f8e0f8c19b078f4f1f7d75fae86f870f4e4e1e1d3f645895046d8d07e48f7b4f6572bd72b634293f06f581295c0567cd4a10f9a94864e995178995ab3293842b8c4a9cf5da8bb4542258912a2343e9e24bbb1485b34169e367e615d694095ee4b2126b79a3844d92b260489909f5a1b0be7420af97e2d6ba6b8d6db5113e2895894227b48023ac55ae13c0e7d2944b99602f5eb73a3b5a497f70abb28c4fab7fe0756952b1b436a58324ca7b2ccecc376799d0748f7c517a3e29dea66512f8c436ab6eb4a93211799b2a3179f5f66c9fae6f220bda53cc8c366b59b3429bff96ae9a9908582807b604ba82d40e6770a22c884378b7b6a513721914d6b553b87bc0b94aedd72a0ab15cf465f3114b412e32454fefdee329d3e69a1f3a41dd3bc87605bacaedb59a7788f31af1e37bdaf10c9bd01de75f2b92a8f203bd38c335164af80af261566495900b6fdd42a5ccf4597972fcf79399c9158e6e339db05448558843e01fd88c87e9cc3cf9e7e5cc9c2b97133f89bf01c08bd291d25c9a956209010c822d1a1dbad5612dbc72da965e286f8bb55c296805df40438948c166c6db5c918c74d078e9f5ca1cf92a2f82cdb163e5094b4b3a8f4d2b63e3234ea40a0d5d0ab02beca8b137d66e6cae036bcf73e92ab3b2c149a841b367753a332951b48629626fe0a7d6f1ffc1bd42c328acab440aadc0332ef712faefbcb8d152c8f8be369a8609d019de1677c47f7b12060ceb78229665aefc463584ce7a96840d6b856348e7d65558e75a7a6277262b480a1aa682989c1c1c9fb056fafd9929ca2c8749e2a82a55b98c9c322ade0a57865247ae9cd5c7bc5674b5c4626303adbd019fb0c595ba510edc57956ab828a0c360321c46217dce7c81d5e11837da9792ecb6d4a12251c334e87409dc8c13c53762622ce987f887787cf8e0e0f1e109ce79d66e1885102d066c7d3d338b4ce2a8adc720b58b4a07264053a60222065b32528b542d818af7897586049a59960ec83003a664cb3ad3f982f6f16cfb524c6ed73a2841de4748f69b423bedf73fd77eefdbc976037ed1e0cc5b1cecd5d184656d27424003ac81096ec7afb5601ec107945a13db4ea5031d50b86389dbe95cb408734618506b6c783b99b70de400bf35f01defc3a0030ab553d8c137d78003ec4d6e643ba9d71dd6bcc51ad0fd2563479f6ecfe5eca0873de001953bfe683ba5570dc23c22dcd34958f96e1224c0a16db4ee6f07c320d80d5af8536e737773db883db49ddaf1ee603495da70ce8dce7907d3d19ef4819c689d499cebe512fedc50109e9f6bb932ecaafae9c406afd9f069fe941dcbe9060eea2e3b6896e8d24d2a3933939fe2f57e879572f6c11e0fd147bb855c1d3884c880ebd7990867dbcbaca46c9b5df4ccbc416c8a28672ac7f5f8616fe8ec3feee4fcef5d68773de850362a599f1fbfa4726de0dceee42312478c3b016b03eb77f01c03ac4d81e89ef076acae6a94585d0d2836b2df4e08901b6e7a4763b6f08d816b2a3139ffc3dac6e7e446a3798ce6f1b3cce3022541c979c9d036ea9216c953138436c49dff58777d501603cc9706f5ad51d441a0440445fd9d5214a5a55e82b609750a158bb70ce519556b7d6b7c7a36155db65f48a3329442994c02e4435512eada32471198251aff4e340a426b12e50c751166667ddfda3aabbe387b06e3ab32656c76f4e4ea89c8508665dc54a989507dbeb065c0737b2a31f1a50625d995d8fbbde29b4a23e335f41255eec383b75adde21edfa1403a45b164afb9bbb1744a71ab03a59072c4e262ede42a2746e40a8f20458d9e060e14de9cd2b97ce90bf09faa2cd08969e802e7c30660f90a0b37eab3a26acdd2ed0af4bc061ca8e03d367fb15140363be462001a9ac277af7730010045d51fb5f7f7a9bd9f13f7fe2f15f8853472c51e7da0c3e70a520c32871448cf96daf9702aa8192b8bc2d9c269ac73d795dbc9dc77a6d88cf8fe7da90ba237154ee5162bb26b25fec58b24b321b68ad2fe1e0d0434c939bda215e994f464107558876ed42daa4685a7424947ad509342eb0a6a4f66d59f386fba951535adebbbcdcc0b6b346a72dade2ba0b075744d43523242a95b506b2b9d5706163ce56da9a7c776cbe7a9619bd6dfa509e582d9144f436aba1114e7d61e7c5928ecae9a770bb021575ee4b496a278d3b864a0de753cff21f7ded8a284bc95d74a2cf54241064dcf126facc8629bd4830d95187a811ed1b8e5cc3c85faa7c248dfefabf22db82b41cd7a833700829ba2e4479bb64dda39827a0801e68802f2e78a9337ec59676c8a2e65e649c4f0882b6aa03e7538dedaa63aa3460916086b1117b95b79f70a5deba36d016f4a26aeea06f9fca2c932fb4afd624373fcb4755733b3c065ddc2d62a8f5d3d37557bd0b1cbdaf5d379bae248e5b9f7fa21594b70478075c62f4b5fe7cefd508ac7d6550e0eb7416715f93acdcd7e9d17d605440c68f78549a39c49f5584074ff53eed9536f9a255133aadec98bc95aaf48893338824caf694603f5a4c526f2b4c0f0e64f4cd5933345ad81b1c06d818d64c3fd58661df5f4490d559d84fb41277f1a47434e8133347c78c55a923379e8d7f1c9c1c957b12d3e88826212acad0d9d463d1c32e8554e4e02dca3d49511482ba682a029f7c642421e04a6e5b4bf26905b6e1c7bbb040e7792f1d4d3555cfca21b6e705b934631822eb0923122bf3b7e3f33e7da27a5afc3f9b34bb2c2603fe8c46676050b9f99674ea64a5c5e2ee855cdf9dedc847903814121d7555638951aed816ca8503c16aba3e3c3c70f457e428713a9646f251ed2fffc3ef5f1258d58524de03424504b1c557e6074ba7fe0d04c2d20544e9930255ec7d35f956ec529396989bb898a82c0dad9f972105aa32dc37172a79ebd1a7ba3be6fc091c9afd222bcbdf350d87df2094e165ab15a629785b6f01d409e9406b6e0c50a751c2400737556a7fe3db8fa84870b740a98914b2ce9c8840cacb15071bb56a64d45242554b072d8671470cf629b4159148b0e1544fbacee6c67f20652a82d7fe0e46a7fd6f9323cc4092474362b3ff4874520c1e91b406ac19634d380c291b2d7ce5ce6bcd3b9cecad690c4ada44924253a3abb3e6da6bc8d9920a4210b8b44da5bf5443233df2ac85366fa8728a2893a5c1d46ca449009cb95c0a581a0f64f050e4a0534f6807f22d6c3dd870d6ea9a9875f728c6d3de8fc1319c2056a791d43351feb32e7c42df45729925074c82d8d661b1706f7881370c549976bc76f31b637664cb6e9e10db294279f413a2ec263e844c484d5401b3ca71c6dfdd9cf1e963467028aaad4c4ef470ed5498290393c41603f03c1ea94265eac66a048e33fd3a6e3f098caac800a50b81c05457a770265fdf66a2a9ebfe6ece0e9d595983c2db9eb9a8a2b88c6287165a3ccf7911b29bc713188123728c469b251af42f48cef1ebee7791d12d9208b5a43c03b9924aa6031412d7ac18026e8eae02e1d240acf2c0fcd4871ebe46ba8afc454f29dc4c37ac6d79bfa75c3be732bbe7df946c8002b2a3817318dd629025d20e74a53d2d1051c6c3d67af67a4e4dc882df4d8bcc9ae815a77a8feedb9ca8185acf00adce5712ba494019e2e5982f31017fdb2c0f3509f45b78a978c96158546490965904968a4eb7870fa3a5e1d2e3050da43da90d35510bb2ee01e825820a143244c7d97a322e0dd68afc1ea0d780df9004778107451505d541419f90d8a884f10aa21594fb3e8375031f2b032ae11efd94467f0b8946c4976dbfbc499b5ca8a483a4540b139543b00ee25679b94df51e04614cb4a0493a442ea5a640afedb3714255c6ed186010680946dc609ccfe545cbe3dba7c71f4ea2520910ec069b20b1ef8e30b5785b5b37995d0cc188e2c20d122cf092f1b6df45f97e76ca7c8d3ad6b7a90f52d912651f9629100993a7e3128c9a876c53502070d4b816799c93cafadb56156130666e6606686f1f0f8cfa277aae630c7e256a96b58ce57b09ce71abe130c1dd0e262054c3e7ec0719335f186d69bb9f3025ee83ab5b7068c7cf708645ed6db50148f41072973f463b425953164a13d3e88499d10763fa7e92584a85b16f48316e66257456c0ac1fb9fd571f9b2f16653b66c476f2107f87772f8ed64ee220ca8ddcfcdbf7c20dfcbe777385d0f7838d8fb4456bfa52eafb1e67dac5f7038fda5c3f5fba9e74efcbe8b331c61b679e90e63f20e7638f2ed92d95d5ad11df0b075dfb9b81d3af63de021957b09e90ec41a9c798b33a039cc42b7d3abe1e735fc805617507668fc77b0c31f0dd42164879b359043790da2ce0e221bc20fcfd206a95d841661e5af21f87e50dcc1d4fbd0033a7782e376525fdf41184e79ee04cb1d841e31e62dc6f0971e3fcbf85f0dcc9e2b86df67b7e56e4f686cb78ced96b1dd32b65bc676cbd86e19db2d63bb656cb78ced96cf6ab78c2d8ab14531b628c616c5d8a2f8e3b428c6e27f2cfec7e27f2cfe7febe2ff537f6d3556ff63f53f56ff63f53f56ffbff7ea7fac85c75a78ac85c75af88f5b0b8f39e798738e39e798738e39e76f94737ece1fa58e49c39834fc9649c3b9f6d07c7daf857eae20e0945bd1267a021d2a72fb8da5d47f949b4727ca3affb34c20fec250a9f993ccdbbd4ddf5ca91dcfb4fb784aef2fe7a7db3e9837a58e7efb21aefe5749bee49b293b7e24e427bee2f6eb7d7de5d7fe02d627d8b9ed6f0bda6f9ab548d0bc8f1fff07c859cf63', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138262, 103, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6523035d0313430d03102d2a60606b9e9008da3084f', X'789ccd56516fdb3610fe2b07bf6c03ec5a76e321d09b9bb448b0a6f31cb7c3300d024d9da49b255223a9da4291ffbea31c2751e2cd751a607b302c921f3fde7d3cdedd975e62ea2c56a2c45e08bd454ea22485bd3ef46a53f8a9dcb9ca86c3e19a5658bed226f35f347c88b4d2880a935838bf611c8c7f1c04a3c1285804a761f03a1c4f5e9d9e9e9c9e4c5a2c4a475a59467ee94d13a620eb8cf073ed94c34dcb72aeadc810de6953da1026417f1404fd31ff4f82a0cc2235d7b5430b3a852e490897577db8fc14a9cb12b4e12f300c358c35f8574d0619a1189ca029450176450a98c9c112536d106a8b4029e44d85c6a2b2e4e833b9060cd955a4ce74596a050bbf1f3eb06a6cdc27725e0a78336a1dac970f7dbce129279605fad1ef7ff0a820b5da0efcda34a90b17b3b7a4b28e006fd0d0927f911a058331fbcc8e81a30436305eb3258b1c154c06affdcaec67f8e51c36a35247ea57f4ae6cf7c29a5c0e6717ef5a9216ca7a30898719457285df594025b1ca45a12be1f226521794e58344b30e9530a81c1ad6c96046252a7f15b7348bcb736f0b24a2b1b7e6f0fdb4760e79d91b049376f538599e4a70381aef90cc7bbfff1f7d3c4cb8db3af8491b2b563a4d63dba8c4687e2737edc55d57284914f14c577521ee637a77f88c155342c906e6bcaa38644398c2f7424a6d121e83d390103a6138b63045e34d04524eacf08748bd17d2b5acb78117c2b548718f92bd392a36634f047dd00e124cf99126bdaedcdefe0b6429481eb9f1abeeedb1eb87e53ef749680bb631a9f88ea17ba15d510ed3dee1638f8fa5709869436cfcf60ebf56bac792bfb87647dec89139e64cfb84472a21b92750a74581266b7c3cca42583bf415e15999ecb3cf98f11c857c7aca3e19aff9c5eaba8b134a547953880d7152112a238d099622e258108a85b17b42799b943b34a4fedc9e049cc07d222315a9cad4865ccdc46b614ace8c3ebfb78a44aa362cbd30248ebdb5673bf1588dffd48b173ffcc8e099e54c27a42e74d674acb810453a2828e5b2fd51ad945ef341579c3597ba205b86f09e38eafa70f6dbec849b837bccdb8d34b86d083e9a5d9f729c4d572873c19d4519eb349eca272dca2c6f2c798b4982d42947bd36cf38e61a319e16561f7c2ebb962bf6994012d78b2676dca67463ef69e5825de58ad4c38a7a745aff17e66f2ca8fd3d7dcf3145bfd5f185e5794ec3f23f5768be6b33ba92bcad3437f0eedb5ad99b9bbf01e4bc2866', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138263, 103, 10.0, 20.0, 'mg', 'IM', 3, 'Adult', X'789c3334d03532c84d57f0f45528c94c51a850302acf0600363305a8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138264, 103, 5.0, 30.0, 'mg', 'PO', 1, 'Adult', X'789c0bc948cd5330d53536c84d5708f057087451a830cccd070048e50662', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138265, 103, 10.0, 30.0, 'mg', 'IV', 3, 'Adult', X'789c3334d03536c84d57f00c5328c94c010019bc03e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138266, 103, 500.0, 500.0, 'mg', 'IV', 3, 'Adult', X'789cf3c84ccfd04dc92f4e5528482c4acd2b492d4acc51284a4dcfcc4dcdb352303530c84d57f00c5308f17451a85030524849ac2c0600d10710ec', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138267, 103, 250.0, 250.0, 'mg', 'IM', 1, 'Adult', X'789c0bc948cd53303235c84d57f0f4d5f70c53087451a85030554849ac2c060073c80812', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138268, 4070, 200.0, 200.0, 'mcg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303430d05130323050c84d4ed74f4c2e294d2cc9cccf53f075f10400002a0c8c', X'789ced58516fdb3610fe2b0703055a2c76642759520718e039c952a0c98c247b18a64260284a224c911a49c5d68afcf71d255b311d634eb2ac43b7be49d4dd77c7ef8ea73b7eeec4ba4c234972d61942e742e5cc12a324ebec40a7d4c22d66d61666b8bb3be35396f7944edd13dff5650dd5a4607144ac53190483efbb41bfdb0f6e82c3e1c1e170efa817f483fefbf7b52ca3962b6950f2736714e75c726335716bf59265f31ae5a62ad830941f6446048b812a6d3955c632ad781cca136548cae04ce9dc0ca11f043b300802c869ba4ba82d6b3cb838f910ca2b555a664025e05b1b428d5d3f8772acf21c356e3489195c2223883a3239916c0ee767a3daf3f276d5f97b5cb2e45630f7f6db277c135c4eeb97875d6c767f3bbf0bbd684deffe93b33a8a4b61236480cbd4e36ca2b9d290b3989739c4ca30e00bfb2d6f0328ca2431f0b6bfced63bf81dfa832c9417643e84a3c5e79854a1bcc1e86ab00a849a316381258923e28ed54642d9d8cd789a6db3fa28467fdbaad24438434aff43867ad07c5f1a723b329062a29444880a48826bf003f467d3e765491dcb09068b58cde9a678f607df41a576e0df8aab6fff4bc7d7b7fe95c7f9ba609413114d54513635c7ac1d5d964a22690557f855a621d6a7f1314c94311c5141733375350c7d2056a54c72ca6d05b7c4601cb07011c973f43b269600b110f4f6ba4773b8b83a3fe985f223b2d3544407e3a03fee1dc33549184294722ad54c6ed853e78a4974794362d615680897ca42cc122e1986a4cd646fbde3f3e2a83867053ab331e15f8efba46abc4ef2f63a7ce27e908db089b88c5a840e1a7c00f609de0edbca474e3ea2c4b214131b9d6f2afc2b11bf1ecf2fcdfceb86fb99276eac24fee9b98c39dd70de4642309d56ae1a50418cd975ad502847c6663909e50e108a6d43287fd44ad24c998298bc5d1cdd616d0072abcbc2c28cdb2cd66446c44b9b84c6e8f6ac59c82d9b803ba60d8bae18a18fb7b729fad70c0b69e9cb9d63978528d270ac83aea0e8051c6e529222ab049973e3d310ca5aab694db8e1b8308ab5cb58306551688625cb01fca4d5cc66ab6bf016bb44038535ef4279eaf2411519171c091f67a54ebbd718b1d21830958c35b69808224849950bc9184b9b46e7d09b9fdd7fa0501a11cc8602d3f472de3e2fb1572d32a22b99e24e11e29c9198d08cb90e331125937fa0896b2e4bd37c6f36ec9e5f546956c87b425c5784bdb2b24ad176184fdac3d94cee76444f2f6af53cec6580b6a3b5929efe3210dbf55b494fbf0ddf539aeaa5a887d0467d3bc283a887e027cb5f43acc83607f9bf7b2cd70bd0b773f9ed5c7e3de7f2f5b3f525bdc1ff3e0c13e43b27540995567e8d2422e90a9eb0211cb8718f21974a7093e37483339d3e86f1af93fd8360087ba37d70dcbb8b1f0cd5e99c6ad6dc009d31ca0c1ceebfd9815f34f69970f4e6059de605a319ce5f268f54128de8a3abacd339d6471cdf17526e8c23d2f22e47c2499ee33ca771bcacf596d358cf5d4ef15b6e0de4d823f342b8a97b459c56564dd163835031145ac5a5db4a2b9c0a3cd38bdb23d7aba2508ee238db3e2c36f3afe93d77cbf7f77f0286f4fbe4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138269, 4070, 100.0, 100.0, 'mcg', NULL, NULL, 'Adult', X'789c335228284d4b2b56d030343050c84d4ed74f4c2e294d2cc9cccfd35428543034ca0000accc0a43', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138270, 4070, 800.0, 800.0, 'mcg', NULL, NULL, 'Adult', X'789cf34dacb052b0303050c84d4ed74f49ac040026fc04dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138271, 4070, 200.0, 200.0, 'mcg', NULL, NULL, 'Adult', X'789c335228284d4b2b56d030323050c84d4ed74f4c2e294d2cc9cccfd35428543034ca0000ace40a44', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138272, 4070, 800.0, 800.0, 'mcg', NULL, NULL, 'Adult', X'789cf34dacb052b0303050c84d4ed74f49ac040026fc04dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138273, 4070, 200.0, 200.0, 'mcg', NULL, NULL, 'Adult', X'789c335228284d4b2b56d030323050c84d4ed74f4c2e294d2cc9cccfd35428543034ca0000ace40a44', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138274, 4070, 800.0, 800.0, 'mcg', NULL, NULL, 'Adult', X'789cf34dacb052b0303050c84d4ed74f49ac040026fc04dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138275, 4070, 100.0, 100.0, 'mcg', NULL, NULL, 'Pediatric', X'789c335228284d4b2b56d030343050c84d4ed74f4c2e294d2cc9cccfd35428543034ca0000accc0a43', X'789ced58516fdb3610fe2b0703055a2c76642759520718e039c952a0c98c247b18a64260284a224c911a49c5d68afcf71d255b311d634eb2ac43b7be49d4dd77c7ef8ea73b7eeec4ba4c234972d61942e742e5cc12a324ebec40a7d4c22d66d61666b8bb3be35396f7944edd13dff5650dd5a4607144ac53190483efbb41bfdb0f6e82c3e1c1e170efa817f483fefbf7b52ca3962b6950f2736714e75c726335716bf59265f31ae5a62ad830941f6446048b812a6d3955c632ad781cca136548cae04ce9dc0ca11f043b300802c869ba4ba82d6b3cb838f910ca2b555a664025e05b1b428d5d3f8772acf21c356e3489195c2223883a3239916c0ee767a3daf3f276d5f97b5cb2e45630f7f6db277c135c4eeb97875d6c767f3bbf0bbd684deffe93b33a8a4b61236480cbd4e36ca2b9d290b3989739c4ca30e00bfb2d6f0328ca2431f0b6bfced63bf81dfa832c9417643e84a3c5e79854a1bcc1e86ab00a849a316381258923e28ed54642d9d8cd789a6db3fa28467fdbaad24438434aff43867ad07c5f1a723b329062a29444880a48826bf003f467d3e765491dcb09068b58cde9a678f607df41a576e0df8aab6fff4bc7d7b7fe95c7f9ba609413114d54513635c7ac1d5d964a22690557f855a621d6a7f1314c94311c5141733375350c7d2056a54c72ca6d05b7c4601cb07011c973f43b269600b110f4f6ba4773b8b83a3fe985f223b2d3544407e3a03fee1dc33549184294722ad54c6ed853e78a4974794362d615680897ca42cc122e1986a4cd646fbde3f3e2a83867053ab331e15f8efba46abc4ef2f63a7ce27e908db089b88c5a840e1a7c00f609de0edbca474e3ea2c4b214131b9d6f2afc2b11bf1ecf2fcdfceb86fb99276eac24fee9b98c39dd70de4642309d56ae1a50418cd975ad502847c6663909e50e108a6d43287fd44ad24c998298bc5d1cdd616d0072abcbc2c28cdb2cd66446c44b9b84c6e8f6ac59c82d9b803ba60d8bae18a18fb7b729fad70c0b69e9cb9d63978528d270ac83aea0e8051c6e529222ab049973e3d310ca5aab694db8e1b8308ab5cb58306551688625cb01fca4d5cc66ab6bf016bb44038535ef4279eaf2411519171c091f67a54ebbd718b1d21830958c35b69808224849950bc9184b9b46e7d09b9fdd7fa0501a11cc8602d3f472de3e2fb1572d32a22b99e24e11e29c9198d08cb90e331125937fa0896b2e4bd37c6f36ec9e5f546956c87b425c5784bdb2b24ad176184fdac3d94cee76444f2f6af53cec6580b6a3b5929efe3210dbf55b494fbf0ddf539aeaa5a887d0467d3bc283a887e027cb5f43acc83607f9bf7b2cd70bd0b773f9ed5c7e3de7f2f5b3f525bdc1ff3e0c13e43b27540995567e8d2422e90a9eb0211cb8718f21974a7093e37483339d3e86f1af93fd8360087ba37d70dcbb8b1f0cd5e99c6ad6dc009d31ca0c1ceebfd9815f34f69970f4e6059de605a319ce5f268f54128de8a3abacd339d6471cdf17526e8c23d2f22e47c2499ee33ca771bcacf596d358cf5d4ef15b6e0de4d823f342b8a97b459c56564dd163835031145ac5a5db4a2b9c0a3cd38bdb23d7aba2508ee238db3e2c36f3afe93d77cbf7f77f0286f4fbe4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138276, 4070, 800.0, 800.0, 'mcg', NULL, NULL, 'Pediatric', X'789cf34dacb052b0303050c84d4ed74f49ac040026fc04dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138277, 4070, 200.0, 200.0, 'mcg', NULL, NULL, 'Pediatric', X'789c335228284d4b2b56d030323050c84d4ed74f4c2e294d2cc9cccfd35428543034ca0000ace40a44', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138278, 4070, 800.0, 800.0, 'mcg', NULL, NULL, 'Pediatric', X'789cf34dacb052b0303050c84d4ed74f49ac040026fc04dd', X'789ced58516fdb3610fe2b0703055a2c76642759520718e039c952a0c98c247b18a64260284a224c911a49c5d68afcf71d255b311d634eb2ac43b7be49d4dd77c7ef8ea73b7eeec4ba4c234972d61942e742e5cc12a324ebec40a7d4c22d66d61666b8bb3be35396f7944edd13dff5650dd5a4607144ac53190483efbb41bfdb0f6e82c3e1c1e170efa817f483fefbf7b52ca3962b6950f2736714e75c726335716bf59265f31ae5a62ad830941f6446048b812a6d3955c632ad781cca136548cae04ce9dc0ca11f043b300802c869ba4ba82d6b3cb838f910ca2b555a664025e05b1b428d5d3f8772acf21c356e3489195c2223883a3239916c0ee767a3daf3f276d5f97b5cb2e45630f7f6db277c135c4eeb97875d6c767f3bbf0bbd684deffe93b33a8a4b61236480cbd4e36ca2b9d290b3989739c4ca30e00bfb2d6f0328ca2431f0b6bfced63bf81dfa832c9417643e84a3c5e79854a1bcc1e86ab00a849a316381258923e28ed54642d9d8cd789a6db3fa28467fdbaad24438434aff43867ad07c5f1a723b329062a29444880a48826bf003f467d3e765491dcb09068b58cde9a678f607df41a576e0df8aab6fff4bc7d7b7fe95c7f9ba609413114d54513635c7ac1d5d964a22690557f855a621d6a7f1314c94311c5141733375350c7d2056a54c72ca6d05b7c4601cb07011c973f43b269600b110f4f6ba4773b8b83a3fe985f223b2d3544407e3a03fee1dc33549184294722ad54c6ed853e78a4974794362d615680897ca42cc122e1986a4cd646fbde3f3e2a83867053ab331e15f8efba46abc4ef2f63a7ce27e908db089b88c5a840e1a7c00f609de0edbca474e3ea2c4b214131b9d6f2afc2b11bf1ecf2fcdfceb86fb99276eac24fee9b98c39dd70de4642309d56ae1a50418cd975ad502847c6663909e50e108a6d43287fd44ad24c998298bc5d1cdd616d0072abcbc2c28cdb2cd66446c44b9b84c6e8f6ac59c82d9b803ba60d8bae18a18fb7b729fad70c0b69e9cb9d63978528d270ac83aea0e8051c6e529222ab049973e3d310ca5aab694db8e1b8308ab5cb58306551688625cb01fca4d5cc66ab6bf016bb44038535ef4279eaf2411519171c091f67a54ebbd718b1d21830958c35b69808224849950bc9184b9b46e7d09b9fdd7fa0501a11cc8602d3f472de3e2fb1572d32a22b99e24e11e29c9198d08cb90e331125937fa0896b2e4bd37c6f36ec9e5f546956c87b425c5784bdb2b24ad176184fdac3d94cee76444f2f6af53cec6580b6a3b5929efe3210dbf55b494fbf0ddf539aeaa5a887d0467d3bc283a887e027cb5f43acc83607f9bf7b2cd70bd0b773f9ed5c7e3de7f2f5b3f525bdc1ff3e0c13e43b27540995567e8d2422e90a9eb0211cb8718f21974a7093e37483339d3e86f1af93fd8360087ba37d70dcbb8b1f0cd5e99c6ad6dc009d31ca0c1ceebfd9815f34f69970f4e6059de605a319ce5f268f54128de8a3abacd339d6471cdf17526e8c23d2f22e47c2499ee33ca771bcacf596d358cf5d4ef15b6e0de4d823f342b8a97b459c56564dd163835031145ac5a5db4a2b9c0a3cd38bdb23d7aba2508ee238db3e2c36f3afe93d77cbf7f77f0286f4fbe4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138279, 4070, 200.0, 200.0, 'mcg', NULL, NULL, 'Pediatric', X'789c335228284d4b2b56d030323050c84d4ed74f4c2e294d2cc9cccfd35428543034ca0000ace40a44', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138280, 4070, 800.0, 800.0, 'mcg', NULL, NULL, 'Pediatric', X'789cf34dacb052b0303050c84d4ed74f49ac040026fc04dd', X'789ced58516fdb3610fe2b0703055a2c76642759520718e039c952a0c98c247b18a64260284a224c911a49c5d68afcf71d255b311d634eb2ac43b7be49d4dd77c7ef8ea73b7eeec4ba4c234972d61942e742e5cc12a324ebec40a7d4c22d66d61666b8bb3be35396f7944edd13dff5650dd5a4607144ac53190483efbb41bfdb0f6e82c3e1c1e170efa817f483fefbf7b52ca3962b6950f2736714e75c726335716bf59265f31ae5a62ad830941f6446048b812a6d3955c632ad781cca136548cae04ce9dc0ca11f043b300802c869ba4ba82d6b3cb838f910ca2b555a664025e05b1b428d5d3f8772acf21c356e3489195c2223883a3239916c0ee767a3daf3f276d5f97b5cb2e45630f7f6db277c135c4eeb97875d6c767f3bbf0bbd684deffe93b33a8a4b61236480cbd4e36ca2b9d290b3989739c4ca30e00bfb2d6f0328ca2431f0b6bfced63bf81dfa832c9417643e84a3c5e79854a1bcc1e86ab00a849a316381258923e28ed54642d9d8cd789a6db3fa28467fdbaad24438434aff43867ad07c5f1a723b329062a29444880a48826bf003f467d3e765491dcb09068b58cde9a678f607df41a576e0df8aab6fff4bc7d7b7fe95c7f9ba609413114d54513635c7ac1d5d964a22690557f855a621d6a7f1314c94311c5141733375350c7d2056a54c72ca6d05b7c4601cb07011c973f43b269600b110f4f6ba4773b8b83a3fe985f223b2d3544407e3a03fee1dc33549184294722ad54c6ed853e78a4974794362d615680897ca42cc122e1986a4cd646fbde3f3e2a83867053ab331e15f8efba46abc4ef2f63a7ce27e908db089b88c5a840e1a7c00f609de0edbca474e3ea2c4b214131b9d6f2afc2b11bf1ecf2fcdfceb86fb99276eac24fee9b98c39dd70de4642309d56ae1a50418cd975ad502847c6663909e50e108a6d43287fd44ad24c998298bc5d1cdd616d0072abcbc2c28cdb2cd66446c44b9b84c6e8f6ac59c82d9b803ba60d8bae18a18fb7b729fad70c0b69e9cb9d63978528d270ac83aea0e8051c6e529222ab049973e3d310ca5aab694db8e1b8308ab5cb58306551688625cb01fca4d5cc66ab6bf016bb44038535ef4279eaf2411519171c091f67a54ebbd718b1d21830958c35b69808224849950bc9184b9b46e7d09b9fdd7fa0501a11cc8602d3f472de3e2fb1572d32a22b99e24e11e29c9198d08cb90e331125937fa0896b2e4bd37c6f36ec9e5f546956c87b425c5784bdb2b24ad176184fdac3d94cee76444f2f6af53cec6580b6a3b5929efe3210dbf55b494fbf0ddf539aeaa5a887d0467d3bc283a887e027cb5f43acc83607f9bf7b2cd70bd0b773f9ed5c7e3de7f2f5b3f525bdc1ff3e0c13e43b27540995567e8d2422e90a9eb0211cb8718f21974a7093e37483339d3e86f1af93fd8360087ba37d70dcbb8b1f0cd5e99c6ad6dc009d31ca0c1ceebfd9815f34f69970f4e6059de605a319ce5f268f54128de8a3abacd339d6471cdf17526e8c23d2f22e47c2499ee33ca771bcacf596d358cf5d4ef15b6e0de4d823f342b8a97b459c56564dd163835031145ac5a5db4a2b9c0a3cd38bdb23d7aba2508ee238db3e2c36f3afe93d77cbf7f77f0286f4fbe4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138281, 929, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacc8cc2dcd5528cf2cc9c82f2d51482dc8cc4b2dc8280292560aa6b9e9fad9e90a1ab989150ac60606b9e99a00a7ca106c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138282, 929, 7.0, 7.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacc8cc2dcd5528cf2cc950482dc8cc4b2dc8482d0252560ae6b9e9fad9e90a1ab989150aa60606b9e99a007dbf0f7d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138283, 929, 1.0, 1.5, 'mg/kg', NULL, NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b05530525530d435d433cd4dd7cf4e07007fd20845', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138284, 929, 0.5, 0.75, 'mg/kg', NULL, NULL, 'Adult', X'789c734c49c92cc9cccf4bcc5148cacf292d4e2d56c84f5330d033d535d03337cd4dd7cf4e572834d53534c8cdcc53282d5028c957c84dac00a931064b0200b10514ae', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138285, 929, 2.0, 2.0, 'mg', NULL, NULL, 'Adult', X'789cf34c53484d4b4b4d2ec92c4b55282e492c2a51c8cc4b2b2dcecccf53c84f5330ca4dd7cfcdcc030010b60de8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138286, 929, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0bcf2cc9c82f2d51482dc8cc4b2dc8482d0252560aa6b9e9fad9e90a1ab989150ac60606b9e99a0030120db3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138287, 929, 7.0, 7.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c0bcf2cc950482dc8cc4b2dc8482d0252560ae6b9e9fad9e90a1ab989150aa60606b9e99a00fc590c5f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138288, 8360, 25.0, 25.0, 'mg', 'PO', NULL, 'Adult', X'789c3332cd4d5708f05730d6355128c9cc4d2d5628482d524849ac04005b9f07b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138289, 8360, 30.0, 50.0, 'mg', 'IN', 1, 'Pediatric', X'789c734cc9cf492d4e4ecd2b29b6523036d03535c84d574849cccca954c8cc5328cecc4bcf4955c82f5248c92ccb4c494d5148c92f4e2d0600eb35129d', X'789ce556df6fdb3610fe570e7a961bdba9b34d6f9ab32201e6d64b3c0c45550817f22471a64881a492a845fef71d95348d93145e82bded492275f7ddafefeef43591aeaf4b832d251924efad0b4e7561d0ca509242d23b1def9b103a9f1d1c5ca92db56facabe39b3a7822ee85c38e6489216acda7f3a3c97436994d37d39fb2c5cfd9e1eccdfc68319bff32ca9208ca1acf925f935cb6ca281f1cc6bbf12ad0f588b2193aca0ab3714a0c422b01688292d439f29e5f0b736c3dd604efac6b3d0b9ed93e90075bc12e6806d6a12eccd2b6ad35b0712809de73e03e83fc920c4791c29acfdabad1bffee2a18b377c15f042533c7dfacc270e7a3b1e1ef8fa0327f7a7f25eb37ca479f3395ace65af43c9912a53ef6467be686b587f80c3c95b088a83818e1c481c5e16c268644d522117543c672897961505e789f375389d2ca66c58a2d2032803515c136718a4ba64f72548ebd9cecb9d38ef4828d4e5da76bdc6ef0cf9e6c7da516dd08801cef8aba90b2eecb230bfa308a33438e5b7f1f2d4549cbff10891076d2cfe1919d4d137d6ccc05840f977ef434b914827d43184b8fbfc5a0e3c76707fed8f630bde0afb5299f21e216183df817743dc0f7b2f5f46f95260a0da3ac5cedf726a690db78632528967f29c6b4dae1e2058101abd3f8883a2307f7a8aadb5ca3f9c82e89de3c43103b8ee4c820e7d80d9dbc83e1f531dc902abd3d87246d85685588f9e01ae546820ce8c2f562b19b55b0acda0c9105ce89e5e419b5c5e92f3549e118aa7c13c03989c9353b6df953b2174815db0629b42e7acb6a6662effb149410ede3543685a8529079582efa52403021d770d9386303485393fcd8f4f0af3abe5505a74ce5ec15d33b3e1c2bceb357331e6a1b9235bc52dd43b62cde0ec969fabc10ab6db7b3641eacbf8ed2fcbb119e6c703b0e881124aa2566148d998899e757e100df3970b909b5a5992d462b29bbcdbe2c729b8133c57c907d5dd4ee0471a7bbbf6ff95ccc75cfa8fb3f92fe05e3ada1b742d0aae413dec16097535d1aa8a2b76450cc11de9db0cbecdc24b85b0fcb89e1f1f15e6b76be1685ca5aff06045a2e1acfab6b455998b276b3eaf2a46f3c023c9f88a5c0a8e34214f0b34127ce0e55d8fa327ce31ae8a46ae3d715d478279a03b7d964041bccca30c4ba4b03861c6459086ff0546add7ac25a232d7deeefe9a2c739e8fd74c9cf0c27dfb638c3dbf09cbbcbc97e6317e73f30f7ac15a55', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138290, 2880, 2.0, 2.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b65228494cca492db15230d033d55130d45130ca4db756c8cccb4a4d06cb2814e7e7949664e6e7592918e6a6ebe7fa0000e8f71618', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138291, 2880, 1.0, 4.0, 'mg', 'IV', 1, 'Adult', X'789c73ad28294a2ca82c4acccd4c49cc5148c92c4e4d2c4eb55230d43551c84d57f00cd3f7f4d50ff007f28d144a3273538b15521233732a01131a121d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138292, 2880, 0.5, 0.5, 'mg', 'IM', 1, 'Adult', X'789c0b482ccacecc2bcecfcb2cceb55230d03355c84d57f0f4d5f70cd30ff0574849cccca9d45128c92c294a2c4955282d50c8cc032902aac9cc4b2e4acd4dcd2b290600f1e31689', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138293, 347, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057284c49ac54a8503052284f4dcd5628c95728284a2d4bcd2b51284acd492c284e05000b670ddd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138294, 347, 150.0, 150.0, 'mg', 'PO', NULL, 'Adult', X'789c0bcd4bcecf2dc8c94c4e2c494db152303435c84d5708f057a85030040087c708b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138295, 347, 6.0, 6.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb3533034514849ac2c56c8cf49b15230cb4dd7cf4e5708f057a85030d45128c948cd53308688151a99640045cd75a11a741472132bac140c0d0c80f24001001f371593', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138296, 347, 3.0, 6.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb3533034514849ac2c56c8cf49b15230d635cb4dd7cf4e5708f057283432c950a8503053284f4dcd2e0600f2780c04', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138297, 16030, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c333230c84d572854303452c85048cb2f523034504849ac2c06004e1606bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138298, 16030, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c333230c84d572854303452c85048cb2f523034504849ac2c06004e1606bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138299, 16030, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c333430c84d572854303452c85048cb2f5230d53534504849ac2c06005a55071d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138300, 16030, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c333230c84d572854303452c85048cb2f523034514849ac2c06004e2e06c0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138301, 16030, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c333230c84d572854303452c85048cb2f523034504849ac2c06004e1606bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138302, 16030, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789c333130c84d572854303452c85048cb2f523034514849ac2c06004e5e06c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138303, 16030, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c333430c84d572854303452c85048cb2f5230574849ac2c060048480691', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138304, 16030, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c333230c84d572834345248cb2f523034504849ac2c06003e400614', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138305, 16030, 10.0, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3cc4b4bcc2b5178d4b9d44821373faf24a358a1245f2139233327a528354fc1c6d048a13235b1a8d84ac1d020375d3f3b5d3f25b152412337b12233b73457c1c800249a925f9caaa950a800549c0100ab041b53', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138306, 16030, 100.0, 400.0, 'mg', NULL, NULL, 'Pediatric', X'789c73cec8cc49294acd53b0333452a84c4d2c2a5628c957484cc9cf492d4e4ecd2bb1523034300009991818e4a62b142a0095650000dc121086', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138307, 16030, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c258c4d0ac2301046aff22d1584d64037e2a64b775e61c8a469d099c1490af6081ec48b7912ffb6ef3dde4927d286d7e31920a66dae688638972b7b521cf7016b22af070c92bb4beed86ac246e85e641184be973fdbe2864f3c6332c700a6b5eec08b532ba6a018cdb968fedec7f10c4fd14492f2cfbf0154cd2e87', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138308, 16030, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3cc4b4bcc2b5178d4b9d44821373faf24a358a1245f2139233327a528354fc1c6d048a13235b1a8d84ac134375d3f3b5d3f25bf3855412337b12233b73457c1d0c0201722a6a950a800549ca190965fa460aa6b68a0909258590c0053031fae', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138309, 16030, 5.0, 5.0, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c4d904d4ec3400c85aff296540a6a12c1067583e8a66b4e60669cc4eafc8419573047e0205c8c93e0922ed87e7a7e3f3ea58992e2e7eb7b44cc49970acd708b045f38e1308c684ca53ee131cefbf3bcf7b932ee227d4abc448c7d1f37b6c33b4cbc60ca05430f4fad7638bd1e9f51d8e518397990f79266bc04499e6273926ef2fbe1e1ef02465652e1a4151fa2664712d81b17150ad0850bad0d76458a22f58c3cc126c89b6415676155aa5272d692542df59a68de8e0a77a09971b86deaaecd2c29342cb9aea214a4b2effedb5d0c6c45acd9b0bd68f70bc9216c4e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138310, 2107, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303430d05130323050c84d070067790738', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138311, 2107, 100.0, 200.0, 'mg', 'PO', 3, 'Adult', X'789c333430d0353230c84d5708f05708f17451a85030524849ac2c06004d7c06a0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138312, 2107, 4.0, 4.0, 'mg/kg', 'PO', 3, 'Pediatric', X'789c33d33534aaccb75230c94dd7cf4e5708f05708f17451a85030524849ac2c06007eee088d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138313, 2107, 100.0, 200.0, 'mg', 'PO', 3, 'Pediatric', X'789cb33334aaccb752303430d0353230c84d5708f05708f17451a85030524849ac2c060084450883', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138314, 24433, 1000.0, 1000.0, 'mg', 'PO', 1, 'Adult', X'789c3331d0353555c84eb75230343030c84d5708f0574849cccca904004d9906cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138315, 24433, 1500.0, 1500.0, 'mg', 'PO', NULL, 'Adult', X'789c33343530c84d5708f057305628c9cc4d2d5628482d52284f4dcd0600629d0822', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138316, 24433, 2000.0, 2000.0, 'mg', 'PO', NULL, 'Adult', X'789c0dc9d109c0200c05c055de08c145ec0ab63c3494245203ae6feff78a8858c75551906a5c98fcb0c917ea78c26ef5961a8ead391039fe6e9d9eeb003b6a1487', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138317, 24433, 1500.0, 1500.0, 'mg', 'PO', 1, 'Adult', X'789c3335d33537cd4eb75230343530c84d5708f0574849cccca904004b2f06bd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138318, 24433, 2500.0, 2500.0, 'mg', 'PO', NULL, 'Adult', X'789c33323530c84d5708f057305628c9cc4d2d5628482d52284f4dcd060062b70823', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138319, 24433, 3000.0, 3000.0, 'mg', 'PO', NULL, 'Adult', X'789c0dc9d10980300c05c055de08c10ea22bb4e5d106492236d0f5f57eaf88880d5c270ea41a171ebed8e40d75f4b0a65e53c3b1352722e7df75d0737d3ba51488', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138320, 24433, 2000.0, 2000.0, 'mg', 'PO', 1, 'Adult', X'789c3337d3b534c84eb75230323030c84d5708f0574849cccca904004aee06b8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138321, 24433, 3000.0, 3000.0, 'mg', 'PO', NULL, 'Adult', X'789c33363030c84d5708f057305628c9cc4d2d5628482d52284f4dcd06006254081f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138322, 24433, 4000.0, 4000.0, 'mg', 'PO', NULL, 'Adult', X'789c33313030c84d5708f057305228c9cc4d2d5628482d52284f4dcd56c8cc5348cecf4dcacc4b2cc9cccf5328cf2cc950c82fc9004a27a6a7e6951403003be01489', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138323, 24433, 15.0, 30.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33345528c957303650c84dd7cf4e5708f0574849cccca954d0c84dac5030323030008aa724566a0200e75e0bae', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138324, 24433, 50.0, 50.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3335c84dd7cf4e5708f057305228c9cc4d2d5628482d52284f4dcd56c8cc5348cecf4dcacc4b2cc9cccf5328cf2cc950c82fc9004a27a6a7e69514030060cc152b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138325, 28179, 250.0, 250.0, 'mg', 'PO', 2, 'Adult', X'789c333235c84d5708f05770f274010013ff031a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138326, 324, 2.5, 25.0, 'mg', 'PO', 1, 'Adult', X'789c33d233d53532cd4d5708f0570874510808f2030028910482', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138327, 324, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb0523032cd4dd74fc92f4e050020710496', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138328, 324, 10.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c3334c84d5708f057a83004000eea02be', X'789cdd576d6fdb3610fe2b077f4a00d996dda6e8944f81b3ac46ebd48b33afc33408b47492584ba4405289b522fded3b4a896b390e1207cb5efac106c53bdefb1d1f7ee944aa4c02c172ec78d09973c3722e82f71d073aa5caec5e6a4ca1bd7eff9a2f31ef4995d815efb75875a8588151c08c3d3174876fbaeea03b702fddb79e7be4b93ff4de0c5ebd7d35ac7931345c0a4d9c5f3a636194ac570657f5e153ae59bee049c92c970733445f2cb15646ab582ad046211ab04683dfb96a0c81f77ec717b58272b1a9e386b60c5b6468bf7eff83be322e96cd87a5fd840215cb5a467c60da68280b301286708db8d40e14526bbec82ac8d9928b0498303c942c29b3da544b375dd28391a52aae9710f138e66199195f8ce740b6e790320d3a6759d670c898e4b022ad32b6e2a464519a9aa0fb0bb22be664465e6a030b243378926204e4ab46c565a9e14e9b2f2eab023db84d8a2f4ea56609c21969d41e0c5c17f2303986a39cfe66a363184fe8373f86e9475f8c649e93f9978a4508e714543a51078587645b041324f38c140ebcb739755d07cee5152b3232607e17fcc133227f1251640232953c68857f87ac6fa51944149690a308ab20ad0a5928695225a96604e69cb5040d7b47dd21394d7ec2cfa730bd38f7c584ad3cb09bfd486aecb46daccdfa965761ba5c446548a5fd98aa81dba8590d9ea0e257a662a6c81b4d049ef13feb0ada9257e7acb1bcbbe0d1b698c7a2fb8201dbcecd7712b19770633b54ff841fcfd5b167fb4e69f4304353e2a92d7c8e5230c3b2cd823c4831974aa52c213911d7c83406320e4c8a81c0eb8554e2b06d39457b36b2b314d895e41113216e4d513818cf0f1d20c9ccc89cd1e7e4b0076767d3fad4ddec0c4993eeed28b5a7364e30bcd73aadced9219a6d5658f0d40a73d792fbb3517f3ce9d35db282c14b0d84a7f8b59dda7fd5b1bf5df99e8d302b30e454d65359dc6201ddd234559808aad30a2e886a6f6b0f46bef8c042d320077be1dbcd198b09e25ca06019343de58bfa92f4404803366d02235fac3b6f6bff1d162430dc3ecba2cf1642d891042c97a5302d11f7c9fbc5e061471f4791a7167d36cc9a3217ac257448e1261edb0cd5e362d7fc81e50f426630918a93f13775c646927027a34ae1e18e7c9d6419aaa4b2e02fcc98d67d8b917d91a2a2a019a62ad8515bbe90578423b7306154a21593526268206b5f84acac098499443d0ec9a6e72027d24583f2025978dffe5d0d3a6ba65e8bafd537a05073ba30689c92ab842649bed0dc70c2d715111b450e8d4f524d135741c663ec5208909c1016f21ecc460e214bc712a9994a8d87be68cde55d0cb52e7b4da9f236947070171a4ba6fb21ab4c8d45b7883b066c83655b5e1ac2f20861ca44820f981013944d1ff4808bcf4d2481c281eb6be51ea1a082da77747daf69d92ebfff5b5efe0bf6ee0bc752a67216ca4c2655cbf0772c8bbbb62a3c28c552c86b7a1f4ee841bd9019d7b9470543a5e3c0e8b7e9eb237783e7c755a8b079849734bc901ea73c437bd606818e5ad87512361cbf687a992eaa465883b32a41208e8ad7b269496ff5cdc11853e14a65a1dad899d36ffcc9f9e48c9c1901b54b9edb18d284a4f36d317685ebb33c2f68a5a90bec34a43b933830c32baac208c6e71770f0f535a4b254f4a03deb5a2df075b8b1331e1ff6f60df4cdcd5f4ba8cf0f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138329, 324, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb0523032cd4dd74fc92f4e050020710496', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138330, 324, 100.0, 100.0, 'mcg', 'PO', 1, 'Adult', X'789c33343050c84d4e5708f0570874d14dca4c0100272e04b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138331, 324, 1.0, 1.0, 'mg', 'SC', NULL, 'Pediatric', X'789c33cc4d5708765648cb2f52482ccbcf4c49cc4b4e55c84f5348cc4b2cc8a8cc49acc82c56d0f00cd3d451c848cd4d2cc9cf4d04727d35f514dcdc02c0ba8a538b32f34b8b1592138b538bf50020e91a6b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138332, 324, 2.5, 5.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d233d535cd4d5708f0570874510808f2030025120450', X'789cdd576d6fdb3610fe2b077f4a00d996dda6e8944f81b3ac46ebd48b33afc33408b47492584ba4405289b522fded3b4a896b390e1207cb5efac106c53bdefb1d1f7ee944aa4c02c172ec78d09973c3722e82f71d073aa5caec5e6a4ca1bd7eff9a2f31ef4995d815efb75875a8588151c08c3d3174876fbaeea03b702fddb79e7be4b93ff4de0c5ebd7d35ac7931345c0a4d9c5f3a636194ac570657f5e153ae59bee049c92c970733445f2cb15646ab582ad046211ab04683dfb96a0c81f77ec717b58272b1a9e386b60c5b6468bf7eff83be322e96cd87a5fd840215cb5a467c60da68280b301286708db8d40e14526bbec82ac8d9928b0498303c942c29b3da544b375dd28391a52aae9710f138e66199195f8ce740b6e790320d3a6759d670c898e4b022ad32b6e2a464519a9aa0fb0bb22be664465e6a030b243378926204e4ab46c565a9e14e9b2f2eab023db84d8a2f4ea56609c21969d41e0c5c17f2303986a39cfe66a363184fe8373f86e9475f8c649e93f9978a4508e714543a51078587645b041324f38c140ebcb739755d07cee5152b3232607e17fcc133227f1251640232953c68857f87ac6fa51944149690a308ab20ad0a5928695225a96604e69cb5040d7b47dd21394d7ec2cfa730bd38f7c584ad3cb09bfd486aecb46daccdfa965761ba5c446548a5fd98aa81dba8590d9ea0e257a662a6c81b4d049ef13feb0ada9257e7acb1bcbbe0d1b698c7a2fb8201dbcecd7712b19770633b54ff841fcfd5b167fb4e69f4304353e2a92d7c8e5230c3b2cd823c4831974aa52c213911d7c83406320e4c8a81c0eb8554e2b06d39457b36b2b314d895e41113216e4d513818cf0f1d20c9ccc89cd1e7e4b0076767d3fad4ddec0c4993eeed28b5a7364e30bcd73aadced9219a6d5658f0d40a73d792fbb3517f3ce9d35db282c14b0d84a7f8b59dda7fd5b1bf5df99e8d302b30e454d65359dc6201ddd234559808aad30a2e886a6f6b0f46bef8c042d320077be1dbcd198b09e25ca06019343de58bfa92f4404803366d02235fac3b6f6bff1d162430dc3ecba2cf1642d891042c97a5302d11f7c9fbc5e061471f4791a7167d36cc9a3217ac257448e1261edb0cd5e362d7fc81e50f426630918a93f13775c646927027a34ae1e18e7c9d6419aaa4b2e02fcc98d67d8b917d91a2a2a019a62ad8515bbe90578423b7306154a21593526268206b5f84acac098499443d0ec9a6e72027d24583f2025978dffe5d0d3a6ba65e8bafd537a05073ba30689c92ab842649bed0dc70c2d715111b450e8d4f524d135741c663ec5208909c1016f21ecc460e214bc712a9994a8d87be68cde55d0cb52e7b4da9f236947070171a4ba6fb21ab4c8d45b7883b066c83655b5e1ac2f20861ca44820f981013944d1ff4808bcf4d2481c281eb6be51ea1a082da77747daf69d92ebfff5b5efe0bf6ee0bc752a67216ca4c2655cbf0772c8bbbb62a3c28c552c86b7a1f4ee841bd9019d7b9470543a5e3c0e8b7e9eb237783e7c755a8b079849734bc901ea73c437bd606818e5ad87512361cbf687a992eaa465883b32a41208e8ad7b269496ff5cdc11853e14a65a1dad899d36ffcc9f9e48c9c1901b54b9edb18d284a4f36d317685ebb33c2f68a5a90bec34a43b933830c32baac208c6e71770f0f535a4b254f4a03deb5a2df075b8b1331e1ff6f60df4cdcd5f4ba8cf0f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138333, 324, 0.5, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d033d535cd4d5708f0d70f76d6f7f4d5f70c53a85030040044a705ca', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138334, 3076, 0.1, 0.1, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230d03354c84d57c82f4acc5128494cca492d290600b9b10b35', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138335, 3076, 0.1, 0.1, 'mg', NULL, 1, 'Adult', X'789c15cbd10d80200c05c055de0415750817700162ab36406a00256c6ff8be9ca319e9c28aaa490a1ec9682201d5e06819c45e63276cfa099ad61ba719c33292c640d8fd386c457065cfaf8fb18fcdd3413f71cc1eb2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138336, 3076, 0.1, 0.1, 'mg', 'PO', 1, 'Adult', X'789c2dcd311682301004d0ab4c894d88852d953d145c60250be419485c93a7b9bd8bdacefc3763cd19db82a1c7e30abffbec29848abcf28e8daa4693303d19b70afbb5adc38bf9aea824e40852f7469cf12f9bce9acbb12924ac6ae590e6124e06232516b8a86b8b902bbfa708d74ee603c19c2c7b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138337, 3076, 0.05, 0.2, 'mg', NULL, NULL, 'Pediatric', X'789c33d03330d535d03352c84dd74f49ac040019e003e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138338, 18223, 10.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c3334c84d57f00c53d028cec92f5728282dce50c82f52c8cc5330f4010074800877', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138339, 18223, 5.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d53534c84d5708f057c82f52f00c532834d3b550c8c82f2d2a06005dad0794', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138340, 18223, 40.0, 40.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb0523031c84dd74f49ac04001bb20426', X'789ced58db6edb3810fd95819f5ac0aa2de7d2d4051608d26d1ba017b709f2b22a049a1c4b5c53a44a52719422ffbe43c9712ad7898374f7218b007e30a999c3c333c3d1503f7ac25659aa5981bd31f426d6f05c195ba265975263af0fbdcaaaf028f7be74e3c16021e758bc30360bffe4609387e396952852e683e36838da8f8671140f4f8707e3e170bc1bbfd88f777776468d2d722f8d7664f9a3f70e35c1a8e6bfc78bc6fdb42e719c68a6bd8c4a57f3dc78c9c3582c27b1c066e68d712c43786b6ce1c6b0d7877898e8afa6f2e8c0cce05014524be72d0beb8de1f8ac0f93cf893e324561349c5a26103e910ee44c73e5cd6eaae9cf24af68cab3a9c230faeb1b8d94d4f3667043bacb76bb8a875d7b5a630dabdde4fd805a5bd7bbfa16b81e8a4af994c4913aeb08bb616fbdf7c804e339760ce36191915cf0cc29b380b27239180b5243fc21d1c7676f13fdbcd71525acfb89550ed9e0cc14d2af2fbd17359893cf018890bfef4707909bcaba447f641763d8a5c703c1ea75dc7b894f94b60b158c5a817e67cfebfa3d9a4dff6b44ef7f3a9a75272824f356f2fb66e428ad4d4a873d354aa0eda7afa278379d77fd462ff65abedfe35134da85fc35104f7819a637094ac375d878378a0f6ec73d88e2d1356c7c4b9836a11e443bafee4085dc2e31efcff48f5f11aff19a38f5a189d1e80e96d11e61ae7382083a38b601ba0b679f44d900146d84b96583dbf26599a7e7cb3ceda70ecfd1e253da3ca5cd5d6973c2737969cadca2966c7bb23ca69d95c82553e9c4949562377bb85e6f6231a3be88d7f09585139350ab7333c799c7ccd81a8e12fd8171df0080956e1eec4ed80c7d0d959e6bb3d0d43ca1660ada423d066d3c089c5157449dd77b2cc9976f7af8d09e699df9f6d7d99bd0bab6c62e953a5d21741ba8ee46b7c3aeecd3609f2e359378dd511d194d5da4d442f20d0138540a6d568337c015736e101aec07bc290f05153a87e95764fcd75536a5f1095a69aaae9d6756c8730451bb3905c74996688d95350acb10bf82291934f3e06a2dac2930d153658c081ed4c69303bdf5596699ae94e1b5a778d384cfc974da8c4b3a629c3a244b3f0237d6e7c6f92639f2ba341eb52386892642742ba82d2ba4a0ac7275517a531016f5bc2442ebf137ab82ac44220f0966bcb9905cfa3ad15f4ea124d646678de6e41676c638306bc93bd10ee565457fc3ad809579ad48362305d86bfd12ad2a6ae4006ded732c08dd5534595ac94ae98ab0242319bc35730c2219cd3c11bd85373cdbb102a893a10b83470bf49a7afe93d742fa5c58b6d8e2b1a188b4f7916e4acd99cf65133b0ad1c285401273212f2f977fa7aa2219049ccb56ec0bb414047a69920ba7bd7b592e65abacd48c0a80458a4c3b952f1b60a2cf1c1126878c2836cf74f3fe4d744161f4b6a2a79216caa8f4587a21376ad323636d1eac1628b3dc4346878360e9e26643cc82fe1a1b2ecd5ca66abe1a9a9b91d4ce143afc6399f44bbe0e2fc2aa948db34af376aea45b927121b1bc3c6fb243d27d4d0601a646d0d1c3225c473da503b46483df83daea95f4f7b87aad4cdb32f1741c1fe5715cafaa4fe7f17f721e9f02f91f06f2210ddf6fc47292335b304e0528ab3b117dcfd42c52728663d889f6a8dba6736e2c53cf5fc3cb76747c4685e123123ba3a8ce8c415141b6a1ae847d9fa3aafbf0ee980a03a99be83f2f3805b4f96018028c7d984a858319f210a28fc873a609a5f9c0c85b3b872a281190802a39cb8c9697e84098928a9646783322f138157c63dd031ac313c4f450b9ee35237cf75b7d3f84eb3afde0c8dc8ab6fdebe3ca2f5df951ccaeaefe0123e1be65', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138341, 18223, 2.5, 2.5, 'mg', 'PO', NULL, 'Pediatric', X'789c33d233cd4d5708f057283434d2353251c8b056f04dac50300709eba724560200868d08b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138342, 18223, 2.5, 2.5, 'mg', 'PO', NULL, 'Pediatric', X'789c33d233cd4d5708f05728b4d0353452c8b056f04dac503034c84dd74f49ac0400783f084d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138343, 18223, 2.5, 2.5, 'mg', 'PO', NULL, 'Pediatric', X'789c33d233cd4d5708f05728b450c828b256f04dac5030040ae9a7245602006f990834', X'789ced58db6edb3810fd95819f5ac0aa2de7d2d4051608d26d1ba017b709f2b22a049a1c4b5c53a44a52719422ffbe43c9712ad7898374f7218b007e30a999c3c333c3d1503f7ac25659aa5981bd31f426d6f05c195ba265975263af0fbdcaaaf028f7be74e3c16021e758bc30360bffe4609387e396952852e683e36838da8f8671140f4f8707e3e170bc1bbfd88f777776468d2d722f8d7664f9a3f70e35c1a8e6bfc78bc6fdb42e719c68a6bd8c4a57f3dc78c9c3582c27b1c066e68d712c43786b6ce1c6b0d7877898e8afa6f2e8c0cce05014524be72d0beb8de1f8ac0f93cf893e324561349c5a26103e910ee44c73e5cd6eaae9cf24af68cab3a9c230faeb1b8d94d4f3667043bacb76bb8a875d7b5a630dabdde4fd805a5bd7bbfa16b81e8a4af994c4913aeb08bb616fbdf7c804e339760ce36191915cf0cc29b380b27239180b5243fc21d1c7676f13fdbcd71525acfb89550ed9e0cc14d2af2fbd17359893cf018890bfef4707909bcaba447f641763d8a5c703c1ea75dc7b894f94b60b158c5a817e67cfebfa3d9a4dff6b44ef7f3a9a75272824f356f2fb66e428ad4d4a873d354aa0eda7afa278379d77fd462ff65abedfe35134da85fc35104f7819a637094ac375d878378a0f6ec73d88e2d1356c7c4b9836a11e443bafee4085dc2e31efcff48f5f11aff19a38f5a189d1e80e96d11e61ae7382083a38b601ba0b679f44d900146d84b96583dbf26599a7e7cb3ceda70ecfd1e253da3ca5cd5d6973c2737969cadca2966c7bb23ca69d95c82553e9c4949562377bb85e6f6231a3be88d7f09585139350ab7333c799c7ccd81a8e12fd8171df0080956e1eec4ed80c7d0d959e6bb3d0d43ca1660ada423d066d3c089c5157449dd77b2cc9976f7af8d09e699df9f6d7d99bd0bab6c62e953a5d21741ba8ee46b7c3aeecd3609f2e359378dd511d194d5da4d442f20d0138540a6d568337c015736e101aec07bc290f05153a87e95764fcd75536a5f1095a69aaae9d6756c8730451bb3905c74996688d95350acb10bf82291934f3e06a2dac2930d153658c081ed4c69303bdf5596699ae94e1b5a778d384cfc974da8c4b3a629c3a244b3f0237d6e7c6f92639f2ba341eb52386892642742ba82d2ba4a0ac7275517a531016f5bc2442ebf137ab82ac44220f0966bcb9905cfa3ad15f4ea124d646678de6e41676c638306bc93bd10ee565457fc3ad809579ad48362305d86bfd12ad2a6ae4006ded732c08dd5534595ac94ae98ab0242319bc35730c2219cd3c11bd85373cdbb102a893a10b83470bf49a7afe93d742fa5c58b6d8e2b1a188b4f7916e4acd99cf65133b0ad1c285401273212f2f977fa7aa2219049ccb56ec0bb414047a69920ba7bd7b592e65abacd48c0a80458a4c3b952f1b60a2cf1c1126878c2836cf74f3fe4d744161f4b6a2a79216caa8f4587a21376ad323636d1eac1628b3dc4346878360e9e26643cc82fe1a1b2ecd5ca66abe1a9a9b91d4ce143afc6399f44bbe0e2fc2aa948db34af376aea45b927121b1bc3c6fb243d27d4d0601a646d0d1c3225c473da503b46483df83daea95f4f7b87aad4cdb32f1741c1fe5715cafaa4fe7f17f721e9f02f91f06f2210ddf6fc47292335b304e0528ab3b117dcfd42c52728663d889f6a8dba6736e2c53cf5fc3cb76747c4685e123123ba3a8ce8c415141b6a1ae847d9fa3aafbf0ee980a03a99be83f2f3805b4f96018028c7d984a858319f210a28fc873a609a5f9c0c85b3b872a281190802a39cb8c9697e84098928a9646783322f138157c63dd031ac313c4f450b9ee35237cf75b7d3f84eb3afde0c8dc8ab6fdebe3ca2f5df951ccaeaefe0123e1be65', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138344, 18223, 5.0, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33cd4d5708f0572834d3b550c8d051f04dacb0523032c84dd74f49ac04006da307ec', X'789ced58db6edb3810fd95819f5ac0aa2de7d2d4051608d26d1ba017b709f2b22a049a1c4b5c53a44a52719422ffbe43c9712ad7898374f7218b007e30a999c3c333c3d1503f7ac25659aa5981bd31f426d6f05c195ba265975263af0fbdcaaaf028f7be74e3c16021e758bc30360bffe4609387e396952852e683e36838da8f8671140f4f8707e3e170bc1bbfd88f777776468d2d722f8d7664f9a3f70e35c1a8e6bfc78bc6fdb42e719c68a6bd8c4a57f3dc78c9c3582c27b1c066e68d712c43786b6ce1c6b0d7877898e8afa6f2e8c0cce05014524be72d0beb8de1f8ac0f93cf893e324561349c5a26103e910ee44c73e5cd6eaae9cf24af68cab3a9c230faeb1b8d94d4f3667043bacb76bb8a875d7b5a630dabdde4fd805a5bd7bbfa16b81e8a4af994c4913aeb08bb616fbdf7c804e339760ce36191915cf0cc29b380b27239180b5243fc21d1c7676f13fdbcd71525acfb89550ed9e0cc14d2af2fbd17359893cf018890bfef4707909bcaba447f641763d8a5c703c1ea75dc7b894f94b60b158c5a817e67cfebfa3d9a4dff6b44ef7f3a9a75272824f356f2fb66e428ad4d4a873d354aa0eda7afa278379d77fd462ff65abedfe35134da85fc35104f7819a637094ac375d878378a0f6ec73d88e2d1356c7c4b9836a11e443bafee4085dc2e31efcff48f5f11aff19a38f5a189d1e80e96d11e61ae7382083a38b601ba0b679f44d900146d84b96583dbf26599a7e7cb3ceda70ecfd1e253da3ca5cd5d6973c2737969cadca2966c7bb23ca69d95c82553e9c4949562377bb85e6f6231a3be88d7f09585139350ab7333c799c7ccd81a8e12fd8171df0080956e1eec4ed80c7d0d959e6bb3d0d43ca1660ada423d066d3c089c5157449dd77b2cc9976f7af8d09e699df9f6d7d99bd0bab6c62e953a5d21741ba8ee46b7c3aeecd3609f2e359378dd511d194d5da4d442f20d0138540a6d568337c015736e101aec07bc290f05153a87e95764fcd75536a5f1095a69aaae9d6756c8730451bb3905c74996688d95350acb10bf82291934f3e06a2dac2930d153658c081ed4c69303bdf5596699ae94e1b5a778d384cfc974da8c4b3a629c3a244b3f0237d6e7c6f92639f2ba341eb52386892642742ba82d2ba4a0ac7275517a531016f5bc2442ebf137ab82ac44220f0966bcb9905cfa3ad15f4ea124d646678de6e41676c638306bc93bd10ee565457fc3ad809579ad48362305d86bfd12ad2a6ae4006ded732c08dd5534595ac94ae98ab0242319bc35730c2219cd3c11bd85373cdbb102a893a10b83470bf49a7afe93d742fa5c58b6d8e2b1a188b4f7916e4acd99cf65133b0ad1c285401273212f2f977fa7aa2219049ccb56ec0bb414047a69920ba7bd7b592e65abacd48c0a80458a4c3b952f1b60a2cf1c1126878c2836cf74f3fe4d744161f4b6a2a79216caa8f4587a21376ad323636d1eac1628b3dc4346878360e9e26643cc82fe1a1b2ecd5ca66abe1a9a9b91d4ce143afc6399f44bbe0e2fc2aa948db34af376aea45b927121b1bc3c6fb243d27d4d0601a646d0d1c3225c473da503b46483df83daea95f4f7b87aad4cdb32f1741c1fe5715cafaa4fe7f17f721e9f02f91f06f2210ddf6fc47292335b304e0528ab3b117dcfd42c52728663d889f6a8dba6736e2c53cf5fc3cb76747c4685e123123ba3a8ce8c415141b6a1ae847d9fa3aafbf0ee980a03a99be83f2f3805b4f96018028c7d984a858319f210a28fc873a609a5f9c0c85b3b872a281190802a39cb8c9697e84098928a9646783322f138157c63dd031ac313c4f450b9ee35237cf75b7d3f84eb3afde0c8dc8ab6fdebe3ca2f5df951ccaeaefe0123e1be65', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138345, 18223, 2.5, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d23355d05530cd4d5708f0572834d3b550c828d251f04dac503032c84dd74f49ac040090990926', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138346, 18223, 2.5, 5.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d233d535cd4d5708f0572834d3b550c828d251f04dac5030020aeaa72456020087e308eb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138347, 5425, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05708f40856a85030d1b550284f4dcd2e06004eb506c8', X'789ced196b6fdbc8f1af0c0c04480049a6a897251f50c852ceced576749693a23805c28a1c915b93bbeceed23673c87fbf59522f2a8a25a7e9e18ada1f64923bef3787bf1ff92a0da682c578d483a3018fd1709f0b3caac051aa22fb303426d1bde3e3077e87714daac05ef1e332acf6144bd09f3263515cc76d579d7ab5eedc3a9d5ecbe935dc9ae3b4dc763d8745cf70293441fe7e748e02158bf26b838f39fa6d96606f222e5c9845d2bb43351143a95980f0b354b1ee81eb381568d89fa6fd39719c389888818c6329e056311fe19a5422c85b16d085818b338b94734f679b027ca14786cd22b477bf7da2bb888bbbfc662dd05a92fd76b970a74bd82f9f2cf5be9f46664a0a701194d4dc21cdd130953e0a164d3f441eaacab44f67f75842cbb585d17bf8f5620c8fd0ac9ec00322895cd6c4b2dea676c5b830f440786592cd0d923bc89c336d14f79654582ed374868207e229d1dadf14eca2361d6591547cfa4ecc0bfd770b74f66e4884ea4ed53d019f655fd17ac27d3b2df04c7bee73cf8b410fb5c0b625ff874df00344dfb6c69f26fb7fc4e8f0d299f31aa1cf596ea9038bdff9db9be1f1e8c3b004788d5230636b79ab4af2c4c1f15d704c1259217d7ecf7df4e1df27d5ba1b4e04e9c48421502bf7d3a0839047be42619b49b5f90dd8f6c5b363e3afa9c2333d374ed0e394e32399a4115b3b68a9d0486160533e831b3a15d47b7b7006af99e0318b409bd4e7a84187f2018404c5f51dcca502e6dfa3d20873340486731b80ba02611a33b1781832154322b5e6241dcc5203a988a8c146d99b89b8a454cba5e9c148c9192990c198cd71226e6c498222cc2622efb83d18a8c1a53523cd1fe0a3a790116f5fd24fcb7955b1c711fc54a7f9a17cd869bd9a8855ecf60ab8dcc2db906eeb15905a01a53f3925ac141c7f7277f1a371061312dedb96f25a1a18e29ce6287f832dd9cd1091fcf1f74e2ddb5eda3fbb0ced305800eb2917d31585c5283390c2282af83ef77644453f8a50051918095ec4b43eb6b3e544782cb5b0c0e7a07237f138615cc5284ce9305cd867e7b1008c7c54e4700b4467ba84eb854a0ac2a570a51190a98c12405bfb6f42d1147955c2e2719c0ae9c938513226f8efb6f4f0ea00db5eade6c13c0ba637c8bcaf8db8ab2e8e5171996e195b90ad4249c290cd4973231fb9c74d36110253a36442ed884d8421c3c433e96566f984058a8934ca1f694e66640939cb1a9e098c2d444214c88af6d2c7442125a314f45867c43047095914a51e174510d011c50885bbe1c69eda814011459bcf029350158f673497671e537e2e17f3c2d54dff63315e4f84be234fab856176f4f862c42f192244e61331f234d1528a6eedd5e7cf64184d5c834c2079d86a480782a5da02dc93bf8bc2e549314f0b0559c08bf24204947cd00b0a8a692ab6fdcbdb4a7f7c4b6188f76c97740705cab7bcb63f7cb630a72b4ce2bba6bfe1fbfd24af37804b54b683663fa9db6d8c12bd5540ed27345a819628ace3f080445bc396a558c6ef0152ac404b14ca617fc0ab6019be2ccd46ca1c20d0267489ce4656ed2773b6015cf6f83a1d0f70f6067089ca328f0f88e68fc54bf2967d17a97c80659790e52859148003626409b985bf281b8710588296f32faf2f07a45e0157c25dd6a4fdd81f9790257c5ba7f6e3de58a8a211fd1fb795ed0efbd2575efaca4b5f79e92b2f7de507f495bf5831fd9e17ba9788f953236664d73ecc93910cb252dc50a59b57233ec71eb817137185e439ea553aeec125a7d7e85318fc73d46c3915a8f7dd0ab8837a977e876d7827423ee346aa8978fb4825aed81aa58a2c65c97821134405e41cfa5e7176c1b561319dc3850b37e86142d89b9f7d9ebb43439cf6232dbf1aafc225230adba7faf6f7c46d99fe61dd7f03be5c75ff0b33456e991b9ca342e16179f4749d7a17fa310da51e13704efff34d9886b1f4389a0cce90e63f18d0dc67cfe043e23383f0f6314165803a1946b527f1730605960ffdf3f13641bba21c4983243d35d88c628825090d329610c2152eb75ef041a3dd48bdb71b29c8d778ba06bf10ef2557cbb296f33b6d775e37dff4da9d66b5dd6dd6c097dcae766b75fa3bfe57a06bf556a7dda9c16fa374461ca0e1b4bb8d6eb3fd896263a9ca527e1bace425132295424a15f29b865ba6efec67510f81247b3fd306f3fde10a92d560a4ece44b1041ca7db46ed1b9b27205cd56d03dba86746124858924dbce32a043f8710295b0326b29a7735a77dad65427cd46f5a4dd589ba4de69d61b5db7614d42351ff11ede56e0ef5226766d7c5581bee2fa335c1259bb6ace5d63df3d6206c56c236c529b9019e03adfab32d03c1056fc622139673c4a15d5988790e216ecda528355748604a113ca40bb8efe1bf9f89d7d091136186a50ef76bba76eb3fdbaf1a6e7363b55b7e56e48ed343bad6ed7b5528f2f46701ba2fd429eda37a2f3b51bc8446363c74ac8bf26d9bd761266117be4145239a2eda63c1f3b2df006194d9ef2210fd17b62b87492c53993344559fd865c5109912a67744d70f18c98d49b152bfc894d17d2895a58644218679ad2c856e2856aaddc1f0dd2acd1e96e6ad6ee3a6ebd6b355352c8f91cce6f2a944cf48a680cfce3ca5e2ba1e197710590ac1dd13f9fd4b1db655210b5a7a8368bc03aaa58dcffbc7440b11bdf34908dd322c5727597df3c6ad02291ad1746f48411741272568151bfb78ed3818c220cd01a6214669a6a1013fa348fb6da732bfa972f7f00b26d323a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138348, 5425, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333130c84d5708f05708f4080600141a0334', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138349, 5425, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05708f40856a8503053284f4dcd2e0600438b0665', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138350, 5425, 400.0, 400.0, 'mg', 'PO', 2, 'Adult', X'789c333130c84d5708f05770f27451a8503034d035b2504849ac2c060051130698', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138351, 5425, 5.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf34bcdcf4b2c492db65230d5553034c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4d03534ca000021f70d36', X'789ced196b6fdbc8f1af0c0c04480049a6a897251f50c852ceced576749693a23805c28a1c915b93bbeceed23673c87fbf59522f2a8a25a7e9e18ada1f64923bef3787bf1ff92a0da682c578d483a3018fd1709f0b3caac051aa22fb303426d1bde3e3077e87714daac05ef1e332acf6144bd09f3263515cc76d579d7ab5eedc3a9d5ecbe935dc9ae3b4dc763d8745cf70293441fe7e748e02158bf26b838f39fa6d96606f222e5c9845d2bb43351143a95980f0b354b1ee81eb381568d89fa6fd39719c389888818c6329e056311fe19a5422c85b16d085818b338b94734f679b027ca14786cd22b477bf7da2bb888bbbfc662dd05a92fd76b970a74bd82f9f2cf5be9f46664a0a701194d4dc21cdd130953e0a164d3f441eaacab44f67f75842cbb585d17bf8f5620c8fd0ac9ec00322895cd6c4b2dea676c5b830f440786592cd0d923bc89c336d14f79654582ed374868207e229d1dadf14eca2361d6591547cfa4ecc0bfd770b74f66e4884ea4ed53d019f655fd17ac27d3b2df04c7bee73cf8b410fb5c0b625ff874df00344dfb6c69f26fb7fc4e8f0d299f31aa1cf596ea9038bdff9db9be1f1e8c3b004788d5230636b79ab4af2c4c1f15d704c1259217d7ecf7df4e1df27d5ba1b4e04e9c48421502bf7d3a0839047be42619b49b5f90dd8f6c5b363e3afa9c2333d374ed0e394e32399a4115b3b68a9d0486160533e831b3a15d47b7b7006af99e0318b409bd4e7a84187f2018404c5f51dcca502e6dfa3d20873340486731b80ba02611a33b1781832154322b5e6241dcc5203a988a8c146d99b89b8a454cba5e9c148c9192990c198cd71226e6c498222cc2622efb83d18a8c1a53523cd1fe0a3a790116f5fd24fcb7955b1c711fc54a7f9a17cd869bd9a8855ecf60ab8dcc2db906eeb15905a01a53f3925ac141c7f7277f1a371061312dedb96f25a1a18e29ce6287f832dd9cd1091fcf1f74e2ddb5eda3fbb0ced305800eb2917d31585c5283390c2282af83ef77644453f8a50051918095ec4b43eb6b3e544782cb5b0c0e7a07237f138615cc5284ce9305cd867e7b1008c7c54e4700b4467ba84eb854a0ac2a570a51190a98c12405bfb6f42d1147955c2e2719c0ae9c938513226f8efb6f4f0ea00db5eade6c13c0ba637c8bcaf8db8ab2e8e5171996e195b90ad4249c290cd4973231fb9c74d36110253a36442ed884d8421c3c433e96566f984058a8934ca1f694e66640939cb1a9e098c2d444214c88af6d2c7442125a314f45867c43047095914a51e174510d011c50885bbe1c69eda814011459bcf029350158f673497671e537e2e17f3c2d54dff63315e4f84be234fab856176f4f862c42f192244e61331f234d1528a6eedd5e7cf64184d5c834c2079d86a480782a5da02dc93bf8bc2e549314f0b0559c08bf24204947cd00b0a8a692ab6fdcbdb4a7f7c4b6188f76c97740705cab7bcb63f7cb630a72b4ce2bba6bfe1fbfd24af37804b54b683663fa9db6d8c12bd5540ed27345a819628ace3f080445bc396a558c6ef0152ac404b14ca617fc0ab6019be2ccd46ca1c20d0267489ce4656ed2773b6015cf6f83a1d0f70f6067089ca328f0f88e68fc54bf2967d17a97c80659790e52859148003626409b985bf281b8710588296f32faf2f07a45e0157c25dd6a4fdd81f9790257c5ba7f6e3de58a8a211fd1fb795ed0efbd2575efaca4b5f79e92b2f7de507f495bf5831fd9e17ba9788f953236664d73ecc93910cb252dc50a59b57233ec71eb817137185e439ea553aeec125a7d7e85318fc73d46c3915a8f7dd0ab8837a977e876d7827423ee346aa8978fb4825aed81aa58a2c65c97821134405e41cfa5e7176c1b561319dc3850b37e86142d89b9f7d9ebb43439cf6232dbf1aafc225230adba7faf6f7c46d99fe61dd7f03be5c75ff0b33456e991b9ca342e16179f4749d7a17fa310da51e13704efff34d9886b1f4389a0cce90e63f18d0dc67cfe043e23383f0f6314165803a1946b527f1730605960ffdf3f13641bba21c4983243d35d88c628825090d329610c2152eb75ef041a3dd48bdb71b29c8d778ba06bf10ef2557cbb296f33b6d775e37dff4da9d66b5dd6dd6c097dcae766b75fa3bfe57a06bf556a7dda9c16fa374461ca0e1b4bb8d6eb3fd896263a9ca527e1bace425132295424a15f29b865ba6efec67510f81247b3fd306f3fde10a92d560a4ece44b1041ca7db46ed1b9b27205cd56d03dba86746124858924dbce32a043f8710295b0326b29a7735a77dad65427cd46f5a4dd589ba4de69d61b5db7614d42351ff11ede56e0ef5226766d7c5581bee2fa335c1259bb6ace5d63df3d6206c56c236c529b9019e03adfab32d03c1056fc622139673c4a15d5988790e216ecda528355748604a113ca40bb8efe1bf9f89d7d091136186a50ef76bba76eb3fdbaf1a6e7363b55b7e56e48ed343bad6ed7b5528f2f46701ba2fd429eda37a2f3b51bc8446363c74ac8bf26d9bd761266117be4145239a2eda63c1f3b2df006194d9ef2210fd17b62b87492c53993344559fd865c5109912a67744d70f18c98d49b152bfc894d17d2895a58644218679ad2c856e2856aaddc1f0dd2acd1e96e6ad6ee3a6ebd6b355352c8f91cce6f2a944cf48a680cfce3ca5e2ba1e197710590ac1dd13f9fd4b1db655210b5a7a8368bc03aaa58dcffbc7440b11bdf34908dd322c5727597df3c6ad02291ad1746f48411741272568151bfb78ed3818c220cd01a6214669a6a1013fa348fb6da732bfa972f7f00b26d323a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138352, 5425, 10.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf3cc4b4bcc2b29b6523034d03532c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4d03534ca0000120c0cd9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138353, 5425, 20.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cec8cc49294acdb3523032d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834f30000fa2d0c80', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138354, 296, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303235c84dd7513035005200730007f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138355, 296, 500.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c333530c84d5708f05770f274010013ec0318', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138356, 296, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c333235c84d572834d3b5c8000011580300', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138357, 296, 5.0, 5.0, 'mg/kg', NULL, 2, 'Pediatric', X'789c33cd4dd7cf4e5770f2740100111302fa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138358, 11118, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138359, 11718, 50.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cc2bcecfcdcb4cb4523035d0353430c84d5708f057482c51484a4d29c9cc4d0500a6b20a3e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138360, 11718, 150.0, 600.0, 'mg', 'IN', NULL, 'Adult', X'789c73492d284a2d2ececccfb352303435d035333050c84dd74f49ac54c8cc5348c92ccb4c494d5148c92f4e2d060034570e5f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138361, 2294, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b65228494cca492db152303235c84dd75130350052d60af94589390ac5a5c505a979c599f979560a8646a6b9e9faa6b93e3a1095202600f26318bd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138362, 2294, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353530c84d5708f057283434ca50a8503034504849ac2c06005c290733', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138363, 2294, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a850303450004a14eb28e42682380620c5400100bc751058', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138364, 1760, 200.0, 200.0, 'mg', 'IV', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303235d0313530b056303230c84dd7cff5b156f00c0300bd5409d0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138365, 1760, 1.0, 1.0, 'g', 'PO', 2, 'Adult', X'789c3354485708f0d7f70c5348ca4c010016880395', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138366, 1760, 1.5, 1.5, 'g', 'PO', 2, 'Adult', X'789c33d43355485708f0d7f70c5348ca4c01001c2103f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138367, 1760, 1.5, 1.5, 'g', 'PO', 2, 'Adult', X'789c33d43355485708f05770f27451c82f523004f23cc3149232530053ac06b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138368, 1760, 1.0, 1.0, 'g', 'PO', 2, 'Adult', X'789c3354485708f05748ca4c01000d7302c7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138369, 1760, 600.0, 600.0, 'mg', 'PO', 2, 'Pediatric', X'789c3356c8cdd735b450a8ccb75270c92f4eb552303330c84dd7cf8d335208f05748ca4cb15670cc29b1523037050a83849c3c5d14d2f28b1492f2532a158a4b8bd2f414128b5213156c150cf58c4c750df54c15809aad150c15f02ab7832bf44dacb002a9d64f01da0f00836828fb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138370, 1760, 1.0, 1.0, 'g', NULL, 2, 'Adult', X'789c4dcc410ac2400c05d0abfc0328a2e06674d72ebaf40a9184129cc984490af6f6baecfef13eca263b72908557b28453aa58c6097dcb5016686bc24a29f01e793e5a19dab94c63aa78deee058dbeb862c55bf98165bebce602eb88cdbd4afbb73f37d627ff', X'789ced5a6d6fdb3812fe2b03030552207e6d9d6c9dde02d9e4ee1ab4d91a49b7c0627d2bd0d248e2462205924a232cfadff721652776e26dcf4171ddeef94b6291c3e1cc332f9c11f57b2731751629517267429df326d655ce4a17c27154ea949d2c3afbd4a94de1e773e72a3be9f73fc82b2e7bda64fe97ecffe9321b1b51711209e7578f06a383ee60d81d0ede0d0e27e3c3c9f3716f34387c311a075a8e9dd4ca82f2f7ce71524a25ad33c28f8521c73781cbbba6e2099d9565adb4adabcab0b542b9993ad556644cffd2a6b4131a8d07fbe3c1e08846834199f5cb374774f67ea62e74edd8924e697d8b094ddfee078a135d965ad13b2312a61f010c989d70519c70e5829cf57c55d48f1872625eb07ffae53f782aa4ba6a1ffcdc7152172e826c52656b7a6ce0d5792d13c54d049994ad0a681519fead25882a038c9b42dc48bbc667481964ef9fbda7b94c66ead209e380cf7bfa205d4e52d1e8794e95b68eeed8ee53ac9593aa66aa2b729a86cf29118ddd278b5571ee87a66fe9f8f2780ad854aa2794c96b26e0c265e51ab24e9722ce8ff0c3eb4e154064e52c95a22127aeb8dd3dd53ae9ac03e43179c590714b2d7be3afa8e7061dde80ce3c4e07fae1ec94b4216fb9a53aede6d62bf51575aaabda468aabdc48b7d1cd5685ad6d6be599420c260825ad78a6827856266c28e1980588128d3fe3c11312a9c3f041a9a10e0b57c263ee4bf18970ba93e56ebfcfe7a6e91dedc7a0e4df35c6eee7925d90ed82ecab05d937e97cf72368e77ddfa8f7fd2d0cf7c01bff2f2cf77594fcef6bfa2fa4e79413299c91f117ee0ca2d11aa76754eaeef03b6a00163642df74d07643bf8e16501ed17181247b38c6f0d2fd53f8ff5c27f0c6daa43d12408afe41c3de68dcf56182c54734a44f927f7f4b782e6e269ebaef6db085436d53ab7d035a6fd9355e561c4b5144535dd585b87383a58a70a84c09153774815995cdd0c09eced41b11bb404d46da2b3f880465e5bc68a85656a49b44e95cb0c24e1bfc30b4ae9399ba0a56584973b7a5e83e22ac100d2794198416a5b50a8c499665f0700e19525713529a44f25b6d43cc7d9a275a741fbef798745769d9489d4c4ecc49412f47e3094ae29b609c60db57a7fde969d8d1bf1f28b8dd31f725894fed853f1d36ed8c3eff96e10796591e50eccf59712add0a5f07b553a91889e83690ffca382df47a366881ba8d863ecea6cd706d6cdafdce1b1356eb2864bc23ad8a1a4e4acb809b296f97437c90c57953823491d6a7e77b4a1f9176392cb45c21cb4a48e367fe14fbfff1d68f3a17ef87ece74f8d53ff6aae25b69154d12d870e36bc63bc1ef49f677b4b1f79fa2886e364da4808df9e4dbb7cb0cb079bf2c1c3170cbb84b07d42d8e5d287d06d591c9da0c73242aa44c61b4aa3e3a2609335bed58a0b616ddfdf7020dc1b38bf65657b7ea6d24563b599fb20f96e407b68eb50d0954f5142b18df3ee8f4d2e14d946254697e8295e735134dd4be6ac949effca542cea3674d1c315683a506b2d43726532a57f9f79a0b401c9da780bf702c3fd05ce6b1473f40d085463f407a0162e3c30b346327dfd13edf92b1814c4b01980edfa4e1420c1bf826af6e9a32e2fae3d68d1058bf821d29b92c2a5cf30f53a9dcb81d45cc70d121a2b2966aae0fa6af95b71edccf241ae5deb042da54adb0deeb0d155a58dabfded8d77ac25c14c5d4b032c4d90f65ab463ded468aa3155db2efc41c73d0a0da68699f206ae7ffe0654359c1b5d1ac5b0340938be0d8236659563f5f2179a8e42a6ecef8cd0b62fed0943230e647b38cf142c0d481150be2ec7031c0f1608e2f4eb220ef6071bf4b73325e2daf1c20752218bdaeb2715ba54e8e6d0025051c3820bf7088deea28a2850d9efd330bc7f90255bd7f255199074580789bcdd1711f2b09e6befb9d60c1562c42146d6819f21d2e07d3830b13fec0b3ff33073c21e18a1b8f4508979a24be9f5409cab200a54a8165658b578eacd180ee044c4399452029dbce85f637ddbcc248dadb80a16804c7a2112ed1951c9c4bf8301fdd3964c79a9625d67f922c6e35c17010dfc2b971caec4e2016d7fa98dc75d05a0ad2e21d3b6f97be7e57f592fbf9f90766efe7837df61b78edd96a7e73417f04c0481ce9a35105fc169bb3ec226343cecbdc8696ffa968cff32e1297cfda07790878aa41d99a973c62e08255b4eda66e5884e7e9e3e1fa37c6fdf83225e7d91e3df7b5e7beb24bec4296f3fca40f6103140d93b9f1e83dd3f6f62c3ed370fb541a5402f9e3da1bd97c327842e04654fc609c48061d9d2c19347e87dce9e0dc48d741a1dc70fbee0902a9773e92cfdd025a1127ad76dd30e5227d34aeec1b2ed37bf602c4669caebd9992b1d83276fca119f64f9f1e31fc3e462b4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138371, 1760, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c4dcc410a02310c05d0abfc03282d0a2eaabb99854b4f20041a24d8a4a5c980737b5dba7fbcb754e31d31c97c34b2c0a010b6f003fa162e9521aa5c858231bac7f1dff2945e0b96b934dcceb940e9834bcefa4afa3ca54afb15f7353dd602ebf06d8cc6fadbbf4ea22a17', X'789ced5a6d6fdb3812fe2b03030552207e6d9d6c9dde02d9e4ee1ab4d91a49b7c0627d2bd0d248e2462205924a232cfadff721652776e26dcf4171ddeef94b6291c3e1cc332f9c11f57b2731751629517267429df326d655ce4a17c27154ea949d2c3afbd4a94de1e773e72a3be9f73fc82b2e7bda64fe97ecffe9321b1b51711209e7578f06a383ee60d81d0ede0d0e27e3c3c9f3716f34387c311a075a8e9dd4ca82f2f7ce71524a25ad33c28f8521c73781cbbba6e2099d9565adb4adabcab0b542b9993ad556644cffd2a6b4131a8d07fbe3c1e08846834199f5cb374774f67ea62e74edd8924e697d8b094ddfee078a135d965ad13b2312a61f010c989d70519c70e5829cf57c55d48f1872625eb07ffae53f782aa4ba6a1ffcdc7152172e826c52656b7a6ce0d5792d13c54d049994ad0a681519fead25882a038c9b42dc48bbc667481964ef9fbda7b94c66ead209e380cf7bfa205d4e52d1e8794e95b68eeed8ee53ac9593aa66aa2b729a86cf29118ddd278b5571ee87a66fe9f8f2780ad854aa2794c96b26e0c265e51ab24e9722ce8ff0c3eb4e154064e52c95a22127aeb8dd3dd53ae9ac03e43179c590714b2d7be3afa8e7061dde80ce3c4e07fae1ec94b4216fb9a53aede6d62bf51575aaabda468aabdc48b7d1cd5685ad6d6be599420c260825ad78a6827856266c28e1980588128d3fe3c11312a9c3f041a9a10e0b57c263ee4bf18970ba93e56ebfcfe7a6e91dedc7a0e4df35c6eee7925d90ed82ecab05d937e97cf72368e77ddfa8f7fd2d0cf7c01bff2f2cf77594fcef6bfa2fa4e79413299c91f117ee0ca2d11aa76754eaeef03b6a00163642df74d07643bf8e16501ed17181247b38c6f0d2fd53f8ff5c27f0c6daa43d12408afe41c3de68dcf56182c54734a44f927f7f4b782e6e269ebaef6db085436d53ab7d035a6fd9355e561c4b5144535dd585b87383a58a70a84c09153774815995cdd0c09eced41b11bb404d46da2b3f880465e5bc68a85656a49b44e95cb0c24e1bfc30b4ae9399ba0a56584973b7a5e83e22ac100d2794198416a5b50a8c499665f0700e19525713529a44f25b6d43cc7d9a275a741fbef798745769d9489d4c4ecc49412f47e3094ae29b609c60db57a7fde969d8d1bf1f28b8dd31f725894fed853f1d36ed8c3eff96e10796591e50eccf59712add0a5f07b553a91889e83690ffca382df47a366881ba8d863ecea6cd706d6cdafdce1b1356eb2864bc23ad8a1a4e4acb809b296f97437c90c57953823491d6a7e77b4a1f9176392cb45c21cb4a48e367fe14fbfff1d68f3a17ef87ece74f8d53ff6aae25b69154d12d870e36bc63bc1ef49f677b4b1f79fa2886e364da4808df9e4dbb7cb0cb079bf2c1c3170cbb84b07d42d8e5d287d06d591c9da0c73242aa44c61b4aa3e3a2609335bed58a0b616ddfdf7020dc1b38bf65657b7ea6d24563b599fb20f96e407b68eb50d0954f5142b18df3ee8f4d2e14d946254697e8295e735134dd4be6ac949effca542cea3674d1c315683a506b2d43726532a57f9f79a0b401c9da780bf702c3fd05ce6b1473f40d085463f407a0162e3c30b346327dfd13edf92b1814c4b01980edfa4e1420c1bf826af6e9a32e2fae3d68d1058bf821d29b92c2a5cf30f53a9dcb81d45cc70d121a2b2966aae0fa6af95b71edccf241ae5deb042da54adb0deeb0d155a58dabfded8d77ac25c14c5d4b032c4d90f65ab463ded468aa3155db2efc41c73d0a0da68699f206ae7ffe0654359c1b5d1ac5b0340938be0d8236659563f5f2179a8e42a6ecef8cd0b62fed0943230e647b38cf142c0d481150be2ec7031c0f1608e2f4eb220ef6071bf4b73325e2daf1c20752218bdaeb2715ba54e8e6d0025051c3820bf7088deea28a2850d9efd330bc7f90255bd7f255199074580789bcdd1711f2b09e6befb9d60c1562c42146d6819f21d2e07d3830b13fec0b3ff33073c21e18a1b8f4508979a24be9f5409cab200a54a8165658b578eacd180ee044c4399452029dbce85f637ddbcc248dadb80a16804c7a2112ed1951c9c4bf8301fdd3964c79a9625d67f922c6e35c17010dfc2b971caec4e2016d7fa98dc75d05a0ad2e21d3b6f97be7e57f592fbf9f90766efe7837df61b78edd96a7e73417f04c0481ce9a35105fc169bb3ec226343cecbdc8696ffa968cff32e1297cfda07790878aa41d99a973c62e08255b4eda66e5884e7e9e3e1fa37c6fdf83225e7d91e3df7b5e7beb24bec4296f3fca40f6103140d93b9f1e83dd3f6f62c3ed370fb541a5402f9e3da1bd97c327842e04654fc609c48061d9d2c19347e87dce9e0dc48d741a1dc70fbee0902a9773e92cfdd025a1127ad76dd30e5227d34aeec1b2ed37bf602c4669caebd9992b1d83276fca119f64f9f1e31fc3e462b4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138372, 6335, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492db1563032cd4dd751303500918606400a0001330bfd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138373, 6335, 25.0, 150.0, 'mg', 'PO', 1, 'Adult', X'789c3332d5353435c84d5708f0574849cccca90400263704f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138374, 6335, 0.1, 1.4, 'mg/kg', NULL, 1, 'Pediatric', X'789c33d0335428c95730d43351c84dd7cf4e574849cccca904004087066e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138375, 2292, 250.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c333235d0353530c84d5708f05770f27451a830d53534504849ac2c06005a0c0708', X'789ced5c6d6fdb3812fe2b830007a458c7b19da6c53a87031c276db34d52234e8bee9d0b839168891b89d492541aed22fffd86945f2447b66c35db6dbbfa50d72fe4c3e1cc336f94943f775c197b634e42bad3859d3e9dc452dc33fcd4809d5806e64b5feb4875f7f73fb35b1a3685f4cc3bb69f1fab1c4922ea8e8936533aadce8bbd567bafddba6ebdec1eb6baad4eb3d3faf9f98b97762c7534135ce1c83f775e534e2509ec7b4defedf4eb24a25de870173cfbab193de20e8d7c12081509c9f0e38950c4a3f04ac8507541939b80ea0644e2b34b254c8404c67f4b179a8f1d6a49b9a7fdd9705ce3b0157a0d386ce17f478593bbf0321dd36e1ee2ebcbf4d5bc743a87de885f8958530562023d37649c299dcadb85c1bb069c7dc07f1723de176128385c4be252b8446da3c8a840cd7803fecb3871e8a4016f538d5a15c537592d3de0575664f3e97f9ff053c0f8adfdb0d05a4e3f9bd82f3bfce19359a3e7c6811ea3b618f77216299069e78205eede85708d81e8f898389a4a468231e393ecb01904aa7acfea191503c76727707f88fc0097246a27bf3d23c950d3480b47380e220e7c2213ee31cdd4fe35e2b22030ef97e133d0ab817b0eda6b7c41ee110451c743c663b519da119cf189e802171a2475d0a494bbd4850839737632ec81173397a26568d1c2ef39ce8802e6a0b6dcf16bc167bb3b2bd657bb3553d67d7bb672caccd970433a87ca3b76df805852ed4bd23082e9383c0237260120df894629b59de9f8010913176d048ed89be364f75220f7299141323e4f423a3e618a12457362e64dda59a9f72bca71af05d4e20288fb5bacac9c47f0e6a40b1ebba3e00a45814c905460444e14530d543da8388a029a0e1e9c74f35f152cfc8646e8904ef1d21a5c3a41833ddaf81a8fb3a84f4bfe65d7aad95fb3ff5b66ffd3f17399f935416b823e0141bf1e8d96095cf3e847e2d17763cd651ad6e62c326755ad2c6bf70753cbd7dbceb222ff9afd6c8eba799f6d810714b7ab6531f4363df2227c8c3b39900308c55ebb0309060e5c8376e10039b97febed231751992a32fc74d91d3339e9f776c7cf242ecc775d484390197e04bd6076c6614e3c56653a6b520bfd99691fa38e7047fc3fed838c108bfe258b33ef61664886170d8c62e91108dc11c9a8829b6411ff4027110e51f40e15a193952dca3b6db2f5f8c2283c9fb38d820e51b4bf573d2fb6355246579bcaf148bd05926cd3e37d0354dba0a83ada908f5fbc50e1a993dcb2b179acc4ce964a3c5ce83063e5ed775eada759e2047105023818add56cc16949335df189ca9a115fd435f8fe4bcad4a51de4b5f538666d56ebac7195beec07f0ef760b3573682d6da0ada17fef3cf7bf34492ecc2d8d38c0c28830697eb103bf6271b1a4826ae938733a3db7f70647d38bb10f6b4fdbea34ba48a3c52729751eadf3689d47eb3c5ae7d13a8fd6bdd5f63961e3eb137552a893429d14eaa4f0bd26853aa455b9da57c7b43aa6d531eddb8b69dfbb5f56b8aba076ccda31bf7dc7fc11885c7eaf45cde41f9fc94f69f575f797d4667f1ab3ff43fd69fd1d374fa7d96d70b7bceb661851c75ced1b88280ec8e39bee06927a9c7027e9c2f1889f1347cf9ec091e20671131892091d716b7c48051c71fbaccb132b7cc4e777086177bc96504fc6a623f84a6c1af1a98d975578b9b06e4e01975f64f5bee05a12c65d532b3cb2792f08a8f412d0029c8028b56f9e6383dd21453be79e6c42d50ba5f630d3e3d2774c2723fe0c8790d8667636013fc15e5f516e8e3c50355ae01efa97b921cb8acdcf9f2a65c5cf8ab23fb0fa403d2b215d2a733f8624e0312a2b7d4a2db7a229788070cd6e9840f83ddca3402fc0aa091c61db17f099d242165dfcdd28fbad57d3960f908d1fcd4719322edabf2c07348366cfa1dd199b8caf2cdcb2ed0b0f62a864225ee20827919f04e49e29e42af67f82ba3424237e2deed16034c2564ea2098053470aeb05233ed4f40ec9b0f78bf0b94263a884bb528448ab338efea2ccb5133b25f28ddd70c6c0841e2d22ca99c1f671f48dc87cd3f324e17160bfb24b9cd3f876f6e32545fbcf3ebca1218a61c8d4e33434df0c53f6e0a43e6a1a99e2b238442e4d26cc61010a95a105fa9d943e2505e9347dfc30a79c93e9681481c458beec7f1021eec7b8f52f4432e5f87b6fa8bcf7290b314ac8a92146fc03f1184f378e10e698ec8a281f77797edd80def01a6840ef8c3cb3787b96f18b745b956ab58c31cb99941d9ce3e182059b80ccc7e63056b3a71cf3faf4320fb68a6ee5504b33c7c3d9ccbcb04b74dc40c4e5197979a784dc40bed9c8dcfc421a6f106b16d3c68b6939e4930cfdd783cd47e6e6cf895d0eb0183a3d6daa834f36f82cc7e63afad4d1a78e3e7f59f4f9f6dcab4a35fa372ad05c1e080956d5c24b726a7c4382c95ec026e6c8b1f91c7c114bec930e9a87e95bd8b56dddc1e1b3c6885f50dc2216e62aecc205c2a36f1e41ffd7013c3fc4ae2fe6b75c7c460d9fde3b92a6dde97b2c9b894c20923858326c5377df47a6a169b75affc2198e4fb847dd6706dbbc4768fb6726a67f96627a17acc35cb312e33e760a5a814383003e137c0963077d28d218298c636b9f4e83c4968d586fde848c87d33609ffd1f29afc2dcdab7338e2d8f53a46245c6d7fd173edc62a468913dcead9883393ea42db46e24fe6e657dbc367a74ab3158ddd11ceb81af1f947d815d25ecaa5137b768bd80e6e063bc8147df8138a9070ec1c713c86517b7166a1b145bb850ef01e87ce253427cbefafcf407063266e43a5d2c8776771e08cf81fdb238e3db34b34badec70e66c85408ecaf50675234e026d65640f44a37231b8e3e58337a3130b33323d36b29e2087aa0ccf52e8816d7b9207f14eec6a6b385d3264c084520e3e11f9f575971ba12a731069db26c8afe6d2534d67f2d490803912ad44c7b273d4bea3411216a73b69d061c37a0df80d73bb6b89a712eb12353b79fc3ae401acc04a415303e300cf604d566375b5d08f45fc6051217bc22948fed129853e309f6020942cc0c570074b52d0e26b22af25c0c87bd0adab8b82a9c562675bfb75771e6506301d684d3b448c2bc5da4b4b3b2e59bf01bc5c451acab3211ce9b109a8b5b58c798bf61b489d5ac835c528f180751cb80974df01010339fa085a42edb0f02609e66363c146ba4d48e42927b0c96041c0c7028c90a3a96e1bc699ad014c494ff51c93d318a9923b00a33df06f44631b30555c5ada70bef2f60e074787cfe5315977c84f476d0af04647dfbc616032ac22a2d8cfad814781518520815892a11073b62f3f04ab19a379d0c581639f6d26f9108a5d16a480274c195c62e9fef33affaec81149a62b80d992437ac9aa3cc30eee2c033657b350873c70ac7361d54d4ac600df47afc60295a0c501a484d6591b20a2692c6dc6545be5b9a0e32302e33e7c371a5b09e81a9b69f1e3a09128b6079502588f41cc6a95e2f42992e068ac6ee540842656ccb0c5201e83896b7be085cf3381d16c21171581598a1a658344a11f953a1b0fbc106de47de5781fb158d8be527013a2d5cccf50ea708a9cc56af2441ea2bcb5e1d07449ae995a2c9b18c9d354e503aff9c7a4cac73a3529b136c38626911c218d56b3abf2ad997d0d09a26366d0176a349913796eee703bb914c98d0c4d9843985bef808e48229e79143a63756589148b14b9517a609b6ba18a9c3456352545894e25c31e7966aadd89708927ab6396222771b16da3d4e4ce67d5cf599669f8b30710a2bc872d25a51042600acfb25f156e4a152ea497a8799c8328f06f83537456db14796d16fe511dcb67bcb02edda1b0c6668cf2a88f52a5619c3d943550c66b25a9f3430f79eaac52da8b15ae1f328d5a7c7072ef5b9c93fe3dc64dbdb60281df7022576f29799e6aa87dd0bc2f8b3aa07b0c548651729e673c6d3390f9f1e1e1efe0f22e05c62', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138376, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Adult', X'789c333235c84d5708f05770f27451a83034504849ac2c06003bf805e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138377, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Adult', X'789c333235c84d5708f05770f27451a83034504849ac2cb656f0cc4bcbb752c8cb2f51284a4dcecfcd4dcd4b494d5128482d52f074097654482fcd4c49cdc9cc4b2d06007b93150a', X'789ced5c6d6fdb3812fe2b830007a458c7b19da6c53a87031c276db34d52234e8bee9d0b839168891b89d492541aed22fffd86945f2447b66c35db6dbbfa50d72fe4c3e1cc336f94943f775c197b634e42bad3859d3e9dc452dc33fcd4809d5806e64b5feb4875f7f73fb35b1a3685f4cc3bb69f1fab1c4922ea8e8936533aadce8bbd567bafddba6ebdec1eb6baad4eb3d3faf9f98b97762c7534135ce1c83f775e534e2509ec7b4defedf4eb24a25de870173cfbab193de20e8d7c12081509c9f0e38950c4a3f04ac8507541939b80ea0644e2b34b254c8404c67f4b179a8f1d6a49b9a7fdd9705ce3b0157a0d386ce17f478593bbf0321dd36e1ee2ebcbf4d5bc743a87de885f8958530562023d37649c299dcadb85c1bb069c7dc07f1723de176128385c4be252b8446da3c8a840cd7803fecb3871e8a4016f538d5a15c537592d3de0575664f3e97f9ff053c0f8adfdb0d05a4e3f9bd82f3bfce19359a3e7c6811ea3b618f77216299069e78205eede85708d81e8f898389a4a468231e393ecb01904aa7acfea191503c76727707f88fc0097246a27bf3d23c950d3480b47380e220e7c2213ee31cdd4fe35e2b22030ef97e133d0ab817b0eda6b7c41ee110451c743c663b519da119cf189e802171a2475d0a494bbd4850839737632ec81173397a26568d1c2ef39ce8802e6a0b6dcf16bc167bb3b2bd657bb3553d67d7bb672caccd970433a87ca3b76df805852ed4bd23082e9383c0237260120df894629b59de9f8010913176d048ed89be364f75220f7299141323e4f423a3e618a12457362e64dda59a9f72bca71af05d4e20288fb5bacac9c47f0e6a40b1ebba3e00a45814c905460444e14530d543da8388a029a0e1e9c74f35f152cfc8646e8904ef1d21a5c3a41833ddaf81a8fb3a84f4bfe65d7aad95fb3ff5b66ffd3f17399f935416b823e0141bf1e8d96095cf3e847e2d17763cd651ad6e62c326755ad2c6bf70753cbd7dbceb222ff9afd6c8eba799f6d810714b7ab6531f4363df2227c8c3b39900308c55ebb0309060e5c8376e10039b97febed231751992a32fc74d91d3339e9f776c7cf242ecc775d484390197e04bd6076c6614e3c56653a6b520bfd99691fa38e7047fc3fed838c108bfe258b33ef61664886170d8c62e91108dc11c9a8829b6411ff4027110e51f40e15a193952dca3b6db2f5f8c2283c9fb38d820e51b4bf573d2fb6355246579bcaf148bd05926cd3e37d0354dba0a83ada908f5fbc50e1a993dcb2b179acc4ce964a3c5ce83063e5ed775eada759e2047105023818add56cc16949335df189ca9a115fd435f8fe4bcad4a51de4b5f538666d56ebac7195beec07f0ef760b3573682d6da0ada17fef3cf7bf34492ecc2d8d38c0c28830697eb103bf6271b1a4826ae938733a3db7f70647d38bb10f6b4fdbea34ba48a3c52729751eadf3689d47eb3c5ae7d13a8fd6bdd5f63961e3eb137552a893429d14eaa4f0bd26853aa455b9da57c7b43aa6d531eddb8b69dfbb5f56b8aba076ccda31bf7dc7fc11885c7eaf45cde41f9fc94f69f575f797d4667f1ab3ff43fd69fd1d374fa7d96d70b7bceb661851c75ced1b88280ec8e39bee06927a9c7027e9c2f1889f1347cf9ec091e20671131892091d716b7c48051c71fbaccb132b7cc4e777086177bc96504fc6a623f84a6c1af1a98d975578b9b06e4e01975f64f5bee05a12c65d532b3cb2792f08a8f412d0029c8028b56f9e6383dd21453be79e6c42d50ba5f630d3e3d2774c2723fe0c8790d8667636013fc15e5f516e8e3c50355ae01efa97b921cb8acdcf9f2a65c5cf8ab23fb0fa403d2b215d2a733f8624e0312a2b7d4a2db7a229788070cd6e9840f83ddca3402fc0aa091c61db17f099d242165dfcdd28fbad57d3960f908d1fcd4719322edabf2c07348366cfa1dd199b8caf2cdcb2ed0b0f62a864225ee20827919f04e49e29e42af67f82ba3424237e2deed16034c2564ea2098053470aeb05233ed4f40ec9b0f78bf0b94263a884bb528448ab338efea2ccb5133b25f28ddd70c6c0841e2d22ca99c1f671f48dc87cd3f324e17160bfb24b9cd3f876f6e32545fbcf3ebca1218a61c8d4e33434df0c53f6e0a43e6a1a99e2b238442e4d26cc61010a95a105fa9d943e2505e9347dfc30a79c93e9681481c458beec7f1021eec7b8f52f4432e5f87b6fa8bcf7290b314ac8a92146fc03f1184f378e10e698ec8a281f77797edd80def01a6840ef8c3cb3787b96f18b745b956ab58c31cb99941d9ce3e182059b80ccc7e63056b3a71cf3faf4320fb68a6ee5504b33c7c3d9ccbcb04b74dc40c4e5197979a784dc40bed9c8dcfc421a6f106b16d3c68b6939e4930cfdd783cd47e6e6cf895d0eb0183a3d6daa834f36f82cc7e63afad4d1a78e3e7f59f4f9f6dcab4a35fa372ad05c1e080956d5c24b726a7c4382c95ec026e6c8b1f91c7c114bec930e9a87e95bd8b56dddc1e1b3c6885f50dc2216e62aecc205c2a36f1e41ffd7013c3fc4ae2fe6b75c7c460d9fde3b92a6dde97b2c9b894c20923858326c5377df47a6a169b75affc2198e4fb847dd6706dbbc4768fb6726a67f96627a17acc35cb312e33e760a5a814383003e137c0963077d28d218298c636b9f4e83c4968d586fde848c87d33609ffd1f29afc2dcdab7338e2d8f53a46245c6d7fd173edc62a468913dcead9883393ea42db46e24fe6e657dbc367a74ab3158ddd11ceb81af1f947d815d25ecaa5137b768bd80e6e063bc8147df8138a9070ec1c713c86517b7166a1b145bb850ef01e87ce253427cbefafcf407063266e43a5d2c8776771e08cf81fdb238e3db34b34badec70e66c85408ecaf50675234e026d65640f44a37231b8e3e58337a3130b33323d36b29e2087aa0ccf52e8816d7b9207f14eec6a6b385d3264c084520e3e11f9f575971ba12a731069db26c8afe6d2534d67f2d490803912ad44c7b273d4bea3411216a73b69d061c37a0df80d73bb6b89a712eb12353b79fc3ae401acc04a415303e300cf604d566375b5d08f45fc6051217bc22948fed129853e309f6020942cc0c570074b52d0e26b22af25c0c87bd0adab8b82a9c562675bfb75771e6506301d684d3b448c2bc5da4b4b3b2e59bf01bc5c451acab3211ce9b109a8b5b58c798bf61b489d5ac835c528f180751cb80974df01010339fa085a42edb0f02609e66363c146ba4d48e42927b0c96041c0c7028c90a3a96e1bc699ad014c494ff51c93d318a9923b00a33df06f44631b30555c5ada70bef2f60e074787cfe5315977c84f476d0af04647dfbc616032ac22a2d8cfad814781518520815892a11073b62f3f04ab19a379d0c581639f6d26f9108a5d16a480274c195c62e9fef33affaec81149a62b80d992437ac9aa3cc30eee2c033657b350873c70ac7361d54d4ac600df47afc60295a0c501a484d6591b20a2692c6dc6545be5b9a0e32302e33e7c371a5b09e81a9b69f1e3a09128b6079502588f41cc6a95e2f42992e068ac6ee540842656ccb0c5201e83896b7be085cf3381d16c21171581598a1a658344a11f953a1b0fbc106de47de5781fb158d8be527013a2d5cccf50ea708a9cc56af2441ea2bcb5e1d07449ae995a2c9b18c9d354e503aff9c7a4cac73a3529b136c38626911c218d56b3abf2ad997d0d09a26366d0176a349913796eee703bb914c98d0c4d9843985bef808e48229e79143a63756589148b14b9517a609b6ba18a9c3456352545894e25c31e7966aadd89708927ab6396222771b16da3d4e4ce67d5cf599669f8b30710a2bc872d25a51042600acfb25f156e4a152ea497a8799c8328f06f83537456db14796d16fe511dcb67bcb02edda1b0c6668cf2a88f52a5619c3d943550c66b25a9f3430f79eaac52da8b15ae1f328d5a7c7072ef5b9c93fe3dc64dbdb60281df7022576f29799e6aa87dd0bc2f8b3aa07b0c548651729e673c6d3390f9f1e1e1efe0f22e05c62', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138378, 2292, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c3d8ccb0dc3200c8657f9074825720d13f4d4ae80c02448184b8e89e8f6253df4fc3d56e71cef78bf30568f67cbb2218ba2b44cd18ab413921149af321674253b342cd0093b7ba41e2a4c291853b35f198f1af893ca04511effcf9d084f2b51fa022b4a29d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138379, 2292, 500.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c333530c84d5708f05770f27451a83032504849ac2c06003bda05e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138380, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c4d8d3b0e83301044af321788b08d684c95888602912b385a63ac000bb2c3e7f631a2a19c377a3339467e488583352a0e562317a3cbbe2e237320fcc28c770bf2ab274b58a4eab14b815486128dd935a410a7914889e71035549132a2f99ce6abae6e423d75e9c7f9d55ed39b8f3d3a66fa03da7a29dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138381, 2292, 250.0, 500.0, 'mg', 'PO', 2, 'Pediatric', X'789c1dca310a80201406e0abfc0728d0c2a5a0215a9aea0a96cf7048432d7ab74f5a3fbe41b6e0d0610a893a344ad44a88f340d61bd605e33ce155b514309a538fd9db924dc915cc1d7576c1e3d1d151c2c670ded2fe5be6ab94440f4597f90311982113', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138382, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c4dcc3d0e83301403e0abf8021549104b985ab13020b842d00b216ae92b4af8bb3d412c1d6debb3c2c48f0207a3e260357231b9eced323207c2127ee85a905f3d59c22cd5885d0aa4319468ccae2185b8446a4a3c3f51431529239afe92afbafa03f577600de7577b5f6f3e8e1898e904a24d2974', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138383, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c558d3d0e84201844af32173002c62db072636361f40a6c3e44b22a1af0eff68bd9ca72dee4cdbc122e703989ca792d91b1c9a45f9392bae037bfa06b4176b7a4092b1703ce3ce10cb1f6051a754a70c66e279202e51824441e3382fadceebbae1e4a3df7f1cbd85dffe70f1b06f4ced10fe08b29a8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138384, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c4d8d410e82301045aff22f6068216eca0ac38685c1c413a01d4a23ed202d08b7b7c48dcbf9f3df7f051c9f648e9d156a0ea4500867b297c974b7232c61c2ad85b6abd5a4f196f9804d0aa4672871ed360529c441a4a444354685fc9c6ec4ee719097a6fe031adf278fe788999eec1cf96375a2194d7daf60966419ada7543576a59fff63e3809e597f01dbd3371d', X'789ced5c6d6fdb3812fe2b830007a458c7b19da6c53a87031c276db34d52234e8bee9d0b839168891b89d492541aed22fffd86945f2447b66c35db6dbbfa50d72fe4c3e1cc336f94943f775c197b634e42bad3859d3e9dc452dc33fcd4809d5806e64b5feb4875f7f73fb35b1a3685f4cc3bb69f1fab1c4922ea8e8936533aadce8bbd567bafddba6ebdec1eb6baad4eb3d3faf9f98b97762c7534135ce1c83f775e534e2509ec7b4defedf4eb24a25de870173cfbab193de20e8d7c12081509c9f0e38950c4a3f04ac8507541939b80ea0644e2b34b254c8404c67f4b179a8f1d6a49b9a7fdd9705ce3b0157a0d386ce17f478593bbf0321dd36e1ee2ebcbf4d5bc743a87de885f8958530562023d37649c299dcadb85c1bb069c7dc07f1723de176128385c4be252b8446da3c8a840cd7803fecb3871e8a4016f538d5a15c537592d3de0575664f3e97f9ff053c0f8adfdb0d05a4e3f9bd82f3bfce19359a3e7c6811ea3b618f77216299069e78205eede85708d81e8f898389a4a468231e393ecb01904aa7acfea191503c76727707f88fc0097246a27bf3d23c950d3480b47380e220e7c2213ee31cdd4fe35e2b22030ef97e133d0ab817b0eda6b7c41ee110451c743c663b519da119cf189e802171a2475d0a494bbd4850839737632ec81173397a26568d1c2ef39ce8802e6a0b6dcf16bc167bb3b2bd657bb3553d67d7bb672caccd970433a87ca3b76df805852ed4bd23082e9383c0237260120df894629b59de9f8010913176d048ed89be364f75220f7299141323e4f423a3e618a12457362e64dda59a9f72bca71af05d4e20288fb5bacac9c47f0e6a40b1ebba3e00a45814c905460444e14530d543da8388a029a0e1e9c74f35f152cfc8646e8904ef1d21a5c3a41833ddaf81a8fb3a84f4bfe65d7aad95fb3ff5b66ffd3f17399f935416b823e0141bf1e8d96095cf3e847e2d17763cd651ad6e62c326755ad2c6bf70753cbd7dbceb222ff9afd6c8eba799f6d810714b7ab6531f4363df2227c8c3b39900308c55ebb0309060e5c8376e10039b97febed231751992a32fc74d91d3339e9f776c7cf242ecc775d484390197e04bd6076c6614e3c56653a6b520bfd99691fa38e7047fc3fed838c108bfe258b33ef61664886170d8c62e91108dc11c9a8829b6411ff4027110e51f40e15a193952dca3b6db2f5f8c2283c9fb38d820e51b4bf573d2fb6355246579bcaf148bd05926cd3e37d0354dba0a83ada908f5fbc50e1a993dcb2b179acc4ce964a3c5ce83063e5ed775eada759e2047105023818add56cc16949335df189ca9a115fd435f8fe4bcad4a51de4b5f538666d56ebac7195beec07f0ef760b3573682d6da0ada17fef3cf7bf34492ecc2d8d38c0c28830697eb103bf6271b1a4826ae938733a3db7f70647d38bb10f6b4fdbea34ba48a3c52729751eadf3689d47eb3c5ae7d13a8fd6bdd5f63961e3eb137552a893429d14eaa4f0bd26853aa455b9da57c7b43aa6d531eddb8b69dfbb5f56b8aba076ccda31bf7dc7fc11885c7eaf45cde41f9fc94f69f575f797d4667f1ab3ff43fd69fd1d374fa7d96d70b7bceb661851c75ced1b88280ec8e39bee06927a9c7027e9c2f1889f1347cf9ec091e20671131892091d716b7c48051c71fbaccb132b7cc4e777086177bc96504fc6a623f84a6c1af1a98d975578b9b06e4e01975f64f5bee05a12c65d532b3cb2792f08a8f412d0029c8028b56f9e6383dd21453be79e6c42d50ba5f630d3e3d2774c2723fe0c8790d8667636013fc15e5f516e8e3c50355ae01efa97b921cb8acdcf9f2a65c5cf8ab23fb0fa403d2b215d2a733f8624e0312a2b7d4a2db7a229788070cd6e9840f83ddca3402fc0aa091c61db17f099d242165dfcdd28fbad57d3960f908d1fcd4719322edabf2c07348366cfa1dd199b8caf2cdcb2ed0b0f62a864225ee20827919f04e49e29e42af67f82ba3424237e2deed16034c2564ea2098053470aeb05233ed4f40ec9b0f78bf0b94263a884bb528448ab338efea2ccb5133b25f28ddd70c6c0841e2d22ca99c1f671f48dc87cd3f324e17160bfb24b9cd3f876f6e32545fbcf3ebca1218a61c8d4e33434df0c53f6e0a43e6a1a99e2b238442e4d26cc61010a95a105fa9d943e2505e9347dfc30a79c93e9681481c458beec7f1021eec7b8f52f4432e5f87b6fa8bcf7290b314ac8a92146fc03f1184f378e10e698ec8a281f77797edd80def01a6840ef8c3cb3787b96f18b745b956ab58c31cb99941d9ce3e182059b80ccc7e63056b3a71cf3faf4320fb68a6ee5504b33c7c3d9ccbcb04b74dc40c4e5197979a784dc40bed9c8dcfc421a6f106b16d3c68b6939e4930cfdd783cd47e6e6cf895d0eb0183a3d6daa834f36f82cc7e63afad4d1a78e3e7f59f4f9f6dcab4a35fa372ad05c1e080956d5c24b726a7c4382c95ec026e6c8b1f91c7c114bec930e9a87e95bd8b56dddc1e1b3c6885f50dc2216e62aecc205c2a36f1e41ffd7013c3fc4ae2fe6b75c7c460d9fde3b92a6dde97b2c9b894c20923858326c5377df47a6a169b75affc2198e4fb847dd6706dbbc4768fb6726a67f96627a17acc35cb312e33e760a5a814383003e137c0963077d28d218298c636b9f4e83c4968d586fde848c87d33609ffd1f29afc2dcdab7338e2d8f53a46245c6d7fd173edc62a468913dcead9883393ea42db46e24fe6e657dbc367a74ab3158ddd11ceb81af1f947d815d25ecaa5137b768bd80e6e063bc8147df8138a9070ec1c713c86517b7166a1b145bb850ef01e87ce253427cbefafcf407063266e43a5d2c8776771e08cf81fdb238e3db34b34badec70e66c85408ecaf50675234e026d65640f44a37231b8e3e58337a3130b33323d36b29e2087aa0ccf52e8816d7b9207f14eec6a6b385d3264c084520e3e11f9f575971ba12a731069db26c8afe6d2534d67f2d490803912ad44c7b273d4bea3411216a73b69d061c37a0df80d73bb6b89a712eb12353b79fc3ae401acc04a415303e300cf604d566375b5d08f45fc6051217bc22948fed129853e309f6020942cc0c570074b52d0e26b22af25c0c87bd0adab8b82a9c562675bfb75771e6506301d684d3b448c2bc5da4b4b3b2e59bf01bc5c451acab3211ce9b109a8b5b58c798bf61b489d5ac835c528f180751cb80974df01010339fa085a42edb0f02609e66363c146ba4d48e42927b0c96041c0c7028c90a3a96e1bc699ad014c494ff51c93d318a9923b00a33df06f44631b30555c5ada70bef2f60e074787cfe5315977c84f476d0af04647dfbc616032ac22a2d8cfad814781518520815892a11073b62f3f04ab19a379d0c581639f6d26f9108a5d16a480274c195c62e9fef33affaec81149a62b80d992437ac9aa3cc30eee2c033657b350873c70ac7361d54d4ac600df47afc60295a0c501a484d6591b20a2692c6dc6545be5b9a0e32302e33e7c371a5b09e81a9b69f1e3a09128b6079502588f41cc6a95e2f42992e068ac6ee540842656ccb0c5201e83896b7be085cf3381d16c21171581598a1a658344a11f953a1b0fbc106de47de5781fb158d8be527013a2d5cccf50ea708a9cc56af2441ea2bcb5e1d07449ae995a2c9b18c9d354e503aff9c7a4cac73a3529b136c38626911c218d56b3abf2ad997d0d09a26366d0176a349913796eee703bb914c98d0c4d9843985bef808e48229e79143a63756589148b14b9517a609b6ba18a9c3456352545894e25c31e7966aadd89708927ab6396222771b16da3d4e4ce67d5cf599669f8b30710a2bc872d25a51042600acfb25f156e4a152ea497a8799c8328f06f83537456db14796d16fe511dcb67bcb02edda1b0c6668cf2a88f52a5619c3d943550c66b25a9f3430f79eaac52da8b15ae1f328d5a7c7072ef5b9c93fe3dc64dbdb60281df7022576f29799e6aa87dd0bc2f8b3aa07b0c548651729e673c6d3390f9f1e1e1efe0f22e05c62', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138385, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Pediatric', X'789c0dca410a80201005d0abfc2368d1a62028dcb82ae804d64c22a4861ae4edebaddf285bd4d843c5cc3d9a4e788b6276ac0b66adf04a0132350fd0e1fc5b8805898fe83d0762c2cd095a6d13ece3882f17387ff9991a4a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138386, 2292, 20.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c158c4d0e40301406aff25d40fa2336b5b5b110ae2079558dd423a5f4f66a3b93991a812ba591d9a0e3680db40c4e6c4ed09c11ef78601a413e79b28453e915af922832b618e6d7a0917f50408b7e5fcac6f964f1f86bc5c24c1fb16f1eb5', X'789ced5c6d6fdb3812fe2b830007a458c7b19da6c53a87031c276db34d52234e8bee9d0b839168891b89d492541aed22fffd86945f2447b66c35db6dbbfa50d72fe4c3e1cc336f94943f775c197b634e42bad3859d3e9dc452dc33fcd4809d5806e64b5feb4875f7f73fb35b1a3685f4cc3bb69f1fab1c4922ea8e8936533aadce8bbd567bafddba6ebdec1eb6baad4eb3d3faf9f98b97762c7534135ce1c83f775e534e2509ec7b4defedf4eb24a25de870173cfbab193de20e8d7c12081509c9f0e38950c4a3f04ac8507541939b80ea0644e2b34b254c8404c67f4b179a8f1d6a49b9a7fdd9705ce3b0157a0d386ce17f478593bbf0321dd36e1ee2ebcbf4d5bc743a87de885f8958530562023d37649c299dcadb85c1bb069c7dc07f1723de176128385c4be252b8446da3c8a840cd7803fecb3871e8a4016f538d5a15c537592d3de0575664f3e97f9ff053c0f8adfdb0d05a4e3f9bd82f3bfce19359a3e7c6811ea3b618f77216299069e78205eede85708d81e8f898389a4a468231e393ecb01904aa7acfea191503c76727707f88fc0097246a27bf3d23c950d3480b47380e220e7c2213ee31cdd4fe35e2b22030ef97e133d0ab817b0eda6b7c41ee110451c743c663b519da119cf189e802171a2475d0a494bbd4850839737632ec81173397a26568d1c2ef39ce8802e6a0b6dcf16bc167bb3b2bd657bb3553d67d7bb672caccd970433a87ca3b76df805852ed4bd23082e9383c0237260120df894629b59de9f8010913176d048ed89be364f75220f7299141323e4f423a3e618a12457362e64dda59a9f72bca71af05d4e20288fb5bacac9c47f0e6a40b1ebba3e00a45814c905460444e14530d543da8388a029a0e1e9c74f35f152cfc8646e8904ef1d21a5c3a41833ddaf81a8fb3a84f4bfe65d7aad95fb3ff5b66ffd3f17399f935416b823e0141bf1e8d96095cf3e847e2d17763cd651ad6e62c326755ad2c6bf70753cbd7dbceb222ff9afd6c8eba799f6d810714b7ab6531f4363df2227c8c3b39900308c55ebb0309060e5c8376e10039b97febed231751992a32fc74d91d3339e9f776c7cf242ecc775d484390197e04bd6076c6614e3c56653a6b520bfd99691fa38e7047fc3fed838c108bfe258b33ef61664886170d8c62e91108dc11c9a8829b6411ff4027110e51f40e15a193952dca3b6db2f5f8c2283c9fb38d820e51b4bf573d2fb6355246579bcaf148bd05926cd3e37d0354dba0a83ada908f5fbc50e1a993dcb2b179acc4ce964a3c5ce83063e5ed775eada759e2047105023818add56cc16949335df189ca9a115fd435f8fe4bcad4a51de4b5f538666d56ebac7195beec07f0ef760b3573682d6da0ada17fef3cf7bf34492ecc2d8d38c0c28830697eb103bf6271b1a4826ae938733a3db7f70647d38bb10f6b4fdbea34ba48a3c52729751eadf3689d47eb3c5ae7d13a8fd6bdd5f63961e3eb137552a893429d14eaa4f0bd26853aa455b9da57c7b43aa6d531eddb8b69dfbb5f56b8aba076ccda31bf7dc7fc11885c7eaf45cde41f9fc94f69f575f797d4667f1ab3ff43fd69fd1d374fa7d96d70b7bceb661851c75ced1b88280ec8e39bee06927a9c7027e9c2f1889f1347cf9ec091e20671131892091d716b7c48051c71fbaccb132b7cc4e777086177bc96504fc6a623f84a6c1af1a98d975578b9b06e4e01975f64f5bee05a12c65d532b3cb2792f08a8f412d0029c8028b56f9e6383dd21453be79e6c42d50ba5f630d3e3d2774c2723fe0c8790d8667636013fc15e5f516e8e3c50355ae01efa97b921cb8acdcf9f2a65c5cf8ab23fb0fa403d2b215d2a733f8624e0312a2b7d4a2db7a229788070cd6e9840f83ddca3402fc0aa091c61db17f099d242165dfcdd28fbad57d3960f908d1fcd4719322edabf2c07348366cfa1dd199b8caf2cdcb2ed0b0f62a864225ee20827919f04e49e29e42af67f82ba3424237e2deed16034c2564ea2098053470aeb05233ed4f40ec9b0f78bf0b94263a884bb528448ab338efea2ccb5133b25f28ddd70c6c0841e2d22ca99c1f671f48dc87cd3f324e17160bfb24b9cd3f876f6e32545fbcf3ebca1218a61c8d4e33434df0c53f6e0a43e6a1a99e2b238442e4d26cc61010a95a105fa9d943e2505e9347dfc30a79c93e9681481c458beec7f1021eec7b8f52f4432e5f87b6fa8bcf7290b314ac8a92146fc03f1184f378e10e698ec8a281f77797edd80def01a6840ef8c3cb3787b96f18b745b956ab58c31cb99941d9ce3e182059b80ccc7e63056b3a71cf3faf4320fb68a6ee5504b33c7c3d9ccbcb04b74dc40c4e5197979a784dc40bed9c8dcfc421a6f106b16d3c68b6939e4930cfdd783cd47e6e6cf895d0eb0183a3d6daa834f36f82cc7e63afad4d1a78e3e7f59f4f9f6dcab4a35fa372ad05c1e080956d5c24b726a7c4382c95ec026e6c8b1f91c7c114bec930e9a87e95bd8b56dddc1e1b3c6885f50dc2216e62aecc205c2a36f1e41ffd7013c3fc4ae2fe6b75c7c460d9fde3b92a6dde97b2c9b894c20923858326c5377df47a6a169b75affc2198e4fb847dd6706dbbc4768fb6726a67f96627a17acc35cb312e33e760a5a814383003e137c0963077d28d218298c636b9f4e83c4968d586fde848c87d33609ffd1f29afc2dcdab7338e2d8f53a46245c6d7fd173edc62a468913dcead9883393ea42db46e24fe6e657dbc367a74ab3158ddd11ceb81af1f947d815d25ecaa5137b768bd80e6e063bc8147df8138a9070ec1c713c86517b7166a1b145bb850ef01e87ce253427cbefafcf407063266e43a5d2c8776771e08cf81fdb238e3db34b34badec70e66c85408ecaf50675234e026d65640f44a37231b8e3e58337a3130b33323d36b29e2087aa0ccf52e8816d7b9207f14eec6a6b385d3264c084520e3e11f9f575971ba12a731069db26c8afe6d2534d67f2d490803912ad44c7b273d4bea3411216a73b69d061c37a0df80d73bb6b89a712eb12353b79fc3ae401acc04a415303e300cf604d566375b5d08f45fc6051217bc22948fed129853e309f6020942cc0c570074b52d0e26b22af25c0c87bd0adab8b82a9c562675bfb75771e6506301d684d3b448c2bc5da4b4b3b2e59bf01bc5c451acab3211ce9b109a8b5b58c798bf61b489d5ac835c528f180751cb80974df01010339fa085a42edb0f02609e66363c146ba4d48e42927b0c96041c0c7028c90a3a96e1bc699ad014c494ff51c93d318a9923b00a33df06f44631b30555c5ada70bef2f60e074787cfe5315977c84f476d0af04647dfbc616032ac22a2d8cfad814781518520815892a11073b62f3f04ab19a379d0c581639f6d26f9108a5d16a480274c195c62e9fef33affaec81149a62b80d992437ac9aa3cc30eee2c033657b350873c70ac7361d54d4ac600df47afc60295a0c501a484d6591b20a2692c6dc6545be5b9a0e32302e33e7c371a5b09e81a9b69f1e3a09128b6079502588f41cc6a95e2f42992e068ac6ee540842656ccb0c5201e83896b7be085cf3381d16c21171581598a1a658344a11f953a1b0fbc106de47de5781fb158d8be527013a2d5cccf50ea708a9cc56af2441ea2bcb5e1d07449ae995a2c9b18c9d354e503aff9c7a4cac73a3529b136c38626911c218d56b3abf2ad997d0d09a26366d0176a349913796eee703bb914c98d0c4d9843985bef808e48229e79143a63756589148b14b9517a609b6ba18a9c3456352545894e25c31e7966aadd89708927ab6396222771b16da3d4e4ce67d5cf599669f8b30710a2bc872d25a51042600acfb25f156e4a152ea497a8799c8328f06f83537456db14796d16fe511dcb67bcb02edda1b0c6668cf2a88f52a5619c3d943550c66b25a9f3430f79eaac52da8b15ae1f328d5a7c7072ef5b9c93fe3dc64dbdb60281df7022576f29799e6aa87dd0bc2f8b3aa07b0c548651729e673c6d3390f9f1e1e1efe0f22e05c62', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138387, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Pediatric', X'789cb3333456a8ccb75270c92f4eb552303235c84d5728494c5208f05770f27451a83034504849ac2c0600d82f0b24', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138388, 2292, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Pediatric', X'789c15cc310e80200c46e1abfc07708015571727bd42c5a2244293528cc757e797efd12e17b7c8d55ac0248d03bc73ae1c30dab02e78fc88b9260948a2c83571b42cb5411222eb9d9f015dd94ea501fac55e46ec9d2e983259f9cebf7c013b1b2448', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138389, 2292, 500.0, 500.0, 'mg', 'PO', 2, 'Pediatric', X'789cb3333456a8ccb75270c92f4eb552303530c84d5728494c5208f05770f27451a83032504849ac2c0600d8090b23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138390, 2292, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c55ca4b0e40301405d0addc0510ea3369cd1898b185269e6ab45a1e12bb676a7a724af8908a024f90688fd6a111b984a8bdc9568371005f1cb117d5a2d07712c6de84293041cf271d98ac760f5b4eb085efc6e8c8d3762a8c5ffed10bacd72275', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138391, 2292, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c55ca4b0e40301405d0addc0510ea3369cd1898b185269e6ab45a1e12bb676a7a724af8908a024f90688fd6a111b984a8bdc9568371005f1cb117d5a2d07712c6de84293041cf271d98ac760f5b4eb085efc6e8c8d3762a8c5ffed10bacd72275', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138392, 11915, 200.0, 1000.0, 'mg', NULL, 1, 'Adult', X'789c15c6410a80300c04c0afec510f42f447c5ac5ad0a4a411f1f7e29c6611996611b97668a9e78b41bd13ca46d30e37ec34cfb711c514abdb7a47d012192c79fd7b6a1ea8968c8de1367eaf361e11', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138393, 11915, 15.0, 15.0, 'mg/kg', NULL, 1, 'Pediatric', X'789cf3482d5070b652b03352a84c4d2c2a56c8cf49b1523034cd4dd7cf4e574849cccca90400b15a0ab6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138394, 11915, 400.0, 1200.0, 'mg', NULL, 1, 'Pediatric', X'789c333130d035343230c84d574849cccca904002008048c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138395, 11915, 20.0, 20.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b0a0e53d0284e2d4b2d4a55484e2c4e2dd6b4523032c84dd7cfcd51484c2dca2fcecfc9ac4a4d51c807aa503034d235b450c8c82f2d2a56a85030d635574849ac2c0600f1f415e5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138396, 8041, 800.0, 800.0, 'mg', NULL, NULL, 'Adult', X'789cb3303050c84d57283434ca2852a850304d010027fb04ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138397, 224, 17.2, 17.2, 'mg', NULL, NULL, 'Adult', X'789c3334d733ca4d5730d4355228c9cc4d2d5628482d524849ac040051e20754', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138398, 224, 4.3, 4.3, 'mg', NULL, NULL, 'Pediatric', X'789c33d235abb45230d133ce4d5730d4355228c9cc4d2d5628482d524849ac0400725b0889', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138399, 224, 8.6, 8.6, 'mg', NULL, NULL, 'Pediatric', X'789c33d33534aab452b0d033cb4d5730d4355228c9cc4d2d5628482d524849ac040078be08c1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138400, 14102, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492d513032cd4dd75130350091e640b6b582a79f170027f30cd9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138401, 14102, 0.142, 0.142, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d033343152c84dd7cf4ed7cfcdcc53f00c53a8300132005153072d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138402, 14102, 75.0, 100.0, 'mg', 'PO', 4, 'Adult', X'789c3337d535343050c84d5708f05728cc4c01001f7f043c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138403, 14102, 100.0, 100.0, 'mg', 'PO', 4, 'Adult', X'789c3335b035343050c84d5708f05728cc4c01001ff40445', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138404, 14102, 50.0, 50.0, 'mg', 'PO', 3, 'Adult', X'789c333550c84d5708f05728c94c01001442037a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138405, 14102, 2.0, 5.0, 'mg/kg', 'PO', 3, 'Pediatric', X'789c33d23555c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128c94c010079680910', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138406, 3511, 1000.0, 1000.0, 'mg', 'IV', NULL, 'Adult', X'789c33343030c84d57f00cb356282e492c2a51482c5130cd4dd7cf4ed7cf28d251c8cc4b2e4a4d2c4e55282d5028c95730844b292416030572528b124b525314d2f28ba02a8c4c328a8a0193331c22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138407, 3511, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789c15cbbb0d80300c05c055de06a4611226c8c74496121b62bb607ba03edd11c5e80e12475323435e843da5d9c15217cd4f0c3db851437950070bd73c609e3d0c7ae2caceffdf108b855075e87a019b6c2032', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138408, 3511, 360.0, 360.0, 'mg/kg', NULL, NULL, 'Adult', X'789c0dcbd10980300c05c055de042a2a1dc40da48d3148124853707cbdff3ba8ba2a59a386537d58a28d10635c123db1ee77403ab6b228cf0fc33c910e7a2bfda5f0f401207216e0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138409, 3511, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c333455c84dd7cf4ed7cf50f00c030018e903b2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138410, 3511, 100.0, 100.0, 'mg', NULL, NULL, 'Pediatric', X'789c333430c84d5748494d4b2dcaaf48cccdcc4b5548ce48cd492c492d56b004caa415a5a62a6416e5e701002cb10ead', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138411, 994, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b6523035d051303400124620c2c4c020371d00ded20a64', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138412, 994, 200.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789cb352303230c84d5708f0570874010015400335', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138413, 994, 100.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789cb352303430d0353230c84d5708f05748ca4c0100258b048d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138414, 994, 200.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789cb352303230c84d5708f0570874010015400335', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138415, 994, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303130c84dd74f49ac04001ee70456', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138416, 994, 200.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789cb352303230c84d5708f05748ca4c0100195603cf', X'789ced58eb6fdb3610ff5708030312c08e1f9ddbd51d0ab84e1f1990c68b13a0c35408347996084ba44052a9b522fffb8e925f74b4daf5d6ae1ff2c5b0a8bbd3ddefdefcdce03a8f424953680c4863040930b510d3469334729db8b3d8dacc0cdaed4f620ee999d291fb27da1ea9619a66c0436a1d47afd37bdaea745bddce4de7d9a0df19749e9c759ff7fbbf3c2b698159a1a441cacf8d214f8514c66aeaceca230b8b52ca4d91c12090ef91d4825682d3845069454bc85942d3945aa50be2d437813c793f195e9c9f36c9e8ea43ab47264e392bee2090e7cad008c81ba55333208c66264f36c713ab414636c657fd4e93743bf8d3733f3f773a6914c86b955b3044cd88afe9808caf02395269aa24b9d19403798f18a21887cb54c3a234359f6e5b7b8f47964e13704f7f7ec4a744c879f9b031fb107bf77b675b4af8404a5849b9ffe8341af23cb121e22164e439e00a2528aa6dac851588f1c02193466839f9fd1ca1892177e204271e1162d85a134e050fe4ad0192a84f602c81d9ac720ce1ca4093985869ebbf408f509b82b484e715d80e686904074d8cc56fa1a2845a74d84fce314bc94e1e11339229a5c9e88f716ff49ca48070ab44fc053a9043392f92d24a6232257991d49a75491783cafb6d4e0b0c94c2a0324aeb18a8475c9a3671fa2ce9dde1a2db24292d48e42ca19c0ba73f3ab2e2c2584199a4ebf494001c50c2980ad92494619cfdd7c28f0d41dff1fb836d871ebfb191551725fb256eb8c27f905befcdfd92377ce1365f950a63e0825a2d585d3ad4a0d9b8924911ce940eb19698f065d80b0ba0da842ae11eef6ff91d4891608072a1326a63c1b693a68b19d327f3e8a3ab425b01f0b23c2d536a7ddaf03d787f9047bff8fdfda0add8c30dfbb65f4aecfe27288e89efef80c6240326b0f48e5596277413302b15c61a2249252bc8b53073f28632accb585eb0d491934c0bac615691271df209606e08426a4b29a75890c84990f77a4ffb356feb62f41ab046d405f4f0ce6565eecaa62406ee4003d18e988834a342bb1abc1b6df8f80ed0e6fa14295bc960148b84b7c679149351428d21af068403c3b26eaab2ef2af70bf2806c342074a5d251515e0bea7e7f9ebb09c8751a199950c8305b8959faf25f03b8eb911f0dc1efebd6c333b6d40b5b3fce5c4272c16af228c621511b90e6cce58b1b6bdacc7db5cd548ae5fd2c903e050e7f33ec99290e13586c869361205dde95d363207148e239735d991a1ba7b47a99e3c4c1a816d41d6742a3b3b14750a45a478a3797b8bc9c6f9212537af8ea2d7e594780031c6a8355c38111c8b717040dc7a683801f59cbd084039a1e1279ddb3b4f78029b224f3382b600ef86445e7f1ae81dccf7ebb26f524ec00f665196f2fc235f16ad4bd73b1105e03650f63a92e5527ce5bb94fb7a544e942f428f6bdd2d7ed3c616ed6bcbc0870fed66a8e4ec6c6a0d2a982d44da226ada9a8d51ae1c735504e598cecbc301964c645dfed358ac50965398bd22957b89360b9c1628361262906156ddfe1a15d02f4d525f47880b7dd7479b19f19693c9e0aaefd7c938acee3ad81f8cb426e76183c692becf78b79b7a2f4f8d71e3ba0f5ac493d09e8e80352e47a07c155641cf0d915a59fda5e3c1d90e22bfab0a4f764d5c4e29e52b3c3b01ca3be49faed26f963fe3de6df63fed5e5dfb7cb8c63669dc7c0f86102631c539d52a61215155e78bca3c9ac958819e0aade8d5d2d5edec19974e0aee57eee7702f97a816b43758d3a0306a649729caa8fd90e2e81c554a2f050cdc2217b70897c21633115d61056b044a94511e17e86abcac9e8eac369abf702171730442a4b68790159de1f77c9098ef1360677a99de3204a98920ce4f2eed79c36cb97302d560b909bfcb109a5e57b7729996985e37f9450cc0adc0d0b6c4360aacb85afb47002100e13a33cb3cac1dc2cf716dc6b1682095b1c7de55c4a3b701d30359b84a7c10132c235fd6ac39e219c08b1dfe97f7d9d298698bb00b9cd6ed439fe7df9b510dedfff0df2386a02', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138417, 994, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2ab152303130c84d5708f057a830d451c84dac5448cf2c4b55484c49c92cc9cccf4bcc5130022bc8cf5348014a1a2a64a629e4a5a6a6a4a6000092651496', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138418, 994, 200.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789c0b48ccccd351484c2e2d49b552303230c84d5708f05748ca4c0100666107b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138419, 994, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2ab152303130c84d5708f057a830d451c84dac5448cf2c4b55484c49c92cc9cccf4bcc5130022bc8cf5348014a1a2a64a629e4a5a6a6a4a6000092651496', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138420, 994, 50.0, 50.0, 'mg', 'PO', 2, 'Pediatric', X'789c3334d0353255c84e8fb5523035c84d5708f05748ca4c01003dec05e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138421, 994, 100.0, 100.0, 'mg', 'PO', 2, 'Pediatric', X'789cb3333255c84eb752303430c84d5708f05748ca4c010034710565', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138422, 3826, 0.125, 0.125, 'mg', 'SL', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6520871745230d0333432cd4db75608f601f1ad10029e7e5e209ea9426eba7eae8fb5824b517e4131441a22040047d91505', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138423, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138424, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138425, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138426, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138427, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138428, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'789ced5bfb6fdb3610fe570803c35accefc4e9ea0e059ca46d3c244d904731602e0446bac85c245223a9d46a91ff7d47ca2fc94ee52476d3aefac912750fdef1bb8fa4447fa97832f61d4e43a87449e52011ca4d68c83854aaa412cbc0b40eb58e54b7d1f8c4ae21ac0be99b2bd6c8092b57d2083c876aa3d36eb6776acd56add53c6fbee8763adde656fde54eabd96c5a597035135ca1e4974acf43134c69494d9b6dd230b256ce9308ba03dee39ab94311a027e93377c0f785a23e90b74286aa4bce7bbba4596fb53ba1ff8a9c1d9afbeeaca1fffe4f73d721a1df080f5f917d2922953e4e9b06fc54c41a14115724db972e399634a812155fa26f3f36d7fda346ffc380ef8930149c9c4bea01798fe9c37e1cc28d62dcc6175fce87788b4d9a5e0660eefefe887768eedadecc62cd05599cffbcc2ed47e3a7e7c581763041d8e14c2e97f4abf2aeef6004ae765444559811b709aa35eb364be4e4b88189fd777b4822c907fc888ebaa495e6d4a349251b9fe9c66e403d0fe4fa0df777cfaa0ef5fe8939765b8fd669fae4627f63a6a9bc665c09feab723ca6802ad894ab5d16302a13c74564b89b72720a9c061b7631c44ad44cadd3e63ea33e170aebc689a470c18b25e41d58fbc81ce46caf618b9d8c5a4b4cf538283d04c5e824fe8c9d4ee8fa8deb222367b1f401c76a998509431154c6f09668efa5c5af3448c493236e407a4241c6ca3b760348765b18d3ced8d8959004a83b34a4586b9b460e2627be6172820fa361a2a60d79bf5fe132dba935524a9ead4a4e2939a5e4949f9053d657f8794a292bbfacfcb2f2bfdfca5f677de66bbf2cd0b240cb027d6481aeb388160ab4aca2b28a7e8e2ada20d21776d125d44ba83fe15e6e23f0cb83bcc45f89bfe5f8db043216d05742e38784c63a862d8f8572dc363e6e8f49717eb8ca1c2fcff1c3f292cfeeff3031f70c299f91ef32a66fd6a9d5cf49a4db24f018d512eb7cc5f30d7be934cff815e59a05d908fe68934454c9567dbbb65d7f49aefd01df269e3d1d72723ce3f8b158a7b63316eadc2df4a2f6722cb473b7d0eb56d38afcbe20f2957314423a5ff9b2daaeb55a687bc09bf5e68ea5bad6d2f9aad5fe6d2c76e7a4b6d2bce3b433ee5fb7ad553456c88e85d0fbf146ecaecfd43fcb903d49bcc5f3f6e6027eacaf7bb2de59042ec33dcb8988e280ce429e783b91e073cadd849ce2538e38ed92bd013fc471b0d24432758d4d34b677d4bb610abcbb77cd4bb8d51e2a5b3031e053425e6a3e87c90388a85ecedd8fb7bfd211bb7ca68acfd8ed9bd391d144cd71a9065f48865e6ee776936b8b283f204f95b2cd8cd73d71bf27b89694718fb94b50df0b02907e42b4206e40956a9883ac03fe2ea0b12b428a577d222e9596b1f568961f389dc46ac0fb5c63fd321c3842b5e009619c40800c162424d2287011b8600e80e202c7bc27c01de1801f4f4c61638c9300d5c304e395b89c314922c32402a9f181693eeaa311ae6c70c4a5d263e2862a17ab5712236f7ad18bd1b7085195c3cce0b918614b083e45cfc2ec30136ab886334a7c4931950f3d5eba185431fa673ace44077dcd6c1ef58b6da04c46271761b101abe0cc14b23d58969e820e4d559cb1cae4e02c2e7371b57b8a4bd845b82dddcd806422cec192538440404706340740350eb814d780b03b3e41a4b9d2bcdc47e4a8c41d6261a15495d0fcf9e6031a04b18b104d9d2dd90ad9e3c719cf7f810123c89021f8f765422001552597412c25780403455b5512269e64141d57899bb8818802f08dc6854477a8254103376eab03eea273cd22db8b8169e0345640ede50d62379d6db04eafe2d4380b23ca8cb7104221932a8191cb348468b18a389737982e9c3c31e873dc2724b6345273110d2296ce57a638f890e152cbf6f22a88d5d03a3a14ca1ed2d6388060b3eba115b0fafbecf367969aee69ccbecd81f8a46c5b957c027a9d5e99cf2c2137cfdf020e388e4b18090cd9852a09a653a68a23647da56ce01712878762d61e34e9cc21629533dd33e10cd0e7a0b4c2c97c1476c6c2192b53d415db988966fbb180cc82ae64e533b6e6e1556c696f5e3a63274565b185f7a95c467702e362ed0f13c92c9dcd70bc0295cd0967accca37f85a19997cea3c496c44a10492533fad32a5a61653415cd58488b6f05a0a772195d5b90c5aaa958463353a10573da5434a5fd6f49e28baf274a162f59bc64f192c54b167f1c8b974cfa544cfa90bd68491925653c39659c0ca90ced3b053fc910074e7657b5805d4197b46b5bf50e194af2ec45fafbe6d47ce50a9f0ff81120cc71b5a7c22e3964b672de8c706198fe6fd8b0079048b2103d060979b6d5ac759abf9098bb43ca7df09e3fe085d8111865f4e8882ba7e72efc5bbac735f505679f4111ea824e82f17a1449cc85480b79cfb747b836bafd0f1ff115c3', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138429, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138430, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138431, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138432, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138433, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138434, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138435, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138436, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138437, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Adult', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138438, 3826, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230d43355c84dd74f49ac040021d40476', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138439, 3826, 0.25, 0.5, 'mg', 'SC', NULL, 'Adult', X'789c33d03332d535d033cd4d570876d6f7f4d5f70c53a83004003a72056c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138440, 3826, 5.0, 5.0, 'mcg/kg', 'SC', NULL, 'Adult', X'789c33cd4d4ed7cf4e570876d6f7f4d5f70c53a8300400399e0580', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138441, 3826, 0.125, 0.125, 'mg', 'IV', NULL, 'Adult', X'789c33d033343255c84d57f00c532828ca03001c32041a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138442, 3826, 0.3, 0.6, 'mg', 'IV', NULL, 'Adult', X'789c73cf2c4b5530d033d635d03353c84d57f00c5348cb2f52484d4cce000a9bea1a8104f352f38b4b32d37333f352158092051995c570010079421545', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138443, 3826, 0.0625, 0.125, 'mg', 'PO', NULL, 'Pediatric', X'789c33d033303332d535d033343255c84d5708f0d70ff6512834c9502828ca03006115076d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138444, 3826, 0.125, 0.25, 'mg', 'PO', NULL, 'Pediatric', X'789c33d0333432d535d0333255c84d5708f0d70ff6512834c9502828ca030055ce0707', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138445, 3826, 5.0, 5.0, 'mcg/kg', 'SC', NULL, 'Pediatric', X'789c3355c84d4ed7cf4e570876d6f7f4d5f70c53a83004003c3405a0', X'789ced5bfb6fdb3610fe570803c35accefc4e9ea0e059ca46d3c244d904731602e0446bac85c245223a9d46a91ff7d47ca2fc94ee52476d3aefac912750fdef1bb8fa4447fa97832f61d4e43a87449e52011ca4d68c83854aaa412cbc0b40eb58e54b7d1f8c4ae21ac0be99b2bd6c8092b57d2083c876aa3d36eb6776acd56add53c6fbee8763adde656fde54eabd96c5a597035135ca1e4974acf43134c69494d9b6dd230b256ce9308ba03dee39ab94311a027e93377c0f785a23e90b74286aa4bce7bbba4596fb53ba1ff8a9c1d9afbeeaca1fffe4f73d721a1df080f5f917d2922953e4e9b06fc54c41a14115724db972e399634a812155fa26f3f36d7fda346ffc380ef8930149c9c4bea01798fe9c37e1cc28d62dcc6175fce87788b4d9a5e0660eefefe887768eedadecc62cd05599cffbcc2ed47e3a7e7c581763041d8e14c2e97f4abf2aeef6004ae765444559811b709aa35eb364be4e4b88189fd777b4822c907fc888ebaa495e6d4a349251b9fe9c66e403d0fe4fa0df777cfaa0ef5fe8939765b8fd669fae4627f63a6a9bc665c09feab723ca6802ad894ab5d16302a13c74564b89b72720a9c061b7631c44ad44cadd3e63ea33e170aebc689a470c18b25e41d58fbc81ce46caf618b9d8c5a4b4cf538283d04c5e824fe8c9d4ee8fa8deb222367b1f401c76a998509431154c6f09668efa5c5af3448c493236e407a4241c6ca3b760348765b18d3ced8d8959004a83b34a4586b9b460e2627be6172820fa361a2a60d79bf5fe132dba935524a9ead4a4e2939a5e4949f9053d657f8794a292bbfacfcb2f2bfdfca5f677de66bbf2cd0b240cb027d6481aeb388160ab4aca2b28a7e8e2ada20d21776d125d44ba83fe15e6e23f0cb83bcc45f89bfe5f8db043216d05742e38784c63a862d8f8572dc363e6e8f49717eb8ca1c2fcff1c3f292cfeeff3031f70c299f91ef32a66fd6a9d5cf49a4db24f018d512eb7cc5f30d7be934cff815e59a05d908fe68934454c9567dbbb65d7f49aefd01df269e3d1d72723ce3f8b158a7b63316eadc2df4a2f6722cb473b7d0eb56d38afcbe20f2957314423a5ff9b2daaeb55a687bc09bf5e68ea5bad6d2f9aad5fe6d2c76e7a4b6d2bce3b433ee5fb7ad553456c88e85d0fbf146ecaecfd43fcb903d49bcc5f3f6e6027eacaf7bb2de59042ec33dcb8988e280ce429e783b91e073cadd849ce2538e38ed92bd013fc471b0d24432758d4d34b677d4bb610abcbb77cd4bb8d51e2a5b3031e053425e6a3e87c90388a85ecedd8fb7bfd211bb7ca68acfd8ed9bd391d144cd71a9065f48865e6ee776936b8b283f204f95b2cd8cd73d71bf27b89694718fb94b50df0b02907e42b4206e40956a9883ac03fe2ea0b12b428a577d222e9596b1f568961f389dc46ac0fb5c63fd321c3842b5e009619c40800c162424d2287011b8600e80e202c7bc27c01de1801f4f4c61638c9300d5c304e395b89c314922c32402a9f181693eeaa311ae6c70c4a5d263e2862a17ab5712236f7ad18bd1b7085195c3cce0b918614b083e45cfc2ec30136ab886334a7c4931950f3d5eba185431fa673ace44077dcd6c1ef58b6da04c46271761b101abe0cc14b23d58969e820e4d559cb1cae4e02c2e7371b57b8a4bd845b82dddcd806422cec192538440404706340740350eb814d780b03b3e41a4b9d2bcdc47e4a8c41d6261a15495d0fcf9e6031a04b18b104d9d2dd90ad9e3c719cf7f810123c89021f8f765422001552597412c25780403455b5512269e64141d57899bb8818802f08dc6854477a8254103376eab03eea273cd22db8b8169e0345640ede50d62379d6db04eafe2d4380b23ca8cb7104221932a8191cb348468b18a389737982e9c3c31e873dc2724b6345273110d2296ce57a638f890e152cbf6f22a88d5d03a3a14ca1ed2d6388060b3eba115b0fafbecf367969aee69ccbecd81f8a46c5b957c027a9d5e99cf2c2137cfdf020e388e4b18090cd9852a09a653a68a23647da56ce01712878762d61e34e9cc21629533dd33e10cd0e7a0b4c2c97c1476c6c2192b53d415db988966fbb180cc82ae64e533b6e6e1556c696f5e3a63274565b185f7a95c467702e362ed0f13c92c9dcd70bc0295cd0967accca37f85a19997cea3c496c44a10492533fad32a5a61653415cd58488b6f05a0a772195d5b90c5aaa958463353a10573da5434a5fd6f49e28baf274a162f59bc64f192c54b167f1c8b974cfa544cfa90bd68491925653c39659c0ca90ced3b053fc910074e7657b5805d4197b46b5bf50e194af2ec45fafbe6d47ce50a9f0ff81120cc71b5a7c22e3964b672de8c706198fe6fd8b0079048b2103d060979b6d5ac759abf9098bb43ca7df09e3fe085d8111865f4e8882ba7e72efc5bbac735f505679f4111ea824e82f17a1449cc85480b79cfb747b836bafd0f1ff115c3', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138446, 929, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138447, 3424, 0.3, 0.6, 'mg', 'SL', NULL, 'Adult', X'789c33d03356d05530d033cb4d5708f6512834cdcdccd351c84dacb052305648c92f4e2d5628cf2cc9c8cc5330345500ca01003cc60e2a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138448, 3424, 5.0, 5.0, 'mcg', 'IV', NULL, 'Adult', X'789cf30c5348cb2fcab5523055c84d4ed7cfcdcc53f00cd351c8cc4b2e4a4d2c4e5530d5353280cb141aeb9a02693d00bc591068', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138449, 3424, 5.0, 200.0, 'mcg', 'IV', NULL, 'Adult', X'789c33d535323050c84d4ed7cfcdcc53f00cd351282e492c2a513045125348cc4b51c8cc4b2e4a4d2c4e45922934d63505d200b3ca151c', X'789ccd565d6fdb3a0cfd2b449eee807c38e9da15be4f41d6ad03da21688abdcc43c0ca8cad5b59f224798d37e4bf5fdaced238e990654381be18faa08e780e2d923f3ab12d92b9c68c3a21743e4a6f4da24a4156ea4e173a8555d57aea7deec2c1e041de53d63736a94672b067ee84c59ce239faead428189df582616f18dc066fc2d3f37074de0f4e82f3b3a0b625e1a5d18e2d7f74de93268baa1e7b5ad6c76fcb9c42f886cec452a137f65f705e66058fc981787f3d85dc9ab8a8614060e1a44e2a7bc126165c668c4f212b9c500496142eb1b28cf45be3302178676ce642985d75e1c3a7484f4c9631ceadc598e0230bc27b3541c5b005aa6e33bb96ceaf87ce33cf8a4971b74d66c54b1eef1455b3cf5f78c608f7cda4da1bc785f2737682715b849fc0ea8c75223576e7280a4f2deba07f023d08fa6759c21ce0eb69267517325c867002b171acd183f4a9d4303c05de8bf4874fb060ce21f05c24035e63e25d905a58424770da1b059b9daf27bd0ab1df69b3a9085c7260ac27edd8cb964b1540d0c26689ac6fdd07a8e3ad2b77efdbbdeea0982f419fdda0bd24819edb97237ffe29c512bd95e2771fc0b6ff83c9e5bbd68161aff1e97e9744d01f9df682fef6ee3af6eb10366b7f23e6b33873a49ab39c8444359f9abc4a8b1bd17eba34b59468d4a2841bded549a4439844fa0a85afad4370b8205f42a1efb579e03770431a1534b189749daa42d00630feaf703e23ed23bd89e1dece25e58c2bf6cf7b88692135c53ba737ebc791ff35c3c345eb6d55f01a6337977abe41e8ac6a4d27467b8b52c7523ca1e85829b24909de8050e8dca0aa9f15292684969929f098e546731589f48cbe91257e459449e4a95431ebbb902ad2053fa875fef129418ecec3e835a4a6b00e8c6594185565ba67f5fabcb18af4e7e117fe8cf8734dbc9d712d3677727dd9048bba30f2d1b4cccdcf14f0873a3fba7e58e12d5bc67ec4d873f230d4fe91d5ba86b2b08ee63784623f484fe5911947c8146dbb2d5d227dc785bf6c6218e9ec295777ca60d330b40189a326528e7c2cbf7fe7938ea3b450854bebe7d0bacfd242d192e32cd2cdb51453b677d5c124f0f7cc76c57a29d49ed38f630b578a3643619449ca964397a8163d2517dcab0e7b274d27c1bf2dde71e3e8b89950927fd52e902d7d6a8d28b979ed3e76a90fa81413b858728d6d3272c1bd3455102245cd0860163016eb6cfdebfed792e35c5b75c0fce00f36c17f20c0c5d293e5e230bf5a2f3f4a70713db192f3fcaccc38ffa754958089c53a24ec3b7766302d1447126d09175500e09fd9643cbd7875ac1fabd5ff711e48fb', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138450, 3424, 1.0, 5.0, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789c33d43555c84d4ed7cf4ed7cfcdcc53f00cd351282e492c2a5130d03332d535d04396d551c84dacb0523032401203005e641321', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138451, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030554849ac2c0600571f071b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138452, 326, 750.0, 750.0, 'g', 'PO', NULL, 'Adult', X'789c3337355048cf5508f0d7f70c53283432c950a85030d73534514849ac2c06006edd07cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138453, 326, 500.0, 500.0, 'MG', 'PO', NULL, 'Adult', X'789c33353050f0755708f0d7f70c53283432c950a85030b2504849ac2c06005ae90729', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138454, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030554849ac2c0600571f071b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138455, 326, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f0d7f70c53283432c950a85030d73534504849ac2c06006a2f07a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138456, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030d73534514849ac2c06006b0607af', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138457, 326, 250.0, 250.0, 'mg', 'PO', NULL, 'Adult', X'789c333235c84d5708f0d7f70c53283432c950a850304e49ac2c060050b306f4', X'789ced5a6d6fdb3812fe2b443ea5a8e3b72669ceb82fae93a6419bac2f4e832ed68541536399178a5449c9b5bac87fbf2165d996ad448ef6a50b9c51b48de4998733c3678633747e3ff074ec8f240de0a0430e3ec14c4d849a53c6e5418d1cc45ad8d7d3280a4da7d1f8ce1f20a82beddb9f786353da304d43f04634b24aed66fbf4a8d93a6a35ef9a6f3b27a79df649bddd3c3b7b73e26481455c498392bf1f5c82044d85fb3982b953bf4b42e89037da23befbd44a0fe57b112badbec55c2aa12498a13c5786fa40de2b1d980ee9ff522357f7f8574ea9006f287b2a089424779a7a406ed04d1442bba9857076c4e375531ef15544c702ecd36f5ff14970f9e01e56a66d1a511ea92d8dc7af76a5ae178b68841e70e9e79c2fb0eca02f21465738cd495aff62c9a3845086f8dafafcf6a419f8188ac6d53df9d63e9e923939211e4d305a37ca28a6024e8513237e90977b7bd43a76a207f940586bfb5a9908f721e22667c249b349ae2ff338edb3275112b02108a77a0be849bb0b60060f5c8eb89ca411cac17c96e8612838a3918d069ab7898a5e361701e9ad8b1618f05c403edf5d3db7707b1bedcd6e8b167bfd0c37d3c8feed04d9a2e89e21ff6c8654db9fad6dde6fd05fb5411523bbb943fbd06e85f6a78464735ffe6131f91bccd9bdbf4a13003c4e23cdd98bbba2d1e1f2a41b6527ddab9cfa2941c1686ac811392609506d8812687febf4a88d1e341efc065a8ded2351da35921e9f710f3cf2add5b64e2d297072d43a5d07384376ecaeff62e286c0f0381ef555180bbaf23c73abafc19754b284dce2a7d21fca0ee90de527ca22278d4db156635c2021033a81a1bc05490549e33b94ae071dcaab09894d8cef3d65807043d25dfd665b68dd13a4dd3c3afe57277b7b7c365dbc6f358f5acbf7f31689a620499a416b52ff6e353b84901b15110f265c5ada7c386ff4cf3bf88e98380c0504208bec58606dd891be9db76ae98229532df9f266158bfd2976b5f3f1592cf8075658527f85d846c44b3e8375cf1c60fad2ad520cf60142dc7cb6d8e50e91abf5ab4e3d9b3c2b9f7aceed68990a1b2cbda325c262fce9613a6acaa5672bc916afbb4280f6131229c20435a66127d5a1bc4ea8b19bc929f1359d71ccc74f4afae43f774369eb97d6e8988d3208fc412b914440e858e27c48059eaaf0c2b2b432686be5f208ac54460b155c6985b8307c87491b05472898d37ed6c1e7f12e56aaa3bc6a3698ce401b18dd0265db3b53d87180e62aded84149c36922e8dc6e528d4c71a247506970a5199669a4fc5445f867ce997becd5b1644e26f824b04c6136683d053a9403e03f62ed867d08f17fe3ae021a487814f53027b1ca2eee07ee943638e91b243be92b2e23ab754f0d8bad7f262b7eab35b34459bdb903e92949741c46b86823c2472ead32391c0bca1ec858cdc977aa25d2ba46b86484fa58e44f9baf1bdc1e40cae6a1b512bc06d211c1b1e906adb88715045ee5180c73ca408f17c60f00a30ee443122a5f240c700a1bcadf5a5f0b9aabf45a2317ed1b8af0b431c3e12d3d066aeb31c407867b15f170b118bea0630f856d3c42cc421b0bea5136c5d85f49a30269973fe73f7e60d530260d4c1a89171c61856c2827e8ba708ef4eb1c2987e9d5472be91c4ec6a9728ca5644e7fc5c41deae04a36875140d672b04c69e4c12853caa1aed85e0eb6269bc3d8e05239d0a6420e2d63e10e91ca2473faebc4dd61cfd7a5733879beef40c24c7ee4e4735859ae94a32c2573fa598695eb2f25f3fccbf27297a066a279f6e5d2b984742bd9f480d897fbbfb6dc6f1eaffb7abfaff7fb7abfaff73fabdefffcfa536562dbd37a4feb6769dd9f521c7d9912ca4f72e4fe40c5e448f00974c8e9d11999e2310e483725b8093aa4f76bfff8a439941773a621bd63fbacd1362bc5a654a2105113d265e967ef7088c67ec9352fb68598f2318f0c39bfe9123fd1d40069903b152a8e1102f77c755fe1eeb42b230456d8818c06cbb68b43f9ecfe11f2ce0f86d2c486418878021a590f07e4d05d818904bb9aaba1b467910edcad157e34a39abb4bc675553c06b989a88c50e37628978fe450697727051377218fd80c9de16c813e788d262412b48ff2d8ae7de7d1943010023b31fc872e3dc532f1194597164e10f7f3dd1551122d3994d8d89904dbb100319677ff88ffa5359452118f465872beb4b134a546704930665ad5c8388e9c81580fbc35db50facd33d22bc135cfac4d975ac521e9121369084988b44ba4efba4cfc706919760631d80baf8b3a99504020dbc37e39aeb2e262a5e577c2cfb67058339d8576f72f350db03d49036ad57ed1bea3b4a38645ad67eed4c8bb1ae9d5c8e5811b0996adbe934cd37409fb04d2f2fe1e2a60dc738d39856173ce563782e25ed846de10bf0aca854d04c514638890eddb9f81c3e3a000e6b604e67a30e85658fdfab650ad6cb55ef7e809cdabd2e063cf5f271721ce733ae05ea598e17cf05fc02a5f1caa2fad12f54f75fba5906249a4ecaf19ed6281cb8f1bf0a9cd0fb3097853273e02e2f1afa090d36551418000ecb0893ad54272ad349d63ada484617d434b2ad2f143dd56261183fc51293bb188e1c9ca2b687e143036dcba602ae563ba706305432e06ef3ebdae02b585f4b1df2b022a4b9334b7c7ae1330618d7483b04724f895cbc40654a8aa6cf100b4fdcdba6a61ce94494035033cf4659109a52938a00253b0f2660fa6dcafacdcd72a022cb601d774ccaba54986318b858f3d504508fb4db164184c13d6abe53c3e38825603e8d9b622e514996888b151ae92b9eb301eb75f22c595aafa1a4c357fba9822482b8abd4115627419b6f3d1f3269455f2be81d85b184141c7aec7a01580dec5fa61aa049e92c80fecad29e34530e5991601b68c5a85d385550115113e21f1ab98f52bee2e77d79a8bbec55e2cb122a4b268bfd714b96f1c7da358506dd52b1593773a66cf6441793f003e577f248ffa14c78d583b8420c6f0daa9afcae14b21705b13dba100c7cca4281d4bfdb9e763cd95ad4d924f382b4cc62d906b6ed856464e050d12cf9944abe5d475c25488853a584d2555da8a5bce1e208a0c7fc28cd298583bd2c4c6a691d0d98ead6357527bec6eb77c76cc972a485861fb584e59678ae2f66278a2a9ffc43154d660f435ccf02072bc0381afa5ed68abe5634f289ca8b0fdc4f8e46edf5f3a1bace11cba5f41c9c05e55a912b159db3709cc55325dadf1ef431829373646d9c4f564c27fddbe6bd95f99fc7f5c99bcf00a6e0030ea0aa30ef2df8b2e434f0eaf2997afaade671723957db3b6d4192d741ebf3e3e3efe0f20133566', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138458, 326, 750.0, 750.0, 'mg', 'PO', NULL, 'Adult', X'789c333735c84d5708f0d7f70c53283432c950a85030554849ac2c0600571f071b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138459, 326, 16.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3334d33532c84dd7cf4ed74f49ac54f00c53c82f5208f0d75148c92ccb4c494d51283434ca50a85030345000ca1703004ae50e23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138460, 326, 8.0, 10.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb3d03534c84dd7cf4ed74f49ac54f00c53c82f5208f0d75148c92ccb4c494d51283434ca50a85030345000ca17030042150df3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138461, 7733, 5.0, 7.5, 'mg', NULL, NULL, 'Adult', X'789c0dc2310a80300c05d0abfc5107058722387b915483164c539238f4f6fa783b752c1b1226ac73920b6af4800299cf28c21842c1d55f635076b516452bfe2c2d3a3c54e8b8c70f34b91859', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138462, 7733, 2.5, 7.5, 'mg', NULL, 1, 'Adult', X'789c7349ac54305248cc4b51484aadcccf4bb15230d23355d05530d733cd4d574849cccca954d0282d2e4dcc013280429a006db00f0b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138463, 2177, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4eb5523034d53532c84dd7cf4e57f00cb356c84c53c8cc4b4d4b4b4d2ec92c4bd551484ecc534807b2140ce18a148c0c147233f31412d34a528b14d2328b8a4bc0660100ed0f1cc8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138464, 2177, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5548c92f4eb552303430c84d5708f0d7f70c53285430d3b5c8282a0600fad30c14', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138465, 2177, 300.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789c333630d0353130c84dd74f49ac5448c92ccb4c494d51c8cc2bc95730d2355648c92f4e2d064b69f8265628405502053501f7bb11bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138466, 2177, 4.0, 7.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dac5448cf2c4b5530d135cf4dd7cf4ed74f018aa4649665a6a4a62864e695e42b18e91a2ba4e417a71683a40085bf101d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138467, 2177, 15.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c73cecf2bce4c492d52c8c94f4cc9cc4b5748c92f4eb5523034d53532c84dd7cf060a64960115a42864e695e42b18e91a8355142ba46796a5e601f9260a1945c50a890589452500e2a81979', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138468, 2177, 10.0, 20.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4eb5523034d03532c84dd7cf4e57f00c53c8cc5330064b142b18e99a286414152b24162416952868e42656289818805482a43501ee691561', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138469, 2177, 4.0, 6.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d135cb4dd7cf4ed74f49ac54f00c5348c92ccb4c494d51c8cc2bc95730d2355648c92f4e2d06c902001f0f0dc9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138470, 2177, 100.0, 200.0, 'mg', 'IM', NULL, 'Adult', X'789c333430d0353230c84d57f0f45528543051c8282a56a8503054284f4dcd06006af607e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138471, 2177, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3c94f4cc9cc4b5748c92f4eb5523034d53532c84dd7cf4e57f00cb356c84c53c8cc4b4d4b4b4d2ec92c4bd551484ecc534807b2140ce18a148c0c147233f31412d34a528b14d2328b8a4bc0660100ed0f1cc8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138472, 2177, 1500.0, 1500.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030343530c84dd74f49ac04001e7c044e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138473, 2177, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c25cc4b0a83401004d0abd4054488b8ca2a47a9a44b19d2cec074c7e0edcd67fde0dddc612d146017acecc56428351b2ec3f4a7d1785c417ff30844b2279898b7757cae5f03ab214b76a670677c8256a165d1237f16eaaf0dae5d1e27c85b2809', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138474, 2177, 5.0, 8.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb33153c8cdb75230d5b5c84dd7cf4ed74f49ac5408f0d7f70c03005a080732', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138475, 2177, 8.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33cbcdd73551a82c2ab652b0d03534c84dd7cf4ed74f49ac5408f0d7f70c030088ee08e1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138476, 2177, 7.5, 9.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d135af2c2ab65230d733d5b5cc4dd7cf4ed74f49ac5408f0d7f70c0300731b0820', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138477, 2177, 7.0, 8.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d7353450a82c2ab65230d7b5c84dd7cf4ed74f49ac5408f0d7f70c03006f710809', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138478, 2177, 6.0, 7.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334d0353453a82c2ab65230d335cf4dd7cf4ed74f49ac5408f0d7f70c030074af0837', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138479, 2185, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c333330c84dd74f5148c92ccb4c494d51283434d23532c9282a5648cb2f523034504849ac04b30107e40ceb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138480, 2185, 14.0, 14.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334c94dd7cf4ed74f5108f05748c92ccb4c494d51283434d23532c9282a56a83034504849ac2cd651c84dac50c84f53303330006a000a0100faad11a2', X'789ced596d6f1b3712fe2b03010738a82c4bb2dd5cd4fb222b6e12244e042b2972a80c81e28e563c73c92d5f1c6f0bfff70eb97a8dd75e7b7bc00177f7c1b648719e9d193ef3b6fea395189fce14cbb03580d608178950c2b4dad0f24686ada573b91d1c1d7d13d79875b449c32771b47bd272c3724c66cc05817eb7ffe361b777d8eb7eeebe1c9cbc1a9cbeecf48e5ff57bafe259e44e6865e9e41fad37a8d030193f3bbc8de29f8b1c07706c1248e3b7e1f45471cc974c6a9b6b2368f95a5b9622fcac4d6607c0596ebdc436680203eb6d8eca46b1d5b98933a852b7dc9ea52774bb59fad3f72203e8f54fb3f4e834fbd086fe69b7fc385597da3bb4a017304c32b2dbba52b3018c3f4dd548679956f0d9b004e123f9921ef4295382e322daece7bb66dfd19663738961f5eb15ada450d771b175c39ec14fb98edde37757e119c3c44b3723170895eeb9f8c760fa510289b8110926f05baf7fd83f591a0b0b6da0d7858415f13359361c4f551bf8d2683267aae6f4972f8513366c334e5e9992e394b7ab3d5a91b37320754ca1d2cd2e4729bd0ccba61e21559ee0073a44685ba9adc2f5c267dbb37b181bfbea21269ba3fb08dffbe409484164b62bb287b8efcf3a726cce96cc18632298338257b1a37742e4b80efc187faaa0c8ed8a1f6dc8d86d0888159b58f1bc8b8d8a4c72e482c9d958e75eb26d6258eb3236982aa6780197f4ad4aa714706753f58171b70e3fa3e7f480022c5b10152f51513c97564d558c80018ccc48c23f8ebbed32e8e1b768c94fabfdde76ffe4ef71dffa3c9798a172c0160e0dbc7d3d551b9fede2bd8cae0a80a53b8e4b5f688b0fa0bcc59c14e790440d416907092e84c2a469587cefa27a3abc0e19bf3c6c6742cd36082b768cb4a2ec26542278c5950ca5449316e03470c9ac3d0a05a4c1d50f931b34166797c8f8fda75400b6ca2cbb77ecb560c62c914dd599d43a211638ada5856f4bc197c00c42ea05e3a03025536e10984ac0a0f346d96081a202427ce15a52e22b6f89a3b5aba2f36befaab56fc55d2da1d108edff3b6cf94fe9f84c228d2945662c40a6c59eb26f995c1c4ab1a062dfeb76210b8dc305129496c26603f848c1c7f2dc8414143248b6faee774ca6eafc9693de31c57ca1928a70f0f2b07ffa3760163c1509a652ca8a81fa2f0268d820ccd81ff052ea8c684d64e02261b20d422dc55c380bf3723b3881b2327c63f4cb16ca2dd13eb7349661a41c016bca29b3496861c8ebf483f50c7c8ffbde9a50e5f696da0ec2937864576064b8b79eb42cc8d077532514a99fc55c485fdd3053fa6e57d404531c538e242ea76ab38403baf490f170b1089a1036276328cb94e8931f4885827abe94ce538efc26dc72c74b6c632975145fe8e846c3d0b57cf9fc0eb4224d0e147562b6b00e33c2106a511a4df85f7b53a534152f47fcfdda9f2a562a211490cf8c6ec3dcbba8a0b774b95bdde8f4f123a7b707772c0b3abd31dae730847bd59fbacead6616128f2138ce3bb0604840a165fa7ad2e489ab2729f414b9823d1ef15444a286e1f6df1896c158970e0d629f4c1a291da911503b6b73da70d686511bdeb462be5b73ae8827cb266503fb00d278ad2036c0f845188a29725b34b6b91214c24269222ea455285f7b3530e7211234d79c13c4fae22a802e9f8b237cd6449f8bc964d8c01b17979562755a8f86870d25278ee5cb0e9ce7d4589a4c24954e7b57f7f80efc0ba9ad69e8ab0f1d20fe695e381da6cca75c5b8c908fabba66bf07fcd8819400a9386a6cc46a02a05651c4fc50ed927a02d02c7b4be992d190eb429d7e809075aabced84e4243daadf1b9942798caab16820f95ee2dc8a60826d12d8ab071f6d61e07c72f6e1872641790fe9fd78d40828467759f56dde8661968f427bf4ef82ca75939c436d6a787f51ede6a70ad3c463a87be324dd84ae132629061b5ff66429d2c6c234353aa4749b09c3e6a25998ac316ebc4ca90d6a92c508228cd78a1a50b079a761d0d32232b41aa1369187d6a224152c0c7a1afbaa42f739308908a39d6fc48a5d9c6a83eaee65484142c4a246bd921ab51a0c39b5fbee711d6a41c6167db25283218d09a1d5600dfc7ae6cdf552cb24cc0cd40ce78c8b2a98fa6873489da3d1f972a515cd618e5644fe4678ffa41ba6269401aeda97f07e893782fad9308a001b39ecbca42952d96615f0cc78fe4828d4b705980afd578269cc68eef02622649e1c1cc6bf26259861162fc787e98026d1a22a266bedf945cc8dd0214329b110fc691179212cbf17954bc9b222892ab186717551709d53beceb6f3495577518b7329f8353a67c55f51643586fb0cd8cd137bc8a162a1fcdeeffdc2c4af7456f0ca3eb29eb451154d7580da7fc3d207ca517dca3178431529520f256dabd0db368cc991d4345e51274a1e4ac482c82364a3dbda053a88af3bd7682f1ae50a6f77ee4e218f19cd349b02c6983b1da748b79ebf1e4e1c57f7dfbdfcff15caffc62b94e7fe530371369456ef7163fb9ecec2c10513ea45d317fed5488fbff2df9199ad64eeaeeeeeeefe04e14ce2bf', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138481, 1748, 30.0, 30.0, 'mg', 'PO', NULL, 'Adult', X'789c3336c84d5708f0572834d3b5c80000188e038b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138482, 20440, 20.0, 20.0, 'mcg', 'IM', NULL, 'Adult', X'789c73cd4b4f2dcaacd075523032c84d4e57f0f4050039a105b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138483, 20440, 10.0, 10.0, 'mcg', 'IM', NULL, 'Adult', X'789c0b4a4dcecf4dca2c4bac50f070523034c84d4e57f0f4050058ec0729', X'789ced5b6d6fdb3812fe2b4480c3a6b8b871d26e0ba48702b693265e24b95c9ce63ed481404b6389178ad492946bdf22fffd8694254bf26bb2018abdaa689088e23cf3ca999148fdb117a834f4048d61ef84ec5d40420d334c7bddbd03b2972a6e472363127d7278f89d3d42fc56aad0fec50e6b93b5af680281478da5396e1f7f68b58f5a47edbbf6c7935fdf9fbc7bfff6e3bb8fefde7f7073c1374c0a8d33ffd8eb52ff3154321581bb343075085d2e65d01a4925809c5e77c884a9540f455ff8e9885a6a92806232382147ad772496c24478fbdece223e15f8936a20d44f0d1c103f525230ff804845a89ec589913182f8848971268b132b1d95257bc22143471cecd5b707bce24c3c6617f65e0f2f994fb9f705a84915e88afcd7963f3d9cc8186d24c2a1b8fdfa2f92502686e2378aca321f86e20b4c40bd80f5291b8f4181300cd99f321a0aa95995ff0ad4bd9e95497b72ec39bb7851eec20a65c70743632664128120464e99cfcc6c28f663a90df1658cc69e9b578e330b13ce501132a68ca321d0aac44440be0e86e2dbd1c350bc718ea19c140c87a2081fd2295f74cb17bdf2c569f9e20c2f06f743719668034cb4ba54a93c44eea942e3724ec97f516028c6efe454269cead8da6a283a4e70ca7d19498ea150920d673281bfaf528d8123e392117a4aa23b910386593cbf8d33cf67ca3a5ad1f26027a68299ca505ffb11c4556e9dd44816c729067a69f4df8c6b297ed1246018471af6aa2161a36000d394723ef390afd0c8dee0fa9b4fafbab41751e12bc9025420e2349e058c12a4f223b70eac02089172bc42e785296ac861c92d2a014d062c4e384c895b69ad631cefa31f2e52d415c33b61dc82cc2d7e892b2d9261013d0181519bc643710d4c6b5cbf94845248a522091419dea1e750242928520f6649c43806674df30d8b635b106fcf6a153aafa0439e0bec5a2c6f077504a5d556412b2d84e724ddce3a94de73507aeb504e9f8372ba0ee5ec3928673594c1fd0ed438a942b59c10b6839469bc8ca6eaef95096507b7e7745e46b70abb9294b64356a75790d6e6b35d82de568382745da46669712721edbc0aed522add0e9393ac59852b33f176d41299b720ab20af48e6db710ba275a84bd56007bf6424eb10978bc976c89c669d8f5715a31d042da8d6e1ae2a679b31338abf1d7fd4794dabf93faf693bf8bc985a4358510a77419b937965b26a042d57d31d222827f21644b5bcbaaa02ef92622d9d37a7f372ba2a767f976cdbaf65db55657f07184be5d5a82ab8eb1a87edd8354aafa0ace0af6c3fb68317645e99ac9a23171dcc0e89b234b982526e7d364314339fb26792a6c3ff4b77f8f527b6a6c56f5afca6c56f5afca6c56f5afca6c56f5afca6c5ffe95bfc9fa825dc7d57a4c9194dce6872c6da9c7136a13c75bba6950471f9e5ce3e9d0eee0e48e7f28e7c2647ed761b47ce384c28a61532420c958eeca6653146f923415b26113598714a37fad7b79868babd03d2bdba4158b489d6646cb75c39b6c602f94f80004ac165c83062e598ccf76235a1f83f49944cd08cd8e3ee6b8093a1f84fb1537a50de40c50b51df5e7db3eaf1b92f9071a2c04ef1b21678f13072430570ef1674cacdf2dee922d16072e908c35ad1e229ee80f4c32b3bf3069b74ab96a528e54da25335a63ef6ea481882c8822ba4f9d41a5e97f8524101ba6166af7ebfd030f76ef6905092350ba1b51a94c1b668505676b3061b663e5f83ee8fd0e0cff9a0979d3728a12f0e1abc9a32bb07d4ebbae313f93db56298995dc1d17a21090e1a290997dff13709c0a0097e84fedb9c59b6cf1afdedc911bfeed5de27428380d989941303da6016534014fc9e32852911b58ee923b877a5567d153391e13e3d541233a6a7d2791a6f00ca26c9d96ed9293f8842063ed8c75ee96a45aa7d480cc379568cca41978baeee8476922819c65ab675d1f5d78cebcab873e24abefdecc932481d5b614fc6e08ce7b14f4afe28b32fc677658f36c558781ddd7760ee2285cfe60c21a8f05ba194e397ffdd22f98c4f64fe0fc3972cdf7e8153e6f9c83e36bc967055d9b607ccc3c6b7ba6e31fc896a5d2ffccdba6ad6d54fbaae9a76b569579b76b569575fbb5d5d2ad72fadb11bdfea3565b729bb7f8db2bbb41eaea8a021c4204c25e407699248e5de7df976b5b917626e8d6e38f7515e50b8dc4deb6c8a12a70abc1b259368c6e9b476a6e74e013596b94d63a17dbd39370fa264efedc6765fdb975205f3554dbe331311e9fb6942e7492102ca718c8aa008b3b4d8d0231ad484b9ac1690110e042e53d81fb0e2e1b50542197ed164427d3fe713316da49a0dc5b7e3876a97ed0cf755e493a1fa0d487fecc0b54c157245bd9c83f7fffec60e0b125a9b5e74fbe7647a341739531607efe702644795be4b943da1cade43bf833da7332ee39eebcef97e6b8eab0d55c6712ee3d837bc55c291fd44c592a7824e28e3562b2747c4c28828a61f57c859c898e36fc0b595c8c158d03213073b8210755b40acb0ec8d8289f5209f790b137b420a4f814ea4084079fb52809721bca958ff1a3d574cb34631180a28550063b447e05ed9baea847ffce3a81df7bf1ec6974e8f1d9d4632af657aa0a4a588c98dd2a38250ae259189b119300185eb27c6fb3e8a95e1d000cb144698ca48110b35cabe08aabbd94992bb594862ca8b46000410bcc4c10ec6da838d0b6d5fea0d8cd51fe38d63a7191a6575502ead92179acfd1ae59042b6c56a435ef1433b6086b36c17c26d0f1ccee1238f7671b0ed81085820a7f66fba011426843c6289fdb2970eab6dfb63f90f8f2f03124fdaba138b776b09193b8c2805ec6201b2b19571ac622a58cf3449705a7021fd804c1f319f688623d984f2ad904e3d94a7b32146722c4fbd356971cb7633f13e716c33b1eb1099d2211399a8fd7cdb3ed7dcaff7711a997cca68a3455a4a9224d1569aac8eb569153a6b387a5dae1811e3266368aeccad1da8a88464351fad7b7e4f3f101e9e68707c8e777ed0312cd1219f2990f31a343d1113372de47e7e6f6ec5b0ff84e10b7cb7f8086a4f6fc8199d9256b240797786ffe391403160a36465f09f7b582542316e0bc43773e51e248620f6ada52629fb542209f7f6d931950f5cc5345f3f356e075d03f15e5973e76c8deba9406f28fbc5fc0f16cea8e4b70ef723e5c3abb898b73c4a461be26fbddd9e2dbef55c71f36f2797afa1f199c1116', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138484, 9007, 400.0, 400.0, 'mg', 'PO', 3, 'Adult', X'789cf3cc2b492dcacd2c2949cd2b5148ce492c4dc94c4e2cc9cccfd351282e492cce2c5628cd494e2db252303130c84d5708f05708f1740100219f12b8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138485, 9007, 1600.0, 1600.0, 'mg', 'PO', NULL, 'Adult', X'789c0b4b2c4e2ecd492c5248c92cce2f4a492d52c84f53c8cccb033252138bac140ccd0c0c72d31502fc150a8042298995404905235d13a0fab2cc94d4148594fce2d462005b4e17a1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138486, 9007, 1200.0, 1200.0, 'mg', 'PO', 1, 'Adult', X'789cf3cbcfd34dcc49cecfc8cfc94c56484b2c29a954c8c92c4b2db25230343230c84d5708f0574849cccca9040042400e74', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138487, 3184, 0.4, 0.4, 'mg', 'PO', 1, 'Adult', X'789c33d033c94d5708f057c8cf4b4e554849cccca954c82f52c8cb4ccf28c9a9040090ad0a3e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138488, 3184, 0.4, 0.4, 'mg', 'PO', NULL, 'Adult', X'789c33d033c94d5708f05708f4085628cd2bc9cc51282ec9cf4b5548ad2828cd29cecccf0300b9640bce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138489, 2066, 5.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c1dca4b0a80300c05c0abbca582ad11298237f002ee03c612b4f5d32a787bc559cf30f670a6a1e05190a5ce19b28d43f0f5e2cb0a811f78bd051ca151b3f28a3f0f2378ce72a225048d5796049dbfc3931c1767c12969df62921760cc1ee6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138490, 2066, 240.0, 48.0, 'mg', 'PO', 1, 'Adult', X'789c0bf0b752303231d035b150c84d574849cccca954c8cc5330d6355148c92ccb4c494d5148c92f4e2d0600e1ad0c32', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138491, 2066, 80.0, 120.0, 'mg', 'PO', NULL, 'Adult', X'789c73cc4bcfcc4bd451c8a82c482d2a49cd2bcecccfb352b030d0353432c84d5708f057305628c9cc4d2d5600ca2ba4245602009d521032', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138492, 2066, 4.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0bf0b75230d1353450c84dd7cf4ed74f49ac54c8cc53305648c92ccb4c494d5148c92f4e2d0600c7cd0b9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138493, 1185, 500.0, 500.0, 'mg', 'IN', NULL, 'Adult', X'789c35cbbb0ac2401046e157f94b052fbbc1905abb144141b0118b8d3b9a816487ec8e31bebd17627dbeb373352596c409b332e02a5dcdc1294bc093b5c1566570fd4302cd71aeb8f5eb4a3c45a784dc98ee8ec31ea3c5877bf7825d401b0ac8f229f5d9a6c1582cadf9f6b4c291068affb73cfd40c44d220aa86072973701c83030', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138494, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c734a4c2e492dca4ccc51f0cc4b4b4d2ec9cccf2b5688363530c84d5708f057a83054c8cf534849ac5430d45128c948cd533032854a151a996428549880248b630148441670', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138495, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789cd32fc9cf2bceccc9c92cc92c5688363530c84d5708f057a83054c8cf534849ac5430d45128c948cd533032854a151a996428549880248b63151c734aac14e0da2072c660390001a31b62', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138496, 1185, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c8b363530c84d5708f057a83054c8cf534849ac5430d45128c948cd533032854a151a996428549880248b63151c734aac14e0da2072c660390058be1655', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);